
<html lang="en"     class="pb-page"  data-request-id="d97c7659-dba2-4bc9-ac30-e0df7997ee46"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2017.60.issue-20;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.7b00922;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3" /></meta><meta name="dc.Creator" content="Allan S.  Wagman" /></meta><meta name="dc.Creator" content="Rustum S.  Boyce" /></meta><meta name="dc.Creator" content="Sean P.  Brown" /></meta><meta name="dc.Creator" content="Eric  Fang" /></meta><meta name="dc.Creator" content="Dane  Goff" /></meta><meta name="dc.Creator" content="Johanna M.  Jansen" /></meta><meta name="dc.Creator" content="Vincent P.  Le" /></meta><meta name="dc.Creator" content="Barry H.  Levine" /></meta><meta name="dc.Creator" content="Simon C.  Ng" /></meta><meta name="dc.Creator" content="Zhi-Jie  Ni" /></meta><meta name="dc.Creator" content="John M.  Nuss" /></meta><meta name="dc.Creator" content="Keith B.  Pfister" /></meta><meta name="dc.Creator" content="Savithri  Ramurthy" /></meta><meta name="dc.Creator" content="Paul A.  Renhowe" /></meta><meta name="dc.Creator" content="David B.  Ring" /></meta><meta name="dc.Creator" content="Wei  Shu" /></meta><meta name="dc.Creator" content="Sharadha  Subramanian" /></meta><meta name="dc.Creator" content="Xiaohui A.  Zhou" /></meta><meta name="dc.Creator" content="Cynthia M.  Shafer" /></meta><meta name="dc.Creator" content="Stephen D.  Harrison" /></meta><meta name="dc.Creator" content="Kirk W.  Johnson" /></meta><meta name="dc.Creator" content="Dirksen E.  Bussiere" /></meta><meta name="dc.Description" content="In an effort to identify new antidiabetic agents, we have discovered a novel family of (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine analogues which are inhibitors of human..." /></meta><meta name="Description" content="In an effort to identify new antidiabetic agents, we have discovered a novel family of (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine analogues which are inhibitors of human..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 10, 2017" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.7b00922" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Â© 2017 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00922" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.7b00922" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.7b00922" /></link>
        
    
    

<title>Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.7b00922" /></meta><meta property="og:title" content="Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0028.jpeg" /></meta><meta property="og:description" content="In an effort to identify new antidiabetic agents, we have discovered a novel family of (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine analogues which are inhibitors of human glycogen synthase kinase 3 (GSK3). We developed efficient synthetic routes to explore a wide variety of substitution patterns and convergently access a diverse array of analogues. Compound 1 (CHIR-911, CT-99021, or CHIR-73911) emerged from an exploration of heterocycles at the C-5 position, phenyl groups at C-4, and a variety of differently substituted linker and aminopyridine moieties attached at the C-2 position. These compounds exhibited GSK3 IC50s in the low nanomolar range and excellent selectivity. They activate glycogen synthase in insulin receptor-expressing CHO-IR cells and primary rat hepatocytes. Evaluation of lead compounds 1 and 2 (CHIR-611 or CT-98014) in rodent models of type 2 diabetes revealed that single oral doses lowered hyperglycemia within 60 min, enhanced insulin-stimulated glucose transport, and improved glucose disposal without increasing insulin levels." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.7b00922"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.7b00922">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=âtrueâ></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=âtrueâ></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.7b00922&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.7b00922&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.7b00922&amp;href=/doi/10.1021/acs.jmedchem.7b00922" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2017</span><span class="cit-fg-volume">, 60</span><span class="cit-fg-issue">, 20</span><span class="cit-fg-pageRange">, 8482-8514</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/60/20" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b00900" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.7b00991" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Allan+S.++Wagman">Allan S. Wagman</a></span><span class="author-xref-symbol "><sup>â </sup></span><span class="author-xref-symbol "><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rustum+S.++Boyce">Rustum S. Boyce</a></span><span class="author-xref-symbol "><sup>â </sup></span><span class="author-xref-symbol "><sup>Â§</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sean+P.++Brown">Sean P. Brown</a></span><span class="author-xref-symbol "><sup>â </sup></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Fang">Eric Fang</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dane++Goff">Dane Goff</a></span><span class="author-xref-symbol "><sup>â </sup></span><span class="author-xref-symbol "><sup>â¥</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Johanna+M.++Jansen">Johanna M. Jansen</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vincent+P.++Le">Vincent P. Le</a></span><span class="author-xref-symbol "><sup>â </sup></span><span class="author-xref-symbol "><sup>#</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barry+H.++Levine">Barry H. Levine</a></span><span class="author-xref-symbol "><sup>â </sup></span><span class="author-xref-symbol "><sup>â</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon+C.++Ng">Simon C. Ng</a></span><span class="author-xref-symbol "><sup>â </sup></span><span class="author-xref-symbol "><sup>â</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhi-Jie++Ni">Zhi-Jie Ni</a></span><span class="author-xref-symbol "><sup>â </sup></span><span class="author-xref-symbol "><sup>â</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+M.++Nuss">John M. Nuss</a></span><span class="author-xref-symbol "><sup>â </sup></span><span class="author-xref-symbol "><sup>Â¶</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keith+B.++Pfister">Keith B. Pfister</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Savithri++Ramurthy">Savithri Ramurthy</a></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-2444-5309" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul+A.++Renhowe">Paul A. Renhowe</a></span><span class="author-xref-symbol "><sup>â </sup></span><span class="author-xref-symbol "><sup>â¡</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+B.++Ring">David B. Ring</a></span><span class="author-xref-symbol "><sup>â </sup></span><span class="author-xref-symbol "><sup>â</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wei++Shu">Wei Shu</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sharadha++Subramanian">Sharadha Subramanian</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xiaohui+A.++Zhou">Xiaohui A. Zhou</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Cynthia+M.++Shafer">Cynthia M. Shafer</a></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephen+D.++Harrison">Stephen D. Harrison</a></span><span class="author-xref-symbol "><sup>â </sup></span><span class="author-xref-symbol "><sup>â</sup></span></span></li><span class="comma-separator">,Â </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kirk+W.++Johnson">Kirk W. Johnson</a></span><span class="author-xref-symbol "><sup>â </sup></span><span class="author-xref-symbol "><sup>â </sup></span></span></li><span class="comma-separator">,Â andÂ </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dirksen+E.++Bussiere">Dirksen E. Bussiere</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="loa-info-orcid"><a href="http://orcid.org/0000-0002-5623-5648" title="Orcid link"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img></a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: (510) 879-9505. E-mail: <a href="/cdn-cgi/l/email-protection#b1d5d8c3dac2d4df9fd3c4c2c2d8d4c3d4f1dfdec7d0c3c5d8c29fd2dedc"><span class="__cf_email__" data-cfemail="f19598839a82949fdf9384828298948394b19f9e879083859882df929e9c">[emailÂ protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00922&amp;href=/doi/10.1021%2Facs.jmedchem.7b00922" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2017</span></span><span class="cit-volume">, 60</span><span class="cit-issue">, 20</span><span class="cit-pageRange">, 8482â8514</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 10, 2017</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 June 2017</li><li><span class="item_label"><b>Published</b> online</span>10 October 2017</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 26 October 2017</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.7b00922" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00922</a></div><div class="article_header-article-copyright"><strong>Copyright Â© 2017 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8482%26pageCount%3D33%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAllan%2BS.%2BWagman%252C%2BRustum%2BS.%2BBoyce%252C%2BSean%2BP.%2BBrown%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D60%26issueNum%3D20%26contentID%3Dacs.jmedchem.7b00922%26title%3DSynthesis%252C%2BBinding%2BMode%252C%2Band%2BAntihyperglycemic%2BActivity%2Bof%2BPotent%2Band%2BSelective%2B%25285-Imidazol-2-yl-4-phenylpyrimidin-2-yl%2529%255B2-%25282-pyridylamino%2529ethyl%255Damine%2BInhibitors%2Bof%2BGlycogen%2BSynthase%2BKinase%2B3%26numPages%3D33%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8514%26publicationDate%3DOctober%2B2017">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.7b00922"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2237</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">16</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.7b00922" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Synthesis, Binding Mode, and Antihyperglycemic Activity of Potent and Selective (5-Imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine Inhibitors of Glycogen Synthase Kinase 3&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Allan&quot;,&quot;last_name&quot;:&quot;S. Wagman&quot;},{&quot;first_name&quot;:&quot;Rustum&quot;,&quot;last_name&quot;:&quot;S. Boyce&quot;},{&quot;first_name&quot;:&quot;Sean&quot;,&quot;last_name&quot;:&quot;P. Brown&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Fang&quot;},{&quot;first_name&quot;:&quot;Dane&quot;,&quot;last_name&quot;:&quot;Goff&quot;},{&quot;first_name&quot;:&quot;Johanna&quot;,&quot;last_name&quot;:&quot;M. Jansen&quot;},{&quot;first_name&quot;:&quot;Vincent&quot;,&quot;last_name&quot;:&quot;P. Le&quot;},{&quot;first_name&quot;:&quot;Barry&quot;,&quot;last_name&quot;:&quot;H. Levine&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;C. Ng&quot;},{&quot;first_name&quot;:&quot;Zhi-Jie&quot;,&quot;last_name&quot;:&quot;Ni&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;M. Nuss&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;B. Pfister&quot;},{&quot;first_name&quot;:&quot;Savithri&quot;,&quot;last_name&quot;:&quot;Ramurthy&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;A. Renhowe&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;B. Ring&quot;},{&quot;first_name&quot;:&quot;Wei&quot;,&quot;last_name&quot;:&quot;Shu&quot;},{&quot;first_name&quot;:&quot;Sharadha&quot;,&quot;last_name&quot;:&quot;Subramanian&quot;},{&quot;first_name&quot;:&quot;Xiaohui&quot;,&quot;last_name&quot;:&quot;A. Zhou&quot;},{&quot;first_name&quot;:&quot;Cynthia&quot;,&quot;last_name&quot;:&quot;M. Shafer&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;D. Harrison&quot;},{&quot;first_name&quot;:&quot;Kirk&quot;,&quot;last_name&quot;:&quot;W. Johnson&quot;},{&quot;first_name&quot;:&quot;Dirksen&quot;,&quot;last_name&quot;:&quot;E. Bussiere&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2017&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;10&quot;,&quot;issue&quot;:&quot;20&quot;,&quot;volume&quot;:&quot;60&quot;,&quot;pages&quot;:&quot;8482-8514&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.7b00922&quot;},&quot;abstract&quot;:&quot;In an effort to identify new antidiabetic agents, we have discovered a novel family of (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine analogues which are inhibitors of human glycogen synthase kinase 3 (GSK3). We developed efficient synthetic routes to explore a wide variety of substitution patterns and convergently access a diverse array of analogues. Compound 1 (CHIR-911, CT-99021, or CHIR-73911) emerged from an exploration of heterocycles at the C-5 position, phenyl groups at C-4, and a variety of differently substituted linker and aminopyridine moieties attached at the C-2 position. These compounds exhibited GSK3 IC50s in the low nanomolar range and excellent selectivity. They activate glycogen synthase in insulin receptor-expressing CHO-IR cells and primary rat hepatocytes. Evaluation of lead compounds 1 and 2 (CHIR-611 or CT-98014) in rodent models of type 2 diabetes revealed that single oral doses lowered hyperglycemia within 60 min, enhanced insulin-stimulated glucose transport,&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00922&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00922" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00922&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00922" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.7b00922&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00922" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.7b00922&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.7b00922&amp;href=/doi/10.1021/acs.jmedchem.7b00922" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.7b00922" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.7b00922" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00922&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.7b00922%26sid%3Dliteratum%253Aachs%26pmid%3D29016121%26genre%3Darticle%26aulast%3DWagman%26date%3D2017%26atitle%3DSynthesis%252C%2BBinding%2BMode%252C%2Band%2BAntihyperglycemic%2BActivity%2Bof%2BPotent%2Band%2BSelective%2B%25285-Imidazol-2-yl-4-phenylpyrimidin-2-yl%2529%255B2-%25282-pyridylamino%2529ethyl%255Damine%2BInhibitors%2Bof%2BGlycogen%2BSynthase%2BKinase%2B3%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D60%26issue%3D20%26spage%3D8482%26epage%3D8514%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">Â»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290925" title="Carbohydrates">Carbohydrates</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/60/20" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/jmcmar.2017.60.issue-20/20171026/jmcmar.2017.60.issue-20.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0028.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">In an effort to identify new antidiabetic agents, we have discovered a novel family of (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine analogues which are inhibitors of human glycogen synthase kinase 3 (GSK3). We developed efficient synthetic routes to explore a wide variety of substitution patterns and convergently access a diverse array of analogues. Compound <b>1</b> (CHIR-911, CT-99021, or CHIR-73911) emerged from an exploration of heterocycles at the C-5 position, phenyl groups at C-4, and a variety of differently substituted linker and aminopyridine moieties attached at the C-2 position. These compounds exhibited GSK3 IC<sub>50</sub>s in the low nanomolar range and excellent selectivity. They activate glycogen synthase in insulin receptor-expressing CHO-IR cells and primary rat hepatocytes. Evaluation of lead compounds <b>1</b> and <b>2</b> (CHIR-611 or CT-98014) in rodent models of type 2 diabetes revealed that single oral doses lowered hyperglycemia within 60 min, enhanced insulin-stimulated glucose transport, and improved glucose disposal without increasing insulin levels.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60101" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60101" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The incidence of noninsulin-dependent diabetes mellitus (NIDDM) or type II diabetes mellitus (T2DM) is growing rapidly worldwide. It is estimated that NIDDM will be one of the leading causes of mortality and morbidity over next 25 years. In 2015, the International Diabetes Foundation (IDF) reports that there were 415 million diagnosed cases of diabetes worldwide. The IDF estimates that by 2040 the number of diagnosed cases will have risen to 642 million.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Currently, there are more than 44.3 million diabetics in North America and the Caribbean and 59.8 million diabetics in Europe.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Several factors have emerged which contribute to the spread of type II diabetes or impaired glucose tolerance (IGT), including an increasingly technological society, high calorie diets rich in fats and carbohydrates, and an ever more sedentary lifestyle. Increasingly, physicians have become aware of the health risks associated with diabetes, and health advocacy organizations are championing the education of the medical community and the public to the dangers of obesity and IGT. Stricter guidelines for monitoring and control of blood glucose levels, and a new lower standard for normal fasting plasma glucose levels have helped to identify type II diabetics more rapidly.</div><div class="NLM_p">Spurring the shift in the diagnosis and treatment of type II diabetes was the landmark United Kingdom Prospective Diabetes Study (UKPDS). This long-term study of multiple risk factors and treatment programs clearly showed that rigorous control of circulating blood glucose levels and hypertension significantly reduced the incidence and severity of related complications such as macrovascular disease, neuropathy, nephropathy, retinopathy, and cataract.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> As the disease inevitably progresses, the task of managing blood glucose levels becomes increasingly difficult. Oral agents such as sulfonylureas, metformin, and thiazolidinediones in combination with exercise and diet can help control diabetes as measured by the amount of circulating glycosylated hemoglobin (HbA1c), but there are still 30â40% of patients who do not respond to such therapy. The UKPDS showed that combination therapies of insulin and one or more oral medications gave the best assurance of maintaining HbA1c levels near the target of 7% and gave an increased quality of life.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> There is an obvious need for new and better antihyperglycemic agents, especially those which target the underlying metabolic dysfunctions which progressively advance the disease. By treating the cellular targets responsible for insulin resistance, insufficient glucose disposal or inadequate Î²-cell function, new therapeutics may be developed that reliably reduce both morbidity and mortality. Because the typical type II diabetic patient is typically over 55 years old, they are likely to be treated for cardiovascular or other health problems and will need chronic treatment, so new hypoglycemic medications must be safe and compatible with a host of supplementary medications.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4-6)</a></div><div class="NLM_p">Insulin signaling controls blood glucose by increasing glucose uptake and expanding its storage as glycogen in muscle and liver. NIDDM, or its precursor state impaired glucose tolerance (IGT), is initially signified by higher than normal circulating levels of plasma insulin and glucose. Insulin secretion increases to overcome the emergent insulin resistance in the peripheral tissues. While the underlying cause or causes of cellular insulin resistance may be heterogeneous through the diabetic population, a pharmaceutical which increases the rate of glycogen synthesis should result in lower circulating blood glucose levels and thereby reduce the burden on pancreatic beta cells. Regulatory control of glycogen synthase (GS), the final enzyme in glycogen biosynthesis, is an obvious system to explore for antihyperglycemic control. GS is considered to be the rate-limiting enzyme for glycogen deposition in skeletal muscle and is responsible for building glycogen stores in the liver. GS activity in resting cells is maintained at minimal levels through phosphorylation and inactivation by the protein kinase GSK3.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7, 8)</a> Constitutively active in resting cells, GSK3 is inhibited by insulin signaling through its phosphorylation by protein kinase B (PKB, also called AKT). Thus, in response to insulin, GSK3 is inhibited, allowing GS to be dephosphorylated and activated, which in turn increases the rate of glycogen synthesis. In diabetic muscle, GS activity is decreased and GSK3 expression is increased compared to normoglycemic muscle, suggesting a potential role for GSK3 in the etiology of insulin resistance.<a onclick="showRef(event, 'ref9 ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref9 ref10 ref11">(9-11)</a> GSK3 has also been implicated in the negative regulation of glucose uptake into the cells of peripheral tissue. GSK3 has been found to phosphorylate insulin receptor substrate-1 (IRS-1) on serine residues which have been observed to block some insulin signaling events.<a onclick="showRef(event, 'ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref12 ref13">(12, 13)</a> It is unclear whether GSK3âs activity toward IRS-1 is part of the pathology of diabetes or part of the complex insulin signaling cascade.<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14, 15)</a> Together, these observations suggest that inhibition of GSK3 might have a more profound effect on glucostasis than merely increasing the rate of glycogen synthesis. GSK3 inhibitors may act as insulin sensitizing drugs which could improve glucose disposal, suppress hepatic glucose output, and increase glucose transport in an insulin-sparing manner.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">Since its discovery in the early 1980s, GSK3âs role in glucose control and various disease states has been extensively studied.<a onclick="showRef(event, 'ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19 ref20 ref21 ref22 ref23 ref24 ref25 ref26">(17-26)</a> However, the details of the signaling pathway linking insulin to GSK3 and GS activity were not fully understood until the mid-1990s. As a negative regulator among the kinases involved in insulin signaling, GSK3 is an attractive target for small-molecule drug therapy. Inhibition of this unique kinase has a direct effect on GS activation and on improving glucose disposal into glycogen. As a kinase, GSK3 presents a well-defined starting point for the project using ATP-competitive kinase inhibitors as molecular tools to understand GSK3âs role in cellular biology and for a structure-based design approach utilizing X-ray crystallography. We recognized that developing highly selective inhibitors would be a primary challenge for this project, particularly for the management of diabetes where chronic treatment would be required.</div><div class="NLM_p">At the time this study was undertaken, natural products and known ATP-competitive kinase inhibitors were available that had activity against GSK3 but none were highly selective. For example, the indirubin dye indirubin-3â²-monoxime and kenpaullone inhibit GSK3-Î² at â¼200 nM IC<sub>50</sub>s but are also active against LCK and CDK2/cyclin A among other kinases.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27, 28)</a> Historically, lithium had been used to probe the biochemistry of GSK3. Unfortunately, lithiumâs potency (â¼2 mM IC<sub>50</sub>) against GSK3 is relatively low and lithium also inhibits several other kinases such as CK2, which phosphorylates GS as a prerequisite for GSK3 activity.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Lithium also affects the levels of inositol phosphates through inhibition of inositol monophosphate phosphomonoesterases which could affect insulin signaling. Because the effects of lithium might not be due to direct inhibition of GSK3, the role of GSK3 in insulin resistance and glucose disposal would have to be confirmed once we had selective and potent compounds. Our approach was to utilize structure-guided drug design to produce novel kinase inhibitor structures which would likely have different kinase selectivity profiles compared to known GSK3 inhibitors and would distinguish our work from other programs in the field.<a onclick="showRef(event, 'ref30 ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref30 ref31 ref32">(30-32)</a> To definitively answer questions about GSK3âs role in diabetes and potential for side effects related to GSK3âs other regulatory roles, we set our goal for potency against GSK3 in the low nM IC<sub>50</sub>s and better than 500-fold selectivity against any other kinase in a broad screening panel which included closely related kinases such as CDC2 and ERK2. Exploiting our ability to quickly produce small focused libraries with known ATP-competitive kinase binding motifs,<a onclick="showRef(event, 'ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref33 ref34 ref35 ref36">(33-36)</a> we identified the initial dihydropyrimidine <b>9c</b> and pyrimidine <b>11d</b> hits (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), which led to our first generation lead series exemplified by the advanced preclinical compound <b>1</b> (also known as CHIR-911, CT-99021 or CHIR-73911<a onclick="showRef(event, 'ref16 ref37'); return false;" href="javascript:void(0);" class="ref ref16 ref37">(16, 37)</a>) and by compound <b>2</b> (CHIR-611 or CT-98014<a onclick="showRef(event, 'ref16 ref37'); return false;" href="javascript:void(0);" class="ref ref16 ref37">(16, 37)</a>) in <a class="ref internalNav" href="#fig1" aria-label="Figure 1">Figure 1</a>.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0001.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Potent and selective GSK3 inhibitors with oral antihyperglycemic efficacy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_83658" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_83658" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Chemistry</h3><div class="NLM_p">GSK3 inhibitor activity was initially identified by screening small combinatorial libraries based on drug-like core scaffolds with moderate to low molecular weight and dense functionality. Libraries of novel pyrimidines and dihydropyrimidines were constructed by following the sequence shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a> which was derived from previous work used to produce dihydropyrimidine calcium channel blockers.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The synthetic scheme incorporated the maximum chemical diversity around the pyrimidine core using simple, easily accessible starting materials as reagents in large excess to drive resin-bound reactions to completion in high purity as described in our previous work.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> Split-and-mix techniques were employed to give focused libraries consisting of 80 pools, with each pool being comprised of a diverse mixture of 18 compounds. Diversity could be introduced into the libraries by varying the substitution of the Rink resin bound aldehyde <b>3</b> or the Î²-ketoester <b>4</b> used in the Knoevenagel condensation to yield Î±-keto substituted cinnamates <b>5a</b>â<b>c</b>. Cyclization of the vinyl ketone in <b>5a</b>â<b>c</b> with pyrazole carboxamidine HCl gave dihydropyrimidines <b>7a</b>â<b>c</b> upon neutralization of the HCl salt with solid powdered sodium bicarbonate and dehydration in NMP at 70 Â°C over 24 h. The pyrazole of <b>7a</b>â<b>c</b> could be displaced with a diverse set of primary or secondary amines under mildly acidic conditions at 70 Â°C over 24â48 h to give a final pool of 18 compounds. Alternately, the resin bound pyrazole of <b>7a</b>â<b>c</b> could be substituted with a single amine such as the ethylene diamine <b>8</b> to give single dihydropyrimidines <b>9a</b>â<b>c</b> after TFA catalyzed cleavage from the solid support. Dihydropyrimidines <b>7</b> and <b>9</b> slowly aromatize upon exposure to air, leading to some contamination of <b>9</b> with the aromatic analogues <b>11</b> under normal synthetic conditions. Pure aminopyrimidine library pools or single compounds <b>11</b> were easily accessed through DDQ oxidation of dihydropyrimidines <b>7</b> which were subsequently elaborated into the final products following the same procedures for amine displacement and TFA cleavage. Also detected in the final product pools and single compounds made on solid support were the corresponding cyano analogues which presumably formed from the primary amides on the C-4 arene under the anhydrous conditions cleavage conditions catalyzed by TFA and upon standing in dry stock DMSO solutions with residual TFA. Thus, compound <b>11d</b>, which was an attractive GSK3 inhibitor hit, was slowly produced from compound <b>11a</b> during storage in DMSO (see <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a> for IC<sub>50</sub> activity).</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>9a</b>â<b>c</b> and <b>11a</b>â<b>d</b> (See Also <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) piperidine, EtOH, dioxane, 25 Â°C, 20 h; (b) NaHCO<sub>3</sub>, NMP, 70 Â°C, 24 h; (c) (i) AcOH, NMP, 80 Â°C, (ii) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (d) DDQ, THF, 25 Â°C, 30 min.</p></p></figure><div class="NLM_p">The synthetic scheme had to be modified to produce the desired aminopyrimidines cleanly and with minimal work up using traditional solution phase chemistry. A convergent scheme which brought together the elements of a guanidine and enamineone to give the desired aminopyrimidines gave the quickest access to diversity around the pyrimidine core and was easily scalable to produce gram quantities of material (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Thus, a substituted ethylene diamine <b>8</b> was reacted with a guanidylating agent, such as benzotriazole carboxamidinium 4-methylbenzenesulfonate (<b>12</b>), to yield a functionalized guanidine salt of interest <b>13</b> which could be made in quantity and stored under anhydrous conditions. While many Î²-ketoesters were available, they could be made on large scale or with a variety of substituted arenes from the appropriate benzoyl chloride and potassium ethyl malonate. The Î²-ketoester <b>14</b> was converted to an enamineone <b>15</b> by heating with <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal (DMFDMA). The resulting dimethylamino enaminones, upon evaporation, could be used directly in the subsequent pyrimidine forming reactions without further purification. Concentrated solutions of enaminones <b>15</b> and guanidine <b>13</b> were cyclized into aminopyrimidines, such as <b>16</b>, with a slight excess of fresh sodium ethoxide and heat. The reactions were sluggish at temperatures below 70 Â°C, and some reactions would not reach completion after 1â2 h. Upon the basis of speculation that water was retarding the rate of reaction, excess absolute EtOH was added and distilled from the reaction to force it to completion. Reactions typically gave C-5 ester products <b>16</b> in high yield and purity. Precipitating the products from organic solvent such as ACN provided <b>16</b> in >95% purity. For further elaboration, the ethyl ester of <b>17</b> was saponified in a MeOH/water mixture to solubilize the starting material. Upon heating with NaOH, the reaction was complete as soon as the turbid mixture became clear. From the free acid <b>17</b>, esters <b>18a</b>â<b>d</b> and amides <b>19a</b>â<b>l</b> were produced in high yield using standard peptide coupling conditions with the activating agent <i>O</i>-benzotriazole-<i>N</i>,<i>N</i>,<i>N</i>â²,<i>N</i>â²-tetramethyluronium-hexafluoro-phosphate (HBTU). The carboxylic acid could also be exploited to make C-5 carbon linked heterocycles. For example, the oxadiazole <b>20</b> was fashioned from the acid <b>17</b> by coupling acetamidoximine via the mixed anhydride.<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> The oxadiazole formation did not provide <b>20</b> cleanly but was obtained after careful reverse phase preparative HPLC purification.</div><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>16</b>, <b>17</b>, <b>18a</b>â<b>d</b>, <b>19a</b>â<b>l</b>, and <b>20</b> (See Also <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIEA, ACN, 25 Â°C, 12 h; (b) DMFDMA, THF, AcOH, 80 Â°C, 3 h; (c) EtOH (dry), NaOEt, 80 Â°C, 12 h; (d) MeOH/H<sub>2</sub>O (1:1), NaOH, 65 Â°C, 45 min; (e) HBTU, various alcohols (ROH), DIEA, DMA, 25 Â°C; (f) HBTU, various amines (R<sub>2</sub>NH), DMA, 25 Â°C; (g) (i) isobutyl chloroformate, TEA, THF, 25 Â°C, 12 h, (ii) MeC(NOH)NH<sub>2</sub>, 70 Â°C, 6 h.</p></p></figure><div class="NLM_p">Unlike compounds with a carbon at C-5, nitrogen-linked heterocycles at C-5 were typically installed at the acetophenone stage of the synthesis as shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>. A wide array of nucleophilic heterocycles, such as substituted imidazoles, pyrazoles, or triazoles, could be reacted with the appropriate bromo- or chloroacetophenone to eventually provide the products <b>25a</b>â<b>w</b> and <b>26</b> shown in <a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. In a variation of procedures described, a chloro- or bromoacetophenone <b>21a</b> was added to a toluene solution containing excess nucleophile, such as imidazole (<b>22</b>), followed by heating at 75 Â°C for 2â3 h to give the substituted acetophenone <b>23</b> in high yield and purity.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> These were typically used without further purification. However, if the acetophenone <b>23</b> was obtained as a sticky solid or glass, it could be stirred and manipulated under dry ether or hexanes to produce a free-flowing solid. The powders of acetophenone <b>23</b> could be stored for several months under dry conditions at room temperature but did eventually decompose to polymeric side products. After exploring several conditions, we found that the enaminones <b>24</b> could be formed cleanly by heating the acetophenones <b>23</b> in neat DMFDMA as a solvent for a few hours. After heating for between 3 and 12 h, the excess DMFDMA was stripped away under reduced pressure and the crude enaminones <b>24</b> could be used directly in the pyrimidine annulation. The synthesis of aminopyrimidines <b>25</b> was optimized by replacing strong bases, such as NaOEt, with cesium carbonate and using THF, DMF, DMA, or NMP as the solvent. If the aminopyrimidines <b>25</b> precipitated from the crude mixture upon cooling, the products could be obtained directly from the reactions in high purity. For those compounds requiring purification, silica gel chromatography or recrystallization from EtOAc/hexanes or ethanol/water was carried out.</div><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>25a</b>â<b>w</b>, <b>26</b> (See Also <a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) toluene 75 Â°C 2.5 h; (b) DMFDMA, reflux, 12 h; (c) Cs<sub>2</sub>CO<sub>3</sub>, THF or DMF, 80 Â°C, 8 h.</p></p></figure><div class="NLM_p">While attempting to install a carbon-linked imidazole at the C-5 position of the pyrimidine, we met with limited success modifying a C-5 acid or aldehyde into a 2-imidazole. Following the example in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, we instead formed the carbon-linked imidazole at the acetophenone step of the synthesis utilizing procedures which react excess benzoyl chloride with a 2-methylimidazole (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>).<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42-44)</a> The enaminones <b>31a</b>,<b>b</b> were formed in neat DMFDMA. It was found that heating at 70â75 Â°C for 2â3 h was sufficient to convert the acetophenone <b>30a</b>,<b>b</b> into the products <b>31a</b>,<b>b</b>. Pyrimidine formation to give <b>1</b>, <b>35c</b>, <b>36b</b>, and <b>37a</b> using the carbon-linked imidazoles <b>31a</b>,<b>b</b> was optimized under the earlier conditions of EtOH and NaOEt. The purity and yields of the reactions were greatly enhanced by adding the enaminones <b>31a</b>,<b>b</b> dissolved in dry EtOH to a preheated mixture of NaOEt and guanidines (<b>13</b>, <b>32</b><b>â34</b>) in EtOH at 75â80 Â°C. The reaction was typically complete within 2â3 h. The rate of reaction could be enhanced further by adding activated powdered 4 Ã molecular sieves to the reaction. The reaction was followed by HPLC and worked up as soon as the reaction reached >95% completion based on conversion of <b>31a</b>,<b>b</b>. Heating longer or using excess base caused side products to form. The products <b>1</b>, <b>35a</b>â<b>c</b>, <b>36a</b>â<b>d</b>, <b>37a</b>,<b>b</b>, <b>61a</b>â<b>u</b>, and <b>62a</b>â<b>g</b> were all made by similar procedures to form the aminopyrimidine core (<a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a>, <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>). The most detailed experimental procedures included are for the synthesis of <b>1</b> and <b>36a</b>â<b>c</b>. For some C-linked imidazole products, such as <b>62c</b>, the appropriate 2-methylimidazole was synthesized from acetaldehyde, ammonia, and a properly adorned glyoxal or glyoxal equivalent. For example, 2-methyl-4(5)-isopropylimidazole used to make <b>62c</b> was made from 1-acetoxy-3-methyl-2-butanone and acetaldehyde under conditions of cupric acetate, KOH, and NH<sub>4</sub>OH as described.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> Other imidazoles were made from 1,2-dicarbonyl compounds reacted with acetaldehyde and ammonia or ammonium hydroxide.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><figure id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>1</b>, <b>35a</b>,<b>b</b>, <b>36a</b>â<b>d</b>, and <b>37a</b>â<b>c</b> (See Also <a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a>,<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) HÃ¼nigâs base, CH<sub>2</sub>Cl<sub>2</sub>, rt to reflux, 3.5 h, (ii) HCl/AcOH; (b) DMFDMA, reflux, 12 h; (c) NaOEt, EtOH, 80 Â°C, 2.5 h.</p></p></figure><div class="NLM_p">The imidazole (<b>28</b>,<b>29</b>) first reacts with benzoyl chloride on the ring nitrogens, which allows the methyl at C-2 to attack an equivalent of benzoyl chloride. The product of 2-methylimidazole reacting with 3 equiv of benzoyl chloride is an enol benzoate of the desired acetophenone. Thus, as in the synthesis of <b>30a</b>, the crude intermediate must be hydrolyzed using a mixture of AcOH and concentrated HCl to obtain the carbon-linked acetophenone <b>30a</b> or <b>30b</b>. Only the methyl at the 2-position of the imidazole appears to react with the benzoyl chloride. Thus, 2,4-dimethylimidazole <b>29</b> used in the synthesis of <b>1</b> yields only acetophenone <b>30b</b>, but none of the product from the methyl at the 4-position, which was confirmed through NMR studies and small-molecule X-ray crystal structures.</div><div class="NLM_p">Variations to the linker or ethylene diamine moiety (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) could be carried out by making a suitably modified and protected linker group. However, installing alkyl groups on the linker nitrogen attached to the C-2 position of the pyrimidine core was simply and cleanly accomplished using solid-phase techniques (<a class="ref internalNav" href="#sch5" aria-label="Scheme 5">Scheme 5</a>). A protected ethylene diamine or similar molecule was bound to the resin by reductive amination to give compounds like <b>40</b>. The nucleophilic amine was then subject to SnAr reaction with an excess of chloropyridine or other active arene to give <b>41</b>. After deprotection of the Boc group under mild conditions with TMSOTf and 2,6-lutidine, the exposed primary amine was coupled with 2-nitrobenzenesulfonyl chloride to furnish <b>42</b>. The relatively acidic sulfonamide readily undergoes Mitsunobu reaction by first activating with excess Ph<sub>3</sub>P and DIAD followed by addition of excess primary alcohol such as 2-(dimethylamino)-ethanol, which leads to the product <b>43b</b>. The Mitsunobu reactions were driven to completion through the use of excess reagent and high concentration. The resin-bound 2-nitrobenzenesulfonamides were subject to thiophenol under basic conditions to reveal the secondary amines <b>44a</b>â<b>h</b>. To form the pyrimidine products, amines <b>44a</b>â<b>h</b> were exposed to excess 1<i>H</i>-pyrazole-1-carboxamidine hydrochloride and DIEA (HÃ¼nigâs base) to produce the guanidines <b>45a</b>â<b>h</b>, which were transformed into the desired products through reaction with the proper enaminone, e.g., <b>24</b>, and base 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene (MTBD) in NMP at 120 Â°C overnight. The progress of the resin-bound reactions was routinely monitored by HPLC and LCMS by hydrolyzing a small sample (5â10 mg) of washed resin with TFA. The final products <b>46a</b>â<b>h</b> were liberated from the acid-sensitive resin in a similar manner using 80% TFA/CH<sub>2</sub>Cl<sub>2</sub>. A small amount of CH<sub>2</sub>Cl<sub>2</sub> used during the cleavage step helps to swell the resin and release most of the product. The resin is filtered after 1 h, washed with CH<sub>2</sub>Cl<sub>2</sub>, and quickly evaporated under reduced pressure. The products were typically dissolved again in CH<sub>2</sub>Cl<sub>2</sub> and evaporated again to drive off residual TFA. The products <b>46a</b>â<b>h</b> were dried in vacuo and were usually purified by reverse phase HPLC. For advanced in vitro and in vivo studies, these compounds and others purified by prep HPLC were converted from their TFA salts to free bases by dissolving the products in EtOAc and washing once with satd NaHCO<sub>3</sub>. The free bases could be converted to HCl salts by lyophilizing from a solution of 2 equiv of HCl in ACN/water (1:1 v/v) to yield light fluffy powders.</div><figure id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0012.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <b>46a</b>â<b>h</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) 2-chloro-5-nitropyridine, DIEA, NMP, 120 Â°C, 12 h, (ii) TMSOTf, 2,6-lutidine, CH<sub>2</sub>Cl<sub>2</sub>, 23 Â°C, 3 h; (b) 2-nitrobenzenesulfonyl chloride, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, 23 Â°C, 6 h; (c) RCH<sub>2</sub>OH, Ph<sub>3</sub>P, DIAD, CH<sub>2</sub>Cl<sub>2</sub>, 23 Â°C, 12 h; (d) PhSH, K<sub>2</sub>CO<sub>3</sub> (powder), water, DMF, 23 Â°C, 12 h; (e) 1<i>H</i>-pyrazole-1-carboxamidine hydrochloride, DIEA, NMP, 90 Â°C, 18 h; (f) (i) 1-(2,4-dichlorophenyl)-3-(dimethylamino)-2-imidazolylprop-2-en-1-one (<b>24</b>), MTBD, NMP, 120 Â°C, 20 h, (ii) 80% TFA/CH<sub>2</sub>Cl<sub>2</sub>, 23 Â°C, 1.5 h.</p></p></figure><div class="NLM_p">To facilitate the investigation of the distal arene, we envisioned using a linker with a free amine at the distal position. By employing mono-Boc ethylene diamine (<b>47</b>), the appropriate guanidine <b>48</b> was produced as described for <b>13</b> and <b>32</b>â<b>34</b> using 1<i>H</i>-pyrazole-1-carboxamidine hydrochloride as the guanidylating agent. The mono-Boc ethylene diamine guanidine (<b>48</b>) reacted smoothly with enamine <b>24</b> using Cs<sub>2</sub>CO<sub>3</sub> as the base in NMP. The product pyrimidine was carefully purified at this stage because the Boc protecting group allowed convenient separation on silica gel to give <b>48</b> in high purity and ca. 80% yield. The Boc group was removed using concd HCl in ACN to give the HCl salt cleanly after about 16 h at room temperature. The product <b>50</b> was free based by extracting into water and neutralizing the aqueous solution with satd aq NaHCO<sub>3</sub> to precipitate the product. After dissolving the precipitate into organic solvent and drying with Na<sub>2</sub>SO<sub>4</sub>, <b>50</b> could be used directly in subsequent reactions. From the primary amine <b>50</b>, a variety of coupling reactions and SnAr reactions gave amides, sulfonamides, ureas, and aminopyridines. Compound <b>50</b> was dissolved in DMF or DMA as a stock solution which was added to solutions of chloropyridine, such as 2-methoxy-3-nitro-6-chloro-pyridine, with DIEA to yield a wide array of novel groups at the distal linker position such as <b>51d</b>. The products <b>51a</b>â<b>s</b> could be purified by column chromatography or directly from the reactions by injection onto a prep HPLC (<a class="ref internalNav" href="#sch6" aria-label="Scheme 6">Scheme 6</a>).</div><figure id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0013.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>51a</b>â<b>s</b> (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1<i>H</i>-pyrazole-1-carboxamidine hydrochloride, CH<sub>3</sub>CN, 80 Â°C, 24 h; (b) 1-(2,4-dichlorophenyl)-3-(dimethylamino)-2-imidazolylprop-2-en-1-one (<b>24</b>), Cs<sub>2</sub>CO<sub>3</sub>, NMP, 100 Â°C, 48 h; (c) aq HCl (3 M), CH<sub>3</sub>CN, 25 Â°C, 16 h; (d) chloro-arene, HÃ¼nigâs base, DMF, 80 Â°C, 12 h.</p></p></figure><div class="NLM_p">Most groups that were explored at the C-5 position of the pyrimidines were installed at the acetophenone stage as in the synthesis of <b>1</b>, <b>2</b>, <b>16</b>, <b>26</b>, <b>35a</b>, <b>36a</b>, and <b>50</b>. Nucleophilic aromatic or nonaromatic heterocycles such as tetrazoles, morpholine, and piperazine were reacted with 2,4-dichlorophenacyl chloride (<b>21b</b>) to give the desired acetophenones which were transformed into the amino pyrimidines <b>60k</b>,<b>p</b>â<b>r</b>,<b>t</b> (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>) by similar procedures as was described for <b>25u</b>. The only exception was 3-trifluoromethyl-1<i>H</i>-pyridin-2-one, which gave a mixture of <i>N</i>- and <i>O</i>-alkylated products when reacted with dichlorophenacyl chloride (<b>21b</b>). The <i>O</i>-alkylated product was easily hydrolyzed with concd HCl to give pure 1-[2-(2,4-dichloro-phenyl)-2-oxo-ethyl]-3-trifluoromethyl-1<i>H</i>-pyridin-2-one, which was used to make <b>60t</b>. The 2-pyridine acetophenone needed to produce <b>60s</b> was synthesized from dichlorophenacyl chloride (<b>21b</b>) and 2-bromopyridine using palladium catalysis.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> The tetrazole of <b>60l</b> was formed with NaN<sub>3</sub> and ZnCl<sub>2</sub> from the corresponding cyano group at C-5, which was produced in the same manner as <b>16</b> but using 3-(2,4-dichloro-phenyl)-3-oxo-propionitrile to obtain the aminopyrimidine.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> To synthesize <b>60i</b> and <b>60j</b>, a C-5 ethyl ester compound with a C-4 2,4-dichloro-phenyl group, was needed. By utilizing 3-(2,4-dichloro-phenyl)-3-oxo-propionic acid ethyl ester and Boc-protected guanidine <b>48</b>, the required C-5 ester was made with the Boc-protected ethylene diamine linker similar to <b>49</b>. The ester was reduced with DIBAL to furnish the hydroxy methyl at C-5 which after deprotection and SnAr with 2-chloro-5-nitro-6-aminopyridine gave <b>60i</b>. The Boc-protected C-5 hydroxy methyl pyrimidine was oxidized under Swern conditions to the aldehyde and was then reductively aminated with morpholine to eventually give <b>60j</b> after installing the distal aminopyridine.</div><div class="NLM_p">To complete the investigation of the C-5 position of the aminopyrimidine scaffold, we sought to incorporate an aniline at C-5 to produce reverse amides and monoketopiperazines. Attempts to use 1-(2,4-dichloro-phenyl)-2-nitro-ethanone to establish a nitro group at C-5 met with limited success, and reduction of the nitro group at C-5 took strong reducing conditions and led to degradation of starting materials. Alternatively, 2,4-dichlorophenacyl chloride (<b>21b</b>) reacted with phthalimide (<b>56</b>) using Cs<sub>2</sub>CO<sub>3</sub> as the base to provide the substituted acetophenone <b>57</b> (<a class="ref internalNav" href="#sch7" aria-label="Scheme 7">Scheme 7</a>). Heating <b>57</b> in neat DMFDMA afforded the enaminone <b>58</b>, which was reacted with a fully elaborated guanidine such as <b>32</b> to give the pyrimidine core. However, during the cyclization of <b>58</b> and <b>32</b>, a mixture of products was obtained. The C-5 phthalimide suffered partial hydrolysis to the monoamide at C-5. This could not be cleanly deprotected but could be smoothly converted back to the phthalimide by heating the mixture in glacial AcOH at 120 Â°C for 4 h to yield <b>59</b>. The aniline <b>60a</b> was easily exposed by treatment of the C-5 phthalimide of <b>59</b> with excess hydrazine. Once purified, the aniline <b>60a</b> was conveniently coupled with methanesulfonic anhydride or acetic anhydride to afford <b>60b</b> and <b>60c</b>, respectively. Ureas <b>60g</b> and <b>60h</b> were fashioned from the aniline <b>60a</b> in a two-step process first reacting the aniline with carbonyldiimidazole (CDI) followed by the proper amine. The amides <b>60d</b>â<b>f</b> were prepared through standard peptide coupling procedures employing HBTU and the required acid. Coupling aniline <b>60a</b> with <i>N</i>-Boc valine gave <b>60f</b> after deprotection with 20% TFA/CH<sub>2</sub>Cl<sub>2</sub>. The cyclic amides <b>60m</b>â<b>o</b> were also made from the aniline <b>60a</b>. Initially, attempts to alkylate the aniline with compounds like 4-bromo-butyric acid led to multiple alkylation products. The aniline <b>60a</b> could be coupled with an appropriately protected acid such as 4-Boc-oxy-butyric acid. After forming the amide bond, the hydroxyl group was deprotected and the amide was cyclized under Mitsunobu conditions to produce <b>60m</b>. Attempts to close the cyclic amide by making the terminal mesylate or tosylate did not give the desired products cleanly. Compounds <b>60n</b> and <b>60o</b> were made by procedures similar to those use for <b>60m</b>. The aniline <b>60a</b> was coupled with chloro-acetic acid, which was further displaced with the proper ethanolamine. The 2-hydroxy-ethylamino acetyl amide was then cyclized under Mitsunobu conditions to produce the monoketopiperazines <b>60n</b> and <b>60o</b>. Compounds were typically purified to >95% purity by either silica gel chromatography using a polar eluent system such as 5% methanol/methylene chloride or by reverse-phase preparative HPLC. Most compounds were lyophilized as HCl salts to form free-flowing dry powders which were easily weighed and dissolved for biological evaluation.</div><figure id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0014.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of <b>60a</b>â<b>t</b> (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 25 Â°C, 14 h; (b) DMFDMA, 80 Â°C, 6 h; (c) (i) guanidine <b>32</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 Â°C, 14 h, (ii) gal AcOH, 120 Â°C, 4 h; (d) hydrazine, ethanol, 75 Â°C, 2 h; (e) Ms<sub>2</sub>O (for <b>60b</b>) or Ac<sub>2</sub>O (for <b>60c</b>), THF, 25 Â°C, 4 h.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> In Vitro Activity</h3><div class="NLM_p">From the dihydropyrimidine library hits, specific pools of compounds showing activity were screened again for a GSK3 IC<sub>50</sub> in an assay that monitored the rate of phosphorylation of a CREB substrate. Only pools containing compounds with an ethylene diamine 5-nitropyridine moiety <b>8</b> had confirmed IC<sub>50</sub> activity. Individual dihydropyrimidine analogues <b>9a</b>â<b>c</b> were made on solid support and found to have modest micromolar IC<sub>50</sub> activity (<a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>). Interestingly, while optimizing the assay conditions, it was noted that the potency of the DMSO stock solutions of <b>9a</b> seemed to steadily increase. Analysis of the DMSO solution showed, along with the expected dihydropyrimidine <b>9a</b>, a large contamination of the solution with the fully aromatized pyrimidine <b>11a</b> and a small amount of a third compound which was tentatively assigned as the 4-cyano dehydration product of the 4-amide on the C-4 phenyl. Once made, the aromatic amino pyrimidines <b>11a</b>â<b>c</b> showed superior potency over the dihydropyrimidines in the range of 100â200 nM IC<sub>50</sub>. However, when tested in the insulin-receptor expressing CHO cells (CHO-IR), compounds <b>11a</b>â<b>c</b> gave little or no change in glycogen deposition in the cells as indicated by the EC<sub>50</sub> values in the high micromolar range. On the basis of indications that the dehydration product of <b>11a</b> might be imparting better cellular potency, the cyano compound <b>11d</b> was made, confirming that the 4-cyano group was approximately 3-fold more potent with an IC<sub>50</sub> = 42 nM and had measurable activity in the CHO-IR whole cell assay (EC<sub>50</sub> = 1.7 Î¼M). With a potent compound identified, we had an excellent foundation with which to explore the SAR of this novel ATP-competitive GSK3 scaffold.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Pyrimidines versus Dihydropyrimidines, IC<sub>50</sub> and EC<sub>50</sub></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">#</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (Î¼M)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9a</b></td><td class="colsep0 rowsep0" align="char" char=".">3.40</td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9b</b></td><td class="colsep0 rowsep0" align="char" char=".">3.70</td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9c</b></td><td class="colsep0 rowsep0" align="char" char=".">2.00</td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11a</b></td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">9.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11b</b></td><td class="colsep0 rowsep0" align="char" char=".">0.14</td><td class="colsep0 rowsep0" align="char" char=".">Â </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11c</b></td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char=".">18.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11d</b></td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td></tr></tbody></table></div></div><div class="NLM_p">While many groups were tolerated at the pyrimidine C-6 position, such as the ethyl group in <b>11a</b>, these groups did not improve the potency of the series and could be removed to maintain a low molecular weight. For example, removing the C-6 ethyl group from the pyrimidine core of <b>11a</b> provided compound <b>16</b>, which had nearly identical IC<sub>50</sub> potency (52 nM) and whole cell activity (EC<sub>50</sub> = 2.2 Î¼M) (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). With compound <b>16</b> representing a lead structure, we next focused on improving the solubility while maintaining the in vitro potency. As the first few esters and amides were made from the acid <b>17</b>, it quickly became apparent that a wide variety of groups were tolerated at the C-5 position of the pyrimidine. The C-5 promiscuity proved to be a common theme throughout the series. However, some trends became apparent, for example, within a series steric bulk in the vicinity of the C-4 ester or amide reduced potency. This trend can be seen when comparing the primary amide <b>19a</b> and methyl amide <b>19b</b> with the bulkier <i>tert</i>-butyl amide <b>19d</b> and morpholino amide <b>19k</b>. Both acidic and basic groups were potent, although primary amines were not as well tolerated as tertiary amines, e.g., <b>19h</b> versus <b>19i</b>. Exchanging the amide proton <b>19b</b> or <b>19i</b> for a methyl group <b>19c</b> or <b>19j</b> was also deleterious. Although the effect could be the result of loss of a hydrogen bond, the magnitude of the difference tends to indicate a steric effect. After an extensive survey of esters and amides, we were unable to identify groups which significantly improved the CHO-IR whole cell potency. Postulating that the C-5 esters and amides might not easily penetrate the cell membrane, we thought to explore small five-membered heterocyclic ring systems. This direction quickly proved fruitful when the C-5 oxadiazole <b>20</b>, triazole <b>26</b>, and <i>N</i>-linked 1-imidazole exhibited improved cell-free and whole-cell potency. Interestingly, the more polar C-linked 2-imidazole <b>35a</b>, while maintaining the IC<sub>50</sub> potency observed with many compact C-5 heteroaromatic rings, lost potency in the CHO-IR cell assay. On the basis of that result, we decided to hold the more potent <i>N</i>-linked imidazole constant and optimize the C-4 phenyl and the linker group. The <i>N</i>-linked imidazole provided us with our first cellularly active compound which could be employed as a tool to help understand the biology and consequences of inhibiting GSK3 in cells and in rodents as will be discussed in the in vivo efficacy section.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Potency of C-5 Groups on C-4 <i>para</i>-Cyanophenyl Pyrimidines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0015.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0016.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">Substitutions around the C-4 phenyl quickly established a well-defined and predictable SAR (<a class="ref internalNav" href="#tbl3" aria-label="Table 3">Table 3</a>). Unlike the 4-CN-phenyl of <b>25a</b>, a bare phenyl (<b>25b</b>) had a 10-fold less potent IC<sub>50</sub>. In the <i>para</i>-position of the C-4 phenyl, a nonpolar group larger than a fluorine was needed to reestablish the cell-free potency. Small groups in the <i>para</i>-position like Clâ, Meâ, and CF<sub>3</sub>â had about equal IC<sub>50</sub>s, but the methyl group of <b>25e</b> was much more active in cells (EC<sub>50</sub> = 0.3 Î¼M). The same trend was seen again when comparing the cellular activity of the 4-MeO (<b>25g</b>) to the much more active 4-Et of <b>25h</b>. When only a <i>para</i>-position group was present, linear alkyl moieties gave the best potencies. Bulkier groups like imidazole <b>25i</b> and morpholine <b>25k</b> were tolerated but did not give potent cellular activity. A short list of small groups on the <i>ortho</i>-position of the C-4 phenyl gave good IC<sub>50</sub>s, such as Cl (<b>25o</b>), Br, Me, and CF<sub>3</sub>. Larger groups like methoxy in the <i>ortho</i>-position (<b>25p</b>) strongly diminished the potency, as did any single group other than fluorine in the <i>meta</i>-position, such as <b>25q</b> or <b>25s</b>. Surprisingly, 2,4-disubstituted phenyls at C-4 were highly active in both IC<sub>50</sub> and EC<sub>50</sub> assays. Even small groups like fluorine, which imparted little or no enhancement alone, were quite potent when occupying the 2- and 4-positions, e.g., <b>25t</b>. The most potent of these arenes was the 2,4-dichlorophenyl of <b>25u</b> which gave single-digit nM IC<sub>50</sub>s and excellent cellular potency. The details of the C-4 arene and other interactions between the inhibitors and protein will be discussed in the section covering the X-ray crystal structure of <b>1</b> and GSK3beta. Structure-based design and the use of inhibitor/kinase co-crystal structures played a significant role in the course of optimizing the SAR and physical properties of this series, and the structures indicated that the 2,4-dichlorophenyl was making highly productive interactions. While we did continue to explore compounds incorporating the 4-ethyl- and 4-CN-phenyl groups at C-4, we found that the 2,4-dichlorophenyl gave the best activity as we continued to develop the SAR. Therefore, we will focus on the analogues made with the optimized 2,4-dichlorophenyl at C-4 as we discuss the SAR of the linker, distal aminopyridine, and further investigation at the C-5 position.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Optimization of C-4 Arene</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0017.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0018.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_p">Crystal structures comparing our compounds and ATP in the active site of GSK3 indicated that the distal aminopyridine group overlapped with the ATP purine, making similar H-bond donor and acceptor interactions with the backbone residues in the binding pocket. As we anticipated, modifications to the distal linker amine were detrimental for binding. Replacing the distal linker nitrogen (group X in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>) with oxygen resulted in a nearly inactive compound <b>38</b>. Other simple augmentations to X in <a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a> such as methylation were similarly deleterious for potency (data not shown). Modeling suggested that branching out from the C-2 proximal nitrogen might project linear groups toward a solvent exposed area of the active site. Indeed, alkylation on this nitrogen was well tolerated. While most groups appended to the proximal nitrogen were nearly as active as <b>25u</b>, no clearly discernible SAR emerged. A wide variety of groups gave acceptable binding and whole cell potency, however, we were not able to increase potency at this position. Modeling of this solvent exposed area to identify high value binding contacts proved difficult, and the marginal increases in solubility made by incorporating solubilizing groups were offset by increased molecular weights. Modeling did indicate that the length of the ethylene diamine linker was optimal for correctly arranging the H-bonding aminopyridine and C-4 arene. To validate the model, linkers of varying length, such as propylene diamine, or cyclic linkers, such as piperazine, were tested. All of which were found to give IC<sub>50</sub>s in the 1 Î¼M or greater range confirming that the four atom ethylene diamine linker was optimal in this series.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Linker Changes</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0019.gif" alt="" id="fx5" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0020.gif" alt="" id="fx6" /></img><div></div></div><div class="NLM_p">The initially discovered hit compounds had a 2-amino-5-nitropyridine on the linker. Early attempts to replace the aminoarene with other groups capable of making H-bonding donor and acceptor interactions, such as amides and ureas, did not yield compounds with useful GSK3 inhibition. For example, the synthetic intermediate compound <b>49</b> with a Boc protecting group in place of the aminopyridine had an IC<sub>50</sub> > 10 Î¼M. Compounds with a nonsubstituted 2-aminopyridine displayed IC<sub>50</sub>s in the 3 Î¼M range and a plain 2-aminopyrimidine replacement <b>51r</b> showed IC<sub>50</sub> > 10 Î¼M (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>). The necessity of a 5-nitro group presented several possibilities: the polar group might be making productive contacts deep in the ATP-binding pocket, the nitro could be adjusting the p<i>K</i><sub>a</sub> of the aminopyridine, or potentially both effects were adding to the potency. To investigate the influence of compact electron withdrawing groups at the 5-position of the aminopyridine, a series of compounds were made with incrementally decreasing calculated p<i>K</i><sub>a</sub>s of the 2-aminopyridine group [NO<sub>2</sub> (<b>25u</b>; calculated p<i>K</i><sub>a</sub> of 2.83) > CN (<b>51b</b>; calculated p<i>K</i><sub>a</sub> of 3.95) > CF<sub>3</sub> (<b>51h</b>; calculated p<i>K</i><sub>a</sub> of 4.13) > CO<sub>2</sub>Et (<b>51p</b>; calculated p<i>K</i><sub>a</sub> of 5.17) > Ac (<b>51q</b>; calculated p<i>K</i><sub>a</sub> of 5.64)].<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49, 50)</a> The IC<sub>50</sub>s for this series of aminopyridines show a perfect correlation with the predicted p<i>K</i><sub>a</sub>s. In fact, throughout the project, the rank order of binding follows the same trend (NO<sub>2</sub> > CN > CF<sub>3</sub>). The position of electron withdrawing groups around the pyridine was also critical. For example, while an isosteric thiazole replacement for pyridine (<b>51a</b>) was potent, relocating the cyano group from the pyridine 5- to 4-position led to an approximate 10-fold erosion in potency (<b>51b</b> versus <b>51f</b>). We hypothesize that the reduction in IC<sub>50</sub> for <b>51f</b> is due to steric effects and poor alignment of the aminopyridine group in the binding pocket. Steric effects were certainly evident as most large groups at the distal position of the linker were poorly active, e.g. (<b>51k</b>), or were more commonly inactive. A few bicyclic aromatic groups, such as (<b>51e</b>), exhibited surprisingly good activity. However, these compounds do not easily fit the active site models and may indicate an alternate binding mode. With the intent of installing another H-bond donor in the 6-position of the pyridine, the diamino-nitropyridine group of <b>2</b> gave a slight improvement in binding potency but was far more active in the whole cell assay than <b>25u</b>. We postulate that the new amino group of <b>2</b> makes an H-bond with a main chain amide carbonyl. The boost in potency could be greatly reduced by a single methylation (<b>51l</b>) or two methyls (<b>51m</b>). Interestingly, adding an amino group to <b>51b</b> to give <b>51c</b> did not result in the expected increased potency. The nitro-amino interaction must be more subtle than a simple H-bond. Potentially, the p<i>K</i><sub>a</sub> of the amino group or the preorganization by a H-bond between the amino and nitro groups may play a role in the binding interaction with the protein, and presumably the 6-amino/5-nitro combination increases permeability through the CHO cell membrane, resulting in the improved whole cell activity. With the improved CHO-IR potency, we proceeded to fine-tune the SAR holding the linker constant with the 5-nitro, 6-aminopyridine.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Optimizing Tails</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0021.gif" alt="" id="fx7" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0022.gif" alt="" id="fx8" /></img><div></div></div><div class="NLM_p">Having explored the SAR around the scaffold and optimized each position, we were interested in improving the solubility and physical characteristics of the series to expand our options for a development formulation. The C-5 position was the most pliable and well suited to tolerate a basic charge. By utilizing a new chemical handle by installing an aniline at C-5 (<b>60a</b>), we embarked on a campaign of diverse âreverseâ amides and ureas (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>) as compared to the earlier series of esters and amides which lacked whole cell activity (<a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>). Small uncharged amides (<b>60c</b>) and sulfonamides (<b>60b</b>) maintained both IC<sub>50</sub> and EC<sub>50</sub> potency. A wide variety of basic groups could be appended to the C-5 aniline, however, extended basic groups such as amide <b>60e</b> lost CHO-IR cell activity. Amino acid analogues where the positively charged amine was proximal to the amide group and partially shielded by lipophilic groups such as the dimethylamino glycine <b>60d</b> and the valine <b>60f</b> retained cellular potency. The ureas such as <b>60g</b> showed poor EC<sub>50</sub>s, presumably because of poor penetrance of the membrane. A basic group could be introduced close to the C-5 position by reductive amination with lipophilic amines such as the morpholino analogue <b>60j</b>. However, the whole cell activity was superior in compounds, such as <b>60o</b>, <b>60p</b>, and <b>60r</b>, where the heterocycle was directly attached to the pyrimidine C-5 position. Mirroring previous results, basic amine groups at C-5 containing an NH may not have penetrated CHO cell membranes as well as the corresponding NMe analogues (<b>60n</b> vs <b>60o</b> and <b>60q</b> vs <b>60r</b>). In general, H-bond donors (<b>60g</b>, <b>60h</b>) tended to exhibit inferior EC<sub>50</sub>s compared to neutral (<b>60c</b>, <b>60p</b>) or H-bond acceptor (<b>60o</b>, <b>60r</b>) groups at C-5. This tendency could be seen in the SAR of the N- versus C-linked imidazoles or in the N- (<b>60k</b>) versus C-linked (<b>60l</b>) tetrazoles (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>). Lipophilic aromatic moieties, such as pyridines (<b>60s</b>) and pyridones (<b>60t</b>), were highly potent in both cell-free and cellular assays but were insufficiently soluble for further advancement. Overall, the C-linked imidazoles at C-5 displayed the best compromise amid all of the characteristics required for a development candidate, including in vitro potency, solubility, formulation, metabolic stability, and PK, which will be discussed in the In vivo efficacy section. Therefore, the C-linked imidazole series was selected for further optimization toward an advanced predevelopment compound. In particular, this entailed replacing the nitro group and addressing PK/metabolism issues.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. C-5 Groups</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0023.gif" alt="" id="fx9" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0024.gif" alt="" id="fx10" /></img><div></div></div><div class="NLM_p">Throughout the SAR of the series, the order of potency for linker pyridines in both IC<sub>50</sub> and EC<sub>50</sub> tended to place the nitro compounds first followed by cyano and then trifluoromethyl. However, with a 2-imidazole at C-5, the CHO-IR cell activity was similar for all of these. Additionally, the IC<sub>50</sub>s were nearly equipotent, e.g., <b>36a</b>, <b>36b</b>, and <b>36c</b> (<a class="ref internalNav" href="#tbl7" aria-label="Table 7">Table 7</a>). We attempted to improve the physical characteristics of the C-linked imidazole series by adjusting the C-4 phenyl substituents. Efforts to improve the PK by replacing the chlorines had the effect of lowering potency in the CHO-IR cell assay. The <i>ortho</i>-bromophenyl compound <b>61e</b> and its analogues <b>61k</b>, <b>61r</b>, and <b>61s</b> were an exception with low EC<sub>50</sub> values. However, these compounds did not demonstrate an advantage in solubility, formulation, or eventually efficacy over the 2,4-dichlorophenyl group. Therefore, the 2,4-dichlorophenyl compound <b>36c</b> with the cyanopyridine moiety looked promising, but we were concerned with the metabolic stability of the imidazole and in vivo half-life.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Optimizing the C-4 Arene with C-Linked Imidazole</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0025.gif" alt="" id="fx11" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0026.gif" alt="" id="fx12" /></img><div></div></div><div class="NLM_p">Subjecting the imidazole compounds to S9 fraction liver microsomes gave acceptable half-lives (>30 min) for rodents and dogs, but some imidazoles were metabolized faster in monkey and human microsomes. Analysis of the metabolic products showed that as expected the primary metabolite was extensive oxidation of the imidazole. To combat the oxidation, additional methyl groups or other bulky alkyl groups were positioned around the imidazole (<a class="ref internalNav" href="#tbl8" aria-label="Table 8">Table 8</a>). While most of these groups had a positive effect on microsomal stability, the extra molecular weight increased the log <i>P</i> and decreased the solubility. The most minimal change which maintained potency while improving microsomal stability was a single additional methyl group at the imidazole 4(5)-position yielding compound <b>1</b>. This methyl group improved the human microsomal half-life from 33 min for <b>36c</b> to 109 min for our lead compound <b>1</b> in the pyrimidine series.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Optimizing the C-Linked Imidazole with 2,4-Dichlorophenyl C-4 Arene</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0027.gif" alt="" id="fx13" /></img><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">#</th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center">X</th><th class="colsep0 rowsep0" align="center">Y</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (Î¼M)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37a</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.008</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37b</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.002</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">CN</td><td class="colsep0 rowsep0" align="char" char=".">0.005</td><td class="colsep0 rowsep0" align="char" char=".">0.77</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62a</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62b</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.034</td><td class="colsep0 rowsep0" align="char" char=".">0.17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62c</b></td><td class="colsep0 rowsep0" align="left">iPr</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.021</td><td class="colsep0 rowsep0" align="char" char=".">0.09</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62d</b></td><td class="colsep0 rowsep0" align="left">tBu</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.027</td><td class="colsep0 rowsep0" align="char" char=".">1.07</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62e</b></td><td class="colsep0 rowsep0" align="left">Ph</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.001</td><td class="colsep0 rowsep0" align="char" char=".">0.13</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62f</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.003</td><td class="colsep0 rowsep0" align="char" char=".">0.44</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>62g</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">NH<sub>2</sub></td><td class="colsep0 rowsep0" align="left">NO<sub>2</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.022</td><td class="colsep0 rowsep0" align="char" char=".">0.32</td></tr></tbody></table></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Binding Mode and Basis of Compound Selectivity</h3><div class="NLM_p">As mentioned in the previous sections, improvements in the series potency and chemical properties were heavily influenced by our in-house structure-based drug design efforts. The series is ATP-competitive and predominately occupies the volume in the active site typically occupied by ATP (<a class="ref internalNav" href="#fig2" aria-label="Figure 2">Figure 2</a>). The major features of compound <b>1</b> which impart the exceptional GSK3-Î±/Î² kinase potency are as follows. The hydrogen-bond donor and acceptor of the aminopyrimidine group are perfectly aligned to interact with the main-chain carbonyl and amide of Val135 at the <i>n</i> + 2 position. The compound does not make an interaction with the mainchain carbonyl of Asp133 (by definition, position <i>n</i>) as does the exocyclic amine of the purine ring of ATP.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> The 5-cyano moiety extends further into the bottom of the ATP-binding pocket, beyond the region typically occupied by the purine group of ATP. The ethylene diamine linker spans the binding site and positions the C-4 2,4-dichlorophenyl group to form both hydrophobic contacts by positioning the chloro groups both in a hydrophobic dimple within the P-loop, formed by residues Ile62, Gly63, and Val70, and in a hydrophobic pocket at formed by residues Val70, Lys85, and Asp200, in the bottom of the ATP-binding pocket, respectively. An additional ÏâÏ interaction is putatively formed between Phe67, at the tip of the P-loop, and the 2,4-dichlorophenyl group, which in turn forms a putative ÏâÏ interaction with the aminopyridine group.<a onclick="showRef(event, 'ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54">(52-54)</a> The formation of the ÏâÏ interaction with Phe67 and the compound requires the phenylalanine to move approximately 7 Ã from its native, extended position when binding ATP and to rotate at a 90Â° angle (using the costructure of human GSK3-Î²:AMPPNP, RSCB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1B">1J1B</a> as a reference<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a>). This arrangement provides significant stabilization of the compound as the series of ÏâÏ interactions spans the length of the active site. The 2,4-dichlorophenyl group occupies the area typically occupied by the ribose ring of ATP.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Both the linker length and flexibility was critical in positioning the hydrogen-bonding groups of the aminopyridine and the 2,4-dichlorophenyl group. The imidazole group forms a hydrogen bond with an adjacent structural water, which in turns forms a hydrogen bond with the main chain carbonyl of Ile62. Finally, there is a hydrogen bond formed between the ethylene diamine linker and a structural water, which subsequently hydrogen-bonds to the main chain carbonyl of Pro136. The kinase maintains an active, DFG-in conformation.</div><figure id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0002.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Co-crystal structure of compound <b>1</b> in the ATP-binding site of human GSK3-Î². The electrostatic potential is superimposed on the solvent-accessible surface of human GSK3-Î². The calculations and visualizations were performed using the CHIMERA program.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The ranges of red (negative) and blue (positive) represent electrostatic potentials of < â7 to > +7 <i>k</i><sub>b</sub><i>T</i>, where <i>k</i><sub>b</sub> is the Boltzmann constant and <i>T</i> is temperature. White surface represents nonpolar amino acid residues. In the figures, the N-terminal and C-terminal domains of the kinase are positioned as indicated. (a) Overall view into the ATP-binding pocket with the compound bound; key hydrogen bonds are shown as dashed lines and key residues are labeled; key waters are shown as red spheres. Note the position of Phe167, which forms the edge of the binding pocket. (b) Orthogonal view of the pocket at a 90Â° rotation to view (a). The co-crystal structure was refined against diffraction data collected to 2.6 Ã.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Three interactions form the basis of the exquisite selectivity of compound <b>1</b> (<a class="ref internalNav" href="#tbl9" aria-label="Table 9">Table 9</a>). The first is the interaction of the compound with the mainchain carbonyl of Val135. The presence of Pro136 at the <i>n</i> + 3 position ensures that the main chain carbonyl faces inward to allow this interaction. Only a small number of human kinases contain a proline at the <i>n</i> + 3 position of the hinge region and allow such interactions<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> The interaction of the compound linker with Pro136 via a structural water also likely provides some selectivity for the same reasons. The second is the positioning of the 2,4-dichlorophenyl group to insert a chloro-group into the hydrophobic dimple within the P-loop. The third is the interaction between the 2,4-dichlorophenyl group and Phe67 to form a face-to-face ÏâÏ interaction. In both isoforms of GSK3, these two interactions can be formed with the compound without compromising the donorâacceptor interactions of the compound with the main chain of Val135. In the other kinases, even closely related kinases like CDC2, sequence differences within the P-loop that comprise the area of the hydrophobic dimple or the residue equivalent to Phe67 ablate the possibility for the formation of the hydrophobic dimple and/or the ÏâÏ interaction at the tip of the P-loop. In both CDC2 and ERK2 kinases, where the sequence within the P-loop is highly homologous, there is a tyrosine (Tyr15 in CDC2 and Tyr36 in ERK2) at the position equivalent to Phe67 at the tip of the P-loop. However, an equivalent conformation of the aromatic side chain which allows an similar ÏâÏ interaction to form with the 2,4-dichlorophenyl group cannot be attained as the exocyclic hydroxyl group of the tyrosine group would collide with the main chain of the P-loop itself, thereby sterically excluding the necessary conformation and abrogating this interaction. These so-called folded P-loop conformations have been seen with other selective kinase inhibitors and are associated with a high degree of selectivity.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56, 57)</a> The C-5 substituent also likely plays a role in selectivity because its removal,while reducing potency for GSK3, increased the affinity for closely related kinases, such as CDC2 and erk1. However, the SAR was promiscuous and most likely the C-5 group acts as an additional anchor for holding the pyrimidine core in position.</div><div class="NLM_table-wrap" id="tbl9"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 9. Kinase Selectivity of GSK3-Specific ATP Competitive Inhibitors</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">species</th><th class="colsep0 rowsep0" align="center">kinase group</th><th class="colsep0 rowsep0" align="center">identity (%)</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (Î¼M)Â <b>1</b></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (Î¼M)Â <b>2</b></th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (Î¼M)Â <b>36b</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK3-Î²</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">CMGC3</td><td class="colsep0 rowsep0" align="center">100</td><td class="colsep0 rowsep0" align="center">0.0049</td><td class="colsep0 rowsep0" align="center">0.0006</td><td class="colsep0 rowsep0" align="center">0.0006</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GSK3-Î±</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">CMGC3</td><td class="colsep0 rowsep0" align="center">91</td><td class="colsep0 rowsep0" align="center">0.0078</td><td class="colsep0 rowsep0" align="center">0.0070</td><td class="colsep0 rowsep0" align="center">0.0271</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDC2</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">CMGC1</td><td class="colsep0 rowsep0" align="center">30</td><td class="colsep0 rowsep0" align="center">8.8</td><td class="colsep0 rowsep0" align="center">4.0</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ERK2</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">CMGC2</td><td class="colsep0 rowsep0" align="center">31</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKC-Î±</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">AGC2</td><td class="colsep0 rowsep0" align="center">22</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PKC-Î¶</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">AGC2</td><td class="colsep0 rowsep0" align="center">19</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AKT1/PKB</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">AGC3</td><td class="colsep0 rowsep0" align="center">21</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>5</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p70S6K</td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">AGC6</td><td class="colsep0 rowsep0" align="center">22</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>1</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">p90RSK2</td><td class="colsep0 rowsep0" align="left">rabbit</td><td class="colsep0 rowsep0" align="left">C6,Â CAMK6%</td><td class="colsep0 rowsep0" align="center">22</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">na</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TIE2</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">PTK13</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">>5</td><td class="colsep0 rowsep0" align="center">>5</td><td class="colsep0 rowsep0" align="center">>25</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">FLT1</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">PTK14</td><td class="colsep0 rowsep0" align="center">17</td><td class="colsep0 rowsep0" align="center">>5</td><td class="colsep0 rowsep0" align="center">>5</td><td class="colsep0 rowsep0" align="center">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">KDR</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">PTK14</td><td class="colsep0 rowsep0" align="center">18</td><td class="colsep0 rowsep0" align="center">>5</td><td class="colsep0 rowsep0" align="center">>2</td><td class="colsep0 rowsep0" align="center">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">bFGFRTK</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">PTK15</td><td class="colsep0 rowsep0" align="center">20</td><td class="colsep0 rowsep0" align="center">>5</td><td class="colsep0 rowsep0" align="center">>1</td><td class="colsep0 rowsep0" align="center">>5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">IGF1RTK</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">PTK16</td><td class="colsep0 rowsep0" align="center">16</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>2</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">insulinÂ RTK</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">PTK16</td><td class="colsep0 rowsep0" align="center">16</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>2</td><td class="colsep0 rowsep0" align="center">na</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AMPÂ kinase</td><td class="colsep0 rowsep0" align="left">rat</td><td class="colsep0 rowsep0" align="left">OPK</td><td class="colsep0 rowsep0" align="center">22</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDK1</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">OPK</td><td class="colsep0 rowsep0" align="center">23</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">na</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CHK1</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">OPK</td><td class="colsep0 rowsep0" align="center">21</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CK1-Îµ</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">OPK</td><td class="colsep0 rowsep0" align="center">17</td><td class="colsep0 rowsep0" align="center">>5</td><td class="colsep0 rowsep0" align="center">>5</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DNAÂ protein</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">PI3K</td><td class="colsep0 rowsep0" align="center">low</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PI3Â kinase</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">PI3K</td><td class="colsep0 rowsep0" align="center">low</td><td class="colsep0 rowsep0" align="center">>10</td><td class="colsep0 rowsep0" align="center">>5</td><td class="colsep0 rowsep0" align="center">>5</td></tr></tbody></table></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Discussion and Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43880" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43880" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> In Vitro Efficacy</h3><div class="NLM_p">With compounds that inhibit GSK3 at least 1000-fold better than any other kinase in our assay panel, our compounds can be used as highly specific probes to modulate GSK3 activity. Our GSK3 inhibitors were also very selective against a wide variety of pharmacologically relevant receptors and nonkinase enzymes.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The most potent activity we found for <b>1</b> was for phosphodiesterase III (<i>K</i><sub>i</sub> = 8.3 Î¼M) with no significant activity for nonkinase enzymes at 20 Î¼M.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> The excellent kinase and nonkinase selectivity gave us confidence that biological activity would be the result of pharmacological modulation of GSK3 and not off-target effects. In CHO-IR cells which express the insulin receptor, our compounds can activate glycogen synthase, many with EC<sub>50</sub>s below 500 nM. The maximal effect of insulin on CHO-IR cells yields an increase in GS activation ratio of â¼50% at 10 nM. Compound <b>2</b> can also achieve a 50% increase in GS activation in CHO-IR cells at 500 nM (EC<sub>50</sub> = 80 nM). Thus, by direct inhibition of GSK3, GS inhibition in CHO cells can be relieved to the same extent as with the signal cascade initiator, insulin. Presumably, GS activation occurs through dephosphorylation of the GSK3 phosphorylation sites by endogenous phosphatases.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> While CHO-IR cells were a convenient functional assay, we wanted to investigate the utility of our GSK3 inhibitors in more biologically relevant cells and tissues. Activation of GS in liver should improve disposal of excess circulating blood glucose. Thus, in primary rat hepatocytes, compound <b>2</b> reached a maximal GS activation at the same concentration as in CHO cells and exhibited an EC<sub>50</sub> of 100 nM, which suggested that the compounds would activate GS in normal mammalian liver cells.</div><div class="NLM_p">Other than liver, muscle is a major tissue involved in glucose disposal. GSK3 inhibition should activate GS in muscle cells but additionally could increase insulin-dependent glucose transport. To investigate the effect of a GSK3 inhibitor in muscle tissue, isolated rat soleus muscle was incubated with insulin, compound <b>2</b>, or both and compared to a vehicle treated group (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>a). Using a maximally effective concentration of GSK3 inhibitor <b>2</b> (0.5 Î¼M), the GS activity increased to the same level as that elicited by insulin (â¼40%) in type I skeletal muscle from lean rats as compared to the nonstimulated control group. Soleus muscle from diabetic ZDF rats was, as expected, markedly resistant to insulin-stimulated GS activation, but the GS activity responded to compound <b>2</b> to approximately the same level as normoglycemic muscle. Notably, the effect of insulin plus a GSK3 inhibitor was additive in muscle from both lean and diabetic rats. The increase in insulin-stimulated GS activity with compound <b>2</b> in diabetic muscle was 3-fold better than insulin stimulation alone, reaching a similar level as that in lean rat muscle. As predicted from the mechanism of action, the total GS activity was not altered by the GSK3 inhibitor in muscle from either lean or ZDF rat. The improvement in glucose deposition into glycogen in both liver and muscle cells was very encouraging. However, a defect in GLUT4 and glucose transport into the cells of diabetics might attenuate the effect of a GSK3 inhibitor by restricting the passage of glucose from blood into the cell.</div><figure id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0003.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Activation of GS in isolated rat soleus muscle with insulin or compound <b>2</b>. Isolated rat soleus muscle was incubated with vehicle as a control (Con), compound <b>2</b>, insulin (Ins), or both <b>2</b> and insulin (<b>2</b> + Ins) for 15 min. The effects of GSK3 inhibitor and insulin were tested in muscle from lean normal rats (left) or muscle from diabetic ZDF rats (right). Inhibitor was used at 0.5 Î¼M and insulin at 2 mU/mL. Data represent means Â± SE for five muscles per group. *<i>P</i> < 0.05 vs vehicle; **<i>P</i> < 0.05 vs all other groups. (b) Effect of compound <b>2</b> on insulin stimulated glucose transport in isolated soleus muscle from diabetic ZDF rats. Muscles were incubated with increasing concentrations of insulin and intracellular 2-deoxyglucose accumulation was measured. The EC<sub>50</sub> values for insulin stimulated glucose transport were 115 nM for insulin alone bottom line (â ) and 66 nM for insulin plus 0.5 Î¼M compound <b>2</b> top line (â). Values are means Â± SE for five muscles per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">To explore the effects of GSK3 inhibition on glucose transport, we again used soleus muscles from lean and diabetic ZDF rats (<a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b). Treatment of muscle from the ZDF rat with compound <b>2</b> at a maximally effective concentration (0.5 Î¼M) improved glucose transport and insulin sensitivity. GSK3 inhibition increased the maximal rate of glucose disposal approximately 30% over that of insulin stimulation alone (bottom line in <a class="ref internalNav" href="#fig3" aria-label="Figure 3">Figure 3</a>b). However, in response to compound <b>2</b>, glucose uptake was only increased to about 70% of the rate achieved in lean muscle.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> While glucose transport rates were not returned to nondiabetic levels, GSK3 inhibition did improve the ZDF muscle sensitivity to insulin signaling, as shown by the shift in insulin EC<sub>50</sub> from 115 nM in untreated muscle to 66 nM in the muscle incubated with compound <b>2</b>. The insulin EC<sub>50</sub> in lean rat muscle was 59 nM. Thus, GSK3 inhibitor treatment of diabetic ZDF muscle resulted in a reestablishment of glucose transport insulin sensitivity to near normal levels. Compound <b>2</b> also increased the GS activation, glucose uptake, and insulin sensitivity in type IIb epitrochlearis muscle from diabetic ZDF rats.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> Further, GSK3 inhibition was shown to improve glucose transport in response to insulin but did not increase the basal glucose uptake without insulin. The improvement in glucose transport was associated with an increase of cell surface GLUT4 in both skeletal muscle groups but only in response to insulin. This indicates that GSK3 inhibition relieves a diabetic defect in insulin-stimulated GLUT4 translocation in ZDF muscle. Unfortunately, compound <b>2</b> did not increase glucose transport in soleus or epitrochlearis muscle from lean rats.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> GSK3 inhibition may not improve glucose uptake in normal lean muscle because the insulin stimulatory effects may already be maximal. The impairment in ZDF rats might be due to GSK3 dysregulation. In studies of <b>2</b> and <b>36a</b> in human skeletal muscle, stimulation of glucose transport required more prolonged exposure to the inhibitors.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Increased insulin-stimulated glucose uptake was detected at 6 h of treatment with a GSK3 inhibitor, and the effect increased with continuous exposure up to 24 h. With increased cell surface GLUT4 but not total cellular GLUT4, the mechanism of GSK3 inhibition seems to be associated with insulin-stimulated translocation signals. Along with the increase of glucose transport in human muscle, IRS-1 protein abundance was decreased while maximal insulin-stimulated AKT phosphorylation was not altered.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> GSK3 phosphorylation of IRS-1 can impair insulin signaling,<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> and hyperphosphorylation of IRS-1 induces its degradation by proteosomes.<a onclick="showRef(event, 'ref10 ref63'); return false;" href="javascript:void(0);" class="ref ref10 ref63">(10, 63)</a> Thus, a GSK3 inhibitor may enhance glucose transport by reducing IRS-1 phosphorylation and/or augmenting its translation through eIF2B activity, also a substrate for GSK3.<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> GSK3 inhibition clearly mimics some of the downstream effects of insulin by activating GS while the insulin-sensitizing effects on glucose uptake could be additive or different from those of the insulin pathway.</div></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> In Vivo Efficacy</h3><div class="NLM_p">The investigation of the pharmacology of our GSK3 inhibitors began with the assumption that dysregulation of GSK3 might play a role in NIDDM or type II diabetes. Insulin resistance, which is also observed in obesity and metabolic syndrome (syndrome X), results in impaired glucose uptake and/or metabolism by the key regulatory peripheral tissues (muscle, adipose, and liver).<a onclick="showRef(event, 'ref65 ref66'); return false;" href="javascript:void(0);" class="ref ref65 ref66">(65, 66)</a> A major pathway for glucose metabolism in the body is muscle glycogen synthesis, which is defective in type II diabetics.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> While it has been hypothesized that the reduced GS activity might be related to downregulation by kinase-mediated phosphorylation, only recently has the link with GSK3 been established. In type II diabetics and other insulin-resistant individuals, GS activity was reduced, but not protein level. The reduced GS activity was correlated with an increase in total GSK3 activity and protein level.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Additionally, because suboptimal glycogenesis in type II diabetics may be linked to impaired glucose transport,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> it is apparent that the rates of both glucose uptake and glycogen synthase (GS) can be limiting for glycogen accumulation.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> With the knowledge that our GSK3 inhibitors could improve the activity of GS in muscle and liver cells and improved the rate of insulin-activated glucose transport in muscle, the in vitro studies supported the potential use of our inhibitors for the improvement of glucose metabolism in type 2 diabetes.</div><div class="NLM_p">Because GSK3 was a novel target for intervention in diabetes, we decided to characterize our compounds in a broad range of animal models and study designs. We expected that this approach would help us establish a detailed pharmacological profile which would help direct chemical optimization and guide clinical development. Compounds which passed our initial potency criteria (IC<sub>50</sub> < 25 nM and EC<sub>50</sub> < 1 Î¼M) were first assessed in <i>db</i>/<i>db</i> and/or <i>ob</i>/<i>ob</i> diabetic mice. These mice, which have a genetic leptin or leptin receptor deficiency respectively, are well validated for their predictive value with other diabetes therapeutics and share similar dysregulation as that reported in humans.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Compounds which gave significant oral efficacy in these models in an oral glucose tolerance test (oGTT) and which had acceptable bioavailability and formulation properties were further examined in Zucker diabetic fatty (ZDF) (<i>fa</i>/<i>fa</i>) GMI rats which are insulin-resistant and perhaps the most well-established animal model for type II diabetes.<a onclick="showRef(event, 'ref70 ref71 ref72 ref73 ref74'); return false;" href="javascript:void(0);" class="ref ref70 ref71 ref72 ref73 ref74">(70-74)</a> A potential link to GSK3 stems from a report that the obese ZDF rats exhibit downregulated IRS-1 and IRS-2 in liver and muscle.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> Additionally, obese, but not lean, ZDF (<i>fa</i>/<i>fa</i>) rats showed an increase in basal GSK3 activity in skeletal muscle.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> These models would provide the foundation for evaluating PD/PK relationships and insight for further in vivo optimization as our program advanced.</div><div class="NLM_p">Our first probes for in vivo activity, <b>25a</b> and <b>35a</b>, gave modest reductions in percent plasma glucose AUC following an oral glucose challenge (<a class="ref internalNav" href="#tbl10" aria-label="Table 10">Table 10</a>). However, as the plasma half-life of these and other similar molecules being screened often ranged 1â2 h in rodents, we chose to dose twice prior to the oGTT (at 4.5 and 0.5 h prior to glucose administration) to improve the sensitivity of the assay as well as to allow responsiveness to compounds of varying pharmacokinetics. The concentration of compound in circulation was monitored following the dosing and during the oGTT at intervals to help assess and compare the efficacy between compounds. While encouraging, the potency of <b>25a</b> and <b>35a</b> was hampered by poor solubility and bioavailability. With a great boost in in vitro potency, compound <b>2</b> gave our first significant (>20%) improvement in glucose disposal in the oGTT. While <b>2</b> suffered from the same obstacles for formulation and absorption, the improved potency of the compound seemed to partially compensate for its low bioavailability. Bioavailability improved with <b>51b</b>, the cyanopyridine analogue of <b>2</b>, but the efficacy fell in relation to the in vitro potency. Thus, we sought to improve the bioavailability and solubility of the compounds while maintaining the excellent potency of the series. However, this proved to be difficult. With a wide array of polar groups at C-5 (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>) showing in vitro potency, few were yielding improvements in oral absorption or efficacy in the <i>db</i>/<i>db</i> mouse oGTT. Strong basic charges at C-5 like the monoketopiperazine <b>60o</b> did not seem to have good bioavailability. Alternately, the noncharged hydroxymethyl compound <b>60i</b> was well absorbed but might not be reaching the important tissues for glucose metabolism, such as muscle, which might account for the low oGTT activity. We turned our attention back to the C-linked imidazoles at C-5 of the pyrimidine. This group appeared to boost bioavailability and increase solubility. Compound <b>36a</b> proved to be a turning point for the optimization of the series.</div><div class="NLM_table-wrap" id="tbl10"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 10. Efficacy of GSK3 Inhibitors in Oral Glucose Tolerance Test (oGTT) in Diabetic <i>db</i>/<i>db</i> Mice and ZDF (<i>fa</i>/<i>fa</i>) Rats</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="center" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">#</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">EC<sub>50</sub> (Î¼M)</th><th class="colsep0 rowsep0" align="center" char=".">mouse efficacy reduction in plasma glucose (AUCÂ %)<a class="ref internalNav" href="#t10fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">mouse plasma conc (Î¼g/mL)<a class="ref internalNav" href="#t10fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">ZDF efficacy reduction in plasma glucose (AUCÂ %)<a class="ref internalNav" href="#t10fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">ZDF % <i>F</i><a class="ref internalNav" href="#t10fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">ZDF <i>T</i><sub>1/2</sub> (min)<a class="ref internalNav" href="#t10fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center">formulation<a class="ref internalNav" href="#t10fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25a</b></td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="center">A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>35a</b></td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="center">A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">0.08</td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="center">A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>51b</b></td><td class="colsep0 rowsep0" align="char" char=".">25</td><td class="colsep0 rowsep0" align="char" char=".">0.79</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="center">A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60a</b></td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="center">B</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60i</b></td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">0.15</td><td class="colsep0 rowsep0" align="char" char=".">9</td><td class="colsep0 rowsep0" align="char" char=".">12</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="center">A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60o</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.03</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="center">A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60p</b></td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="center">A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>60r</b></td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">0.05</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="center">C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36a</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.37</td><td class="colsep0 rowsep0" align="char" char=".">35</td><td class="colsep0 rowsep0" align="char" char=".">97</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="char" char=".">143</td><td class="colsep0 rowsep0" align="center">A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36b</b></td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">30</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">46</td><td class="colsep0 rowsep0" align="center">C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>36c</b></td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">0.51</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">18</td><td class="colsep0 rowsep0" align="char" char=".">21</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="center">A</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>61r</b></td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">13</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="center">C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37a</b></td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">0.29</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="char" char=".">Â </td><td class="colsep0 rowsep0" align="center">C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>37b</b></td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">0.12</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="char" char=".">7</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="center">C</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">5</td><td class="colsep0 rowsep0" align="char" char=".">0.77</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="char" char=".">15</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="char" char=".">36</td><td class="colsep0 rowsep0" align="char" char=".">92</td><td class="colsep0 rowsep0" align="center">B</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t10fn1"><div class="footnote" id="t10fn1"><sup>a</sup><p class="last">Diabetic <i>db</i>/<i>db</i> mice were used except where noted. Compound was dosed orally (30 mg/kg) at â4.5 and â0.5 h relative to <i>t</i> = 0 oral glucose challenge. Groups of 6â8 mice per treatment fasted for â¼6 h prior to oGTT. Efficacy is measured as the percent reduction in circulating plasma glucose AUC post inhibitor treatment compared to untreated following an oral glucose challenge.</p></div><div class="footnote" id="t10fn2"><sup>b</sup><p class="last">Concentration of compound (Î¼g/mL) in mouse plasma at 20 min after second dose, <i>t</i> = â0.16 h relative to <i>t</i> = 0 oral glucose challenge.</p></div><div class="footnote" id="t10fn3"><sup>c</sup><p class="last">Obese 10 week-old ZDF (<i>fa</i>/<i>fa</i>) rats (<i>n</i> = 8/group) fasted overnight and treated orally with compound (8 mg/kg) at 4.5 and 0.5 h prior to oGTT. Efficacy is measured as the percent reduction in circulating plasma glucose AUC post inhibitor treatment compared to untreated following an oral glucose challenge.</p></div><div class="footnote" id="t10fn4"><sup>d</sup><p class="last">Obese 10 week-old ZDF (<i>fa</i>/<i>fa</i>) rats (<i>n</i> = 8/group) fasted overnight and treated orally with compound (8 mg/kg).</p></div><div class="footnote" id="t10fn5"><sup>e</sup><p class="last">A = 15% captisol, B = 1% CMC, C = water (pH was adjusted as needed).</p></div></div></div><div class="NLM_p">In captisol formulation, <b>36a</b> was well absorbed and gave excellent potency in the mouse oGTT (<a class="ref internalNav" href="#tbl10" aria-label="Table 10">Table 10</a>). When advanced to the ZDF rat model, <b>36a</b> was remarkably efficacious at 8 mg/kg, showing a 29% reduction in glucose AUC following the oGTT. Additionally, the compound was acceptably bioavailable (33%) with a half-life of more than 2 h in rat. With the C-linked imidazole, the compounds were more bioavailable and more easily formulated. However, when formulated in slightly acidic water, the absorption fell, as seen in <b>36b</b>. However, despite the 6% bioavailability and 43 min half-life, <b>36b</b> was still as highly efficacious as <b>36a</b>. The in vivo potency of <b>36b</b> seems to indicate enhanced tissue distribution to important compartments for efficacy. Compound <b>36c</b>, while possessing better bioavailability then <b>36b</b>, was less active in mice and ZDF rats. A detailed analysis of the tissue distribution demonstrated that efficacy in the oGTT studies was correlated with good bioavailability and with compounds which partitioned well into muscle and liver tissue. Efficacy did not correlate with plasma protein binding, but lower protein binding was associated with broader tissue distribution. Many of the similar C-5 imidazole analogues, such as <b>61r</b>, were potent in vivo but did not show improvements in bioavailability or half-life. Caco-2 experiments indicated that these compounds were not PGP pump substrates. In general, the compounds tended to be permeable but poorly soluble. Bioavailability could be enhanced with formulations such as captisol. As noted earlier, another factor in efficacy and PK was metabolism. The C-imidazole underwent first pass metabolism which could be addressed by installing a methyl group. Also noted during the rodent studies was the increased absorption of the cyanopyridine group. Bringing these enhancements together in compound <b>1</b> yielded a compromise between potency, efficacy, and bioavailability. While compound <b>1</b> was not easily formulated in water as a solution, it was readily absorbed as a microcrystalline CMC suspension as the free base. Possessing superior efficacy in the ZDF model (38% reduction in oGTT) and a 90 min half-life, compound <b>1</b> became our first lead compound and advanced into more sophisticated pharmacological evaluation.</div><div class="NLM_p">Oral administration of <b>1</b> to <i>db/db</i> mice prior to an oral glucose challenge yielded a dose-related improvement in glucose disposal (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>a). The PD/PK relationship closely matched the time course of the PK studies at doses relevant for efficacy in the <i>db</i>/<i>db</i> mouse oGTT (<a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a>b). At the higher dose of 30 mg/kg, there was a trend for reduced hyperglycemia prior to the glucose administration. In treated animals, plasma insulin levels were similar, or possibly conserved, relative to vehicle controls. During oGTT studies, glucose levels in the urine were not elevated in compound- or vehicle-treated rodents (data not shown); therefore, it was concluded that there was a dose-dependent improvement in whole body glucose disposal. By employing the oGTT, efficacy could be quantified as the percent reduction in glucose AUC for comparison between GSK3 inhibitors and reference therapeutics, such as troglitazone, rosiglitazone, and metformin. The magnitude of improved glucose disposal observed with compound <b>1</b> at 30 mg/kg was comparable to that following treatment with metformin or troglitazone. Notably, however, efficacy can be seen 30 min after dosing with compound <b>1</b> while observable improvement in oGTT typically requires several days to 2 weeks of dosing with metformin or troglitazone.</div><figure id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0004.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Oral exposure and efficacy of compound <b>1</b> administered to diabetic <i>db</i>/<i>db</i> mice. (a) Improved glucose tolerance with insulin conservation. Treatment with vehicle control (10% captisol) or indicated doses of compound <b>1</b> at â4.5 and â0.5 h relative to <i>t</i> = 0 oral glucose. Groups of 6â8 mice per treatment fasted for â¼6 h prior to a oGTT, SEM â¤ 15%. (b) Plasma concentration vs time profile: 50 mg/kg compound <b>1</b> formulated in 15% captisol administered once orally to 8â9 week old female <i>db</i>/<i>db</i> mice. Quantitation by LC/MS/MS. Results are mean Â± SE< from six animals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Similar results were observed with compound <b>1</b> when tested in an oGTT in <i>ob</i>/<i>ob</i> mice. Glucose disposal was improved in an insulin-sparing manner (<a class="ref internalNav" href="#fig5" aria-label="Figure 5">Figure 5</a>). Within the age ranges tested, the <i>ob</i>/<i>ob</i> mice are less hyperglycemic and insulin resistant than the <i>db</i>/<i>db</i> mice and generally exhibited slightly greater efficacy upon comparison. Further, monitoring of blood glucose levels for an extended period up to 20 h following GSK3 inhibitor treatment indicated that there was no compensatory rebound hyperglycemia in the treated animals. To further demonstrate the utility of our GSK3 inhibitors beyond genetic defects in leptin or leptin receptor (<i>ob</i>/<i>ob</i> or <i>db</i>/<i>db</i> mice respectively), we made use of an alternative mouse model based on a high fat diet and intermittent streptozotocin treatment wherein animals progress to glucose intolerance and then overt diabetes as is observed in man.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> Employing the same test compound <b>1</b> and regimen, these mice were likewise tested in an oGTT and showed improved glucose tolerance (53% reduction in postchallenge glucose AUC) in an insulin-conserving manner (data not shown). Thus, in three different mouse models of hyperglycemia, compound <b>1</b> consistently improved glucose disposal without an increase in peripheral insulin levels, increasing our confidence in GSK3 as a target for therapeutic intervention in type II diabetes.</div><figure id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0005.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Improved glucose tolerance with insulin sparing in diabetic <i>ob</i>/<i>ob</i> mice treated orally with compound <b>1</b>. (a) Improved glucose tolerance. oGTT as described in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a> with 9â10 week old <i>ob</i>/<i>ob</i> mice. <i>n</i> = 6â8 animals/group, mean Â± SEM. (b) Insulin conservation. Plasma insulin levels (<i>n</i> = 6â8 animals/group, mean Â± SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To further validate the concept for GSK3 inhibition, we wanted to demonstrate that inhibitor treatment, while lowering hyperglycemia, would not induce hypoglycemia which can be caused by other treatments such as insulin. To investigate the potential for hypoglycemia at an efficacious dose, compound <b>1</b> was evaluated in 12-week-old ZDF (<i>fa</i>/<i>fa</i>) obese, diabetic rats for alteration of glucose disposal in a oGTT model as described above. Oral administration of <b>1</b> led to significant improvement of glucose disposal accompanied by insulin sparing relative to controls at dose levels of 30â48 mg/kg (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>a). To determine if the glucose response to GSK3 inhibition was limited to insulin-resistant, glucose-intolerant animals rather than animals with normal metabolic control, we treated lean littermates of 10-week-old obese, mildly diabetic animals with compound <b>1</b> at 30 mg/kg dose. Confirming our expectation that GSK3 inhibition would only have a significant effect in diabetic animals, the metabolically impaired animals showed normalization of their oral glucose tolerance following treatment with <b>1</b> (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>a), whereas the lean littermates showed little or no change in plasma glucose or insulin response (<a class="ref internalNav" href="#fig6" aria-label="Figure 6">Figure 6</a>b). This indicates that GSK3 inhibition should only correct hyperglycemia in diabetic animals to normoglycemic levels and underscores an important safety profile for an antidiabetic therapy. As in the nongenetic mouse model, a recently derived rat model of obesity and glucose-intolerance uses SHHF rats which also exhibit congestive heart failure (SHHF rats were purchased from Charles River). Because the metabolic abnormality in SHHF rats is not linked to a leptin defect as in ZDF rats, the impressive reduction in hyperglycemia and improved glucose tolerance observed with treatment of SHHF rats represented an additional element of concept validation for GSK3 inhibition (data not shown).</div><figure id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0006.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Differential responsiveness of obese vs lean ZDF rats to oral treatment with compound <b>1</b>. (a) Obese ZDF rats. Ten-week-old ZDF (<i>fa</i>/<i>fa</i>) rats fasted overnight and treated with vehicle control (captisol solution) or 30 mg/kg compound <b>1</b> 4.5 and 0.5 h prior to oGTT. Methods as described above, <i>n</i> = 8/group, results are mean Â± SEM. (b) Lean littermates. Same as in (a) except age-matched lean littermates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To better understand the pharmacodynamics of GSK3 inhibition in a setting more closely aligned with diabetic treatment in humans, we investigated the regulation of glucose metabolism by compound <b>1</b> independent of glucose challenges. Acute studies were performed to monitor the effect of GSK3 inhibition on plasma hyperglycemia and insulin levels. The GSK3 inhibitor was orally administered once to moderately diabetic ZDF (<i>fa</i>/<i>fa</i>) rats with a fasted basal hyperglycemia at 500â550 mg/dL. A dose-related and significant (at 30 mg/kg) reduction in hyperglycemia was observed which initiated within 60 min of administration and yielded a maximum reduction of â¥150 mg/dL (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>a). However, there was only a trend toward insulin lowering relative to the vehicle controls (<a class="ref internalNav" href="#fig7" aria-label="Figure 7">Figure 7</a>b). The pharmacodynamics correlated well with the pharmacokinetics as the onset of glucose lowering coincided with compound plasma levels approaching maximal concentrations (<i>C</i><sub>max</sub>) and later with diminishing response coinciding with compound elimination. In ZDF rat, compound <b>1</b> had an oral half-life of 92â98 min, %<i>F</i> of 36â43%, oral <i>C</i><sub>max</sub> of 0.4 Î¼g/mL, oral AUC of 85 Î¼gÂ·min/mL, iv <i>C</i><sub>L</sub> of 43 (mL/min)/kg, and iv <i>V</i><sub>SS</sub> of 3.6 L/kg. In the longer-term studies, compound <b>1</b> was continuously infused intravenously over a 4-day period at a total dose of â¼92 mg/kg/d in order to ascertain the impact of high, sustained GSK3 inhibitor exposure on circulating glucose and insulin levels. Interestingly, a significant reduction in fasting hyperglycemia to nearly normoglycemia was observed without a significant change in plasma insulin (<a class="ref internalNav" href="#tbl11" aria-label="Table 11">Table 11</a>). Further studies using compound <b>1</b> suggest that glucose disposal occurs primarily in the liver due to a 2â3-fold increase in liver glycogen formation with a concomitant â¼40% reduction in basal endogenous glucose output.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> However, on the basis of our previous findings that compound <b>1</b> activates GS and improves insulin-initiated glucose uptake in muscle cells, chronic treatment may lead to increased glucose disposal in muscle. Both acute and chronic studies indicate that compound <b>1</b>, and GSK3 inhibitors of this class in general, have the potential to significantly reduce circulating plasma hyperglycemia with an onset of action just 1â2 h after dosing without an immediate hyperglycemic rebound. Together, these results indicate that GSK3 inhibitors, like compound <b>1</b>, can correct glucose metabolism in insulin-resistant nonfasted hyperglycemic animals which would be comparable to the disease state in man.</div><figure id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0007.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Given orally, compound <b>1</b> reduces hyperglycemia with insulin conservation in ZDF (<i>fa</i>/<i>fa</i>) rats. (a) Reduced hyperglycemia. Twelve week old male ZDF (<i>fa</i>/<i>fa</i>) rats with food removal 3â4 h prior to single oral administration of vehicle control (15% captisol) or indicated doses of compound <b>1</b>. Serial tail-snip bleeds from <i>n</i> = 8/group. (b) Insulin conservation. Plasma insulin levels in same animals. Results are mean Â± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl11"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 11. Effect of Sustained Compound <b>1</b> Exposure<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a> on ZDF (<i>fa</i>/<i>fa</i>) Rat Glycemia and Insulinemia</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="+" /></col><col align="char" char="+" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">parameter</th><th class="colsep0 rowsep0" align="center">time</th><th class="colsep0 rowsep0" align="center" char="+">control<a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char="+">compd <b>1</b><a class="ref internalNav" href="#t11fn1" aria-label="a">a</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">glucose (mg/dL)<a class="ref internalNav" href="#t11fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">pretreatment</td><td class="colsep0 rowsep0" align="char" char="+">188 + 18</td><td class="colsep0 rowsep0" align="char" char="+">223 + 18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">day 4</td><td class="colsep0 rowsep0" align="char" char="+">181 + 20</td><td class="colsep0 rowsep0" align="char" char="+">116 + 6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Insulin (ng/mL)<a class="ref internalNav" href="#t11fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="left">pretreatment</td><td class="colsep0 rowsep0" align="char" char="+">3.5 + 0.4</td><td class="colsep0 rowsep0" align="char" char="+">3.9 + 0.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Â </td><td class="colsep0 rowsep0" align="left">day 4</td><td class="colsep0 rowsep0" align="char" char="+">4.0 + 0.4</td><td class="colsep0 rowsep0" align="char" char="+">3.1 + 0.4</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t11fn1"><div class="footnote" id="t11fn1"><sup>a</sup><p class="last">Intravenous prime (5 mg/kg) with continuous infusion at 64 Î¼g/kg/min for 4 days to 12â13 week old ZDF (<i>fa</i>/<i>fa</i>) rats.</p></div><div class="footnote" id="t11fn2"><sup>b</sup><p class="last">Plasma samples from overnight-fasted animals.</p></div></div></div><div class="NLM_p">Because of GSK3âs role in the wnt pathway, there is concern that inhibition of GSK3 might lead to increased risk of cancer or tumorigenicity.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> The wnt pathway is important in early embryonic development in mammals, but overexpressed or mutated components of wnt signaling, such as mutated Î²-catenin or APC, have been identified in cancer.<a onclick="showRef(event, 'ref80 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref80 ref81 ref82">(80-82)</a> GSK3 phosphorylation of Î²-catenin leads to the degradation of the protein. Many colon cancers are associated with mutated Î²-catenin which, like GSK3 inhibition, renders the protein resistant to degradation. Mice which express Î²-catenin lacking the GSK3 phosphorylation sites quickly develop intestinal polyps.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> On the basis of these and other observations, there is concern that long-term GSK3 inhibition may increase carcinogenic risk as a result of raised Î²-catenin levels and Î²-catenin-regulated transcription. Further, lithium ions, a nonspecific GSK3 inhibitor, have been shown to increase the concentration of Î²-catenin in transformed cells.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> However, lithium treatment, which has been used for over 50 years at therapeutic concentrations which should inhibit GSK3, does not lead to increased incidence of cancer.<a onclick="showRef(event, 'ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref85 ref86">(85, 86)</a> In fact, use of lithium seems to correlate with increased survival rates in some cancers.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> Chronic lithium inhibition was tested in the APC multiple intestinal neoplasia mouse model, which resulted in no increase in tumorigenesis.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a> This indicates that GSK3 inhibitors may not exacerbate intestinal polyp formation. Studies with our GSK3 inhibitors indicate that Î²-catenin is not stabilized in primary cells following inhibitor treatment.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> In contrast, we and others have observed elevation of Î²-catenin in partially transformed cells with GSK3 inhibitors.<a onclick="showRef(event, 'ref84 ref89'); return false;" href="javascript:void(0);" class="ref ref84 ref89">(84, 89)</a> Unlike transformed cells with an activated ras oncogene, our GSK3 inhibitors were unable to induce cell growth in NIH3T3 cells or rat1 fibroblasts in soft agar. Furthermore, a 20 h infusion of compound <b>1</b> in ZDF rats (equivalent to 130 mg/kg/day), which is 3-fold above the efficacious dose, does not elevate Î²-catenin levels or cyclin D1 mRNA in brain, liver, lung, colon, or adipose tissue.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> These results may indicate that GSK3 inhibition alone is not enough to increase Î²-catenin levels in normal cells but might require that additional transforming signals already exist. For example, in contrast to intestinal polyposis, stabilization of Î²-catenin and activation of the Wnt pathway is not sufficient for hepatocarcinogenesis.<a onclick="showRef(event, 'ref90'); return false;" href="javascript:void(0);" class="ref ref90">(90)</a> In standard preclinical 5 day toxicity studies in rodents, the compounds were well tolerated at many-fold above their efficacious doses. Active compounds, such as <b>1</b>, and structurally related inactive compounds (IC<sub>50</sub> > 1 Î¼M, no CHO cell activity) showed similar mild adverse effects at high doses, which mostly included liver chemistry changes. Because superior in vitro potency and in vivo efficacy did not correlate with toxicity, these studies suggest that our observed adverse side effects were not target related. While these studies are very encouraging, long-term animal studies will certainly be needed to assess the carcinogenic risk and effects of chronic dosing of GSK3 inhibitors.</div><div class="NLM_p">In addition to demonstrated efficacy in the treatment of NIDDM, <b>1</b> has been evaluated for treatment of several other indications. These include the treatment type I diabetes-related cardiac parasympathetic dysfunction<a onclick="showRef(event, 'ref91'); return false;" href="javascript:void(0);" class="ref ref91">(91)</a> as well as the treatment of hyperglycemia and dyslipidemia for reducing atherogenesis.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> It has shown potential outside of the metabolic disease area in the treatment of human pancreatic cancer.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> Compound <b>1</b> has also been used to investigate the role of GSK3-Î² in multiple pathways using chemogenomics. It has also shown value in keeping embryonic stem cells in a pluripotent state, thus allowing more efficient culturing.<a onclick="showRef(event, 'ref94 ref95'); return false;" href="javascript:void(0);" class="ref ref94 ref95">(94, 95)</a></div><div class="NLM_p last">In conclusion, we have developed highly selective, potent, low-molecular-weight GSK3 inhibitors. The series was found to be ATP-competitive and X-ray crystallography confirmed that the compounds bound in the ATP-binding site. Selectivity arose from lipophilic interactions in areas unique to GSK3. We have demonstrated that our inhibitor series activates GS in liver and muscles cells and has the ability to improve glucose transport in treated muscle cells. The ability of compound <b>1</b> to enhance insulin action in insulin-resistant rodent models was shown in studies of acute glucose tolerance (oGTT) and in reduction of fasting basal hyperglycemia. Enhanced glucose disposal was associated with a trend toward insulin sparing. The onset of improved glucose disposal was observed within 1â2 h of acute dosing with a tight PD/PK relationship. In comparison to other diabetes treatments, GSK3 inhibition does not lead to hypoglycemia when lean nondiabetic rodents are given efficacious doses of compound <b>1</b>. Our research indicates that GSK3 inhibitors hold promise as novel insulin sensitizers and potentially a new treatment for diabetes. Characterization of our compounds in conjunction with metformin and thiazolidinediones may show that combination therapy will yield enhanced benefits over monotherapy.</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i27">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75702" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75702" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> General</h3><div class="NLM_p">Unless otherwise noted, all starting materials and dry solvents where obtained from commercial suppliers and were used without further purification. Solvents were stored with 3 Ã molecular sieves under dry argon. Reactions involving air and/or moisture sensitive reagents were executed under an atmosphere of dry argon, and the glassware was flame-dried under vacuum. All compounds which were synthesized on resin were first cleaved under acidic (TFA) conditions, filtered to remove most polymer residue, and dried to remove solvents before undergoing physical characterization by NMR, HPLC, LCMS (HPLC/MS), and elemental analysis. While the same number is used for both the resin-bound and the related cleaved material, only resin free material was characterized, only yields of cleaved material was reported, and every attempt was made to clearly indicate which material was being described in the text and through footnotes. Nuclear magnetic resonance (NMR) analysis was performed with a Varian 300 MHz NMR (Palo Alto, California). Proton (<sup>1</sup>H, 300 MHz) and carbon (<sup>13</sup>C, 75 MHz) nuclear magnetic resonance (NMR) spectra were obtained as solutions in deuteriochloroform (CDCl<sub>3</sub>) unless otherwise indicated. <sup>1</sup>H and <sup>13</sup>C chemical shifts are reported in parts per million (ppm, Î´) downfield relative to tetramethylsilane (TMS), which was referenced to the solvent. Coupling constants are reported in hertz (Hz). Spectral splitting patterns are designated as s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; and br, broad.</div><div class="NLM_p">Analytical HPLC samples were run on a Waters Millennium chromatography system with a 2690 separation module (Milford, Massachusetts) using reverse phase analytical columns (Alltima 5 Î¼ C-18, 4.6 mm Ã 250 mm from Alltech (Deerfield, Illinois)). A gradient elution was used, typically starting with 5% acetonitrile/95% water and progressing to 100% acetonitrile over a period of 40 min. All solvents contained 0.1% trifluoroacetic acid (TFA). Compounds were detected by ultraviolet light (UV) absorption at 220 and 254 nm. Liquid chromatography/mass spectrometric analysis (LCMS) was performed on either a Waters Micromass Platform LCZ or a Hewlett-Packard (HP) 1100 series LC/MSD electrospray mass spectrometer with an LC module. High resolution mass spectrometry (HRMS) was performed at UC Berkeleyâs mass spectrometry facility or on a Fisons VG electrospray mass spectrometer. All masses are reported as those of the protonated parent ions. Elemental analysis of compounds was determined by Desert Analytics (Tucson, Arizona). Melting points were determined on a Laboratory Devices Mel-Temp apparatus (Holliston, Massachusetts).</div><div class="NLM_p last">Flash chromatography was performed according to the established protocol with Merck silica gel 60 Ã (230â400 ASTM). Purity was assessed by thin layer chromatography (TLC) using glass or plastic backed silica gel plates, such as, for example, Baker-Flex Silica Gel 1B2-F flexible sheets. TLC results were readily detected visually under ultraviolet light or by employing well-known iodine vapor and other various staining techniques. Preparative separations were carried out using either a Flash 40 chromatography system and a KP-Sil, 60 Ã (Biotage, Charlottesville, Virginia), a Chromatotron radial chromatography device (Harrison Research, Palo Alto, California), or by HPLC using a C-18 reversed phase HPLC column. Typical solvents employed were dichloromethane, methanol, ethyl acetate, hexane, acetonitrile water, TFA, and triethyl amine.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Syntheses</h3><div class="NLM_p">All compounds were examined for purity by HPLC, HPLC/MS, and/or <sup>1</sup>H NMR, as specified below. Unless explicitly stated, all compounds have a purity of at least 95%.</div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 6-{2-[4-(2,4-Dichloro-phenyl)-5-(4-methyl-1<i>H</i>-imidazol-2-yl)-pyrimidin-2-ylamino]-ethylamino}-nicotinonitrile (<b>1</b>)</h4><div class="NLM_p last">A solution of sodium ethoxide (0.62 g, 8.66 mmol) dissolved in abs ethanol (15 mL) was added to a stirred mixture of 1-(2,4-dichloro-phenyl)-3-dimethylamino-2-(4-methyl-1<i>H</i>-imidazol-2-yl)-propenone (<b>31b</b>) (2.67 g, 8.25 mmol), <i>N</i>-[2-(5-cyano-pyridin-2-ylamino)-ethyl]-guanidine (<b>33</b>) (2.08 g, 8.65 mmol), and abs ethanol (20 mL). The reaction was then heated to 75â80 Â°C for 2.5 h. On cooling, the reaction was diluted with ethyl acetate (400 mL) washed with satd aq NaHCO<sub>3</sub> (100 mL), distilled water (2 Ã 100 mL), and brine (100 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated. The crude product (â¼50% purity) was purified by flash chromatography over silica gel. The column was run starting with ethyl acetate/hexane (50:50 v/v), then ethyl acetate which was used until all of the fast moving impurities had been removed. The product was eluted with 1.5% methanol/ethyl acetate (1.5:98.5 v/v). The column was monitored by TLC using methanol/ethyl acetate (5:95 v/v) as the solvent system. The product had UV activity in the long wavelength region. The proper fractions were condensed. The off-white solid was dried overnight in vacuo, giving 1.04 g (28%) of final product 6-{2-[4-(2,4-dichloro-phenyl)-5-(4-methyl-1<i>H</i>-imidazol-2-yl)-pyrimidin-2-ylamino]-ethylamino}-nicotinonitrile (<b>1</b>) (HPLC, 99% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 324 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 8.65 (d, <i>J</i> = 20 Hz, 1H), 8.40â8.17 (m, 2H), 7.81 (br s, 1 H), 7.73â743 (m, 4H), 7.30 (s, 1 H), 6.55 (dd, <i>J</i> = 22, 9 Hz, 1H), 4.12â3.05 (br m, 4H), 2.23 (s, 3H). <sup>1</sup>H NMR (pyridine-<i>d</i><sub>5</sub>, 70 Â°C) Î´ 11.96 (br s, 3H), 9.29 (s, 1H), 8.57 (br s, 1H), 8.46 (d, <i>J</i> = 2 Hz, 1H), 8.37 (br s, 1H), 7.70 (d, <i>J</i> = 8 Hz, 1H), 7.47 (dd, <i>J</i> = 9, 2 Hz, 1H), 7.37 (d, <i>J</i> = 2 Hz, 1H), 7.25 (dd, <i>J</i> = 8, 2 Hz, 1H), 7.21 (s, 2H), 6.73 (d, <i>J</i> = 9 Hz, 1H), 4.02â3.86 (br m, 4H), 2.29 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 163.1, 161.1, 160.3, 153.4, 141.5, 138.8, 136.0, 133.8, 133.6, 131.6, 129.8, 127.8, 119.4, 118.2, 110.8, 96.3, 41.7, 10.9. <sup>13</sup>C NMR (pyridine-<i>d</i><sub>5</sub>) Î´ 163.2, 162.1, 160.5, 156.8, 142.7, 136.5, 134.0, 133.8, 129.9, 128.1, 121.9, 119.7, 111.5, 42.1, 41.9. HRMS (FAB+): <i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>19</sub>Cl<sub>2</sub>N<sub>8</sub> [MH<sup>+</sup>] 465.1104, found 465.1099. Anal. (C<sub>22</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>8</sub> + HCl) Calcd: C, 52.66; H, 3.82; N, 22.33; Cl, 21.20, Found: C, 52.36; H, 3.86; N, 22.04; Cl, 21.17.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>N</i><sup>6</sup>-{2-[4-(2,4-Dichloro-phenyl)-5-imidazol-1-yl-pyrimidin-2-ylamino]-ethyl}-3-nitro-pyridine-2,6-diamine (<b>2</b>)</h4><div class="NLM_p last">Compound <b>2</b> was made by similar procedures as compound <b>25u</b> except that the pyrimidine formation was carried out in DMF with (2-(6-amino-5-nitro(2-pyridyl)amino)ethyl)carboxamidinium 4-methylbenzenesulfonate (<b>32</b>) and the mixture was stirred for 8 h at 100 Â°C. The mixture was cooled, filtered, and the filtrate diluted with ethyl acetate and washed with saturated aqueous sodium bicarbonate. Concentration of the organic layers yielded to give 143 mg (76%) of <b>2</b> as a yellow solid (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 486 [MH<sup>+</sup>]). <sup>1</sup>H NMR (AcOD-<i>d</i><sub>4</sub>) Î´ 8.76 (br s, 1H), 8.59 (br s, 1H), 8.28 (br s, 1H), 8.02 (d, <i>J</i> = 15 Hz, 1H), 7.56â7.34 (m, 3H), 7.21 (s, 1H), 6.21 (s, 1H), 3.86â3.62 (br m, 4H). Anal. (C<sub>20</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>9</sub>O<sub>2</sub>) Calcd: C, 49.39; H, 3.52; N, 25.92; Cl, 14.58, Found: C, 49.11; H, 3.42; N, 24.15; Cl, 14.94.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 2-(4-Carbamoyl-benzylidene)-3-oxo-pentanoic Acid Ethyl Ester (<b>5a</b>)</h4><div class="NLM_p last">A suspension of 4-formyl-benzamide-bound Rink resin <b>3</b> (1g, 0.52 mmol) in 8 mL of 1:1 ethanol:dioxane was treated with 3-oxo-pentanoic acid ethyl ester (<b>4a</b>) (317 mg, 2.2 mmol) and piperidine (111 mg, 1.3 mmol). The reaction mixture was shaken for 20 h at room temperature. The resin was then filtered, washed with dichloromethane (4 Ã 10 mL), dried in vacuo, and used in its subsequent reaction without further purification (after TFA cleavage, crude yield: â¼100%. HPLC: 95% at 220 nm. HPLC/MS: <i>m</i>/<i>z</i> 276 [MH<sup>+</sup>]).</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 3-(4-Carbamoyl-phenyl)-2-(pyridine-4-carbonyl)-acrylic Acid Ethyl Ester (<b>5b</b>)</h4><div class="NLM_p last">Starting from <b>3</b> and <b>4b</b>, intermediate <b>5b</b> was prepared in a similar manner as <b>5a</b> (after TFA cleavage, crude yield: â¼100%. HPLC: 97% at 220 nm. HPLC/MS: <i>m</i>/<i>z</i> 325 [MH<sup>+</sup>]).</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 3-(4-Carbamoyl-phenyl)-2-(4-nitro-benzoyl)-acrylic Acid Ethyl Ester (<b>5c</b>)</h4><div class="NLM_p last">Starting from <b>3</b> and <b>4c</b>, intermediate <b>5c</b> was prepared in a similar manner as <b>5a</b> (after TFA cleavage, crude yield, â¼100%; HPLC, 98% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 369 [MH<sup>+</sup>]).</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 6-(4-Carbamoyl-phenyl)-4-ethyl-2-pyrazol-1-yl-1,6-dihydro-pyrimidine-5-carboxylic Acid Ethyl Ester (<b>7a</b>)</h4><div class="NLM_p last">Resin-bound 2-(4-carbamoyl-benzylidene)-3-oxo-pentanoic acid ethyl ester (<b>5a</b>) (100 mg, 0.052 mmol) was treated with pyrazole carboxamidine hydrochloride (<b>6</b>) (38 mg, 0.26 mmol), powdered NaHCO<sub>3</sub> (11 mg, 0.13 mmol), and <i>N</i>-methylpyrrolidinone (1 mL). The reaction mixture was shaken at 70 Â°C for 24 h. Following cooling, the resin was filtered and washed successively with water (10 mL), methanol (10 mL), DMF (10 mL), methylene chloride (10 mL), and ether (10 mL), then dried in vacuo and used in its subsequent reaction without further purification (after TFA cleavage, crude yield, â¼100%; HPLC, 96% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 368 [MH<sup>+</sup>]).</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 6-(4-Carbamoyl-phenyl)-2-pyrazol-1-yl-4-pyridin-4-yl-1,6-dihydro-pyrimidine-5-carboxylic Acid Ethyl Ester (<b>7b</b>)</h4><div class="NLM_p last">Starting from <b>5b</b> and <b>6</b>, intermediate <b>7b</b> was prepared in a similar manner as <b>7a</b> (after TFA cleavage, crude yield, â¼100%; HPLC, 94% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 417 [MH<sup>+</sup>]).</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 6-(4-Carbamoyl-phenyl)-4-(4-nitro-phenyl)-2-pyrazol-1-yl-1,6-dihydro-pyrimidine-5-carboxylic Acid Ethyl Ester (<b>7c</b>)</h4><div class="NLM_p last">Starting from <b>5c</b> and <b>6</b>, intermediate <b>7c</b> was prepared in a similar manner as <b>7a</b> (after TFA cleavage, crude yield, â¼100%; HPLC, 95% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 461 [MH<sup>+</sup>]).</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> (2-Aminoethyl)(5-nitro(2-pyridyl))amine (<b>8</b>)</h4><div class="NLM_p last">2-Chloro-5-nitropyridine (2.0 g, 12.6 mmol) in acetonitrile (10 mL) was added dropwise to ethylenediamine (2.5 mL) in acetonitrile (10 mL). The mixture was stirred overnight at room temperature. Caution is needed at this stage, as when the diamine is added, this reaction can become exothermic. The solvent was removed by rotary evaporation, and the residue was partitioned between dichloromethane (100 mL) and 2.5 M aqueous sodium hydroxide (25 mL). The aqueous layer was further extracted with dichloromethane (4 Ã 10 mL). The combined organic layers were washed with a saturated sodium chloride solution (20 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), and concentrated in vacuo to give (2-aminoethyl)(5-nitro(2-pyridyl))amine as an orange solid 1.74 g (76%), which was used without further purification (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 183 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 7.99 (d, <i>J</i> = 9 Hz, 2H), 5.93 (d, <i>J</i> = 9 Hz, 1H), 3.48 (t, <i>J</i> = 6 Hz, 2H), 2.82 (t, <i>J</i> = 6 Hz, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 162.6, 157.4, 135.5, 119.1, 103.5, 44.6, 42.0.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 6-(4-Carbamoyl-phenyl)-4-ethyl-2-[2-(5-nitro-pyridin-2-ylamino)-ethylamino]-1,6-dihydro-pyrimidine-5-carboxylic Acid Ethyl Ester (<b>9a</b>)</h4><div class="NLM_p last">A suspension of dihydropyrimidine <b>7a</b> (50 mg, 0.026 mmol) in NMP (0.75 mL) was treated with <i>N</i><sup>1</sup>-(5-nitro-pyridin-2-yl)-ethane-1,2-diamine (<b>8</b>) (182 mg, 1 mmol) and acetic acid (16 mg, 0.26 mmol). The reaction mixture was shaken at 80 Â°C for 24â48 h. After cooling, the resin was filtered and washed with methanol (4 Ã 10 mL), DMF (4 Ã 10 mL), and methylene chloride (4 Ã 10 mL). The resin was then dried in vacuo, and a solution of 5% trifluoroacetic acid in methylene chloride was added. The resin was shaken for 2 h, then filtered and washed with methylene chloride (3 Ã 2 mL). The combined filtrates were concentrated, taken up in 1:1 water/acetonitrile and lyophilized to dryness (crude yield, 79%; HPLC, 92% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 482 [MH<sup>+</sup>]).</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 6-(4-Carbamoyl-phenyl)-2-[2-(5-nitro-pyridin-2-ylamino)-ethylamino]-4-pyridin-4-yl-1,6-dihydro-pyrimidine-5-carboxylic Acid Ethyl Ester (<b>9b</b>)</h4><div class="NLM_p last">Starting from <b>7b</b> and amine <b>8</b>, intermediate <b>9b</b> was prepared in a similar manner as <b>9a</b> (crude yield, 75%; HPLC, 88% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 531 [MH<sup>+</sup>]).</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 6-(4-Carbamoyl-phenyl)-4-(4-nitro-phenyl)-2-[2-(5-nitro-pyridin-2-ylamino)-ethylamino]-1,6-dihydro-pyrimidine-5-carboxylic Acid Ethyl Ester (<b>9c</b>)</h4><div class="NLM_p last">Starting from <b>7c</b> and amine <b>8</b>, intermediate <b>9c</b> was prepared in a similar manner as <b>9a</b> (crude yield, 83%; HPLC, 90% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 575 [MH<sup>+</sup>]).</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 4-(4-Carbamoyl-phenyl)-6-ethyl-2-pyrazol-1-yl-pyrimidine-5-carboxylic Acid Ethyl Ester (<b>10a</b>)</h4><div class="NLM_p last">The dihydropyrimidine-bound resin <b>7a</b> (50 mg, 0.026 mmol) was then suspended in THF followed by addition of dicyanodichloroquinone (DDQ) (7 mg, 0.029 mmol). The resulting slurry was stirred for 30 min, at which time the resin was filtered, washed with DMF (2 Ã 10 mL), 10% Na<sub>2</sub>HCO<sub>3</sub> (2 Ã 10 mL), H<sub>2</sub>O (2 Ã 10 mL), DMF (2 Ã 10 mL), methanol (2 Ã 10 mL), methylene chloride (2 Ã 10 mL), and ether (2 Ã 10 mL), dried in vacuo, and used in its subsequent reaction without further purification (after TFA cleavage, crude yield, â¼100%; HPLC, 98% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 366 [MH<sup>+</sup>]).</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 4-(4-Carbamoyl-phenyl)-2-pyrazol-1-yl-6-pyridin-4-yl-pyrimidine-5-carboxylic Acid Ethyl Ester (<b>10b</b>)</h4><div class="NLM_p last">Starting from dihydropyrimidine <b>7b</b> and treating with DDQ, intermediate <b>10b</b> was prepared in a similar manner as <b>10a</b> (after TFA cleavage, crude yield, â¼100%; HPLC, 95% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 415 [MH<sup>+</sup>]).</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 4-(4-Carbamoyl-phenyl)-6-(4-nitro-phenyl)-2-pyrazol-1-yl-pyrimidine-5-carboxylic Acid Ethyl Ester (<b>10c</b>)</h4><div class="NLM_p last">Starting from dihydropyrimidine <b>7c</b> and treating with DDQ, intermediate <b>10c</b> was prepared in a similar manner as <b>10a</b> (after TFA cleavage, crude yield, â¼100%; HPLC, 97% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 459 [MH<sup>+</sup>]).</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 4-(4-Carbamoyl-phenyl)-6-ethyl-2-[2-(5-nitro-pyridin-2-ylamino)-ethylamino]-pyrimidine-5-carboxylic Acid Ethyl Ester (<b>11a</b>)</h4><div class="NLM_p last">A suspension of pyrimidine <b>10a</b> (50 mg, 0.026 mmol) in NMP (0.75 mL) was treated with <i>N</i><sup>1</sup>-(5-nitro-pyridin-2-yl)-ethane-1,2-diamine (<b>8</b>) (182 mg, 1 mmol) and acetic acid (16 mg, 0.26 mmol). The reaction mixture was shaken at 80 Â°C for 24â48 h. After cooling, the resin was filtered and washed with methanol (4 Ã 10 mL), DMF (4 Ã 10 mL), and methylene chloride (4 Ã 10 mL). The resin was then dried in vacuo, and a solution of 5% trifluoroacetic acid in methylene chloride was added. The resin was shaken for 2 h, then filtered and washed with methylene chloride (3 Ã 2 mL). The combined filtrates were concentrated, taken up in 1:1 water/acetonitrile and lyophilized to dryness (crude yield, 81%; HPLC, 96% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 480 [MH<sup>+</sup>]).</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 4-(4-Carbamoyl-phenyl)-2-[2-(5-nitro-pyridin-2-ylamino)-ethylamino]-6-pyridin-4-yl-pyrimidine-5-carboxylic Acid Ethyl Ester (<b>11b</b>)</h4><div class="NLM_p last">Starting from pyrimidine <b>10b</b> and amine <b>8</b>, intermediate <b>11b</b> was prepared in a similar manner as <b>11a</b> (crude yield, 72%; HPLC, 95% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 529 [MH<sup>+</sup>]).</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 4-(4-Carbamoyl-phenyl)-6-(4-nitro-phenyl)-2-[2-(5-nitro-pyridin-2-ylamino)-ethylamino]-pyrimidine-5-carboxylic Acid Ethyl Ester (<b>11c</b>)</h4><div class="NLM_p last">Starting from pyrimidine <b>10c</b> and amine <b>8</b>, intermediate <b>11c</b> was prepared in a similar manner as <b>11a</b> (crude yield, 83%; HPLC, 97% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 531 [MH<sup>+</sup>]).</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> <i>N</i>-[2-(5-Nitro-pyridin-2-ylamino)-ethyl]-guanidine (<b>13</b>)</h4><div class="NLM_p last">A mixture of 2-(2-aminoethylamino)-5-nitropyridine (<b>8</b>) (43 g, 236 mmol), 1<i>H</i> -pyrazole-1-carboxamidine hydrochloride (35 g, 236 mmol), and acetonitrile (500 mL) were stirred overnight (ca. 20 h) at 70â80 Â°C. Upon cooling, a yellow precipitate was collected by filtration. The yellow solid was washed thoroughly with acetonitrile (3 Ã 100 mL), ethyl ether (3 Ã 100 mL), and dried overnight in vacuo, resulting in 53.5 g (87%) of hydroscopic <i>N</i>-[2-(5-nitro-pyridin-2-ylamino)-ethyl]-guanidine (<b>13</b>) (HPLC, 99% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 225 [MH<sup>+</sup>]).</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 4-(4-Cyano-phenyl)-2-[2-(5-nitro-pyridin-2-ylamino)-ethylamino]-pyrimidine-5-carboxylic Acid Ethyl Ester (<b>16</b>)</h4><div class="NLM_p">Benzotriazole carboxamidinium 4-methylbenzenesulfonate (<b>12</b>) (2.0 g, 6.6 mmol) was added to a mixture of amine (<b>8</b>) (1.2 g, 6.6 mmol) and DIEA (1.16 mL, 6.6 mmol) in dry acetonitrile (10 mL) stirred at room temperature overnight. Addition of ether resulted in the precipitation of amino{2-[(5-nitro(2-pyridyl))amino]ethyl}carboxamidinium 4-methylbenzenesulfonate (<b>13</b>) as a yellow solid. The solid was quickly filtered and dried in vacuo and used without further purification in its subsequent step (crude yield, â¼100%; HPLC, 98% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 397 [MH<sup>+</sup>]).</div><div class="NLM_p last"><i>N</i>,<i>N</i>-Dimethylformamide dimethyl acetal (DMFDMA) (53 Î¼L, 0.4 mmol) was added to a stirred solution of ethyl 3-(4-cyanophenyl)-3-oxopropionate (<b>14</b>) (65 mg, 0.3 mmol) in THF (1 mL). After the addition, the solution was heated at 70 Â°C for 3 h. The reaction solution of <b>15</b> was then added to a mixture of amino[2-[(5-nitro(2-pyridyl)amino]ethyl}carboxamidinium 4-methylbenzenesulfonate (<b>13</b>) (120 mg, 0.3 mmol), ethanol (dry) (1 mL), and 1.0 M sodium ethoxide (0.35 mL). The mixture was heated at 80 Â°C and stirred overnight. Upon cooling, the mixture was diluted with dichloromethane (60 mL) and washed with saturated aqueous sodium bicarbonate (10 mL). The organic layer was concentrated in vacuo and then dissolved in acetonitrile (â¼10 mL). The solid product <b>16</b> was precipitated by addition of water (â¼10 mL), filtered, and dried in vacuo to give 120 mg (92%) of the product as a yellow solid (HPLC, 97% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 434 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 8.86 (s, 1H), 8.78 (s, 1H), 8.21 (d, <i>J</i> = 12 Hz, 1H), 7.85 (d, <i>J</i> = 11 Hz, 2H), 7.78â7.63 (m, 3H), 6.67 (br s, 1H), 6.56 (br s, 1H), 4.14 (qt, <i>J</i> = 10 Hz, 2H), 2.83 (d, <i>J</i> = 21 Hz, 4H), 1.02 (t, <i>J</i> = 10 Hz, 3H).</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 4-(4-Cyano-phenyl)-2-[2-(5-nitro-pyridin-2-ylamino)-ethylamino]-pyrimidine-5-carboxylic Acid (<b>17</b>)</h4><div class="NLM_p last">Powdered sodium hydroxide (60 mg, 1.5 mmol) was added at a suspension of ethyl 4-(4-cyanophenyl)-2-({2-[(5-nitro(2-pyridyl)amino]ethyl}amino)pyrimidine-5-carboxylate (<b>16</b>) (1.0 g, 2.3 mmol) in 1:1 methanol/water (25 mL). The mixture was warmed to 60 Â°C for 45 min with stirring, during which time the reaction became clear. After cooling, the reaction was adjusted to approximately pH 5, which caused the product to precipitated from solution. This yellow solid was collected and dried in vacuo to give 890 mg (98% yield) of 2-((2-((5-nitro(2-pyridyl)amino)ethyl)amino)-4-(4-cyanophenyl)-pyrimidine-5-carboxylate (<b>16</b>) as a light-yellow powder (crude yield, â¼100%; HPLC, 96% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 406 [MH<sup>+</sup>]).</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 4-(4-Cyano-phenyl)-2-[2-(5-nitro-pyridin-2-ylamino)-ethylamino]-pyrimidine-5-carboxylic Acid 2-Dimethylamino-ethyl Ester (<b>18d</b>)</h4><div class="NLM_p last"><i>O</i>-Benzotriazole-<i>N</i>,<i>N</i>,<i>N</i>â²,<i>N</i>â²-tetramethyluronium-hexafluoro-phosphate (HBTU) was added to a mixture of 2-((2-((5-nitro(2-pyridyl)amino)ethyl)amino)-4-(4-cyanophenyl)-pyrimidine-5-carboxylate (<b>17</b>) (300 mg, 0.74 mmol) and 2-(dimethylamino)ethanol (2 mL) in DMA (2 mL) at room temperature. After 18 h, the solution was partitioned between water (25 mL) and EtOAc (60 mL). The aqueous layer was extracted with ethyl acetate (2 Ã 10 mL). The combined organic layers were washed with brine (10 mL), dried with sodium sulfate, filtered, and concentrated in vacuo to give 348 mg (99%) of the product <b>18d</b> as a yellow solid (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 477 [MH<sup>+</sup>]). <sup>1</sup>H NMR (acetone-<i>d</i><sub>6</sub>) Î´ 9.37 (s, 1H), 9.19 (s, 1H), 8.64 (d, <i>J</i> = 9 Hz, 1H), 7.74â7.99 (m, 5H), 6.87 (br s, 4H), 6.77 (t, <i>J</i> = 6 Hz, 2H), 6.65 (t, <i>J</i> = 9 Hz, 2H), 6.65 (t, <i>J</i> = 9 Hz, 2H), 3.72 (t, <i>J</i> = 6 Hz, 2H), 8.30 (s, 6H).</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 4-{5-(3-Methyl-[1,2,4]oxadiazol-5-yl)-2-[2-(5-nitro-pyridin-2-ylamino)-ethylamino]-pyrimidin-4-yl}-benzonitrile (<b>20</b>)</h4><div class="NLM_p last">To a mixture of ethyl 4-(4-cyanophenyl)-2-({2-[(5-nitro(2-pyridyl))amino]ethyl}amino)pyrimidine-5-carboxylate (<b>17</b>) (28 mg, 0.069 mmol) and triethylamine (19.3 Î¼L, 0.14 mmol) in THF (1 mL) was added isobutyl chloroformate (13.4 Î¼L, 0.14 mmol). After stirring at room temperature overnight, acetamidoximine<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(40)</a> (10 mg, 0.14 mmol) was added and the mixture was stirred at 70 Â°C for 6 h until complete as determined by LCMS. The reaction was allowed to cool to room temperature. After stirring an additional 72 h, a light-yellow precipitate was filtered. The solid filter cake was washed successively with methanol (2 Ã 5 mL) and water (2 Ã 5 mL) and dried under vacuum. The crude product was purified by preparative C18 reverse phase HPLC to give 3 mg (10%) of the desired oxadiazole (<b>20</b>). (HPLC, 97% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 444 [MH<sup>+</sup>]).</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 4-{5-Imidazol-1-yl-2-[2-(5-nitro-pyridin-2-ylamino)-ethylamino]-pyrimidin-4-yl}-benzonitrile (<b>25a</b>)</h4><div class="NLM_p">4-(2-Imidazol-1-yl-acetyl)-benzonitrile (<b>23</b>) was prepared following a variation of the method described in by Sakurai et al.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> A solution of 4-cyanophenacyl bromide (<b>21a</b>) (0.72 g, 3.2 mmol) and imidazole (<b>22</b>) (0.55 g, 8.0 mmol) in toluene (20 mL) was heated at 75 Â°C for 2.5 h. The mixture was concentrated to dryness in vacuo. The residue was dissolved in dichloromethane (60 mL), washed with a 5% aqueous potassium carbonate solution (10 mL) and water (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo to give 0.35 g (53%) of 4-(2-imidazol-1-yl-acetyl)-benzonitrile (<b>23</b>) as a pink solid which was used in its subsequent reaction without further purification (HPLC, 97% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 212 [MH<sup>+</sup>]).</div><div class="NLM_p last">4-(2-Imidazol-1-yl-acetyl)-benzonitrile (<b>23</b>) (63 mg, 0.3 mmol) was heated with DMFDMA (2 mL) at 105 Â°C for 9 h. The solvent was removed in vacuo, and the residue of <b>24</b> was dissolved in dry THF (2 mL). The resulting solution of <b>24</b> was added to a mixture of amino[2-[(5-nitro(2-pyridyl))amino]ethyl}carboxamidinium 4-methylbenzenesulfonate (<b>13</b>) (105 mg, 0.3 mmol) and cesium carbonate (326 mg, 1.0 mmol) in THF (15 mL). The mixture was heated overnight at 80 Â°C, then concentrated in vacuo, redissolved in dichloromethane (60 mL), washed with a saturated sodium bicarbonate solution (10 mL) and brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo to give the crude product as a yellow solid. The residue was crystallized from ethanol/water to give 83 mg (65%) of <b>25a</b> as yellow needles (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 428 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 8.89 (br s, 1H), 8.41 (br s, 1H), 8.45 (br s, 1H), 8.25 (br s, 1H), 7.78 (br s, 2H), 7.62 (s, 1H), 7.38 (d, <i>J</i> = 9 Hz, 2H), 7.19 (s, 1H), 7.03 (s, 1H), 6.58 (br s, 1H), 3.73â3.51 (br m, 4H). Anal. (C<sub>21</sub>H<sub>17</sub>N<sub>9</sub>O<sub>2</sub>/2CH<sub>3</sub>CH<sub>2</sub>OH) Calcd: C, 57.79; H, 5.63; N, 24.26; O, 12.32, Found: C, 57.92; H, 4.91; N, 24.86; O, 12.07. HRMS (FAB+): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>18</sub>N<sub>9</sub>O<sub>2</sub> [MH<sup>+</sup>] 428.1577, found 428.1560.</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> <i>N</i>-[4-(2,4-Dichloro-phenyl)-5-imidazol-1-yl-pyrimidin-2-yl]-<i>N</i>â²-(5-nitro-pyridin-2-yl)-ethane-1,2-diamine (<b>25u</b>)</h4><div class="NLM_p">1-(2,4-Dichloro-phenyl)-2-imidazol-1-yl-ethanone (<b>23</b>) was prepared following a variation of the method described by Sakurai et al.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> A solution of 2,4-dichlorophenacyl chloride (<b>21b</b>) (1.42 g, 6.4 mmol) and imidazole (<b>22</b>) (1.18 g, 16.0 mmol) in toluene (40 mL) were heated at 75 Â°C with stirring for 2.25 h. The mixture was concentrated to dryness in vacuo. The residue was dissolved in dichloromethane (100 mL), washed with 5% aqueous potassium carbonate solution (10 mL), water (10 mL), and brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo. The crude product was purified by passage over a pad of silica gel (50 g), eluting with 5% methanol in dichloromethane to give 1.04 g (64%) of 1-(2,4-dichloro-phenyl)-2-imidazol-1-yl-ethanone (<b>23</b>) as an orange solid after drying in vacuo (HPLC, 95% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 255 [MH<sup>+</sup>]).</div><div class="NLM_p">A solution of 1-(2,4-dichloro-phenyl)-2-imidazol-1-yl-ethanone (<b>23</b>) (95 mg, 0.37 mmol) and DMFDMA (2 mL) was heated with stirring at 105 Â°C for 9 h. The solvent was removed in vacuo, and the residue (<b>24</b>) was dissolved in dry THF (2 mL) and added to a mixture of amino[2-[(5-nitro(2-pyridyl)amino]ethyl}carboxamidinium 4-methylbenzenesulfonate (<b>13</b>) (147 mg, 0.37 mmol) and cesium carbonate (200 mg, 0.6 mmol). The mixture was heated overnight at 80 Â°C then concentrated in vacuo. The residue was taken up in dichloromethane (50 mL), washed with saturated aqueous sodium bicarbonate (5 mL), water (5 mL), and brine (5 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo to give the crude product. The crude product was purified by radial chromatography on silica gel eluting with MeOH in dichloromethane to give 134 mg (77%) of <i>N</i>-[4-(2,4-dichloro-phenyl)-5-imidazol-1-yl-pyrimidin-2-yl]-<i>N</i>â²-(5-nitro-pyridin-2-yl)-ethane-1,2-diamine (<b>25u</b>) as a yellow solid (HPLC, 96% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 471 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 8.86 (br s, 1H), 8.47 (br s, 1H), 8.22 (br s, 1H), 8.19 (br s, 1H), 7.91 (br s, 1H), 7.57 (d, <i>J</i> = 42 Hz, 2H), 7.48 (s, 1H), 6.93 (d, <i>J</i> = 42 Hz, 2H), 6.58 (br s, 1H), 3.75â3.21 (br m, 4H). Anal. (C<sub>20</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>8</sub>O<sub>2</sub>) Calcd: C, 50.97; H, 3.42; N, 23.78; O, 6.79; Cl: 15.04, Found: C, 50.41; H, 3.39; N, 22.83; O, 10.24; Cl, 13.85.</div><div class="NLM_p last">Compounds <b>25b</b>â<b>25w</b> were prepared by similar procedures as <b>25u</b>. Identity and purity were minimally assessed by HPLC and HPLC/MS.</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 4-{2-[2-(5-Nitro-pyridin-2-ylamino)-ethylamino]-5-[1,2,4]triazol-1-yl-pyrimidin-4-yl}-benzonitrile (<b>26</b>)</h4><div class="NLM_p">Following a variation of the method described in by Sakurai et al.,<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> a solution of 4-cyanophenacyl bromide (0.72 g, 3.2 mmol) and 1<i>H</i>-[1,2,4]triazole (0.55 g, 8 mmol) in toluene (20 mL) was heated at 75 Â°C for 2.5 h. The mixture was concentrated to dryness in vacuo. The residue was dissolved in dichloromethane (60 mL) and washed with a 5% aqueous potassium carbonate solution (2 Ã 10 mL) and water (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo to give 0.35 g (74%) of 4-(2-[1,2,4]triazol-1-yl-acetyl)-benzonitrile as an off-white solid which was used in its subsequent reaction without further purification (HPLC, 98% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 213 [MH<sup>+</sup>]).</div><div class="NLM_p last">A solution of 4-(2-[1,2,4]triazol-1-yl-acetyl)-benzonitrile (64 mg, 0.3 mmol) in DMFDMA (1 mL) was heated at 105 Â°C with stirring for 8 h. The solvent was removed in vacuo, and the residue was dissolved in dry THF (2 mL). The resulting solution was added to a mixture of amino[2-[(5-nitro(2-pyridyl)amino]ethyl}carboxamidinium 4-methylbenzenesulfonate (<b>13</b>) (120 mg, 0.3 mmol), cesium carbonate (326 mg, 1.0 mmol), and THF (15 mL). The reaction was heated overnight at 80 Â°C, then concentrated in vacuo, redissolved in dichloromethane (60 mL), washed with a saturated sodium bicarbonate solution (10 mL) and brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo to give the crude yellow product. The organic layer was concentrated in vacuo. The residue was purified by crystallization ethanol/water to give 47 mg (35%) of <b>26</b> as a yellow solid (HPLC, 98% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 429 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 8.90 (s, 1H), 8.64 (s, 1H), 8.45 (s, 1H), 8.38 (d, <i>J</i> = 10 Hz, 1H), 8.30 (s, 1H), 8.22 (d, <i>J</i> = 12 Hz, 2H), 7.75 (d, <i>J</i> = 10 Hz, 2H), 6.65 (d, <i>J</i> = 10 Hz, 1H), 3.62â3.44 (m, 4H).</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> 1-(2,4-Dichloro-phenyl)-2-(1<i>H</i>-imidazol-2-yl)-ethanone (<b>30a</b>)</h4><div class="NLM_p last">Using procedures similar to those described by Macco et al.,<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42-44)</a> a solution of 2,4-dichlorobenzoyl chloride (<b>27</b>) (153 g, 731 mmol) in dichloromethane (75 mL) was added dropwise over 30 min to a stirred solution of 2-methylimidazole (<b>28</b>) (20 g, 244 mmol) in dichloromethane (500 mL) (The imidazole was heated to dissolve it in CH<sub>2</sub>Cl<sub>2</sub>) and <i>N</i>,<i>N</i>-diisopropylethylamine (HÃ¼nigâs base) (101 g, 780 mmol). The reaction mixture was cooled during the addition using an iceâwater bath. The ice bath was used to keep the reaction from refluxing. Precooling caused the imidazole to precipitate. The reaction mixture was then heated to reflux for 3.5 h. A thick reddish-black mixture formed. To dilute the thick heterogeneous reaction, additional dichloromethane (100â200 mL) was added as needed to maintain stirring. On cooling, dichloromethane (500 mL) was added, and the solution was transferred to a separatory funnel. The organic layer was washed with distilled water (3 Ã 200 mL). An emulsion formed that broke apart on sitting for 15 min or by filtering. The wet organic layer was directly concentrated under reduced pressure without drying. The solid product was then dried in vacuo for several hours. To the resulting dry solid was added a solution of glacial acetic acid and aq concd HCl (2:1 v/v, 500â600 mL). The mixture was then stirred at reflux for ca. 75 min. The acetic acid was removed via rotary evaporator under reduced pressure at 60â80 Â°C. Distilled water (800 mL) and benzene (400 mL) were added to the solid residue, which was vigorously stirred for 15 min. The solids were filtered off, and the filtrate was transferred to a separatory funnel. After the organic layer was discarded, the aqueous layer was washed with benzene (4 Ã 150 mL). The aqueous layer was transferred to a large beaker (4 L) and diluted with isopropyl ether (100 mL), which was chosen as a solvent due to its high boiling point. The stirred mixture was basified (pH 7â8) by careful addition of sodium bicarbonate, which leads to the formation of a white solid. Do not use NaOH or any strong bases; this causes the formation of side products. After 2 h of additional stirring, the desired solid was filtered, washed with distilled water (3 Ã 60 mL) and isopropyl ether (2 Ã 60 mL), and dried in vacuo overnight, giving 35.0 g (56%) of 1-(2,4-dichloro-phenyl)-2-(1<i>H</i>-imidazol-2-yl)-ethanone (<b>30a</b>) (HPLC, 99% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 255 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 7.61 (d, <i>J</i> = 6 Hz, 2H), 7.43 (d, <i>J</i> = 6 Hz, 1H), 7.06 (s, 2 H), 5.74 (s, 1H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 160.4, 147.3, 135.8, 133.1, 131.3, 130.9, 129.3, 127.1, 118.3, 87.3.</div></div><div id="sec4_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> 1-(2,4-Dichloro-phenyl)-2-(4-methyl-1<i>H</i>-imidazol-2-yl)-ethanone (<b>30b</b>)</h4><div class="NLM_p last">Prepared by a method similar to that of Macco,<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42-44)</a> a solution of 2,4-dichlorobenzoyl chloride (<b>27</b>) (37.9 g, 181.0 mmol) in dichloromethane (25 mL) was added dropwise over 20 min to an overhead stirred solution of 2,4-dimethylimidazole (<b>29</b>) (5.8 g, 60.3 mmol) (the 2,4-dimethylimidazole (<b>29</b>) was heated to dissolve it in CH<sub>2</sub>Cl<sub>2</sub>) and <i>N</i>,<i>N</i>-diisopropylethylamine (HÃ¼nigâs base) (24.9 g, 193 mmol) in dichloromethane (75 mL). The reaction mixture was cooled during the addition using a water bath. The water bath was only used to keep the reaction from excessive refluxing. Precooling or excessive cooling may cause the imidazole to precipitate. The reaction mixture was then heated to reflux for 5 h. The reaction can turn a darker color. The product was stripped of solvent under reduced pressure, and the resulting solid was dried in vacuo for 1 h. To the resulting dry solid was added a solution (2:1 v/v, 120 mL) of glacial acetic acid and aq concd HCl. The mixture was then stirred at reflux for ca. 90 min. It is important to reflux the mixture at approximately 110â125 Â°C for 90 min or more as needed to completely break up the benzoyl intermediates. The acetic acid was removed via rotary evaporator. Upon cooling, distilled water (200 mL) and toluene (100 mL) were added to the solid residue, which was vigorously stirred for 30 min. The solids were filtered, rinsed with 50 mL of distilled water, and discarded. The filtrate was transferred to a separatory funnel. After the organic layer was discarded, the aqueous layer was washed with toluene (2 Ã 100 mL). The aqueous layer was transferred to a large beaker (2 L) and diluted with isopropyl ether (50 mL), which was used due to its higher boiling point. The stirred mixture was basified (pH 7â8) by careful addition of sodium bicarbonate, which led to the formation of a sticky white solid (do not use NaOH or any strong bases; this causes the formation of side products). Dichloromethane (200 mL) was added and stirring continued for 10 min. The organic layer was separated, and the aqueous layer was again extracted with dichloromethane (100 mL). The organic layers were combined and washed with satd aq NaHCO<sub>3</sub> (100 mL), distilled water (100 mL), and brine (100 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, concentrated, and dried in vacuo, giving 7.4 g (46%) of 1-(2,4-dichloro-phenyl)-2-(4-methyl-1<i>H</i>-imidazol-2-yl)-ethanone (<b>30b</b>) (HPLC, 99% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 269 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 70 Â°C) Î´ 7.60 (d, <i>J</i> = 8 Hz, 1H), 7.55 (s, 1H), 7.41 (d, <i>J</i> = 8 Hz, 1H), 6.71 (s, 1H), 5.68 (s, 1H), 3.21 (s, 1H), 2.18 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 70 Â°C) Î´ 160.3, 146.7, 135.9, 135.9, 132.7, 131.0, 130.5, 129.0, 126.7, 113.8, 86.7, 10.7.</div></div><div id="sec4_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> 1-(2,4-Dichloro-phenyl)-3-dimethylamino-2-(1<i>H</i>-imidazol-2-yl)-propenone (<b>31a</b>)</h4><div class="NLM_p last">A mixture of 1-(2,4-dichloro-phenyl)-2-(1<i>H</i>-imidazol-2-yl)-ethanone (<b>30a</b>) (15 g, 59 mmol) and <i>N</i>,<i>N</i>-dimethylformamide dimethyl acetal (DMFDMA) (150 mL) was stirred for 2.5 h at 70â75 Â°C. The DMFDMA was then removed under reduced pressure and dried under high vacuum for several hours, giving an orange-yellow solid <b>31a</b> in quantitative yield. The enaminone product <b>31a</b> was typically used without further purification. The product can be redissolved in solvent and evaporated several times to give a better solid. This can be done if the product is not fee flowing (HPLC, 99% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 310 [MH<sup>+</sup>]).</div></div><div id="sec4_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 1-(2,4-Dichloro-phenyl)-3-dimethylamino-2-(4-methyl-1<i>H</i>-imidazol-2-yl)-propenone (<b>31b</b>)</h4><div class="NLM_p last">A mixture of 1-(2,4-dichloro-phenyl)-2-(4-methyl-1<i>H</i>-imidazol-2-yl)-ethanone (<b>30b</b>) (2.22 g, 8.25 mmol) and <i>N</i>,<i>N</i>-dimethylformamide-dimethyl acetal (DMFDMA, <b>9</b>) (25 mL) was stirred for 2.5 h at 70â75 Â°C. The DMFDMA was then removed under reduced pressure and dried under high vacuum for several hours, giving a light-orange solid <b>31b</b> in quantitative yield. The enaminone product <b>31b</b> was typically used without further purification. The product can be redissolved in solvent and evaporated several times to give a better solid. This can be done if the product is not fee flowing (HPLC, 99% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 324 [MH<sup>+</sup>]).</div></div><div id="sec4_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> <i>N</i>-[2-(6-Amino-5-nitro-pyridin-2-ylamino)-ethyl]-guanidine (<b>32</b>)</h4><div class="NLM_p last">A mixture of 2-(2-aminoethyl)amino-6-amino-5-nitropyridine (prepared by similar procedures as <b>8</b>) (6.50 g, 33.0 mmol), 1<i>H</i>-pyrazole-1-carboxamidine hydrochloride (<b>6</b>) (4.84 g, 33.0 mmol), and acetonitrile (75 mL) were stirred overnight (ca. 24 h) at 75â80 Â°C. Upon cooling, a yellow precipitate was collected by filtration. The yellow solid was washed thoroughly with acetonitrile (3 Ã 50 mL) and ethyl ether (3 Ã 50 mL) and dried overnight in vacuo, giving 7.49 g (82%) of <i>N</i>-[2-(6-amino-5-nitro-pyridin-2-ylamino)-ethyl]-guanidine (<b>32</b>) as the HCl salt (HPLC, 92% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 240 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 7.93 (d, <i>J</i> = 9 Hz, 1H), 5.97 (d, <i>J</i> = 9 Hz, 1H), 3.48â3.39 (br m, 2H), 3.36â3.26 (br m, 2H).</div></div><div id="sec4_2_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> <i>N</i>-[2-(5-Cyano-pyridin-2-ylamino)-ethyl]-guanidine (<b>33</b>)</h4><div class="NLM_p last">A mixture of 6-(2-amino-ethylamino)-nicotinonitrile (see procedure below) (9.14 g, 56.4 mmol), 1<i>H</i> -pyrazole-1-carboxamidine hydrochloride (<b>6</b>) (8.26 g, 56.4 mmol), and acetonitrile (120 mL) were stirred ca. 24 h at 75â80 Â°C. Upon cooling, a precipitate was collected by filtration. The white solid was washed thoroughly with acetonitrile (2 Ã 100 mL) and ethyl ether (3 Ã 100 mL) and dried overnight in vacuo, giving 11.0 g (82%) of <i>N</i>-[2-(5-cyano-pyridin-2-ylamino)-ethyl]-guanidine (<b>33</b>) as the HCl salt (HPLC, 99% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 205 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 70 Â°C) Î´ 8.36 (d, <i>J</i> = 2 Hz, 1H), 7.90 (br s, 1H), 7.63 (dd, <i>J</i> = 9, 2 Hz, 1H), 7.34 (br s, 3H), 6.65 (d, <i>J</i> = 9 Hz, 1H), 3.45 (t, <i>J</i> = 5 Hz, 2H), 3.36 (t, <i>J</i> = 5 Hz, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 70 Â°C) Î´ 159.6, 157.1, 152.4, 138.2, 118.3, 108.5, 94.8, 40.0, 39.6.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 6-(2-Amino-ethylamino)-nicotinonitrile</h4><div class="NLM_p last">A mixture of 2-chloro-5-cyanopyridine (10.0 g, 72.2 mmol), acetonitrile (120 mL), and ethylene diamine (85 mL) were stirred overnight (ca. 16 h) at 75â80 Â°C under argon. Caution must be taken as the chloropyridine might need to be heated to completely dissolve. <i>When the diamine is added, this reaction can become exothermic!</i> The ethylene diamine was removed under reduced pressure and then dried in vacuo for 2â3 h. The residual solution was basified with 1 M sodium hydroxide solution (â¼100 mL). The aqueous solution was saturated with sodium chloride and extracted with a solution of ethyl acetate/methanol (95:5 v/v) (3 Ã 150 mL) and with a solution of 95% acetonitrile/methanol (95:5 v/v) (3 x150 mL). The organic extracts were combined and extracted with a saturated sodium chloride solution (2 Ã 70 mL). The organic layer was dried with sodium sulfate, filtered, and concentrated under reduced pressure. The crude white to tan solid was triturated with ether (2 Ã 50 mL) and dried overnight in vacuo, resulting in 9.14 g (78%) of 6-(2-amino-ethylamino)-nicotinonitrile (HPLC, 98% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 163 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 70 Â°C) Î´ 8.33 (d, <i>J</i> = 2 Hz, 1H), 7.60 (dd, <i>J</i> = 9, 2 Hz, 1H), 7.42 (br s, 1H), 6.56 (d, <i>J</i> = 9 Hz, 1H), 3.38â3.26 (m, 2H), 2.73 (t, <i>J</i> = 6 Hz, 2H), 1.98 (br s, 2H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>, 70 Â°C) Î´ 159.8, 152.4, 137.9, 118.5, 107.7, 94.0, 44.0, 40.7.</div></div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> 4-{5-(1<i>H</i>-Imidazol-2-yl)-2-[2-(5-nitro-pyridin-2-ylamino)-ethylamino]-pyrimidin-4-yl}-benzonitrile (<b>35a</b>)</h4><div class="NLM_p">A solution of 4-(2-imidazol-2-ylacetyl)benzenecarbonitrile (<b>30a</b>) (0.32 g, 1.5 mmol) (prepared from 4-cyano-benzoyl chloride (<b>27</b>) and 2-methylimidazole (<b>28</b>) according to the procedure described by Macco et al.<a onclick="showRef(event, 'ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref43 ref44">(42-44)</a>) and DMFDMA (15 mL) was stirred at reflux for 12 h. After concentration of this solution in vacuo, the residual solid was dissolved in DMF (15 mL). To the resulting solution was added Cs<sub>2</sub>CO<sub>3</sub> (0.98 g, 3.0 mmol) and (2-(5-nitro(2-pyridyl)amino]ethyl)carboxamidinium 4-methylbenzenesulfonate (<b>13</b>) (0.59 g, 1.5 mmol), and the mixture stirred for 8 h at 100 Â°C. The mixture was cooled, filtered and the filtrate diluted with ethyl acetate (100 mL), and washed with saturated aqueous sodium bicarbonate (2 Ã 10 mL), water (4 Ã 10 mL), and brine (10 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated in vacuo to give 513 mg (80%) of the product as a yellow solid (HPLC, 94% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 428 [MH<sup>+</sup>]).</div><div class="NLM_p last">Compounds <b>35b</b> and <b>36a</b>â<b>d</b> were synthesized by procedures similar to those used to produce <b>36a</b> with the exception that the correct 1-(substituted phenyl)-2-(1<i>H</i>-imidazol-2-yl)-ethanone (<b>30a</b>) was used to form the pyrimidine products. Identity and purity were minimally assessed by HPLC and HPLC/MS.</div></div><div id="sec4_3_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i64" class="anchor-spacer"></div><h4 class="article-section__title" id="_i64"> <i>N</i>-[4-(2,4-Dichloro-phenyl)-5-(1<i>H</i>-imidazol-2-yl)-pyrimidin-2-yl]-<i>N</i>â²-(5-nitro-pyridin-2-yl)-ethane-1,2-diamine (<b>36a</b>)</h4><div class="NLM_p last">A solution of sodium ethoxide (4.0 g, 58.8 mmol) dissolved in abs ethanol (100 mL) was added to a stirred mixture of enaminone <b>31a</b> (18.2 g, 58.8 mmol), guanidine <b>13</b> (15.6 g, 60.0 mmol), and abs ethanol (260 mL). The reaction was stirred at room temperature for 15 min and then at 75â80 Â°C for 2.5 h. On cooling, a yellow precipitate was collected by filtration. The filtrate was stored for possible further isolation and purification of <b>36a</b>. The solid product was washed with abs ethanol (3 Ã 50 mL), distilled water (3 Ã 50 mL), and ethyl ether (3 Ã 50 mL). The yellow solid was dried overnight in vacuo, giving 14.6 g (53%) of final product <i>N</i>-[4-(2,4-dichloro-phenyl)-5-(1<i>H</i>-imidazol-2-yl)-pyrimidin-2-yl]-<i>N</i>â²-(5-nitro-pyridin-2-yl)-ethane-1,2-diamine (<b>36a</b>) (HPLC, 99% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 471 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 8.84 (s, 1H), 8.62 (s, 1H), 8.21 (br s, 1 H), 8.01 (br s, 1H), 7.65 (s, 1H), 7.47 (s, 1H), 7.35 (d, <i>J</i> = 11 Hz, 2H), 6.90 (s, 2 H), 6.51 (br s, 1H), 4.12â305 (br m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 161.6, 161.3, 158.5, 158.0, 146.9, 141.9, 137.2, 134.4, 133.7, 132.6, 132.2, 131.7, 128.6, 127.2, 114.3, 108.8. HRMS (FAB+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>8</sub>O<sub>2</sub> [MH<sup>+</sup>] 471.0846, found 471.0859.</div></div><div id="sec4_3_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i65" class="anchor-spacer"></div><h4 class="article-section__title" id="_i65"> <i>N</i><sup>6</sup>-{2-[4-(2,4-Dichloro-phenyl)-5-(1<i>H</i>-imidazol-2-yl)-pyrimidin-2-ylamino]-ethyl}-3-nitro-pyridine-2,6-diamine (<b>36b</b>)</h4><div class="NLM_p last">A solution of sodium ethoxide (0.27 g, 4.00 mmol) dissolved in abs ethanol (8 mL) was added to a stirred mixture of 1-(2,4-dichloro-phenyl)-3-dimethylamino-2-(1<i>H</i>-imidazol-2-yl)-propenone (<b>31a</b>) (1.24 g, 4.00 mmol), <i>N</i>-[2-(6-amino-5-nitro-pyridin-2-ylamino)-ethyl]-guanidine <b>32</b> (1.13 g, 4.08 mmol), and abs ethanol (7 mL). The reaction was then heated to 75â80 Â°C for 2.5 h (<i>Note: use of excess base or heat can cause side products</i>). On cooling, a yellow precipitate was collected by filtration. The filtrate was stored for possible further isolation and purification of <b>36b</b>. The solid product was washed with abs ethanol (3 Ã 10 mL), distilled water (3 Ã 10 mL), and ethyl ether (3 Ã 10 mL). The yellow solid was dried overnight in vacuo, giving 1.36 g (70%) of final product <i>N</i><sup>6</sup>-{2-[4-(2,4-dichloro-phenyl)-5-(1<i>H</i>-imidazol-2-yl)-pyrimidin-2-ylamino]-ethyl}-3-nitro-pyridine-2,6-diamine (<b>36b</b>) (HPLC, 98% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 486 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 8.68 (d, <i>J</i> = 22 Hz, 1H), 8.41 (br s, 1H), 8.28 (br s, 1 H), 7.91 (dd, <i>J</i> = 26, 9 Hz, 2H), 7.68â7.42 (m, 5H), 5.95 (dd, <i>J</i> = 26, 9 Hz, 2H), 4.12â305 (br m, 4H). <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 9.40 (br s, 4H), 9.29 (s, 1H), 8.70 (s, 1H), 8.13 (d, <i>J</i> = 9 Hz, 1H), 7.70 (d, <i>J</i> = 9 Hz, 1H), 7.61 (s, 1H), 7.44 (s, 2 H), 7.34 (d, <i>J</i> = 3 Hz, 1H), 7.28 (dd, <i>J</i> = 9, 3 Hz, 1H), 6.27 (d, <i>J</i> = 9 Hz, 1H), 4.04â3.83 (br m, 4H). <sup>13</sup>C NMR (pyridine-<i>d</i><sub>5</sub>) Î´ 163.2, 162.1, 160.5, 156.8, 142.7, 136.5, 134.0, 133.8, 129.9, 128.1, 121.9, 119.7, 111.5, 42.1, 41.9. HRMS (FAB+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>18</sub>Cl<sub>2</sub>N<sub>9</sub>O<sub>2</sub> [MH<sup>+</sup>] 486.0955, found 486.0937.</div></div><div id="sec4_3_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i66" class="anchor-spacer"></div><h4 class="article-section__title" id="_i66"> 6-{2-[4-(2,4-Dichloro-phenyl)-5-(1<i>H</i>-imidazol-2-yl)-pyrimidin-2-ylamino]-ethylamino}-nicotinonitrile (<b>36c</b>)</h4><div class="NLM_p">A solution of 1-(2,4-dichloro-phenyl)-3-dimethylamino-2-(1<i>H</i>-imidazol-2-yl)-propenone (<b>31a</b>) (2.67 g, 8.25 mmol) in abs EtOH (10 mL) was added to a stirring and preheated solution of sodium ethoxide [(0.62 g, 8.66 mmol) (dissolved in abs ethanol (15 mL))], <i>N</i>-[2-(5-cyano-pyridin-2-ylamino)-ethyl]-guanidine (<b>33</b>) (2.18 g, 9.08 mmol), and abs ethanol (10 mL) at 75â80 Â°C. The reaction was then heated to 75â80 Â°C for 2.5 h. The reaction can be monitored by HPLC or by TLC by using 5% methanol in ethyl acetate as the solvent system. The product has UV activity in the long wavelength region. On cooling, the reaction was diluted with ethyl acetate (400 mL) washed with satd aq NaHCO<sub>3</sub> (100 mL), distilled water (2 Ã 100 mL), and brine (100 mL), dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under reduced pressure. Please note: Dry over Na<sub>2</sub>SO<sub>4</sub> for only 10â20 min. Longer times may cause the product to precipitate over the drying agent! The crude product ca. 2 g (â¼50â70% purity) was dried in vacuo, resulting in a hard tacky white glass. To the dry glass was added a solution of MeOH/Et<sub>2</sub>O (15:85 v/v) (10 mL). The glass was manipulated and stirred to break up any lumps of material until a fine suspension forms. The suspension was allowed to stand for 10â15 min and then filtered. The off-white solid was washed with a solution of MeOH/Et<sub>2</sub>O (10:90 v/v) (2 Ã 5 mL) and then with Et<sub>2</sub>O (2 Ã 5 mL). This procedure gave material in a purity range of 90â99% and ca. 50% yield. The compound can be purified further using a prep HPLC. Impure <b>36c</b> (1 g) was loaded onto a large prep HPLC in DMSO (4 mL) containing TFA (100 Î¼L). Using a C18 reverse phase column, the gradient was started at 90:10 H<sub>2</sub>O/CH<sub>3</sub>CN with a 1 mL/min gradient. After 45 min, the gradient reached 45:50 H<sub>2</sub>O/CH<sub>3</sub>CN. The compound typically eluted at about 20â25 min. 6-{2-[4-(2,4-Dichloro-phenyl)-5-(1<i>H</i>-imidazol-2-yl)-pyrimidin-2-ylamino]-ethylamino}-nicotinonitrile (<b>36c</b>) was obtained in high purity (99% pure) with yields between 25 and 45% (HPLC, 99% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 451 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 8.67 (d, <i>J</i> = 20 Hz, 1H), 7.75â7.43 (m, 6H), 6.62 (dd, <i>J</i> = 23, 9 Hz, 1H), 4.12â3.05 (br m, 4H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 163.3, 162.7, 162.5, 160.1, 159.3, 159.1, 151.9, 151.4, 140.6, 140.5, 139.0, 135.5, 134.0, 132.0, 131.8, 129.1, 128.9, 128.0, 120.2, 118.7, 118.5, 107.1, 106.9, 94.8. HRMS (FAB+): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>17</sub>Cl<sub>2</sub>N<sub>8</sub> [MH<sup>+</sup>] 451.0947, found 451.0937.</div><div class="NLM_p last">Compounds <b>37a</b> were synthesized by procedures similar to those used to produce <b>1</b> with the exception that the correct 1-(2,4-dichloro-phenyl)-2-(4-methyl-1<i>H</i>-imidazol-2-yl)-ethanone (<b>30b</b>) was used to form the pyrimidine products. Identity and purity were minimally assessed by HPLC and HPLC/MS.</div></div><div id="sec4_3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> <i>N</i><sup>2</sup>-(2-(4-(2,4-Dichlorophenyl)-5-(4-methyl-1<i>H</i>-imidazol-2-yl)pyrimidin-2-ylamino)ethyl)-5-nitropyridine-2,6-diamine (<b>37b</b>)</h4><div class="NLM_p last">Compound <b>37b</b> was synthesized by procedures similar to those used to produce <b>1</b>, with the exception that 2-(2-aminoethyl)amino-6-amino-5-nitropyridine was used to form the pyrimidine (HPLC, 99% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 500 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 8.67 (d, <i>J</i> = 21 Hz, 1H), 8.53 (br s, 1H), 8.25 (br s, 2H), 7.90 (dd, <i>J</i> = 29, 9 Hz, 1H), 7.62â7.43 (m, 3H), 7.29 (s, 1H), 5.97 (dd, <i>J</i> = 29, 9 Hz, 1H), 3.82â3.22 (br m, 4H), 2.23 (s, 3H). <sup>13</sup>C NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 163.6, 163.0, 160.5, 159.9, 158.9, 155.6, 154.9, 140.2, 135.9, 135.9, 135.5, 134.4, 132.6, 132.4, 130.4, 129.6, 128.4, 117.3, 107.7, 103.1, 41.3, 40.3, 10.9. HRMS (FAB+): <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>20</sub>Cl<sub>2</sub>N<sub>9</sub>O<sub>2</sub> [MH<sup>+</sup>] 500.1111, found 500.1106.</div></div><div id="sec4_3_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> Preparation of Polymer-Bound <i>N</i>-BOC-ethylenediamine (<b>40</b>)</h4><div class="NLM_p last">To a suspension of Merrifield resin (30 g, 21 mmol) and NMP (200 mL) was added 4-hydroxy-2-methoxybenzaldehyde (6.4 g, 42 mmol) and K<sub>2</sub>CO<sub>3</sub> (8.7 g, 63 mmol). The resulting mixture was heated at 120 Â°C with shaking for 16 h. The resulting light-brown mixture was filtered, and the resin was washed with H<sub>2</sub>O, NMP, and CH<sub>2</sub>Cl<sub>2</sub>. The resin was dried under vacuum at 40 Â°C for 12 h. To a suspension of the resin-bound aldehyde (30 g, 21 mmol) and (MeO)<sub>3</sub>CH (200 mL) was added <i>N</i>-BOC-ethylenediamine (6.7 mL, 42 mmol). The resulting mixture was shaken at 23 Â°C for 12 h, filtered, and washed with CH<sub>2</sub>Cl<sub>2</sub>. The resin-bound imine was used immediately, slightly moist, with CH<sub>2</sub>Cl<sub>2</sub>. To a suspension of the resin-bound imine (30 g, 21 mmol) and MeOH/CH<sub>2</sub>Cl<sub>2</sub>/HOAc (200 mL, 2:2:1) was added boraneâpyridine complex (6.8 mL, 67 mmol). The resulting mixture was shaken at 23 Â°C for 12 h, filtered, and washed with NMP and CH<sub>2</sub>Cl<sub>2</sub>. The resin was dried under vacuum at 30 Â°C for 12 h to yield polymer-bound <i>N</i>-BOC-ethylenediamine.</div></div><div id="sec4_3_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> Polymer-Bound (2-Aminoethyl)(5-nitro(2-pyridyl))amine (<b>41</b>)</h4><div class="NLM_p last">To a suspension of polymer-bound <i>N</i>-BOC-ethylenediamine (<b>40</b>) (30 g, 21 mmol), NMP (200 mL), and <i>i</i>-Pr<sub>2</sub>NEt (18.3 mL, 105 mmol) at 23 Â°C was added 2-chloro-5-nitropyridine (16.6 g, 105 mmol). The resulting mixture was heated at 120 Â°C with shaking for 12 h, filtered, and washed with NMP, H<sub>2</sub>O, and CH<sub>2</sub>Cl<sub>2</sub>. To the resin-bound, <i>N</i>-BOC-protected amine was added a solution of 2,6-lutidine and CH<sub>2</sub>Cl<sub>2</sub> (100 mL, 150 mmol), followed by a solution of TMSOTf and CH<sub>2</sub>Cl<sub>2</sub> (100 mL, 100 mmol). The resulting mixture was shaken at 23 Â°C for 3 h, filtered, and washed with MeOH, TEA, and CH<sub>2</sub>Cl<sub>2</sub>. The resin was air-dried to yield polymer-bound (2-aminoethyl)(5-nitro(2-pyridyl))amine. A sample of the reaction was checked for purity. The air-dried resin (10 mg) was suspended in 80% TFA/CH<sub>2</sub>Cl<sub>2</sub> (1 mL) for 1 h, filtered, washed with CH<sub>2</sub>Cl<sub>2</sub> (1 mL), and concentrated under a stream of air to yield a light-yellow residue (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 183 [MH<sup>+</sup>]).</div></div><div id="sec4_3_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> Polymer-Bound {2-[(5-Nitro(2-pyridyl))amino]ethyl}[(2-nitrophenyl)sulfonyl]amine (<b>42</b>)</h4><div class="NLM_p last">To a suspension of resin-bound (2-aminoethyl)(5-nitro(2-pyridyl))amine (<b>41</b>) (30 g, 21 mmol), CH<sub>2</sub>Cl<sub>2</sub> (250 mL), and <i>i</i>-Pr<sub>2</sub>NEt (18.3 mL, 105 mmol) at 23 Â°C was added 2-nitrobenzenesulfonyl chloride (23.3 g, 105 mmol). The resulting mixture was shaken at 23 Â°C for 6 h, filtered, washed with NMP, H<sub>2</sub>O, and CH<sub>2</sub>Cl<sub>2</sub> and air-dried to yield polymer-bound {2-[(5-nitro(2-pyridyl))amino]ethyl}[(2-nitrophenyl)sulfonyl]amine (<b>42</b>). A sample of the reaction was checked for purity. The air-dried resin (10 mg) was suspended in 80% TFA/CH<sub>2</sub>Cl<sub>2</sub> (1 mL) for 1 h, filtered, washed with CH<sub>2</sub>Cl<sub>2</sub> (1 mL), and concentrated under a stream of air to yield a light-yellow residue (HPLC, 98% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 368 [MH<sup>+</sup>]).</div></div><div id="sec4_3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i71" class="anchor-spacer"></div><h4 class="article-section__title" id="_i71"> Polymer-Bound [2-(Dimethylamino)ethyl]{2-[(5-nitro(2-pyridyl))amino]ethyl}[(2-nitrophenyl)sulfonyl]amine (<b>43b</b>)</h4><div class="NLM_p last">To a solution of Ph<sub>3</sub>P (11 g, 42 mmol) and CH<sub>2</sub>Cl<sub>2</sub> (20 mL) at 23 Â°C was added DIAD (6.6 mL, 42 mmol), and the resulting yellow solution was maintained at 23 Â°C for 30 min. To this solution was added 2-(dimethylamino)-ethanol (4.2 mL, 42 mmol), and the resulting solution was maintained at 23 Â°C for 5 min then added to a suspension of resin-bound {2-[(5-nitro(2-pyridyl))amino]ethyl}[(2-nitrophenyl)sulfonyl]amine (<b>42</b>) (3.0 g, 2.1 mmol) and CH<sub>2</sub>Cl<sub>2</sub> (30 mL). The resulting mixture was shaken at 23 Â°C for 12 h, filtered, washed with NMP, H<sub>2</sub>O, and CH<sub>2</sub>Cl<sub>2</sub>, and air-dried to yield polymer-bound [2-(dimethylamino)ethyl]{2-[(5-nitro(2-pyridyl))amino]ethyl}[(2-nitrophenyl)sulfonyl]amine (<b>43b</b>). A sample of the reaction was checked for purity. The air-dried resin (10 mg) was suspended in 80% TFA/CH<sub>2</sub>Cl<sub>2</sub> (1 mL) for 1 h, filtered, washed with CH<sub>2</sub>Cl<sub>2</sub> (1 mL), and concentrated under a stream of air to yield a light-yellow residue (HPLC, 98% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 439 [MH<sup>+</sup>]).</div></div><div id="sec4_3_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i72" class="anchor-spacer"></div><h4 class="article-section__title" id="_i72"> Polymer-Bound Dimethyl[2-({2-[(5-nitro(2-pyridyl))amino]ethyl}amino)ethyl]amine (<b>44b</b>)</h4><div class="NLM_p last">To a suspension of resin-bound [2-(dimethylamino)ethyl]{2-[(5-nitro(2-pyridyl))-amino]ethyl}[(2-nitrophenyl)sulfonyl]amine (<b>43b</b>) (3.0 g, 2.1 mmol) and DMF (30 mL) at 23 Â°C was added H<sub>2</sub>O (2 drops), K<sub>2</sub>CO<sub>3</sub> (2.9 g, 21 mmol), and PhSH (2.2 mL, 21 mmol). The resulting mixture was shaken at 23 Â°C for 12 h, filtered, washed with NMP, H<sub>2</sub>O, and CH<sub>2</sub>Cl<sub>2</sub>, and air-dried to yield polymer-bound dimethyl[2-({2-[(5-nitro(2-pyridyl))amino]-ethyl}amino)ethyl]amine (<b>44b</b>). A sample of the reaction was checked for purity. The air-dried resin (10 mg) was suspended in 80% TFA/CH<sub>2</sub>Cl<sub>2</sub> (1 mL) for 1 h, filtered, washed with CH<sub>2</sub>Cl<sub>2</sub> (1 mL), and concentrated under a stream of air to yield a light-yellow residue (HPLC, 98% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 254 [MH<sup>+</sup>]).</div></div><div id="sec4_3_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i73" class="anchor-spacer"></div><h4 class="article-section__title" id="_i73"> Polymer-Bound Amino[2-(dimethylamino)ethyl]{2-[(5-nitro(2-pyridyl))amino]ethyl}carboxamidine Hydrochloride (<b>45b</b>)</h4><div class="NLM_p last">To a suspension of polymer-bound dimethyl[2-({2-[(5-nitro(2-pyridyl))amino]-ethyl}amino)ethyl]amine (<b>44b</b>) (3.0 g, 2.1 mmol), NMP (30 mL), and iPr<sub>2</sub>NEt (3.7 mL, 21 mmol) at 23 Â°C was added 1<i>H</i>-pyrazole-1-carboxamidine hydrochloride (3.1 g, 21 mmol). The resulting mixture was heated at 90 Â°C for 18 h, filtered, washed with NMP, H<sub>2</sub>O, and CH<sub>2</sub>Cl<sub>2</sub>, and air-dried to yield polymer-bound amino[2-(dimethylamino)ethyl]{2-[(5-nitro(2-pyridyl))amino]ethyl}carboxamidine hydrochloride (<b>45b</b>). A sample of the reaction was checked for purity. The air-dried resin (10 mg) was suspended in 80% TFA/CH<sub>2</sub>Cl<sub>2</sub> (1 mL) for 1 h, filtered, washed with CH<sub>2</sub>Cl<sub>2</sub> (1 mL), and concentrated under a stream of air to yield a light-yellow residue (HPLC, 96% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 296 [MH<sup>+</sup>]).</div></div><div id="sec4_3_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i74" class="anchor-spacer"></div><h4 class="article-section__title" id="_i74"> <i>N</i>-[4-(2,4-Dichloro-phenyl)-5-imidazol-1-yl-pyrimidin-2-yl]-<i>N</i>-(2-dimethylamino-ethyl)-<i>N</i>â²-(5-nitro-pyridin-2-yl)-ethane-1,2-diamine (<b>46b</b>)</h4><div class="NLM_p">To a suspension of resin-bound amino[2-(dimethylamino)ethyl]{2-[(5-nitro(2-pyridyl))amino]ethyl}-carboxamidine hydrochloride (<b>45b</b>) (3.0 g, 2.1 mmol), and NMP (30 mL) at 23 Â°C was added 7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene (MTBD) (1.5 mL, 10.5 mmol) and 1-(2,4-dichlorophenyl)-3-(dimethylamino)-2-imidazolylprop-2-en-1-one (<b>24</b>) (1.3 g, 4.2 mmol). The resulting mixture was heated at 120 Â°C for 20 h, filtered, washed with NMP, H<sub>2</sub>O, and CH<sub>2</sub>Cl<sub>2</sub>, and air-dried to yield resin-bound [4-(2,4-dichlorophenyl)-5-imidazolylpyrimidin-2-yl][2-(dimethylamino)-ethyl]{2-[(5-nitro(2-pyridyl))amino]ethyl}amine (<b>46b</b>). The resin was suspended in 80% TFA/CH<sub>2</sub>Cl<sub>2</sub> (30 mL) and shaken at 23 Â°C for 1.5 h, filtered, and concentrated in vacuo. The resulting crude material was purified by reversed-phase HPLC (gradient of 95:5 H<sub>2</sub>O:MeCN to 5:95 H<sub>2</sub>O:MeCN), and the recovered material was dissolved in MeCN/0.5 M HCl (3 mL, 1:1), frozen, and lyophilized to yield 182 mg (16%) of <b>46b</b> as a yellow solid HCl salt (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 542 [MH<sup>+</sup>]).</div><div class="NLM_p last">Compounds <b>46a</b>,<b>c</b>â<b>h</b> were prepared by similar procedures as <b>46b</b>. Identity and purity were minimally assessed by HPLC and HPLC/MS.</div></div><div id="sec4_3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i75" class="anchor-spacer"></div><h4 class="article-section__title" id="_i75"> Preparation of <i>N</i>-[4-(2,4-Dichloro-phenyl)-5-imidazol-1-yl-pyrimidin-2-yl]-<i>N</i>â²-(5-nitro-pyridin-2-yl)-<i>N</i>-(2-pyrrolidin-1-yl-ethyl)-ethane-1,2-diamine (<b>46c</b>)</h4><div class="NLM_p last">Compound <b>46c</b> was made using the same procedures as for <b>46b</b> except that 2-pyrrolidin-1-yl-ethanol was used to give 2 mg of the product as a yellow solid HCl salt in 10% yield (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 568 [MH<sup>+</sup>]).</div></div><div id="sec4_3_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i76" class="anchor-spacer"></div><h4 class="article-section__title" id="_i76"> <i>N</i>-[4-(2,4-Dichloro-phenyl)-5-imidazol-1-yl-pyrimidin-2-yl]-<i>N</i>-(2-morpholin-4-yl-ethyl)-<i>N</i>â²-(5-nitro-pyridin-2-yl)-ethane-1,2-diamine (<b>46e</b>)</h4><div class="NLM_p last">Compound <b>46e</b> was made using the same procedures as for <b>46b</b> except that 4-(2-hydroxyethyl)morpholine was used to give the product as a yellow solid HCl salt (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 584 [MH<sup>+</sup>]).</div></div><div id="sec4_3_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i77" class="anchor-spacer"></div><h4 class="article-section__title" id="_i77"> <i>N</i>-(2-Aminoethyl)(<i>tert</i>-butoxy)carboxamide (<b>47</b>)</h4><div class="NLM_p last">A solution of <i>tert</i>-butyl [(<i>tert</i>-butyl)oxycarbonyloxy]formate (Boc<sub>2</sub>O) (181.1 g, 0.83 mol) in dichloromethane (1 L) was added slowly (3 h) to a mechanically stirred solution of ethylene diamine (250 g, 4.16 mol) in dichloromethane (2.5 L) at room temperature. After 24 h, the reaction solution was washed with water (3 Ã 500 mL) and brine (500 mL), dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The pure <i>N</i>-(2-aminoethyl)(<i>tert</i>-butoxy)carboxamide (<b>47</b>) (66.5 g, 50%) was obtained as a thick clear syrup and was used in its subsequent reactions without further purification (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 161 [MH<sup>+</sup>]). Note: Upon standing, a white precipitate forms which is a disproportionated product, diBoc ethylene diamine. The diBoc ethylene diamine can be removed by adding ACN to make a free-flowing suspension which was then filtered. Excess ACN and ethylene diamine can be removed in vacuo.</div></div><div id="sec4_3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i78" class="anchor-spacer"></div><h4 class="article-section__title" id="_i78"> <i>N</i>-[2-(Amidinoamino)ethyl](<i>tert</i>-butoxy)carboxamide, Hydrochloride (<b>48</b>)</h4><div class="NLM_p last">Portions of solid 1<i>H</i> -pyrazole-1-carboxamidine hydrochloride (91.10 g, 0.62 mol)) are added to a stirred solution of <i>N</i>-(2-aminoethyl)(<i>tert</i>-butoxy)carboxamide (<b>47</b>) (99.3 g, 0.62 mol) in CH<sub>3</sub>CN (1 L) at 80 Â°C. After 24 h, the reaction was stripped of solvent under reduced pressure. The residue was triturated with ether (3 Ã 100 mL) and dried in vacuo. The <i>N</i>-[2-(amidinoamino)ethyl](<i>tert</i>-butoxy)carboxamide hydrochloride (<b>48</b>) was obtained in approximately 100% yield containing a small amount of pyrazole. The <i>N</i>-[2-(amidinoamino)ethyl](<i>tert</i>-butoxy)carboxamide (<b>48</b>) hydrochloride was used without further purification (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 203 [MH<sup>+</sup>]).</div></div><div id="sec4_3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i79" class="anchor-spacer"></div><h4 class="article-section__title" id="_i79"> {2-[4-(2,4-Dichloro-phenyl)-5-imidazol-1-yl-pyrimidin-2-ylamino]-ethyl}-carbamic Acid <i>tert</i>-Butyl Ester (<b>49</b>)</h4><div class="NLM_p last">1-(2,4-Dichloro-phenyl)-3-dimethylamino-2-imidazol-1-yl-propenone (<b>24</b>) (9.3 g, 30.0 mmol) in NMP (5 mL) was added to a stirred mixture of <i>N</i>-[2-(amidinoamino)ethyl](<i>tert</i>-butoxy)carboxamide hydrochloride (<b>48</b>) (13.8 g, 45 mmol)) and Cs<sub>2</sub>CO<sub>3</sub> (11.72, 36.0 mmol) in NMP (15 mL). The reaction was heated to 100 Â°C for 48 h. The reaction was followed by HPLC. Upon completion, the reaction was partitioned with water (50 mL) and dichloromethane (250 mL). The organic layer was separated and washed with water (2 Ã 50 mL) and brine (50 mL), dried Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The product was purified by flash chromatography eluting with 10% methanol in dichloromethane. After stripping off the solvents and drying in vacuo, 11.2 g (83%) of <b>49</b> was obtained as a dark-red glass (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 449 [MH<sup>+</sup>]). <sup>1</sup>H NMR (CDCl<sub>3</sub>) Î´ 8.33 (s, 1H), 7.37 (d, <i>J</i> = 15 Hz, 1H), 7.29â7.23 (m, 2H), 7.17 (d, <i>J</i> = 9 Hz, 1H), 7.03 (s, 1H), 6.77 (s, 1H), 5.82 (br s, 1H), 4.89 (br s, 1H), 3.68â3.52 (br m, 2H), 3.44â3.35 (br m, 2H), 1.43 (s, 9H).</div></div><div id="sec4_3_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i80" class="anchor-spacer"></div><h4 class="article-section__title" id="_i80"> <i>N</i><sup>1</sup>-[4-(2,4-Dichloro-phenyl)-5-imidazol-1-yl-pyrimidin-2-yl]-ethane-1,2-diamine (<b>50</b>)</h4><div class="NLM_p">Aqueous 3 M HCl (15â30 mL) was added to a stirred solution of {2-[4-(2,4-dichloro-phenyl)-5-imidazol-1-yl-pyrimidin-2-ylamino]-ethyl}-carbamic acid <i>tert</i>-butyl ester (<b>49</b>) (3.3 g, 7.4 mmol) in CH<sub>3</sub>CN (50 mL) at room temperature until the reaction became slightly turbid. After 16 h, the reaction was partitioned between dichloromethane (200 mL) and 1 M HCl (200 mL). The layers were separated, and the aqueous layer was extracted with dichloromethane (3 Ã 200 mL). The aqueous layer was basified carefully with solid NaHCO<sub>3</sub> to pH 7â8. A solid forms which can be filtered and dissolved in CH<sub>3</sub>CN (100 mL). The organic solution is washed with satd aq NaHCO<sub>3</sub> (50 mL) and brine (50 mL), dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by flash chromatography over silica gel. The column was eluted first with a 1:1 mixture of dichloromethane/methanol followed by a mixture of 5% TEA/10% water/85% methanol to elute the product. The proper fractions were condensed. The dark-yellow glass was dried overnight in vacuo, giving 2 g (77%) of final product <b>50</b> (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 349 [MH<sup>+</sup>]).</div><div class="NLM_p last">Compounds <b>51a</b>,<b>c</b>,<b>e</b>â<b>s</b> were synthesized by procedures similar to those used to produce <b>51d</b>. Identity and purity were minimally assessed by HPLC and HPLC/MS.</div></div><div id="sec4_3_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i81" class="anchor-spacer"></div><h4 class="article-section__title" id="_i81"> 6-(2-(4-(2,4-Dichlorophenyl)-5-(1<i>H</i>-imidazol-1-yl)pyrimidin-2-ylamino)ethylamino)pyridine-3-carbonitrile (<b>51b</b>)</h4><div class="NLM_p last">Compound <b>51b</b> was synthesized by procedures similar to those used to produce <b>51d</b>. (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 451 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 8.48 (br s, 1H), 8.37 (br s, 1H), 7.88 (br s, 1H), 7.69 (br s, 1H), 7.62 (s, 1H), 7.51 (d, <i>J</i> = 42 Hz, 2H), 6.93 (d, <i>J</i> = 42 Hz, 2H), 6.57 (br s, 1H), 3.62â3.21 (br m, 4H). Anal. (C<sub>21</sub>H<sub>16</sub>Cl<sub>2</sub>N<sub>8</sub>) Calcd: C, 55.89; H, 3.57; N, 24.83; Cl: 15.71, Found: C, 54.08; H, 3.54; N, 23.97; Cl, 15.55.</div></div><div id="sec4_3_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i82" class="anchor-spacer"></div><h4 class="article-section__title" id="_i82"> <i>N</i>-[4-(2,4-Dichloro-phenyl)-5-imidazol-1-yl-pyrimidin-2-yl]-<i>N</i>â²-(6-methoxy-5-nitro-pyridin-2-yl)-ethane-1,2-diamine (<b>51d</b>)</h4><div class="NLM_p last">To a solution of <i>N</i><sup>1</sup>-[4-(2,4-dichloro-phenyl)-5-imidazol-1-yl-pyrimidin-2-yl]-ethane-1,2-diamine (<b>50</b>) (20 mg, 0.06 mmol) in DMF (1 mL), 2-methoxy-3-nitro-6-chloro-pyridine (see procedure below) (8.3 mg, 0.04 mmol), and diisopropylethyl amine (31 Î¼L, 0.18 mmol) were added. The reaction mixture was stirred for 12 h at 80 Â°C. The crude mixture was concentrated in vacuo and subjected to column chromatography (10% methanol in methylene chloride) to afford 10 mg (50%) <i>N</i>-[4-(2,4-dichloro-phenyl)-5-imidazol-1-yl-pyrimidin-2-yl]-<i>N</i>â²-(6-methoxy-5-nitro-pyridin-2-yl)-ethane-1,2-diamine (<b>51d</b>) as bright-yellow solid (HPLC, 96% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 501 [MH<sup>+</sup>]).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i83" class="anchor-spacer"></div><h4 class="article-section__title" id="_i83"> 6-Chloro-2-methoxy-3-nitro-pyridine</h4><div class="NLM_p last">To a suspension of sodium hydride (684 mg, 28.49 mmol) in xylene (100 mL), methanol (0.98 mL, 25.9 mmol) in xylene (30 mL) was added under nitrogen. The mixture was stirred for 20 min. A solution of 2,6-dichloro-3-nitropyridine (5.0 g, 25.9 mmol) in xylene (100 mL) was added to the reaction mixture and stirred at room temperature overnight. Water (50 mL) was added and the organic layer was separated. The organics was washed with water (1 Ã 50 mL) and brine (2 Ã 50 mL), dried, and concentrated in vacuo. The crude product was purified by flash chromatography (10:1 methylene chloride and acetone) to provide 4.4 g (90%) of the desired compound, 6-chloro-2-methoxy-3-nitro-pyridine, as the only isomer as light-yellow solid (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 189 [MH<sup>+</sup>]).</div></div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i84" class="anchor-spacer"></div><h4 class="article-section__title" id="_i84"> 2-[2-(2,4-Dichlorophenyl)-2-oxoethyl]isoindoline-1,3-dione (<b>57</b>)</h4><div class="NLM_p last">A solution of 2,4-dichlorophenacyl chloride (<b>21b</b>) (223 mg, 1 mmol) in DMF (5 mL) was added dropwise to a mixture of phthalimide (<b>56</b>) (294 mg, 2 mmol) and Cs<sub>2</sub>CO<sub>3</sub> (652 mg, 2 mmol) in DMF (10 mL) at room temperature. After 14 h, the reaction was concentrated in vacuo and then purified by trituration with diethyl ether to obtain 0.317 g (95%) 2-[2-(2,4-dichlorophenyl)-2-oxoethyl]isoindoline-1,3-dione (<b>57</b>) (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 334 [MH<sup>+</sup>]).</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i85" class="anchor-spacer"></div><h4 class="article-section__title" id="_i85"> 2-{2-(2,4-Dichlorophenyl)-1-[(dimethylamino)methylene]-2-oxoethyl}isoindoline-1,3-dione (<b>58</b>)</h4><div class="NLM_p last">A solution of 2-[2-(2,4-dichlorophenyl)-2-oxoethyl]isoindoline-1,3-dione (<b>57</b>) (334 mg, 1 mmol) was heated to 80 Â°C in neat <i>N</i>,<i>N</i>-dimethylformamidedimethyl (DMFDMA) acetal (10 mL) for 6 h. The reaction mixture was concentrated in vacuo and purified by trituration with diethyl ether to obtain 0.378 g (97%) of 2-{2-(2,4-dichlorophenyl)-1-[(dimethylamino)methylene]-2-oxoethyl}-isoindoline-1,3-dione (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 389 [MH<sup>+</sup>]).</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i86" class="anchor-spacer"></div><h4 class="article-section__title" id="_i86"> 2-[2-({2-[(6-Amino-5-nitro(2-pyridyl))amino]ethyl}amino)-4-(2,4-dichlorophenyl)pyrimidin-5-yl]isoindoline-1,3-dione (<b>59</b>)</h4><div class="NLM_p last">A mixture of 2-{2-(2,4-dichlorophenyl)-1-[(dimethylamino)methylene]-2-oxoethyl}isoindoline-1,3-dione (<b>58</b>) (334 mg, 1 mmol), amino{2-[(6-amino-5-nitro(2-pyridyl))amino]ethyl}carboxamidine (<b>32</b>) (240 mg, 1 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (978 mg, 3 mmol) in DMF (10 mL) were stirred at 90 Â°C for 14 h. The reaction mixture was concentrated in vacuo, diluted with water (20 mL), and extracted with ethyl acetate (50 mL). The solution was extracted with ethyl acetate (3 Ã 25 mL), dried over sodium sulfate, filtered, and concentrated under reduced pressure to obtain a mixture of the desired product (<b>59</b>) and half-hydrolyzed open phthalimide that was cyclized to the desired compound by refluxing the mixture in glacial acetic acid for 4 h and then concentrated in vacuo to obtain 0.367 g (65%) of 2-[2-({2-[(6-amino-5-nitro(2-pyridyl))amino]ethyl}amino)-4-(2,4-dichlorophenyl)pyrimidin-5-yl]isoindoline-1,3-dione (<b>59</b>) (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 565 [MH<sup>+</sup>]).</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i87" class="anchor-spacer"></div><h4 class="article-section__title" id="_i87"> <i>N</i><sup>2</sup>-[2-(6-Amino-5-nitro-pyridin-2-ylamino)-ethyl]-4-(2,4-dichloro-phenyl)-pyrimidine-2,5-diamine (<b>60a</b>)</h4><div class="NLM_p last">A solution of 2-[2-({2-[(6-amino-5-nitro(2-pyridyl))amino]ethyl}amino)-4-(2,4-dichlorophenyl)pyrimidin-5-yl]isoindoline-1,3-dione (<b>59</b>) (565 mg, 1 mmol) and hydrazine (641 mg, 20 mmol) in ethanol (10 mL) were stirred at 75 Â°C for 2 h. The resulting mixture of crude product and 2-amino-isoindole-1,3-dione was purified by column chromatography eluting with 5% methanol/methylene chloride gave 0.39 g (90%) <i>N</i><sup>2</sup>-[2-(6-amino-5-nitro-pyridin-2-ylamino)-ethyl]-4-(2,4-dichloro-phenyl)-pyrimidine-2,5-diamine (<b>60a</b>) (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 435 [MH<sup>+</sup>]).</div></div><div id="sec4_4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i88" class="anchor-spacer"></div><h4 class="article-section__title" id="_i88"> <i>N</i>-[2-[2-(6-Amino-5-nitro-pyridin-2-ylamino)-ethylamino]-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-methanesulfonamide (<b>60b</b>)</h4><div class="NLM_p last">A solution of <i>N</i><sup>2</sup>-[2-(6-amino-5-nitro-pyridin-2-ylamino)-ethyl]-4-(2,4-dichloro-phenyl)-pyrimidine-2,5-diamine (<b>60a</b>) (435 mg, 1 mmol) and methanesulfonic anhydride (174 mg, 1 mmol) in THF (10 mL) were stirred at 25 Â°C for 4 h. The reaction mixture was concentrated in vacuo, diluted with water (10 mL), and extracted with ethyl acetate (30 mL). The solution was extracted with ethyl acetate (3 Ã 10 mL), dried over sodium sulfate, filtered, concentrated under reduced pressure, and purified by column chromatography eluting with 5% methanol/methylene chloride to obtain 0.33 g (65%) of <i>N</i>-[2-[2-(6-amino-5-nitro-pyridin-2-ylamino)-ethylamino]-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-methanesulfonamide (<b>60b</b>) (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 513 [MH<sup>+</sup>]).</div></div><div id="sec4_4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i89" class="anchor-spacer"></div><h4 class="article-section__title" id="_i89"> <i>N</i>-[2-[2-(6-Amino-5-nitro-pyridin-2-ylamino)-ethylamino]-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-acetamide (<b>60c</b>)</h4><div class="NLM_p">A solution of <i>N</i><sup>2</sup>-[2-(6-amino-5-nitro-pyridin-2-ylamino)-ethyl]-4-(2,4-dichloro-phenyl)-pyrimidine-2,5-diamine (<b>60a</b>) (435 mg, 1 mmol) and acetic anhydride (102 mg, 1 mmol) in THF (10 mL) was stirred at 25 Â°C for 4 h. The reaction mixture was concentrated in vacuo, diluted with water (10 mL), and extracted with ethyl acetate (30 mL). The solution was extracted with ethyl acetate (3 Ã 10 mL), dried over sodium sulfate, filtered, concentrated under reduced pressure, and purified by column chromatography eluting with 5% methanol/methylene chloride to obtain 0.405 g (85%) <i>N</i>-[2-[2-(6-amino-5-nitro-pyridin-2-ylamino)-ethylamino]-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-acetamide (<b>60c</b>) (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 477 [MH<sup>+</sup>]).</div><div class="NLM_p">Compounds <b>60d</b>â<b>f</b> were synthesized by procedures similar to those used to produce <b>60b</b>, with the exception that the acids were coupled with HBTU and <b>60f</b> was deprotected from the Boc-valine to final product with TFA in CH<sub>2</sub>Cl<sub>2</sub>. Identity and purity were minimally assessed by HPLC and HPLC/MS.</div><div class="NLM_p last">Compounds <b>60g</b>,<b>h</b> were synthesized by procedures similar to those used to produce <b>60b</b>, with the exception that the aniline <b>60a</b> was first reacted with carbonyldiimidazole and then the appropriate amine. Identity and purity were minimally assessed by HPLC and HPLC/MS.</div></div><div id="sec4_4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i90" class="anchor-spacer"></div><h4 class="article-section__title" id="_i90"> [2-[2-(6-Amino-5-nitro-pyridin-2-ylamino)-ethylamino]-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-methanol (<b>60i</b>)</h4><div class="NLM_p last">2-Chloro-5-nitro-6-aminopyridine (143 mg, 0.9 mmol) was added to a stirred suspension of [2-(2-amino-ethylamino)-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-methanol tri-TFA salt (see procedure below) (540 mg, 0.9 mmol) and cesium carbonate (1.47 g, 4.50 mmol) in anhydrous THF (3 mL) at 25 Â°C. To the resulting mixture was heated at 70 Â°C for 18 h. The reaction mixture was filtered, concentrated under reduced pressure, and the residue purified by column chromatography (silica gel, 5% methanol/methylene chloride) to give 216 mg (53%) of [2-[2-(6-amino-5-nitro-pyridin-2-ylamino)-ethylamino]-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-methanol (<b>60i</b>) as a yellow solid (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 450 [MH<sup>+</sup>]).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i91" class="anchor-spacer"></div><h4 class="article-section__title" id="_i91"> {2-[4-(2,4-Dichloro-phenyl)-5-hydroxymethyl-pyrimidin-2-ylamino]-ethyl}-carbamic Acid <i>tert</i>-Butyl Ester</h4><div class="NLM_p last">A solution of DIBAL-H (1 M in THF) (25 mL, 25.0 mmol) was added dropwise to a stirred suspension of ethyl 4-(2,4-dichlorophenyl)-2-({2-[(<i>tert</i>-butoxy)carbonylamino]ethyl}amino)pyrimidine-5-carboxylate (2.2 g, 4.7 mmol) (made from <b>48</b> and 3-(2,4-dichloro-phenyl)-3-oxo-propionic acid ethyl ester by procedures similar to those used to make compound <b>16</b> and <b>17</b>) in THF (10 mL) at room temperature under nitrogen. During the DIBAL-H addition, the suspension gradually turned into a homogeneous yellow solution. After 1 h, the resulting solution was heated to 70 Â°C for an additional 7 h. The reaction was then cooled, and the reaction was quenched by the addition of Rochelleâs salt. The resulting suspension was partitioned between CH<sub>2</sub>Cl<sub>2</sub> (150 mL) and water (30 mL). The aqueous layer was extracted twice with CH<sub>2</sub>Cl<sub>2</sub> (2 Ã 10 mL) and the combined organic layers washed with brine (30 mL), dried with sodium sulfate, and concentrated under reduced pressure to give 2.05 g of crude product as a yellow foam. Column chromatography on silica gel (110 g) using 5% methanol/ether as eluent gave 430 mg (22%) of {2-[4-(2,4-dichloro-phenyl)-5-hydroxymethyl-pyrimidin-2-ylamino]-ethyl}-carbamic acid <i>tert</i>-butyl ester as a colorless foam (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 413 [MH<sup>+</sup>]).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i92" class="anchor-spacer"></div><h4 class="article-section__title" id="_i92"> [2-(2-Amino-ethylamino)-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-methanol</h4><div class="NLM_p last">{2-[4-(2,4-Dichloro-phenyl)-5-hydroxymethyl-pyrimidin-2-ylamino]-ethyl}-carbamic acid <i>tert</i>-butyl ester (372 mg, 0.90 mmol) was dissolved in anhydrous trifluoroacetic acid (2 mL) and stirred at room temperature for 2 h. Evaporation of the solvent afforded 540 mg of [2-(2-amino-ethylamino)-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-methanol, as its trifluoroacetate salt, in approximately quantitative yield (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 313 [MH<sup>+</sup>]).</div></div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i93" class="anchor-spacer"></div><h4 class="article-section__title" id="_i93"> <i>N</i><sup>6</sup>-{2-[4-(2,4-Dichloro-phenyl)-5-morpholin-4-ylmethyl-pyrimidin-2-ylamino]-ethyl}-3-nitro-pyridine-2,6-diamine (<b>60j</b>)</h4><div class="NLM_p last">Solid 2-chloro-5-nitro-6-aminopyridine (11 mg, 0.06 mmol) was added to a suspension of <i>N</i><sup>1</sup>-[4-(2,4-dichloro-phenyl)-5-morpholin-4-ylmethyl-pyrimidin-2-yl]-ethane-1,2-diamine, as its trifluoroacetate salt (see procedure below) (40 mg, 0.06), and cesium carbonate (160 mg, 0.50 mmol) in anhydrous THF (3 mL) at 25 Â°C. To the resulting mixture was heated at 70 Â°C for 18 h. The reaction mixture was filtered, concentrated under reduced pressure, and the residue purified by column chromatography (silica gel, 5% methanol/methylene chloride) to afforded 191 mg (60%) of <i>N</i><sup>6</sup>-{2-[4-(2,4-dichloro-phenyl)-5-morpholin-4-ylmethyl-pyrimidin-2-ylamino]-ethyl}-3-nitro-pyridine-2,6-diamine (<b>60j</b>) as a yellow solid (HPLC, 99% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 519 [MH<sup>+</sup>]).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i94" class="anchor-spacer"></div><h4 class="article-section__title" id="_i94"> {2-[4-(2,4-Dichloro-phenyl)-5-formyl-pyrimidin-2-ylamino]-ethyl}-carbamic Acid <i>tert</i>-Butyl Ester</h4><div class="NLM_p last">Using the method of Swern, a solution of {2-[4-(2,4-dichloro-phenyl)-5-hydroxymethyl-pyrimidin-2-ylamino]-ethyl}-carbamic acid <i>tert</i>-butyl ester (100 mg, 0.24 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (3 mL) was added to a stirred solution of oxalyl chloride (31 Î¼L, 0.36 mmol) and DMSO (52 Î¼L, 0.73 mmol) in anhydrous CH<sub>2</sub>Cl<sub>2</sub> (5 mL) at â78 Â°C. After stirring for an additional 30 min at â78 Â°C, TEA (202 Î¼L, 1.45 mmol) was added. After 15 min, the resulting suspension was allowed to warm to room temperature. Water (1 mL) was added to the reaction and the layers separated. The aqueous layer was extracted with methylene chloride (1 Ã 3 mL), and the combined organic layers were dried (sodium sulfate) and filtered. The organic solution was concentrated at â¼25â30 Â°C to afford {2-[4-(2,4-dichloro-phenyl)-5-formyl-pyrimidin-2-ylamino]-ethyl}-carbamic acid <i>tert</i>-butyl ester as a light-yellow foam. This product proved to be air sensitive and was used quickly without further manipulation (HPLC, 95% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 411 [MH<sup>+</sup>]).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i95" class="anchor-spacer"></div><h4 class="article-section__title" id="_i95"> {2-[4-(2,4-Dichloro-phenyl)-5-morpholin-4-ylmethyl-pyrimidin-2-ylamino]-ethyl}-carbamic Acid <i>tert</i>-Butyl Ester</h4><div class="NLM_p last">A solution of sodium cyanoborohydride (1 M in THF) (242 Î¼L, 0.24 mmol) was added to a stirred solution of {2-[4-(2,4-dichloro-phenyl)-5-formyl-pyrimidin-2-ylamino]-ethyl}-carbamic acid <i>tert</i>-butyl ester (50 mg, 0.12 mmol), morpholine (62 mg, 0.72 mmol), and AcOH glacial (15 Î¼L) in THF (5 mL) at room temperature. After 5 min, the mixture was heated to 70 Â°C for 18 h. Following slow addition of water (1 mL), the mixture was partitioned between ethyl acetate (50 mL) and satd aq citric acid solution (10 mL). The organic layer was discarded, and aqueous layer was carefully basified with sodium hydroxide (10 M) to pH 9 then extracted with ethyl acetate (2 Ã 25 mL). The combined organic layers were dried (sodium sulfate), concentrated under reduced pressure, and purified by column chromatography (silica gel, 10% methanol/methylene chloride) to afford 30 mg (52%) of {2-[4-(2,4-dichloro-phenyl)-5-morpholin-4-ylmethyl-pyrimidin-2-ylamino]-ethyl}-carbamic acid <i>tert</i>-butyl ester (HPLC, 95% at 482 nm. HPLC/MS, <i>m</i>/<i>z</i> 411 [MH<sup>+</sup>]).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i96" class="anchor-spacer"></div><h4 class="article-section__title" id="_i96"> <i>N</i><sup>1</sup>-[4-(2,4-Dichloro-phenyl)-5-morpholin-4-ylmethyl-pyrimidin-2-yl]-ethane-1,2-diamine</h4><div class="NLM_p last">Using the conditions described above, {2-[4-(2,4-dichloro-phenyl)-5-morpholin-4-ylmethyl-pyrimidin-2-ylamino]-ethyl}-carbamic acid <i>tert</i>-butyl ester (30 mg, 0.06) was dissolved in anhydrous trifluoroacetic acid (2 mL) and stirred at room temperature for 2 h. Evaporation of the solvent afforded (40 mg, 0.06) of <i>N</i><sup>1</sup>-[4-(2,4-dichloro-phenyl)-5-morpholin-4-ylmethyl-pyrimidin-2-yl]-ethane-1,2-diamine, as its trifluoroacetate salt, in near quantitative yield (HPLC, 95% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 382 [MH<sup>+</sup>]).</div></div><div id="sec4_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i97" class="anchor-spacer"></div><h4 class="article-section__title" id="_i97"> <i>N</i>-(2-(5-Nitropyridin-2-ylamino)ethyl)-4-(2,4-dichlorophenyl)-5-(1<i>H</i>-tetrazol-1-yl)pyrimidin-2-amine (<b>60k</b>)</h4><div class="NLM_p last">This compound was prepared by similar procedures as compound <b>60p</b>, with the exceptions that 1-(2,4-dichloro-phenyl)-2-tetrazol-1-yl-ethanone was used to obtain 0.156g (32%) <i>N</i>-(2-(5-nitropyridin-2-ylamino)ethyl)-4-(2,4-dichlorophenyl)-5-(1<i>H</i>-tetrazol-1-yl)pyrimidin-2-amine (<b>60k</b>) (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 475 [MH<sup>+</sup>]).</div></div><div id="sec4_9_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i98" class="anchor-spacer"></div><h4 class="article-section__title" id="_i98"> <i>N</i>-[2-[2-(6-Amino-5-nitro-pyridin-2-ylamino)-ethylamino]-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-acetamide (<b>60m</b>)</h4><div class="NLM_p last">A solution of <i>N</i><sup>2</sup>-[2-(6-amino-5-nitro-pyridin-2-ylamino)-ethyl]-4-(2,4-dichloro-phenyl)-pyrimidine-2,5-diamine (<b>60a</b>) (400 mg, 0.9 mmol) in chloroform (2 mL) was coupled with 4-chloro-butyryl chloride (194 mg, 1.3 mmol) in the presence of disodium hydrogen phosphate pentahydrate (857 mg, 3.6 mmol). After stirring for 2 days at room temperature, the reaction solution was washed with 1 N sodium hydroxide solution (1 mL), and the crude reaction was treated with sodium ethoxide (330 mg, 4.5 mmol) in ethanol (2 mL). After 1 h, the reaction mixture was neutralized with 1 N HCl (pH 7) concentrated in vacuo, diluted with water (10 mL), and extracted with ethyl acetate (30 mL). The aqueous layer was extracted again with ethyl acetate (3 Ã 10 mL), the combined organic fractions were dried over sodium sulfate, filtered, concentrated under reduced pressure, and purified by column chromatography eluting with 5% methanol/methylene chloride to obtain 275 mg (60%) of <i>N</i>-[2-[2-(6-amino-5-nitro-pyridin-2-ylamino)-ethylamino]-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-acetamide (<b>60m</b>) (HPLC, 97% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 504.3 [MH<sup>+</sup>]).</div></div><div id="sec4_9_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i99" class="anchor-spacer"></div><h4 class="article-section__title" id="_i99"> 1-[2-[2-(6-Amino-5-nitro-pyridin-2-ylamino)-ethylamino]-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-piperazin-2-one (<b>60n</b>)</h4><div class="NLM_p">Starting from 2,4-dichlorophenacyl chloride (<b>21b</b>) and 3-oxo-piperazine-1-carboxylic acid <i>tert</i>-butyl ester in place of phthalimide, compound <b>60n</b> was synthesized in the same manner as <b>60a</b>. The Boc group was remove with TFA in CH<sub>2</sub>Cl<sub>2</sub> to give 1-[2-[2-(6-amino-5-nitro-pyridin-2-ylamino)-ethylamino]-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-piperazin-2-one (<b>60n</b>) in 36% overall yield (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 518 [MH<sup>+</sup>]).</div><div class="NLM_p last">Compound <b>60o</b> was synthesized by procedures similar to those used to produce <b>60n</b>, with the exception that the aniline of <b>60a</b> was reacted in sequence with bromoacetic acid, followed by bromine displacement by 2-methylamino-ethanol, which was cyclized through Mitsunobu employing Ph<sub>3</sub>P and DIAD to give the final product. Identity and purity were minimally assessed by HPLC and HPLC/MS.</div></div><div id="sec4_9_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i100" class="anchor-spacer"></div><h4 class="article-section__title" id="_i100"> <i>N</i><sup>6</sup>-{2-[4-(2,4-Dichloro-phenyl)-5-morpholin-4-yl-pyrimidin-2-ylamino]-ethyl}-3-nitro-pyridine-2,6-diamine (<b>60p</b>)</h4><div class="NLM_p last">A mixture of 1 mmol of 1-(2,4-dichloro-phenyl)-3-dimethylamino-2-morpholin-4-yl-propenone (see procedures below) (329 mg, 1 mmol), amino{2-[(6-amino-5-nitro(2-pyridyl))amino]ethyl}carboxamidine (<b>32</b>), and Cs<sub>2</sub>CO<sub>3</sub> (978 mg, 3 mmol) in DMF (10 mL) were stirred at 90 Â°C for 14 h. The reaction mixture was concentrated in vacuo, diluted with water (20 mL), and extracted with ethyl acetate (50 mL). The solution was extracted with ethyl acetate (3 Ã 25 mL) and dried over sodium sulfate, filtered, concentrated under reduced pressure, and purified by column chromatography eluting with 5% methanol/methylene chloride to obtain 0.404 g (80%) <i>N</i><sup>6</sup>-{2-[4-(2,4-dichloro-phenyl)-5-morpholin-4-yl-pyrimidin-2-ylamino]-ethyl}-3-nitro-pyridine-2,6-diamine (<b>60p</b>) (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 505 [MH<sup>+</sup>]).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i101" class="anchor-spacer"></div><h4 class="article-section__title" id="_i101"> 1-(2,4-Dichlorophenyl)-2-morpholin-4-ylethan-1-one</h4><div class="NLM_p last">A solution of 2,4-dichlorophenacyl chloride (<b>21b</b>) (223 mg, 1 mmol) in DMF (10 mL) was added dropwise to a stirred solution of morpholine (871 mg, 10 mmol) in DMF (10 mL) at room temperature. After 14 h, the reaction mixture was concentrated in vacuo, diluted with water (10 mL), and extracted with ethyl acetate (30 mL). The solution was extracted with ethyl acetate (3 Ã 10 mL), dried over sodium sulfate, filtered, concentrated under reduced pressure, and purified by column chromatography eluting with 50% ethyl acetate and 50% hexane to obtain 0.164 g (60%) 1-(2,4-dichlorophenyl)-2-morpholin-4-ylethan-1-one (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 274 [MH<sup>+</sup>]).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i102" class="anchor-spacer"></div><h4 class="article-section__title" id="_i102"> 1-(2,4-Dichloro-phenyl)-3-dimethylamino-2-morpholin-4-yl-propenone</h4><div class="NLM_p last">A solution of 1-(2,4-dichlorophenyl)-2-morpholin-4-ylethan-1-one (435 mg, 1 mmol) in <i>N</i>,<i>N</i>-dimethylformamidedimethyl acetal (DMFDMA) (10 mL) was stirred at 80 Â°C in for 6 h. The reaction mixture was concentrated in vacuo and purified by trituration with diethyl ether to obtain 0.316 g (96%) 1-(2,4-dichloro-phenyl)-3-dimethylamino-2-morpholin-4-yl-propenone (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 329 [MH<sup>+</sup>]).</div></div><div id="sec4_11_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i103" class="anchor-spacer"></div><h4 class="article-section__title" id="_i103"> <i>N</i><sup>6</sup>-{2-[4-(2,4-Dichloro-phenyl)-5-piperazin-1-yl-pyrimidin-2-ylamino]-ethyl}-3-nitro-pyridine-2,6-diamine (<b>60q</b>)</h4><div class="NLM_p last">This compound was prepared by similar procedures as compound <b>60p</b>, with the exceptions that <i>tert</i>-butyl piperazinecarboxylate was used to make <i>tert</i>-butyl 4-[2-(2,4-dichlorophenyl)-2-oxoethyl]piperazinecarboxylate and the Boc protecting group was removed from the final product with aq HCl (3M) in MeOH at 60 Â°C over 1 h and then concentrated in vacuo to obtain 0.136 g (27%) of <i>N</i><sup>6</sup>-{2-[4-(2,4-dichloro-phenyl)-5-piperazin-1-yl-pyrimidin-2-ylamino]-ethyl}-3-nitro-pyridine-2,6-diamine (<b>60q</b>) as an HCl salt (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 504 [MH<sup>+</sup>]).</div></div><div id="sec4_11_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i104" class="anchor-spacer"></div><h4 class="article-section__title" id="_i104"> <i>N</i><sup>6</sup>-{2-[4-(2,4-Dichloro-phenyl)-5-(4-methyl-piperazin-1-yl)-pyrimidin-2-ylamino]-ethyl}-3-nitro-pyridine-2,6-diamine (<b>60r</b>)</h4><div class="NLM_p last">This compound was prepared by similar procedures as compound <b>60p</b>, with the exception that methylpiperazine was used to make 1-(2,4-dichlorophenyl)-2-(4-methylpiperazinyl)ethan-1-one to obtain 0.145 g (28%) of <i>N</i><sup>6</sup>-{2-[4-(2,4-dichloro-phenyl)-5-(4-methyl-piperazin-1-yl)-pyrimidin-2-ylamino]-ethyl}-3-nitro-pyridine-2,6-diamine (<b>60r</b>) as a light-yellow powder (HPLC, 95% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 518 [MH<sup>+</sup>]).</div></div><div id="sec4_11_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i105" class="anchor-spacer"></div><h4 class="article-section__title" id="_i105"> <i>N</i><sup>6</sup>-{2-[4-(2,4-Dichloro-phenyl)-5-pyridin-2-yl-pyrimidin-2-ylamino]-ethyl}-3-nitro-pyridine-2,6-diamine (<b>60s</b>)</h4><div class="NLM_p last">This compound was prepared by similar procedures as compound <b>60p</b>, with the exception that 1-(2,4-dichloro-phenyl)-2-pyridin-2-yl-ethanone (prepared by the method of Buchwald et al.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a>) was used to obtain 0.183 g (19.6%) of <i>N</i><sup>6</sup>-{2-[4-(2,4-dichloro-phenyl)-5-pyridin-2-yl-pyrimidin-2-ylamino]-ethyl}-3-nitro-pyridine-2,6-diamine (<b>60s</b>) as a light-yellow powder (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 497 [MH<sup>+</sup>]). <sup>1</sup>H NMR (CDCl3) Î´ 8.68 (s, 1H), 8.54 (d, 1H, <i>J</i> = 6 Hz), 8.02 (d, 1 H, <i>J</i> = 12 Hz), 7.53 (t, <i>J</i> = 9 Hz, 1 H), 7.28â7.38 (m, 2 H), 7.18 (dd, <i>J</i> = 6, 3 Hz, 1 H), 6.88 (d, <i>J</i> = 9 Hz, 1 H), 3.84 (s, 4H), 3.70 (br s, 3H).</div></div><div id="sec4_11_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i106" class="anchor-spacer"></div><h4 class="article-section__title" id="_i106"> 1-[2-[2-(6-Amino-5-nitro-pyridin-2-ylamino)-ethylamino]-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-3-trifluoromethyl-1<i>H</i>-pyridin-2-one (<b>60t</b>)</h4><div class="NLM_p">This compound was prepared by similar procedures as compound <b>25u</b>, with the exception that 3-trifluoromethyl-1<i>H</i>-pyridin-2-one with DIEA and <b>21b</b> was used to prepare 1-[2-(2,4-dichloro-phenyl)-2-oxo-ethyl]-3-trifluoromethyl-1<i>H</i>-pyridin-2-one (2.9 g, 8.3 mmol), which was used to obtain 1.08 g (22%) 1-[2-[2-(6-amino-5-nitro-pyridin-2-ylamino)-ethylamino]-4-(2,4-dichloro-phenyl)-pyrimidin-5-yl]-3-trifluoromethyl-1<i>H</i>-pyridin-2-one (<b>60t</b>) as a light-yellow powder after prep HPLC purification (HPLC, 99% at 220 nm; HPLC/MS, <i>m</i>/<i>z</i> 581 [MH<sup>+</sup>]).</div><div class="NLM_p last">Compounds <b>61a</b>â<b>u</b> were synthesized by procedures similar to those used to produce <b>36a</b>, with the exception that the correct 1-(substituted phenyl)-2-(1<i>H</i>-imidazol-2-yl)-ethanone (<b>30a</b>) was used to form the pyrimidine products. Identity and purity were minimally assessed by HPLC and HPLC/MS.</div></div><div id="sec4_11_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i107" class="anchor-spacer"></div><h4 class="article-section__title" id="_i107"> <i>N</i><sup>2</sup>-(2-(4-(2-Bromo-4-chlorophenyl)-5-(1<i>H</i>-imidazol-2-yl)pyrimidin-2-ylamino)ethyl)-5-nitropyridine-2,6-diamine (<b>61r</b>)</h4><div class="NLM_p">Compound <b>61r</b> was synthesized by procedures similar to those used to produce <b>36b</b> with the exception that 1-(substituted phenyl)-2-(1<i>H</i>-imidazol-2-yl)-ethanone (<b>30a</b>) was used to form the pyrimidine (HPLC, 99% at 482 nm; HPLC/MS, <i>m</i>/<i>z</i> 530 [MH<sup>+</sup>]). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) Î´ 8.73 (d, <i>J</i> = 22 Hz, 1H), 8.42â8.23 (br m, 2H), 7.91 (dd, <i>J</i> = 22, 9 Hz, 2H), 7.75â7.49 (m, 5H), 7.63 (s, 1H), 5.95 (dd, <i>J</i> = 22, 9 Hz, 2H), 3.62â3.21 (br m, 4H). HRMS (FAB+): <i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>18</sub>Br<sub>1</sub>Cl<sub>1</sub>N<sub>9</sub>O<sub>2</sub> [MH<sup>+</sup>] 530.0449, found 530.0458.</div><div class="NLM_p last">Compounds <b>62a</b>â<b>g</b> were synthesized by procedures similar to those used to produce <b>1</b>, with the exception that the correct 1-(2,4-dichloro-phenyl)-2-(4-methyl-1<i>H</i>-imidazol-2-yl)-ethanone (<b>30b</b>) was used to form the pyrimidine products. Identity and purity were minimally assessed by HPLC and HPLC/MS.</div></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i108" class="anchor-spacer"></div><h3 class="article-section__title" id="_i108"> Kinases and Kinase Assays</h3><div class="NLM_p last">ERK2, protein kinase C (PKC)-Î±, PKC-Î¶, p90RSK2, AMPK, and pdk1 kinases were purchased from Upstate Biotechnology (Lake Placid, NY). DNA-PK was purified from HeLa cells as described previously.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Other recombinant human protein kinases were expressed in SF9 cells with glu- or hexahis-peptide tags. Glu-tagged proteins were purified as described previously,<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> and his-tagged proteins were purified according to the manufacturerâs instructions (Qiagen, Valencia, CA). All kinase assays followed the same core protocol with variations in peptide substrate and activator concentrations described below. Polypropylene 96-well plates were filled with 300 Î¼L/well buffer (50 mmol/L tris HCl, 10 mmol/L MgCl<sub>2</sub>, 1 mmol/L EGTA, 1 mmol/L dithiothreitol, 25 mmol/L Î²-glycerophosphate, 1 mmol/L NaF, 0.01% BSA, pH 7.5) containing kinase, peptide substrate, and any activators. Information on the kinase concentration, peptide substrate, and activator (if applicable) for these assays is as follows: GSK3-Î± (27 nmol/L and 0.5 Î¼mol/L biotin-CREB peptide); GSK3-Î² (29 nmol/L and 0.5 Î¼mol/L biotin-CREB peptide); CDC2 (0.8 nmol/L and 0.5 Î¼mol/L biotin histone H1 peptide); ERK2 (400 units/mL and myelin basic protein-coated Flash Plate [PerkinElmer]); PKC-Î± (1.6 nmol/L, 0.5 Î¼mol/L biotin-histone H1 peptide, and 0.1 mg/mL phosphatidylserine +0.01 mg/mL diglycerides); PKC-Î¶ (0.1 nmol/L, 0.5 Î¼mol/L biotin-PKC-86 peptide, and 50 Î¼g/mL phosphatidylserine +5 Î¼g/mL diacylglycerol); AKT1 (5.55 nmol/L and 0.5 Î¼mol/L biotin phospho-AKT peptide); p70 S6 kinase (1.5 nmol/L and 0.5 Î¼mol/L biotin-GGGKRRLASLRA); p90 RSK2 (0.049 units/mL and 0.5 Î¼mol/L biotin-GGGKRRRLASLRA); Tie2 (1 Î¼g/mL and 200 nmol/L biotin-GGGGAPDLYKDFLT); flt1 (1.8 nmol/L and 0.25 Î¼mol/L KDRY1175 [B91616] biotin-GGGGQDGKDYIVLPI-NH<sub>2</sub>); KDR (0.95 nmol/L and 0.25 Î¼mol/L KDRY1175 [B91616] biotin-GGGGQDGKDYIVLPI-NH<sub>2</sub>); bFGF receptor tyrosine kinase (RTK; 2 nmol/L and 0.25 Î¼mol/L KDRY1175 [B91616] biotin-GGGGQDGKDYIVLPI-NH<sub>2</sub>); IGF1 RTK (1.91 nmol/L and 1 Î¼mol/L biotin-GGGGKKKSPGEYVNIEFG-amide); insulin RTK (using DG44 IR cells<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> AMP kinase (470 units/mL, 50 Î¼mol/L SAMS peptide, and 300 Î¼mol/L AMP); pdk1 (0.25 nmol/L, 2.9 nmol/L unactivated AKT, and 20 Î¼mol/L each of DOPC and DOPS + 2 Î¼mol/L PIP3); CHK1 (1.4 nmol/L and 0.5 Î¼mol/L biotin-CDC25 peptide); CK1-Îµ (3 nmol/L and 0.2 Î¼mol/L biotin-peptide); DNA PK<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> and phosphatidylinositol (PI) 3-kinase (5 nmol/L and 2 Î¼g/mL PI). Test compounds or controls were added in 3.5 Î¼L of DMSO, followed by 50 Î¼L of ATP stock to yield a final concentration of 1 Î¼mol/L ATP in all cell-free assays. After incubation, triplicate 100 Î¼L aliquots were transferred to Combiplate eight plates (LabSystems, Helsinki, Finland) containing 100 Î¼L/well 50 Î¼mol/L ATP and 20 mmol/L EDTA. After 1 h, the wells were rinsed five times with PBS, filled with 200 Î¼L of scintillation fluid, sealed, left 30 min, and counted in a scintillation counter. All steps were performed at room temperature. Inhibition was calculated as 100%(inhibited â no enzyme control)/(DMSO control â no enzyme control).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i109" class="anchor-spacer"></div><h3 class="article-section__title" id="_i109"> Enzyme and Receptor Panels</h3><div class="NLM_p">Selectivity against nonkinase enzymes was tested on the Cerep âEnzymeâ panel, including acetylcholinesterase, adenylate cyclase, Na/K ATPase, cathepsin B and G, cyclooxygenase 1 and 2, ECE, epithelial growth factor receptor, elastase, guanylate cyclase, HIV-1 protease, inducible nitric oxide synthase, 5-lipoxygenase, monoamine oxidase A and B, phosphodiesterase I, II, III, and IV, PKC, phospholipase A2 and C, and tyrosine hydroxylase (Celle LâEvescault, France).</div><div class="NLM_p last">Selectivity against receptors was tested on the MDS âProfilingâ panel, including adenosine A1, adrenergic (Î±1 and Î±2 nonselective and Î²1 and Î²2), calcium channel type L, dopamine D1 and D2, estrogen Î±, GABAA (agonist site and sodium channel), glucocorticoid, glutamate (NMDA/phencyclidine and nonselective), glycine (strychnine sensitive), histamine H1 (central), insulin, muscarinic M2 and M3, opiates Î´, Îº, and Î¼, phorbol ester, potassium channel, progesterone, serotonin (5-HT1 and 5-HT2/nonselective), sigma (nonselective), sodium channel (site 2), and testosterone (MDS Pharma Services, Bothell, WA).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i110" class="anchor-spacer"></div><h3 class="article-section__title" id="_i110"> GS Activity Assays</h3><div class="NLM_p">CHO-IR cells expressing human insulin receptor (provided by Hans Bos) were grown to 80% confluence in Hammâs F12 medium with 10% fetal bovine serum and without hypoxanthine.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a> Trypsinized cells were seeded in 6-well plates at 1 Ã 10<sup>6</sup> cells/well in 2 mL of medium without fetal bovine serum. After 24 h, medium was replaced with 1 mL of serum-free medium containing GSK-3 inhibitor or control (final DMSO concentration 0.1%) for 30 min at 37 Â°C. Cells were lysed by freeze/thaw in 50 mmol/L tris (pH 7.8) containing 1 mmol/L EDTA, 1 mmol/L DTT, 100 mmol/L NaF, 1 mmol/L phenylmethylsulfonyl fluoride, and 25 Î¼g/mL leupeptin (buffer A) and centrifuged 15 min at 4 Â°C/14000<i>g</i>. The activity ratio of GS was calculated as the GS activity in the absence of glucose-6-phosphate divided by the activity in the presence of 5 mmol/L glucose-6-phosphate, using the filter paper assay of Thomas et al.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></div><div class="NLM_p last">Primary hepatocytes from male SpragueâDawley rats that weighed 140 g were prepared at the Rice Liver Laboratory (San Francisco, CA) and used 1â3 h after isolation. Aliquots of 1 Ã 10<sup>6</sup> cells in 1 mL of DMEM/F12 medium plus 0.2% BSA and GSK-3 inhibitors or controls were incubated in 12-well plates on a low-speed shaker for 30 min at 37 Â°C in a CO<sub>2</sub>-enriched atmosphere, collected by centrifugation, and lysed by freeze/thaw in buffer A plus 0.01% NP40; the GS assay was again performed using the method of Thomas et al.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a></div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i111" class="anchor-spacer"></div><h3 class="article-section__title" id="_i111"> Isolated Rat Skeletal Muscle Incubations</h3><div class="NLM_p last">Overnight-fasted animals were anesthetized with pentobarbital sodium (50 mg/kg ip). Soleus muscles were dissected into strips (ca. 25 mg) and incubated for 1 h at 37 Â°C in 3 mL of oxygenated (95% O<sub>2</sub>/5% CO<sub>2</sub>) KrebsâHenseleit buffer with 8 mmol/L glucose, 32 mmol/L mannitol, and 0.1% BSA (radioimmunoassay grade; Sigma Chemical) with or without the indicated concentrations of insulin (Humulin R; Eli Lilly, Indianapolis, IN) or the GSK-3 inhibitor. Thereafter, the muscle was used to assess the activity ratio (activity in the absence of glucose-6-phosphate divided by the activity in the presence of 5 mmol/L glucose-6-phosphate) of GS<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> or glucose transport activity, using 1 mmol/L 2-deoxyglucose.<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a></div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i112" class="anchor-spacer"></div><h3 class="article-section__title" id="_i112"> Animals</h3><div class="NLM_p last">Female <i>db</i>/<i>db</i> mice were obtained from The Jackson Laboratories (Bar Harbor, ME) at 6 weeks and used when 8â9 weeks of age. Male ZDF rats were obtained from Genetic Models Inc. (Indianapolis, IN) at 8â9 weeks and used at 10â13 weeks of age. Animals were fed Purina 5008 laboratory chow, received water ad libitum, and were maintained on a 12 h light/dark cycle (6:00 A.M., 6:00 P.M.) at 22â24 Â°C.</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i113" class="anchor-spacer"></div><h3 class="article-section__title" id="_i113"> Efficacy Models</h3><div class="NLM_p last">Blood was obtained by shallow tail snipping at lidocaine-anesthetized tips. Blood glucose was measured directly (One-Touch Glucometer; LifeScan, San Jose, CA) or heparinized plasma was collected for measurement of glucose (Beckman Glucose Analyzer, Mountain View, CA) or insulin (Alpco Elisa, Windham, NH). Animals were prebled and randomized to vehicle control or GSK-3 inhibitor treatment groups. For glucose tolerance tests (GTTs), animals were fasted throughout the procedure with food removal early in the morning, 3 h before first prebled (<i>db</i>/<i>db</i> mice), or the previous night, 16 h before the bleed (ZDF rats). When the time course of plasma glucose and insulin changes in fasting ZDF rats was measured, food was removed â¼16 h before test agent administration. The glucose challenges in the GTT were 1.35 g/kg ip (ipGTT) or 2 g/kg via oral gavage (oGTT). Test inhibitors were formulated as solutions in 20 mmol/L citrate-buffered 15% captisol (Cydex, Overland Park, KS) or as fine suspensions in 0.5% carboxymethylcellulose (CMC).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i114" class="anchor-spacer"></div><h3 class="article-section__title" id="_i114"> Statistical Analysis</h3><div class="NLM_p last">The significance of differences between multiple groups was assessed by a factorial ANOVA with a post hoc Fisherâs protected least significant difference test (StatView version 5.0; SAS Institute Inc., Cary, NC). Differences between two groups were determined by an unpaired Studentâs <i>t</i> test. <i>P</i> 0.05 was considered to be statistically significant. All data are reported as means Â± SE.</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i115" class="anchor-spacer"></div><h3 class="article-section__title" id="_i115"> Purification of GSK3-Î² for Crystallization</h3><div class="NLM_p">Traditional techniques for generating co-structures with this family of aminopyrimidines, such as soaking of compounds into apo-crystals of GSK3-Î² or co-crystallizing the protein in the presence of the compound, failed to generate well-diffracting of the complex. In the former approach, exposure of the apo-crystals to even small quantities of the compound led to significant cracking and damage to the GSK3-Î² crystals and loss of atomic level diffraction despite the use of synchrotron X-ray sources. This crystal damage suggests that GSK3-Î² underwent significant structural changes during binding of the compound. In the latter approach, co-crystallization screens run in the presence of compounds failed to generate any co-crystals. To overcome these limitations, it was necessary to generate a ternary complex of GSK3-Î² bound to adenosine diphosphate (ADP) and a peptide derived from a client protein of GSK3-Î². When crystallized, this complex was amenable to forming the cocrystal of a broad range of chemical scaffolds without suffering damage or reduction in resolution of the data.</div><div class="NLM_p">A construct consisting of residues 37â384 of human GSK3-Î² and a C-terminal Glu-tag were expressed in SF-9 cells using a baculovirus expression system. Cell paste from 20 L of cell culture was washed with 100 mL of PBS buffer (10 mM NaPi, pH 7.5, 150 mM NaCl) and then resuspended in 300 mL of buffer A (20 mM Tris, 1 mM tungstate, 1 mM arsenate, 50 mM DTT, 10 Î¼g/mL leupeptin, 1 Î¼g/mL pepstatin A, 10% glycerol (w:v), 0.35% (w:v) octylglucoside, 1 mM Mg<sup>2+</sup>). The cells were then homogenized in a 100 mL of Douncer (20 strokes with pestle B). The homogenate was centrifuged in a Ti45 rotor at 45000 rpm for 35 min to remove cell debris and nuclei.</div><div class="NLM_p">Following the centrifugation, the supernatant was carefully decanted and filtered through a 0.45 Î¼ filter to remove cell debris. The filtrate was loaded on an S-fractogel column (EM Science) equilibrated with buffer A supplemented with 50 mM DTT. The filtered cell filtrate was then loaded onto the column. After loading, the column was washed with 3 column volumes of buffer A containing 50 mM DTT and two column volumes of buffer A. The protein was then eluted with a linear gradient of 0 to 1 M NaCl in buffer A over 20 column volumes. Fractions containing GSK3-Î² were detected using anti-GSK antibody (Santa Cruz Biotech). The Western-blot positive fractions were pooled and mixed with an equal volume of buffer B (20 mM Tris, pH 7.5, 10% (w:v) glycerol, 3.1 M NaCl) and filtered.</div><div class="NLM_p">The filtrate was then loaded onto a phenyl-650 M column (Tosohass) equilibrated with buffer C (20 mM Tris, pH 7.5, 10% (w:v) glycerol, 1.6 M NaCl). After the loading was completed, the column was washed with 5 column volumes of buffer C and then eluted with a linear gradient of 0â100% of buffer A over 20 column volumes. Fractions containing GSK3-b were detected using anti-GSK antibody as in the previous purification step. Western-blot positive fractions were pooled.</div><div class="NLM_p last">The pooled fractions were then loaded onto a Affi-Gel 10 Glu-tag affinity column (BioRad) equilibrated with buffer D (20 mM Tris, pH 7.5, 20% (w:v) glycerol, 0.3 M NaCl, 0.2% (w:v) octylglucoside). The column was then washed with 5 column volumes of buffer D, and the protein subsequently was eluted with 100 mL of glu-tag peptide (at 100 Î¼g/mL) in buffer D. GSK3-b containing fractions were detected using SDS-PAGE and Coomassie Blue staining. These fractions were pooled and filtered into to buffer D. The pure protein was concentrated into buffer D using an Amicon concentrator using a 10 kDa MWCO YM10 membrane to a concentration of approximately 4.8 mg/mL. This concentrated material was used for crystallization.</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i116" class="anchor-spacer"></div><h3 class="article-section__title" id="_i116"> Crystallization of GSK3-Î² Ternary Complex and Generation of GSK3-Î²:Compound <b>1</b> Co-structure</h3><div class="NLM_p">To form the ternary complex, a solution containing 100 mM of the seven-residue peptide H<sub>2</sub>N-LSRRPS(P)Y-CO<sub>2</sub>H (the sixth position is a phosphoserine), 20 mM ATP, 100 mM MgCl<sub>2</sub>, and 100 mM Tris-HCl, pH 7.5, was mixed in a 1:10 (v:v) ratio with GSK3-Î² protein at 4.8 mg/mL in buffer D. The resulting solution was incubated on ice at 4 Â°C for 2 h. The purpose of this incubation was to allow the kinase to fully phosphorylate the client peptide and then subsequently form the ternary complex. Following the incubation period, crystallization trials were set up using the hanging drop vapor diffusion method. A two-dimensional grid of precipitant containing 7â12 (w:v) PEG 6000 and 5â8% MPD (v:v) was established using a 24-well Linbro plate. Then 2 Î¼L of the protein ternary complex solution was mixed with 2 Î¼L of the precipitant solution from the reservoir on a glass coverslip. The coverslip was then placed over the reservoir, and the coverslip and reservoir were sealed with vacuum grease. The crystals grew to a maximum size over the course of 4 days at room temperature. The resulting crystals crystallized in the <i>P</i>2<sub>1</sub> space group with a monomer of the ternary complex in the asymmetric unit and had the following approximate unit cell: <i>a</i> = 57.0 Ã, <i>b</i> = 64.8 Ã, <i>c</i> = 57.2 Ã, Î± = Î³ = 90Â°, Î² = 100.9Â°. This varied from crystal to crystal. The crystals were then harvested for soaking experiments.</div><div class="NLM_p last">To generate a co-structure, the ternary complex crystals were transplanted to a 5 Î¼L drop of soaking solution drawn from the reservoir precipitant solution and 1 mM of compound <b>1</b> for 12â24 h. During this time, the ADP was displaced and replaced by the compound. This displacement lowered the resolution of the crystal somewhat, but no visible cracking or damage was seen and atomic level resolutions could still be achieved using an in-house X-ray generator. The crystals were cryoprotected using a cryosolution consisting of 12% (w:v) PEG 6000, 11% (v:v) MPD, 0.1 M HEPES, pH 7.5, and 20% (w:v) glycerol, supplemented with 1 mM of compound <b>1</b>. The crystals were then frozen in the LN<sub>2</sub>, and X-ray crystal data was collected. This protocol also worked for all other chemical scaffolds tested, as well as for larger molecules, such as peptides.</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i117" class="anchor-spacer"></div><h3 class="article-section__title" id="_i117"> X-ray Crystallography Data Collection and Processing</h3><div class="NLM_p last">X-ray crystallographic data was collected in-house on a Rigaku RU-300 X-ray generator and a Rigaku R-AXIS IIc area detector using Cu KÎ± X-ray radiation. Two separate crystals were used, and data sets were collected for each. Data for these crystals were processed, merged, and scaled using DENZO/HKL2000. Data was collected to 2.6 Ã.</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i118" class="anchor-spacer"></div><h3 class="article-section__title" id="_i118"> Structure Solution and Refinement</h3><div class="NLM_p last">The co-structure was solved using molecular replacement and a search model of GSK3-Î² solved previously. The structure was refined to convergence using COOT,<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> BUSTER,<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> and the PHENIX suite<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> of programs. Data collection and refinement statistics for all structures are listed in <a href="/doi/suppl/10.1021/acs.jmedchem.7b00922/suppl_file/jm7b00922_si_002.pdf" class="ext-link">Table S1</a> (see Supporting Information).</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i119"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00922">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27437" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27437" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.7b00922" class="ext-link">10.1021/acs.jmedchem.7b00922</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Copies of <sup>1</sup>H and <sup>13</sup>C NMR spectra, HPLC and LCMS traces of representative compounds (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00922/suppl_file/jm7b00922_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.7b00922/suppl_file/jm7b00922_si_001.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00922/suppl_file/jm7b00922_si_001.csv">jm7b00922_si_001.csv (9.12 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00922/suppl_file/jm7b00922_si_002.pdf">jm7b00922_si_002.pdf (2.52 MB)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors for the GSK3:compound <b>1</b> costructure have been deposited in the Protein Data Bank (RCSB) under PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B8J">6B8J</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.7b00922" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81413" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81413" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dirksen E. Bussiere</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5623-5648" title="Orcid link">http://orcid.org/0000-0002-5623-5648</a>;Â 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#f4909d869f87919ada968187879d918691b49a9b829586809d87da979b99"><span class="__cf_email__" data-cfemail="a3c7cad1c8d0c6cd8dc1d6d0d0cac6d1c6e3cdccd5c2d1d7cad08dc0ccce">[emailÂ protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allan S. Wagman</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rustum S. Boyce</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sean P. Brown</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Fang</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dane Goff</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Johanna M. Jansen</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vincent P. Le</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barry H. Levine</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon C. Ng</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhi-Jie Ni</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John M. Nuss</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith B. Pfister</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Savithri Ramurthy</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span>;Â 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-2444-5309" title="Orcid link">http://orcid.org/0000-0002-2444-5309</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul A. Renhowe</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David B. Ring</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wei Shu</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sharadha Subramanian</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaohui A. Zhou</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cynthia M. Shafer</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen D. Harrison</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kirk W. Johnson</span> - <span class="hlFld-Affiliation affiliation">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, 5300 Chiron Way, Emeryville, California 94608, United States</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through the contributions of all of the authors. All authors have given approval to the final version of the manuscript. The authors declare no competing financial interests.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): All authors are current or former employees of Novartis and/or Chiron Corporation.<br /></br><sup>â </sup>No longer at Novartis Institutes for BioMedical ResearchâEmeryville, formerly Chiron Corporation.<br /></br></div></li></ul></div><div class="ack" id="ACK-d53e8955-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i136">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33533" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33533" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Weiping Jia and Gavin Dollinger for MS services, Alice Wang for compound purification, and Anu Sharma for collecting HPLC and LCMS data of several compounds. We thank Drs. Lewis T. Williams, Manoj Desai, Yumi Nakagawa, and Jacob Plattner for their advice and mentorship during the project.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i137" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i137"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i138" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i138"> Abbreviations Used</h2><tr><td class="NLM_term">CHO-IR</td><td class="NLM_def"><p class="first last">Chinese hamster ovary transfected with human insulin receptor</p></td></tr><tr><td class="NLM_term">CMC</td><td class="NLM_def"><p class="first last">critical micelle concentration</p></td></tr><tr><td class="NLM_term">DIEA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMA</td><td class="NLM_def"><p class="first last">dimethylacetamide</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethyl sulfoxide</p></td></tr><tr><td class="NLM_term">DTT</td><td class="NLM_def"><p class="first last">dithiothreitol</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatographyâmass spectrometry</p></td></tr><tr><td class="NLM_term">NIDDM</td><td class="NLM_def"><p class="first last">noninsulin dependent diabetes mellitus</p></td></tr><tr><td class="NLM_term">NMP</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-2-pyrrolidone</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">oGTT</td><td class="NLM_def"><p class="first last">oral glucose tolerance test</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structureâactivity relationship</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TMSOTf</td><td class="NLM_def"><p class="first last">trimethylsilyl trifluoromethanesulfonate</p></td></tr><tr><td class="NLM_term">ZDF</td><td class="NLM_def"><p class="first last">Zucker diabetic fatty</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i139">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_75433" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_75433" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 104 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span> <span class="citation_source-book">IDF Diabetes Atlas</span>, <span class="NLM_edition">7th</span> ed.; <span class="NLM_publisher-name">International Diabetes Foundation</span>: <span class="NLM_publisher-loc">Brussels</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=IDF+Diabetes+Atlas%2C+7th+ed.%3B+International+Diabetes+Foundation%3A+Brussels%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DIDF%2520Diabetes%2520Atlas%26pub%3DInternational%2520Diabetes%2520Foundation%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Turner, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cull, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frighi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, R. R.</span><span> </span><span class="NLM_article-title">Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">2005</span><span class="NLM_x">â</span> <span class="NLM_lpage">2012</span><span class="refDoi">Â DOI: 10.1001/jama.281.21.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1001%2Fjama.281.21.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10359389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOls7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1999&pages=2005-2012&issue=21&author=R.+C.+Turnerauthor=C.+A.+Cullauthor=V.+Frighiauthor=R.+R.+Holman&title=Glycemic+control+with+diet%2C+sulfonylurea%2C+metformin%2C+or+insulin+in+patients+with+type+2+diabetes+mellitus%3A+progressive+requirement+for+multiple+therapies+%28UKPDS+49%29&doi=10.1001%2Fjama.281.21.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)</span></div><div class="casAuthors">Turner, Robert C.; Cull, Carole A.; Frighi, Valeria; Holman, Rury R.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2005-2012</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Treatment with diet alone, insulin, sulfonylurea, or metformin is known to improve glycemia in patients with type 2 diabetes mellitus, but which treatment most frequently attains target fasting plasma glucose (FPG) concn. of less than 7.8 mmol/L (140 mg/dL) or glycosylated Hb A1c (HbA1c) below 7% is unknown.  To assess how often each therapy can achieve the glycemic control target levels set by the American Diabetes Assocn, a randomized controlled trial was conducted between 1977 and 1997.  Patients were recruited between 1977 and 1991 and were followed up every 3 mo for 3, 6, and 9 yr after enrollment.  A total of 4075 patients newly diagnosed as having type 2 diabetes ranged in age between 25 and 65 yr and had a median (interquartile range) FPG concn. of 11.5(9.0-14.4) mmol/L [207 (162-259) mg/dL], HbA1c levels of 9.1% (7.5%-10.7%), and a mean (SD) body mass index of 29 (6) kg/m2.  After 3 mo on a low-fat, high-carbohydrate, high-fiber diet, patients were randomized to therapy with diet alone, insulin, sulfonylurea, or metformin.  Fasting plasma glucose and HbA1c levels, and the proportion of patients who achieved target levels below 7% HbA1c or less than 7.8 mmol/L (140 mg/dL) FPG at 3, 6, or 9 yr following diagnosis were measured.  The proportion of patients who maintained target glycemic levels declined markedly over 9 yr of follow-up.  After 9 yr of monotherapy with diet, insulin, or sulfonylurea, 8%, 42%, and 24%, resp., achieved FPG levels of less than 7.8 mmol/L (140 mg/dL) and 9%, 28%, and 24% achieved HbA1c levels below 7%.  In obese patients randomized to metformin, 18% attained FPG levels of less than 7.8 mmol/L (140 mg/dL) and 13% attained HbA1c levels below 7%.  Patients less likely to achieve target levels were younger, more obese, or more hyperglycemic than other patients.  Each therapeutic agent, as monotherapy, increased 2- to 3-fold the proportion of patients who attained HbA1c below 7% compared with diet alone.  However, the progressive deterioration of diabetes control was such that after 3 yr approx. 50% of patients could attain this goal with monotherapy, and by 9 yr this declined to approx. 25%.  The majority of patients need multiple therapies to attain these glycemic target levels in the longer term.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0Zh8zDye3SrVg90H21EOLACvtfcHk0liOmFrw2b9iGw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOls7g%253D&md5=a95773f6579a175ce288930779f0434e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1001%2Fjama.281.21.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.281.21.2005%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DR.%2BC.%26aulast%3DCull%26aufirst%3DC.%2BA.%26aulast%3DFrighi%26aufirst%3DV.%26aulast%3DHolman%26aufirst%3DR.%2BR.%26atitle%3DGlycemic%2520control%2520with%2520diet%252C%2520sulfonylurea%252C%2520metformin%252C%2520or%2520insulin%2520in%2520patients%2520with%2520type%25202%2520diabetes%2520mellitus%253A%2520progressive%2520requirement%2520for%2520multiple%2520therapies%2520%2528UKPDS%252049%2529%26jtitle%3DJAMA%26date%3D1999%26volume%3D281%26issue%3D21%26spage%3D2005%26epage%3D2012%26doi%3D10.1001%2Fjama.281.21.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">UK Prospective Diabetes Study (UKPDS) Group</span><span> </span><span class="NLM_article-title">Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x"> (</span><span class="NLM_issue">9131</span><span class="NLM_x">) </span> <span class="NLM_fpage">837</span><span class="NLM_x">â</span> <span class="NLM_lpage">853</span><span class="refDoi">Â DOI: 10.1016/S0140-6736(98)07019-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FS0140-6736%2898%2907019-6" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=1998&pages=837-853&issue=9131&author=UK+Prospective+Diabetes+Study+%28UKPDS%29+Group&title=Intensive+blood-glucose+control+with+sulphonylureas+or+insulin+compared+with+conventional+treatment+and+risk+of+complications+in+patients+with+type+2+diabetes+%28UKPDS+33%29&doi=10.1016%2FS0140-6736%2898%2907019-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2898%2907019-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252898%252907019-6%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DIntensive%2520blood-glucose%2520control%2520with%2520sulphonylureas%2520or%2520insulin%2520compared%2520with%2520conventional%2520treatment%2520and%2520risk%2520of%2520complications%2520in%2520patients%2520with%2520type%25202%2520diabetes%2520%2528UKPDS%252033%2529%26jtitle%3DLancet%26date%3D1998%26volume%3D352%26issue%3D9131%26spage%3D837%26epage%3D853%26doi%3D10.1016%2FS0140-6736%2898%2907019-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Hauner, H.</span><span> </span><span class="NLM_article-title">Managing type 2 diabetes mellitus in patients with obesity</span> <span class="citation_source-journal">Treat. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">â</span> <span class="NLM_lpage">232</span><span class="refDoi">Â DOI: 10.2165/00024677-200403040-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2165%2F00024677-200403040-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=16026105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2cXms1Wqu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=223-232&issue=4&author=H.+Hauner&title=Managing+type+2+diabetes+mellitus+in+patients+with+obesity&doi=10.2165%2F00024677-200403040-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Managing type 2 diabetes mellitus in patients with obesity</span></div><div class="casAuthors">Hauner, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Treatments in Endocrinology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">TERNAN</span>;
        ISSN:<span class="NLM_cas:issn">1175-6349</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Obesity is the most important modifiable risk factor for type 2 diabetes mellitus and most patients with diabetes are overweight or obese.  It is well known that excess bodyweight induces or aggravates insulin resistance, which is a characteristic feature of type 2 diabetes.  Thus, bodyweight plays a central role in the prevention and treatment of diabetes.  Recent data suggest that lifestyle intervention in patients with impaired glucose tolerance results in an impressive redn. in the conversion to overt diabetes, which is greater than the effect of early intervention with drugs such as metformin or acarbose.  The prevention of diabetes has been shown to be assocd. with the extent of wt. loss.  In patients with type 2 diabetes, wt. loss by any means is followed by an improvement of metabolic control and assocd. risk factors.  The most appropriate recommendation for obese patients with type 2 diabetes is a nutritionally balanced, moderately hypocaloric diet with a reduced intake of satd. fat and an increase in phys. activity.  If this std. approach is only partly successful or not at all, addnl. strategies such as wt.-lowering drugs, very low-calorie diets for limited periods of up to 12 wk, and, for severely obese patients, bariatric surgery should be carefully considered.  A large body of data suggests that such measures can be very effective in this patient group by improving metabolic disturbances and blood pressure.  However, it is extremely important for the long-term outcome that the treatment is tailored to the needs and wishes of the individual patient.  There is growing agreement that due to the low success rate of conventional therapies and the overwhelming benefit from wt. loss, more detd. and aggressive strategies may be appropriate to achieve the central goal of wt. redn. in obese patients with type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFlS595fjBYbVg90H21EOLACvtfcHk0lhdNBBOCBvQqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXms1Wqu70%253D&md5=ffc56378538e6a7080e294320c86c172</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2165%2F00024677-200403040-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00024677-200403040-00004%26sid%3Dliteratum%253Aachs%26aulast%3DHauner%26aufirst%3DH.%26atitle%3DManaging%2520type%25202%2520diabetes%2520mellitus%2520in%2520patients%2520with%2520obesity%26jtitle%3DTreat.%2520Endocrinol.%26date%3D2004%26volume%3D3%26issue%3D4%26spage%3D223%26epage%3D232%26doi%3D10.2165%2F00024677-200403040-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Davidson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCorkle, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, R. H.</span><span> </span><span class="NLM_article-title">Glucagon therapeutics: Dawn of a new era for diabetes care</span> <span class="citation_source-journal">Diabetes/Metab. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">660</span><span class="NLM_x">â</span> <span class="NLM_lpage">665</span><span class="refDoi">Â DOI: 10.1002/dmrr.2773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1002%2Fdmrr.2773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=26729301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A280%3ADC%252BC28rmvFOhsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=660-665&issue=7&author=J.+A.+Davidsonauthor=W.+L.+Hollandauthor=M.+G.+Rothauthor=M.+Wangauthor=Y.+Leeauthor=X.+Yuauthor=S.+K.+McCorkleauthor=P.+E.+Schererauthor=R.+H.+Unger&title=Glucagon+therapeutics%3A+Dawn+of+a+new+era+for+diabetes+care&doi=10.1002%2Fdmrr.2773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Glucagon therapeutics: Dawn of a new era for diabetes care</span></div><div class="casAuthors">Davidson Jaime A; Holland William L; Wang May-Yun; Lee Young; Yu Xinxin; Scherer Philipp E; Unger Roger H; Roth Michael G; McCorkle Sara K; Unger Roger H</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes/metabolism research and reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">660-665</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although insulin monotherapy prevents death from ketoacidosis, it does not prevent either the hyperglycemic surges or the hypoglycemic plunges of glucose levels that plague the majority of patients with type 1 diabetes.  However, significant improvements have occurred with the combination of continuous insulin delivery matched by continuous glucose monitoring, but the technology is not available for all patients, requires extensive education, is expensive and moreover, while much better than standard care, it almost never reduces haemoglobin A1c (HbA1c ) to below 6%.  This may indicate that an improved diabetes therapy involving antagonism of glucagon action will for the first time control glucose levels to normal and eradicate the long-term complications of diabetes.  Although one can never predict that results in animals will be reproduced in humans, the available evidence suggests that patients with type 1 and type 2 diabetes may expect far superior control of the metabolic abnormalities without the need for significant monitoring of glucose, a very important but expensive part of any insulin regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR_4D_xHoAY3nO4gDb7JggCfW6udTcc2eZrEgKzmGkvgLntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rmvFOhsQ%253D%253D&md5=23d9961e0610ac9d2f4cc068b57631dc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fdmrr.2773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdmrr.2773%26sid%3Dliteratum%253Aachs%26aulast%3DDavidson%26aufirst%3DJ.%2BA.%26aulast%3DHolland%26aufirst%3DW.%2BL.%26aulast%3DRoth%26aufirst%3DM.%2BG.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DMcCorkle%26aufirst%3DS.%2BK.%26aulast%3DScherer%26aufirst%3DP.%2BE.%26aulast%3DUnger%26aufirst%3DR.%2BH.%26atitle%3DGlucagon%2520therapeutics%253A%2520Dawn%2520of%2520a%2520new%2520era%2520for%2520diabetes%2520care%26jtitle%3DDiabetes%252FMetab.%2520Res.%2520Rev.%26date%3D2016%26volume%3D32%26issue%3D7%26spage%3D660%26epage%3D665%26doi%3D10.1002%2Fdmrr.2773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Rotella, D. P.</span><span> </span><span class="NLM_article-title">Novel âsecond-generationâ approaches for the control of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">4111</span><span class="NLM_x">â</span> <span class="NLM_lpage">4112</span><span class="refDoi">Â DOI: 10.1021/jm030626a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030626a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4111-4112&issue=17&author=D.+P.+Rotella&title=Novel+%E2%80%9Csecond-generation%E2%80%9D+approaches+for+the+control+of+type+2+diabetes&doi=10.1021%2Fjm030626a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm030626a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030626a%26sid%3Dliteratum%253Aachs%26aulast%3DRotella%26aufirst%3DD.%2BP.%26atitle%3DNovel%2520%25E2%2580%259Csecond-generation%25E2%2580%259D%2520approaches%2520for%2520the%2520control%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D17%26spage%3D4111%26epage%3D4112%26doi%3D10.1021%2Fjm030626a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders</span> <span class="citation_source-journal">Curr. Drug Targets: Immune, Endocr. Metab. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">281</span><span class="NLM_x">â</span> <span class="NLM_lpage">290</span><span class="refDoi">Â DOI: 10.2174/1568008033340153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2174%2F1568008033340153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=14683459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVaktLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=281-290&issue=4&author=J.+R.+Woodgett&title=Physiological+roles+of+glycogen+synthase+kinase-3%3A+potential+as+a+therapeutic+target+for+diabetes+and+other+disorders&doi=10.2174%2F1568008033340153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological roles of glycogen synthase kinase-3: Potential as a therapeutic target for diabetes and other disorders</span></div><div class="casAuthors">Woodgett, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: Immune, Endocrine and Metabolic Disorders</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">281-290</span>CODEN:
                <span class="NLM_cas:coden">CDTIBT</span>;
        ISSN:<span class="NLM_cas:issn">1568-0088</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3 (GSK-3) has perplexed signal transduction researchers since its detection in skeletal muscle 25 yr ago.  The enzyme confounds most of the rules normally assocd. with protein kinases in that it exhibits significant activity, even in resting, unstimulated cells.  However, the protein is highly regulated and potently inactivated in response to signals such as insulin and polypeptide growth factors.  The enzyme also displays a distinct and unusual preference for substrates that have been previously phosphorylated by other protein kinases which provides obvious opportunities for cross-talk.  Its substrates are diverse and are predominantly regulatory mols.  The mol. cloning of the kinase revealed it to be encoded by two related but distinct genes.  Moreover, the mammalian proteins showed remarkable similarity to a fruitfly protein isolated on the basis of its role in cell fate detn.  From these humble beginnings, study of the enzyme has accrued further surprises such as its inhibition by lithium, its regulation by serine and tyrosine phosphorylation and its implication in several human disorders including Alzheimer's disease, bipolar disorder, cancer and diabetes.  Most recently, small mol. inhibitors of GSK-3 have been developed and assessed for therapeutic potential in several of models of pathophysiol.  The question is whether modulation of such an "involved" enzyme could lead to selective restoration of defects without multiple unwanted side effects.  This review summarizes current knowledge of GSK-3 with respect to its known functions, together with an assessment of its real-life potential as a drug target for chronic conditions such as type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ji6S5PgFELVg90H21EOLACvtfcHk0lhdNBBOCBvQqg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVaktLY%253D&md5=ff6419934a458e33e7a63ff0b0323a12</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F1568008033340153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568008033340153%26sid%3Dliteratum%253Aachs%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DPhysiological%2520roles%2520of%2520glycogen%2520synthase%2520kinase-3%253A%2520potential%2520as%2520a%2520therapeutic%2520target%2520for%2520diabetes%2520and%2520other%2520disorders%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520Immune%252C%2520Endocr.%2520Metab.%2520Disord.%26date%3D2003%26volume%3D3%26issue%3D4%26spage%3D281%26epage%3D290%26doi%3D10.2174%2F1568008033340153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Jope, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G. V. W.</span><span> </span><span class="NLM_article-title">The glamour and gloom of glycogen synthase kinase-3</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">95</span><span class="NLM_x">â</span> <span class="NLM_lpage">102</span><span class="refDoi">Â DOI: 10.1016/j.tibs.2003.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.tibs.2003.12.004" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=95-102&issue=2&author=R.+S.+Jopeauthor=G.+V.+W.+Johnson&title=The+glamour+and+gloom+of+glycogen+synthase+kinase-3&doi=10.1016%2Fj.tibs.2003.12.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2003.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2003.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DJope%26aufirst%3DR.%2BS.%26aulast%3DJohnson%26aufirst%3DG.%2BV.%2BW.%26atitle%3DThe%2520glamour%2520and%2520gloom%2520of%2520glycogen%2520synthase%2520kinase-3%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2004%26volume%3D29%26issue%3D2%26spage%3D95%26epage%3D102%26doi%3D10.1016%2Fj.tibs.2003.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Nikoulina, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaraldi, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudaliar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohideen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. R.</span><span> </span><span class="NLM_article-title">Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">263</span><span class="NLM_x">â</span> <span class="NLM_lpage">271</span><span class="refDoi">Â DOI: 10.2337/diabetes.49.2.263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdiabetes.49.2.263" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2000&pages=263-271&issue=2&author=S.+E.+Nikoulinaauthor=T.+P.+Ciaraldiauthor=S.+Mudaliarauthor=P.+Mohideenauthor=L.+Carterauthor=R.+R.+Henry&title=Potential+role+of+glycogen+synthase+kinase-3+in+skeletal+muscle+insulin+resistance+of+type+2+diabetes&doi=10.2337%2Fdiabetes.49.2.263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.49.2.263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.49.2.263%26sid%3Dliteratum%253Aachs%26aulast%3DNikoulina%26aufirst%3DS.%2BE.%26aulast%3DCiaraldi%26aufirst%3DT.%2BP.%26aulast%3DMudaliar%26aufirst%3DS.%26aulast%3DMohideen%26aufirst%3DP.%26aulast%3DCarter%26aufirst%3DL.%26aulast%3DHenry%26aufirst%3DR.%2BR.%26atitle%3DPotential%2520role%2520of%2520glycogen%2520synthase%2520kinase-3%2520in%2520skeletal%2520muscle%2520insulin%2520resistance%2520of%2520type%25202%2520diabetes%26jtitle%3DDiabetes%26date%3D2000%26volume%3D49%26issue%3D2%26spage%3D263%26epage%3D271%26doi%3D10.2337%2Fdiabetes.49.2.263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Nikoulina, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaraldi, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudaliar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. R.</span><span> </span><span class="NLM_article-title">Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2190</span><span class="NLM_x">â</span> <span class="NLM_lpage">2198</span><span class="refDoi">Â DOI: 10.2337/diabetes.51.7.2190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdiabetes.51.7.2190" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=2190-2198&issue=7&author=S.+E.+Nikoulinaauthor=T.+P.+Ciaraldiauthor=S.+Mudaliarauthor=L.+Carterauthor=K.+Johnsonauthor=R.+R.+Henry&title=Inhibition+of+glycogen+synthase+kinase+3+improves+insulin+action+and+glucose+metabolism+in+human+skeletal+muscle&doi=10.2337%2Fdiabetes.51.7.2190"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.51.7.2190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.51.7.2190%26sid%3Dliteratum%253Aachs%26aulast%3DNikoulina%26aufirst%3DS.%2BE.%26aulast%3DCiaraldi%26aufirst%3DT.%2BP.%26aulast%3DMudaliar%26aufirst%3DS.%26aulast%3DCarter%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DHenry%26aufirst%3DR.%2BR.%26atitle%3DInhibition%2520of%2520glycogen%2520synthase%2520kinase%25203%2520improves%2520insulin%2520action%2520and%2520glucose%2520metabolism%2520in%2520human%2520skeletal%2520muscle%26jtitle%3DDiabetes%26date%3D2002%26volume%3D51%26issue%3D7%26spage%3D2190%26epage%3D2198%26doi%3D10.2337%2Fdiabetes.51.7.2190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Ciaraldi, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudaliar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. R.</span><span> </span><span class="NLM_article-title">GSK-3Î² and control of glucose metabolism and insulin action in human skeletal muscle</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x"> (</span><span class="NLM_issue">1â2</span><span class="NLM_x">) </span> <span class="NLM_fpage">153</span><span class="NLM_x">â</span> <span class="NLM_lpage">158</span><span class="refDoi">Â DOI: 10.1016/j.mce.2009.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.mce.2009.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=19505532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFyms7bE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2010&pages=153-158&issue=1%E2%80%932&author=T.+P.+Ciaraldiauthor=L.+Carterauthor=S.+Mudaliarauthor=R.+R.+Henry&title=GSK-3%CE%B2+and+control+of+glucose+metabolism+and+insulin+action+in+human+skeletal+muscle&doi=10.1016%2Fj.mce.2009.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3Î² and control of glucose metabolism and insulin action in human skeletal muscle</span></div><div class="casAuthors">Ciaraldi, T. P.; Carter, L.; Mudaliar, S.; Henry, R. R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">153-158</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The involvement of the Î²-isoform of glycogen synthase kinase (GSK-3) in glucose metab. and insulin action was investigated in cultured human skeletal muscle cells.  A 60% redn. in GSK-3Î² protein expression was attained by treatment with siRNA; GSK-3Î± expression was unaltered.  GSK-3Î² knockdown did not influence total glycogen synthase (GS) activity, but increased the phosphorylation-dependent activity (fractional velocity-FV) in the basal state.  Insulin responsiveness of GSFV was doubled by GSK-3Î² knockdown (p < 0.05).  Basal rates of glucose uptake (GU) were not significantly influenced by GSK-3Î² knockdown, while insulin stimulation of GU was increased.  Improvements in insulin action on GS and GU did not involve changes in protein expression of either IRS-1 or Akt 1/2.  Maximal insulin stimulation of phosphorylation of Akt was unaltered by GSK-3Î² knockdown.  Unlike GSK-3Î±, GSK-3Î² directly regulates both GS activity in the absence of added insulin and through control of insulin action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvKhT1c5rYWLVg90H21EOLACvtfcHk0lggcD0FQL9IkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFyms7bE&md5=0ad04a4bf0e209dd2dde51c441bfe3ab</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2009.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2009.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DCiaraldi%26aufirst%3DT.%2BP.%26aulast%3DCarter%26aufirst%3DL.%26aulast%3DMudaliar%26aufirst%3DS.%26aulast%3DHenry%26aufirst%3DR.%2BR.%26atitle%3DGSK-3%25CE%25B2%2520and%2520control%2520of%2520glucose%2520metabolism%2520and%2520insulin%2520action%2520in%2520human%2520skeletal%2520muscle%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2010%26volume%3D315%26issue%3D1%25E2%2580%25932%26spage%3D153%26epage%3D158%26doi%3D10.1016%2Fj.mce.2009.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Tanti, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GrÃ©meaux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BarrÃ¨s, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Marchand-Brustel, Y.</span><span> </span><span class="NLM_article-title">Alteration in insulin action: role of IRS-1 serine phosphorylation in the retroregulation of insulin signalling</span> <span class="citation_source-journal">Ann. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">43</span><span class="NLM_x">â</span> <span class="NLM_lpage">48</span><span class="refDoi">Â DOI: 10.1016/S0003-4266(04)95629-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FS0003-4266%2804%2995629-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkslymtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=43-48&issue=1&author=J.+F.+Tantiauthor=P.+Gualauthor=T.+Gr%C3%A9meauxauthor=T.+Gonzalezauthor=R.+Barr%C3%A8sauthor=Y.+Le+Marchand-Brustel&title=Alteration+in+insulin+action%3A+role+of+IRS-1+serine+phosphorylation+in+the+retroregulation+of+insulin+signalling&doi=10.1016%2FS0003-4266%2804%2995629-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration in insulin action: Role of IRS-1 serine phosphorylation in the retroregulation of insulin signalling</span></div><div class="casAuthors">Tanti, J. F.; Gual, P.; Gremeaux, T.; Gonzalez, T.; Barres, R.; Le Marchand-Brustel, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Annales d'Endocrinologie</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">ANENAG</span>;
        ISSN:<span class="NLM_cas:issn">0003-4266</span>.
    
            (<span class="NLM_cas:orgname">Masson Editeur</span>)
        </div><div class="casAbstract">A review.  Insulin resistance, when combined with impaired insulin secretion, contributes to the development of type 2 diabetes.  Insulin resistance is characterized by a decrease in insulin effect on glucose transport in muscle and adipose tissue.  Tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1) and its binding to phosphatidylinositol 3-kinase (PI 3-kinase) are crit. events in the insulin signaling cascade leading to insulin-stimulated glucose transport.  Modification of IRS-1 by serine phosphorylation could be one of the mechanisms leading to a decrease in IRS-1 tyrosine phosphorylation, PI 3-kinase activity and glucose transport.  Recent findings demonstrate that "diabetogenic" factors such as free fatty acids (FFA), TNFÎ±, hyperinsulinemia and cellular stress, increase the serine phosphorylation of IRS-1 and identified Ser307/612/632 as phosphorylated sites.  Moreover, several kinases able to phosphorylate these serine residues have been identified.  These exciting results suggest that serine phosphorylation of IRS-1 is a possible hallmark of insulin resistance in biol. insulin responsive cells or tissues.  Identifying the pathways by which "diabetogenic" factors activate IRS-1 kinases and defining the precise role of serine phosphorylation events in IRS-1 regulation represent important goals.  Such studies may enable rational drug design to selectively inhibit the activity of the relevant enzymes and generate a novel class of therapeutic agents for type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOowz0kZ8hJbVg90H21EOLACvtfcHk0lggcD0FQL9IkQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkslymtLs%253D&md5=8f55af63948905c6b6bff0e0a99a6fb5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0003-4266%2804%2995629-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0003-4266%252804%252995629-6%26sid%3Dliteratum%253Aachs%26aulast%3DTanti%26aufirst%3DJ.%2BF.%26aulast%3DGual%26aufirst%3DP.%26aulast%3DGr%25C3%25A9meaux%26aufirst%3DT.%26aulast%3DGonzalez%26aufirst%3DT.%26aulast%3DBarr%25C3%25A8s%26aufirst%3DR.%26aulast%3DLe%2BMarchand-Brustel%26aufirst%3DY.%26atitle%3DAlteration%2520in%2520insulin%2520action%253A%2520role%2520of%2520IRS-1%2520serine%2520phosphorylation%2520in%2520the%2520retroregulation%2520of%2520insulin%2520signalling%26jtitle%3DAnn.%2520Endocrinol.%26date%3D2004%26volume%3D65%26issue%3D1%26spage%3D43%26epage%3D48%26doi%3D10.1016%2FS0003-4266%2804%2995629-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Kirwan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Aguila, L. F.</span><span> </span><span class="NLM_article-title">Insulin signalling, exercise and cellular integrity</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1281</span><span class="NLM_x">â</span> <span class="NLM_lpage">1285</span><span class="refDoi">Â DOI: 10.1042/bst0311281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1042%2Fbst0311281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=14641043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps12jsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1281-1285&issue=6&author=J.+P.+Kirwanauthor=L.+F.+del+Aguila&title=Insulin+signalling%2C+exercise+and+cellular+integrity&doi=10.1042%2Fbst0311281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin signalling, exercise and cellular integrity</span></div><div class="casAuthors">Kirwan, J. P.; del aguila, L. F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1281-1285</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Although the effects of exercise on insulin sensitivity are generally pos., eccentric exercise presents a paradox because it induces a transient state of insulin resistance that persists for up to 48 h after the exercise bout.  Excessive eccentric contractions, such as prolonged downhill running, or marathon running, causes muscle damage and disruption of the integrity of the cell.  Down-regulation of insulin receptor tyrosine phosphorylation and subsequent steps in the insulin signaling pathway, including insulin receptor substrate-1 (IRS-1)-assocd. phosphoinositide 3-kinase (PI3K), Akt kinase serine phosphorylation and activity and glucose transporter (GLUT-4) protein content, are evident in skeletal muscle after eccentric exercise.  Furthermore, increased tumor necrosis factor Î± (TNF-Î±) secretion from monocytes is assocd. with the decrease in PI3K activity after this type of exercise.  Recent studies have shown that TNF-Î± can increase IRS-1 serine/threonine phosphorylation, which impairs IRS-1 docking to the insulin receptor, and this inhibits insulin signaling.  Thus a unifying hypothesis to explain insulin resistance after eccentric exercise may include inflammation arising from the disruption of muscle-cell integrity, leading to an acute-phase response that includes TNF-Î±, with the latter inhibiting insulin signaling and subsequent metabolic events.  In contrast, exercise training increases insulin signaling and GLUT-4 expression, decreases TNF-Î± expression in skeletal muscle, and is assocd. with enhanced insulin sensitivity.  These observations highlight the complexity of the cellular and mol. adaptations to exercise.  Understanding these adaptations is essential to establish a sound theor. basis for recommending exercise as a therapeutic intervention for insulin resistance and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkqiluKHSk27Vg90H21EOLACvtfcHk0lgwHMBwnvzuyA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps12jsLs%253D&md5=e73833668083cc0f0ae3a2a104e5862b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1042%2Fbst0311281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0311281%26sid%3Dliteratum%253Aachs%26aulast%3DKirwan%26aufirst%3DJ.%2BP.%26aulast%3Ddel%2BAguila%26aufirst%3DL.%2BF.%26atitle%3DInsulin%2520signalling%252C%2520exercise%2520and%2520cellular%2520integrity%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26issue%3D6%26spage%3D1281%26epage%3D1285%26doi%3D10.1042%2Fbst0311281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Qiao, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X. J.</span><span> </span><span class="NLM_article-title">Identification of enhanced serine kinase activity in insulin resistance</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">10625</span><span class="NLM_x">â</span> <span class="NLM_lpage">10632</span><span class="refDoi">Â DOI: 10.1074/jbc.274.15.10625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1074%2Fjbc.274.15.10625" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=10625-10632&issue=15&author=L.+Y.+Qiaoauthor=J.+L.+Goldbergauthor=J.+C.+Russellauthor=X.+J.+Sun&title=Identification+of+enhanced+serine+kinase+activity+in+insulin+resistance&doi=10.1074%2Fjbc.274.15.10625"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.15.10625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.15.10625%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DL.%2BY.%26aulast%3DGoldberg%26aufirst%3DJ.%2BL.%26aulast%3DRussell%26aufirst%3DJ.%2BC.%26aulast%3DSun%26aufirst%3DX.%2BJ.%26atitle%3DIdentification%2520of%2520enhanced%2520serine%2520kinase%2520activity%2520in%2520insulin%2520resistance%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26issue%3D15%26spage%3D10625%26epage%3D10632%26doi%3D10.1074%2Fjbc.274.15.10625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Tanti, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GrÃ©meaux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Obberghen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Marchand-Brustel, Y.</span><span> </span><span class="NLM_article-title">Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">6051</span><span class="NLM_x">â</span> <span class="NLM_lpage">6057</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=6051-6057&issue=8&author=J.+F.+Tantiauthor=T.+Gr%C3%A9meauxauthor=E.+van+Obberghenauthor=Y.+Le+Marchand-Brustel&title=Serine%2Fthreonine+phosphorylation+of+insulin+receptor+substrate+1+modulates+insulin+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanti%26aufirst%3DJ.%2BF.%26aulast%3DGr%25C3%25A9meaux%26aufirst%3DT.%26aulast%3Dvan%2BObberghen%26aufirst%3DE.%26aulast%3DLe%2BMarchand-Brustel%26aufirst%3DY.%26atitle%3DSerine%252Fthreonine%2520phosphorylation%2520of%2520insulin%2520receptor%2520substrate%25201%2520modulates%2520insulin%2520receptor%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26issue%3D8%26spage%3D6051%26epage%3D6057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Wagman, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, D. E.</span><span> </span><span class="NLM_article-title">Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1105</span><span class="NLM_x">â</span> <span class="NLM_lpage">1137</span><span class="refDoi">Â DOI: 10.2174/1381612043452668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2174%2F1381612043452668" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1105-1137&issue=10&author=A.+S.+Wagmanauthor=K.+W.+Johnsonauthor=D.+E.+Bussiere&title=Discovery+and+development+of+GSK3+inhibitors+for+the+treatment+of+type+2+diabetes&doi=10.2174%2F1381612043452668"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1381612043452668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043452668%26sid%3Dliteratum%253Aachs%26aulast%3DWagman%26aufirst%3DA.%2BS.%26aulast%3DJohnson%26aufirst%3DK.%2BW.%26aulast%3DBussiere%26aufirst%3DD.%2BE.%26atitle%3DDiscovery%2520and%2520development%2520of%2520GSK3%2520inhibitors%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26issue%3D10%26spage%3D1105%26epage%3D1137%26doi%3D10.2174%2F1381612043452668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Jope, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitbon, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beurel, E.</span><span> </span><span class="NLM_article-title">Stressed and inflamed, can GSK3 be blamed?</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">180</span><span class="NLM_x">â</span> <span class="NLM_lpage">192</span><span class="refDoi">Â DOI: 10.1016/j.tibs.2016.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.tibs.2016.10.009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=180-192&issue=3&author=R.+S.+Jopeauthor=Y.+Chengauthor=J.+A.+Lowellauthor=R.+J.+Worthenauthor=Y.+H.+Sitbonauthor=E.+Beurel&title=Stressed+and+inflamed%2C+can+GSK3+be+blamed%3F&doi=10.1016%2Fj.tibs.2016.10.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2016.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2016.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DJope%26aufirst%3DR.%2BS.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DLowell%26aufirst%3DJ.%2BA.%26aulast%3DWorthen%26aufirst%3DR.%2BJ.%26aulast%3DSitbon%26aufirst%3DY.%2BH.%26aulast%3DBeurel%26aufirst%3DE.%26atitle%3DStressed%2520and%2520inflamed%252C%2520can%2520GSK3%2520be%2520blamed%253F%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2017%26volume%3D42%26issue%3D3%26spage%3D180%26epage%3D192%26doi%3D10.1016%2Fj.tibs.2016.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">McCubrey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steelman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lertpiriyapong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmiroli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martelli, A. M.</span><span> </span><span class="NLM_article-title">Effects of mutations in Wnt/Î²-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activityâDiverse effects on cell growth, metabolism and cancer</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">1863</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">2942</span><span class="NLM_x">â</span> <span class="NLM_lpage">2976</span><span class="refDoi">Â DOI: 10.1016/j.bbamcr.2016.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.bbamcr.2016.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=27612668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyjsL%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2016&pages=2942-2976&issue=12&author=J.+A.+McCubreyauthor=D.+Rakusauthor=A.+Gizakauthor=L.+S.+Steelmanauthor=S.+L.+Abramsauthor=K.+Lertpiriyapongauthor=T.+L.+Fitzgeraldauthor=L.+V.+Yangauthor=G.+Montaltoauthor=M.+Cervelloauthor=M.+Libraauthor=F.+Nicolettiauthor=A.+Scalisiauthor=F.+Torinoauthor=C.+Fengaauthor=L.+M.+Neriauthor=S.+Marmiroliauthor=L.+Coccoauthor=A.+M.+Martelli&title=Effects+of+mutations+in+Wnt%2F%CE%B2-catenin%2C+hedgehog%2C+Notch+and+PI3K+pathways+on+GSK-3+activity%E2%80%94Diverse+effects+on+cell+growth%2C+metabolism+and+cancer&doi=10.1016%2Fj.bbamcr.2016.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of mutations in Wnt/Î²-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer</span></div><div class="casAuthors">McCubrey, James A.; Rakus, Dariusz; Gizak, Agnieszka; Steelman, Linda S.; Abrams, Steve L.; Lertpiriyapong, Kvin; Fitzgerald, Timothy L.; Yang, Li V.; Montalto, Giuseppe; Cervello, Melchiorre; Libra, Massimo; Nicoletti, Ferdinando; Scalisi, Aurora; Torino, Francesco; Fenga, Concettina; Neri, Luca M.; Marmiroli, Sandra; Cocco, Lucio; Martelli, Alberto M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2942-2976</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase that participates in an array of crit. cellular processes.  GSK-3 was first characterized as an enzyme that phosphorylated and inactivated glycogen synthase.  However, subsequent studies have revealed that this moon-lighting protein is involved in numerous signaling pathways that regulate not only metab. but also have roles in: apoptosis, cell cycle progression, cell renewal, differentiation, embryogenesis, migration, regulation of gene transcription, stem cell biol. and survival.  In this review, we will discuss the roles that GSK-3 plays in various diseases as well as how this pivotal kinase interacts with multiple signaling pathways such as: PI3K/PTEN/Akt/mTOR, Ras/Raf/MEK/ERK, Wnt/beta-catenin, hedgehog, Notch and TP53.  Mutations that occur in these and other pathways can alter the effects that natural GSK-3 activity has on regulating these signaling circuits that can lead to cancer as well as other diseases.  The novel roles that microRNAs play in regulation of the effects of GSK-3 will also be evaluated.  Targeting GSK-3 and these other pathways may improve therapy and overcome therapeutic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOccRRGe88_7Vg90H21EOLACvtfcHk0lgwHMBwnvzuyA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyjsL%252FE&md5=528be1c3c5faac0bb11b501a5fc65af3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2016.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2016.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DMcCubrey%26aufirst%3DJ.%2BA.%26aulast%3DRakus%26aufirst%3DD.%26aulast%3DGizak%26aufirst%3DA.%26aulast%3DSteelman%26aufirst%3DL.%2BS.%26aulast%3DAbrams%26aufirst%3DS.%2BL.%26aulast%3DLertpiriyapong%26aufirst%3DK.%26aulast%3DFitzgerald%26aufirst%3DT.%2BL.%26aulast%3DYang%26aufirst%3DL.%2BV.%26aulast%3DMontalto%26aufirst%3DG.%26aulast%3DCervello%26aufirst%3DM.%26aulast%3DLibra%26aufirst%3DM.%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DScalisi%26aufirst%3DA.%26aulast%3DTorino%26aufirst%3DF.%26aulast%3DFenga%26aufirst%3DC.%26aulast%3DNeri%26aufirst%3DL.%2BM.%26aulast%3DMarmiroli%26aufirst%3DS.%26aulast%3DCocco%26aufirst%3DL.%26aulast%3DMartelli%26aufirst%3DA.%2BM.%26atitle%3DEffects%2520of%2520mutations%2520in%2520Wnt%252F%25CE%25B2-catenin%252C%2520hedgehog%252C%2520Notch%2520and%2520PI3K%2520pathways%2520on%2520GSK-3%2520activity%25E2%2580%2594Diverse%2520effects%2520on%2520cell%2520growth%252C%2520metabolism%2520and%2520cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2016%26volume%3D1863%26issue%3D12%26spage%3D2942%26epage%3D2976%26doi%3D10.1016%2Fj.bbamcr.2016.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Zeidan-Chulia, F.; Moreira, J. C. F.</span><span> </span><span class="NLM_article-title">Targeting the GSK3Î²/Î²-catenin signaling to treat Alzheimerâs disease: Plausible or utopic?</span> In  <span class="citation_source-book">Drug Design and Discovery in Alzheimerâs Disease</span>; <span class="NLM_publisher-name">Bentham Science</span>: <span class="NLM_publisher-loc">Sharjah</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">6</span>, pp  <span class="NLM_fpage">623</span><span class="NLM_x">â</span> <span class="NLM_lpage">642</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FB978-0-12-803959-5.50014-3" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=623-642&author=F.+Zeidan-Chulia&author=J.+C.+F.+Moreira&title=Drug+Design+and+Discovery+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-803959-5.50014-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-803959-5.50014-3%26sid%3Dliteratum%253Aachs%26aulast%3DZeidan-Chulia%26aufirst%3DF.%26atitle%3DTargeting%2520the%2520GSK3%25CE%25B2%252F%25CE%25B2-catenin%2520signaling%2520to%2520treat%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Plausible%2520or%2520utopic%253F%26btitle%3DDrug%2520Design%2520and%2520Discovery%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26pub%3DBentham%2520Science%26date%3D2014%26volume%3D6%26spage%3D623%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Golpich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dargahi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghasemi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadiani, A.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 beta (GSK-3Î²) signaling: Implications for Parkinsonâs disease</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">â</span> <span class="NLM_lpage">26</span><span class="refDoi">Â DOI: 10.1016/j.phrs.2015.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.phrs.2015.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=25829335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlslCktrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=16-26&author=M.+Golpichauthor=E.+Aminiauthor=F.+Hemmatiauthor=N.+M.+Ibrahimauthor=B.+Rahmaniauthor=Z.+Mohamedauthor=A.+A.+Raymondauthor=L.+Dargahiauthor=R.+Ghasemiauthor=A.+Ahmadiani&title=Glycogen+synthase+kinase-3+beta+%28GSK-3%CE%B2%29+signaling%3A+Implications+for+Parkinson%E2%80%99s+disease&doi=10.1016%2Fj.phrs.2015.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase-3 beta (GSK-3Î²) signaling: Implications for Parkinson's disease</span></div><div class="casAuthors">Golpich, Mojtaba; Amini, Elham; Hemmati, Fatemeh; Ibrahim, Norlinah Mohamed; Rahmani, Behrouz; Mohamed, Zahurin; Raymond, Azman Ali; Dargahi, Leila; Ghasemi, Rasoul; Ahmadiani, Abolhassan</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16-26</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Glycogen synthase kinase 3 (GSK-3) dysregulation plays an important role in the pathogenesis of numerous disorders, affecting the central nervous system (CNS) encompassing both neuroinflammation and neurodegenerative diseases.  Several lines of evidence have illustrated a key role of the GSK-3 and its cellular and mol. signaling cascades in the control of neuroinflammation.  Glycogen synthase kinase 3 beta (GSK-3Î²), one of the GSK-3 isomers, plays a major role in neuronal apoptosis and its inhibition decreases expression of alpha-Synuclein (Î±-Synuclein), which make this kinase an attractive therapeutic target for neurodegenerative disorders.  Parkinson's disease (PD) is a chronic neurodegenerative movement disorder characterized by the progressive and massive loss of dopaminergic neurons by neuronal apoptosis in the substantia nigra pars compacta and depletion of dopamine in the striatum, which lead to pathol. and clin. abnormalities.  Thus, understanding the role of GSK-3Î² in PD will enhance our knowledge of the basic mechanisms underlying the pathogenesis of this disorder and facilitate the identification of new therapeutic avenues.  In recent years, GSK-3Î² has been shown to play essential roles in modulating a variety of cellular functions, which have prompted efforts to develop GSK-3Î² inhibitors as therapeutics.  In this review, we summarize GSK-3 signaling pathways and its assocn. with neuroinflammation.  Moreover, we highlight the interaction between GSK-3Î² and several cellular processes involved in the pathogenesis of PD, including the accumulation of Î±-Synuclein aggregates, oxidative stress and mitochondrial dysfunction.  Finally, we discuss about GSK-3Î² inhibitors as a potential therapeutic strategy in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwfZuHcsXpsrVg90H21EOLACvtfcHk0lh_wiLOOIOGIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlslCktrc%253D&md5=72fe420eb5fa1f8135fcb7a862becfb6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DGolpich%26aufirst%3DM.%26aulast%3DAmini%26aufirst%3DE.%26aulast%3DHemmati%26aufirst%3DF.%26aulast%3DIbrahim%26aufirst%3DN.%2BM.%26aulast%3DRahmani%26aufirst%3DB.%26aulast%3DMohamed%26aufirst%3DZ.%26aulast%3DRaymond%26aufirst%3DA.%2BA.%26aulast%3DDargahi%26aufirst%3DL.%26aulast%3DGhasemi%26aufirst%3DR.%26aulast%3DAhmadiani%26aufirst%3DA.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520beta%2520%2528GSK-3%25CE%25B2%2529%2520signaling%253A%2520Implications%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D97%26spage%3D16%26epage%3D26%26doi%3D10.1016%2Fj.phrs.2015.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Beurel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grieco, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jope, R. S.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">â</span> <span class="NLM_lpage">131</span><span class="refDoi">Â DOI: 10.1016/j.pharmthera.2014.11.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.pharmthera.2014.11.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=25435019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVeisr7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2015&pages=114-131&author=E.+Beurelauthor=S.+F.+Griecoauthor=R.+S.+Jope&title=Glycogen+synthase+kinase-3+%28GSK3%29%3A+Regulation%2C+actions%2C+and+diseases&doi=10.1016%2Fj.pharmthera.2014.11.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases</span></div><div class="casAuthors">Beurel, Eleonore; Grieco, Steven F.; Jope, Richard S.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114-131</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3 (GSK3) may be the busiest kinase in most cells, with over 100 known substrates to deal with.  How does GSK3 maintain control to selectively phosphorylate each substrate, and why was it evolutionarily favorable for GSK3 to assume such a large responsibility.  GSK3 must be particularly adaptable for incorporating new substrates into its repertoire, and we discuss the distinct properties of GSK3 that may contribute to its capacity to fulfill its roles in multiple signaling pathways.  The mechanisms regulating GSK3 (predominantly post-translational modifications, substrate priming, cellular trafficking, protein complexes) have been reviewed previously, so here we focus on newly identified complexities in these mechanisms, how each of these regulatory mechanism contributes to the ability of GSK3 to select which substrates to phosphorylate, and how these mechanisms may have contributed to its adaptability as new substrates evolved.  The current understanding of the mechanisms regulating GSK3 is reviewed, as are emerging topics in the actions of GSK3, particularly its interactions with receptors and receptor-coupled signal transduction events, and differential actions and regulation of the two GSK3 isoforms, GSK3Î± and GSK3Î².  Another remarkable characteristic of GSK3 is its involvement in many prevalent disorders, including psychiatric and neurol. diseases, inflammatory diseases, cancer, and others.  We address the feasibility of targeting GSK3 therapeutically, and provide an update of its involvement in the etiol. and treatment of several disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonota4sOu8PbVg90H21EOLACvtfcHk0lh_wiLOOIOGIw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVeisr7J&md5=a6c54e0331492b0b61a9d67b1f07575d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.11.016%26sid%3Dliteratum%253Aachs%26aulast%3DBeurel%26aufirst%3DE.%26aulast%3DGrieco%26aufirst%3DS.%2BF.%26aulast%3DJope%26aufirst%3DR.%2BS.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520%2528GSK3%2529%253A%2520Regulation%252C%2520actions%252C%2520and%2520diseases%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D148%26spage%3D114%26epage%3D131%26doi%3D10.1016%2Fj.pharmthera.2014.11.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Seira, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del RÃ­o, J. A.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase 3 beta (GSK3Î²) at the tip of neuronal development and regeneration</span> <span class="citation_source-journal">Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">931</span><span class="NLM_x">â</span> <span class="NLM_lpage">944</span><span class="refDoi">Â DOI: 10.1007/s12035-013-8571-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1007%2Fs12035-013-8571-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=24158777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1OqsLrM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=931-944&issue=2&author=O.+Seiraauthor=J.+A.+Del+R%C3%ADo&title=Glycogen+synthase+kinase+3+beta+%28GSK3%CE%B2%29+at+the+tip+of+neuronal+development+and+regeneration&doi=10.1007%2Fs12035-013-8571-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen Synthase Kinase 3 Beta (GSK3Î²) at the Tip of Neuronal Development and Regeneration</span></div><div class="casAuthors">Seira, Oscar; del Rio, Jose Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">931-944</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Gaining a basic understanding of the inhibitory mols. and the intracellular signaling involved in axon development and repulsion after neural lesions is of clear biomedical interest.  In recent years, numerous studies have described new mols. and intracellular mechanisms that impair axonal outgrowth after injury.  In this scenario, the role of glycogen synthase kinase 3 beta (GSK3Î²) in the axonal responses that occur after central nervous system (CNS) lesions began to be elucidated.  GSK3Î² function in the nervous tissue is assocd. with neural development, neuron polarization, and, more recently, neurodegeneration.  In fact, GSK3Î² has been considered as a putative therapeutic target for promoting functional recovery in injured or degenerative CNS.  In this review, we summarize current understanding of the role of GSK3Î² during neuronal development and regeneration.  In particular, we discuss GSK3Î² activity levels and their possible impact on cytoskeleton dynamics during both processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnxrCXn4rKvLVg90H21EOLACvtfcHk0lh-WaSmxgT_-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1OqsLrM&md5=933d4a54fce55644e5b7d43767268ae3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs12035-013-8571-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-013-8571-y%26sid%3Dliteratum%253Aachs%26aulast%3DSeira%26aufirst%3DO.%26aulast%3DDel%2BR%25C3%25ADo%26aufirst%3DJ.%2BA.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%2520beta%2520%2528GSK3%25CE%25B2%2529%2520at%2520the%2520tip%2520of%2520neuronal%2520development%2520and%2520regeneration%26jtitle%3DMol.%2520Neurobiol.%26date%3D2014%26volume%3D49%26issue%3D2%26spage%3D931%26epage%3D944%26doi%3D10.1007%2Fs12035-013-8571-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Takahashi-Yanaga, F.</span><span> </span><span class="NLM_article-title">Activator or inhibitor? GSK-3 as a new drug target</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">191</span><span class="NLM_x">â</span> <span class="NLM_lpage">199</span><span class="refDoi">Â DOI: 10.1016/j.bcp.2013.04.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.bcp.2013.04.022" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2013&pages=191-199&issue=2&author=F.+Takahashi-Yanaga&title=Activator+or+inhibitor%3F+GSK-3+as+a+new+drug+target&doi=10.1016%2Fj.bcp.2013.04.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.04.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.04.022%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi-Yanaga%26aufirst%3DF.%26atitle%3DActivator%2520or%2520inhibitor%253F%2520GSK-3%2520as%2520a%2520new%2520drug%2520target%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D86%26issue%3D2%26spage%3D191%26epage%3D199%26doi%3D10.1016%2Fj.bcp.2013.04.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Osolodkin, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palyulin, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zefirov, N. S.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase 3 as an anticancer drug target: novel experimental findings and trends in the design of inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">665</span><span class="NLM_x">â</span> <span class="NLM_lpage">679</span><span class="refDoi">Â DOI: 10.2174/13816128130407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2174%2F13816128130407" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=665-679&issue=4&author=D.+I.+Osolodkinauthor=V.+A.+Palyulinauthor=N.+S.+Zefirov&title=Glycogen+synthase+kinase+3+as+an+anticancer+drug+target%3A+novel+experimental+findings+and+trends+in+the+design+of+inhibitors&doi=10.2174%2F13816128130407"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F13816128130407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13816128130407%26sid%3Dliteratum%253Aachs%26aulast%3DOsolodkin%26aufirst%3DD.%2BI.%26aulast%3DPalyulin%26aufirst%3DV.%2BA.%26aulast%3DZefirov%26aufirst%3DN.%2BS.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%2520as%2520an%2520anticancer%2520drug%2520target%253A%2520novel%2520experimental%2520findings%2520and%2520trends%2520in%2520the%2520design%2520of%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26issue%3D4%26spage%3D665%26epage%3D679%26doi%3D10.2174%2F13816128130407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Ghaderi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alidadiani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dilaver, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidari, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parvizi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahbarghazi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleimani-Rad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baradaran, B.</span><span> </span><span class="NLM_article-title">Role of glycogen synthase kinase following myocardial infarction and ischemiaâreperfusion</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">887</span><span class="NLM_x">â</span> <span class="NLM_lpage">897</span><span class="refDoi">Â DOI: 10.1007/s10495-017-1376-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1007%2Fs10495-017-1376-0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=887-897&issue=7&author=S.+Ghaderiauthor=N.+Alidadianiauthor=N.+Dilaverauthor=H.+R.+Heidariauthor=R.+Parviziauthor=R.+Rahbarghaziauthor=J.+Soleimani-Radauthor=B.+Baradaran&title=Role+of+glycogen+synthase+kinase+following+myocardial+infarction+and+ischemia%E2%80%93reperfusion&doi=10.1007%2Fs10495-017-1376-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs10495-017-1376-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10495-017-1376-0%26sid%3Dliteratum%253Aachs%26aulast%3DGhaderi%26aufirst%3DS.%26aulast%3DAlidadiani%26aufirst%3DN.%26aulast%3DDilaver%26aufirst%3DN.%26aulast%3DHeidari%26aufirst%3DH.%2BR.%26aulast%3DParvizi%26aufirst%3DR.%26aulast%3DRahbarghazi%26aufirst%3DR.%26aulast%3DSoleimani-Rad%26aufirst%3DJ.%26aulast%3DBaradaran%26aufirst%3DB.%26atitle%3DRole%2520of%2520glycogen%2520synthase%2520kinase%2520following%2520myocardial%2520infarction%2520and%2520ischemia%25E2%2580%2593reperfusion%26jtitle%3DApoptosis%26date%3D2017%26volume%3D22%26issue%3D7%26spage%3D887%26epage%3D897%26doi%3D10.1007%2Fs10495-017-1376-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Ko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. Y.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase 3Î² in Toll-like receptor signaling</span> <span class="citation_source-journal">BMB Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">305</span><span class="NLM_x">â</span> <span class="NLM_lpage">310</span><span class="refDoi">Â DOI: 10.5483/BMBRep.2016.49.6.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.5483%2FBMBRep.2016.49.6.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=26996345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFyqtrzL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2016&pages=305-310&issue=6&author=R.+Koauthor=S.+Y.+Lee&title=Glycogen+synthase+kinase+3%CE%B2+in+Toll-like+receptor+signaling&doi=10.5483%2FBMBRep.2016.49.6.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase 3Î² in Toll-like receptor signaling</span></div><div class="casAuthors">Ko, Ryeojin; Lee, Soo Young</div><div class="citationInfo"><span class="NLM_cas:title">BMB Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">305-310</span>CODEN:
                <span class="NLM_cas:coden">BRMEC2</span>;
        ISSN:<span class="NLM_cas:issn">1976-670X</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) play a crit. role in the innate immune response against pathogens.  Each TLR recognizes specific pathogen-assocd. mol. patterns, after which they activate the adaptor protein MyD88 or TRIF-assembled signaling complex to produce immune mediators, including inflammatory cytokines and type I IFNs.  Although the activation of TLR is important for host defense, its uncontrolled activation can damage the host.  During the past decade, numerous studies have demonstrated that GSK3Î² is a key regulator of inflammatory cytokine prodn. in MyD88-mediated TLR signaling via TLR2 and TLR4.  Recently, GSK3Î² has also been implicated in the TRIF-dependent signaling pathway via TLR3.  In this review, we describe current advances on the regulatory role of GSK3Î² in immune responses assocd. with various TLRs.  A better understanding of the role of GSK3Î² in TLR signaling might lead to more effective anti-inflammatory interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUI8aIdn8TkbVg90H21EOLACvtfcHk0lh-WaSmxgT_-A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFyqtrzL&md5=722b56ff02fdf7d30b8a321d7250c517</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.5483%2FBMBRep.2016.49.6.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5483%252FBMBRep.2016.49.6.059%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DS.%2BY.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%25CE%25B2%2520in%2520Toll-like%2520receptor%2520signaling%26jtitle%3DBMB%2520Rep.%26date%3D2016%26volume%3D49%26issue%3D6%26spage%3D305%26epage%3D310%26doi%3D10.5483%2FBMBRep.2016.49.6.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The specificities of protein kinase inhibitors: an update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">199</span><span class="NLM_x">â</span> <span class="NLM_lpage">204</span><span class="refDoi">Â DOI: 10.1042/bj20021535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&issue=1&author=H.+McLauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+specificities+of+protein+kinase+inhibitors%3A+an+update&doi=10.1042%2Fbj20021535"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520specificities%2520of%2520protein%2520kinase%2520inhibitors%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26issue%3D1%26spage%3D199%26epage%3D204%26doi%3D10.1042%2Fbj20021535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plater, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mclauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevernic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">297</span><span class="NLM_x">â</span> <span class="NLM_lpage">315</span><span class="refDoi">Â DOI: 10.1042/BJ20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&issue=3&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+Mclauchlanauthor=I.+Klevernicauthor=J.+S.+C.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update&doi=10.1042%2FBJ20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0lh4wdzrLZ94Yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMclauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26issue%3D3%26spage%3D297%26epage%3D315%26doi%3D10.1042%2FBJ20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Davies, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caivano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Specificity and mechanism of action of some commonly used protein kinase inhibitors</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">95</span><span class="NLM_x">â</span> <span class="NLM_lpage">105</span><span class="refDoi">Â DOI: 10.1042/bj3510095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1042%2Fbj3510095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10998351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnslWltrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2000&pages=95-105&issue=1&author=S.+P.+Daviesauthor=H.+Reddyauthor=M.+Caivanoauthor=P.+Cohen&title=Specificity+and+mechanism+of+action+of+some+commonly+used+protein+kinase+inhibitors&doi=10.1042%2Fbj3510095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity and mechanism of action of some commonly used protein kinase inhibitors</span></div><div class="casAuthors">Davies, Stephen P.; Reddy, Helen; Caivano, Matilde; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 28 com. available compds. reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases have been examd. against a large panel of protein kinases.  The compds. KT 5720, Rottlerin and quercetin were found to inhibit many protein kinases, sometimes much more potently than their presumed targets, and conclusions drawn from their use in cell-based expts. are likely to be erroneous.  Ro 318220 and related bisindoylmaleimides, as well as H89, HA1077 and Y 27632, were more selective inhibitors, but still inhibited two or more protein kinases with similar potency.  LY 294002 was found to inhibit casein kinase-2 with similar potency to phosphoinositide (phosphatidylinositol) 3-kinase.  The compds. with the most impressive selectivity profiles were KN62, PD 98059, U0126, PD 184352, rapamycin, wortmannin, SB 203580 and SB 202190.  U0126 and PD 184352, like PD 98059, were found to block the mitogen-activated protein kinase (MAPK) cascade in cell-based assays by preventing the activation of MAPK kinase (MKK1), and not by inhibiting MKK1 activity directly.  Apart from rapamycin and PD 184352, even the most selective inhibitors affected at least one addnl. protein kinase.  Our results demonstrate that the specificities of protein kinase inhibitors cannot be assessed simply by studying their effect on kinases that are closely related in primary structure.  The authors propose guidelines for the use of protein kinase inhibitors in cell-based assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCs5LPDkzaGrVg90H21EOLACvtfcHk0lh4wdzrLZ94Yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnslWltrY%253D&md5=e14eb47a52dc43afca7373c276b2d147</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1042%2Fbj3510095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3510095%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DS.%2BP.%26aulast%3DReddy%26aufirst%3DH.%26aulast%3DCaivano%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DSpecificity%2520and%2520mechanism%2520of%2520action%2520of%2520some%2520commonly%2520used%2520protein%2520kinase%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D2000%26volume%3D351%26issue%3D1%26spage%3D95%26epage%3D105%26doi%3D10.1042%2Fbj3510095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Maeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweiker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truesdale, A. T.</span><span> </span><span class="NLM_article-title">4-Acylamino-6-arylfuro[2,3-d]pyrimidines: potent and selective glycogen synthase kinase-3 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">3907</span><span class="NLM_x">â</span> <span class="NLM_lpage">3911</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2004.05.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.bmcl.2004.05.064" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3907-3911&issue=15&author=Y.+Maedaauthor=M.+Nakanoauthor=H.+Satoauthor=Y.+Miyazakiauthor=S.+L.+Schweikerauthor=J.+L.+Smithauthor=A.+T.+Truesdale&title=4-Acylamino-6-arylfuro%5B2%2C3-d%5Dpyrimidines%3A+potent+and+selective+glycogen+synthase+kinase-3+inhibitors&doi=10.1016%2Fj.bmcl.2004.05.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.05.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.05.064%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DY.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DMiyazaki%26aufirst%3DY.%26aulast%3DSchweiker%26aufirst%3DS.%2BL.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DTruesdale%26aufirst%3DA.%2BT.%26atitle%3D4-Acylamino-6-arylfuro%255B2%252C3-d%255Dpyrimidines%253A%2520potent%2520and%2520selective%2520glycogen%2520synthase%2520kinase-3%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D15%26spage%3D3907%26epage%3D3911%26doi%3D10.1016%2Fj.bmcl.2004.05.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Tavares, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucheron, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preugschat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.-Q.</span><span> </span><span class="NLM_article-title">N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">4716</span><span class="NLM_x">â</span> <span class="NLM_lpage">4730</span><span class="refDoi">Â DOI: 10.1021/jm040063i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040063i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsFSgtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4716-4730&issue=19&author=F.+X.+Tavaresauthor=J.+A.+Boucheronauthor=S.+H.+Dickersonauthor=R.+J.+Griffinauthor=F.+Preugschatauthor=S.+A.+Thomsonauthor=T.+Y.+Wangauthor=H.-Q.+Zhou&title=N-Phenyl-4-pyrazolo%5B1%2C5-b%5Dpyridazin-3-ylpyrimidin-2-amines+as+potent+and+selective+inhibitors+of+glycogen+synthase+kinase+3+with+good+cellular+efficacy&doi=10.1021%2Fjm040063i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy</span></div><div class="casAuthors">Tavares, Francis X.; Boucheron, Joyce A.; Dickerson, Scott H.; Griffin, Robert J.; Preugschat, Frank; Thomson, Stephen A.; Wang, Tony Y.; Zhou, Hui-Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4716-4730</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glycogen synthase kinase 3 regulates glycogen synthase, the rate-detg. enzyme for glycogen synthesis.  Liver and muscle glycogen synthesis is defective in type 2 diabetics, resulting in elevated plasma glucose levels.  Inhibition of GSK-3 could potentially be an effective method to control plasma glucose levels in type 2 diabetics.  Structure-activity studies on a N-phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine series have led to the identification of potent and selective compds. with good cellular efficacy.  Mol. modeling studies have given insights into the mode of binding of these inhibitors.  Since the initial leads were also potent inhibitors of CDK-2/CDK-4, an extensive SAR was performed at various positions of the pyrazolo[1,5-b]pyridazin core to afford potent GSK-3 inhibitors that were highly selective over CDK-2.  In addn., these inhibitors also exhibited very good cell efficacy and functional response.  A representative example was shown to have good oral exposure levels, extending their utility in an in vivo setting.  These inhibitors provide a viable lead series in the discovery of new therapies for the treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY8mmZ2qIdFLVg90H21EOLACvtfcHk0lh4wdzrLZ94Yw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsFSgtL4%253D&md5=934bcecaed8f087510bfc8fb41e2e7a5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm040063i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040063i%26sid%3Dliteratum%253Aachs%26aulast%3DTavares%26aufirst%3DF.%2BX.%26aulast%3DBoucheron%26aufirst%3DJ.%2BA.%26aulast%3DDickerson%26aufirst%3DS.%2BH.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DPreugschat%26aufirst%3DF.%26aulast%3DThomson%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DT.%2BY.%26aulast%3DZhou%26aufirst%3DH.-Q.%26atitle%3DN-Phenyl-4-pyrazolo%255B1%252C5-b%255Dpyridazin-3-ylpyrimidin-2-amines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase%25203%2520with%2520good%2520cellular%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D19%26spage%3D4716%26epage%3D4730%26doi%3D10.1021%2Fjm040063i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Synthesis and target identification of hymenialdisine analogs</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">247</span><span class="NLM_x">â</span> <span class="NLM_lpage">259</span><span class="refDoi">Â DOI: 10.1016/j.chembiol.2004.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.chembiol.2004.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=15123286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsleks78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=247-259&issue=2&author=Y.+Wanauthor=W.+Hurauthor=C.+Y.+Choauthor=Y.+Liuauthor=F.+J.+Adrianauthor=O.+Lozachauthor=S.+Bachauthor=T.+Mayerauthor=D.+Fabbroauthor=L.+Meijerauthor=N.+S.+Gray&title=Synthesis+and+target+identification+of+hymenialdisine+analogs&doi=10.1016%2Fj.chembiol.2004.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Target Identification of Hymenialdisine Analogs</span></div><div class="casAuthors">Wan, Yongqin; Hur, Wooyoung; Cho, Charles Y.; Liu, Yi; Adrian, Francisco J.; Lozach, Olivier; Bach, Stephane; Mayer, Thomas; Fabbro, Doriano; Meijer, Laurent; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-259</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Hymenialdisine (HMD) is a sponge-derived natural product kinase inhibitor with nanomolar activity against CDKs, Mek1, GSK3Î², and CK1 and micromolar activity against Chk1.  To explore the broader application of the pyrrolo[2,3-c]azepine skeleton of HMD as a general kinase inhibitory scaffold, we searched for addnl. protein targets using affinity chromatog. in conjunction with the synthesis of diverse HMD analogs and profiled HMD against a panel of 60 recombinant enzymes.  This effort has led to nanomolar to micromolar inhibitors of 11 new targets including p90RSK, KDR, c-Kit, Fes, MAPK1, PAK2, PDK1, PKCÎ¸, PKD2, Rsk1, and SGK.  The synthesis of HMD analogs has resulted in the identification of compds. with enhanced and/or dramatically altered selectivities relative to HMD and in mols. with antiproliferative activities 30-fold higher than HMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoulWkl47lr-bVg90H21EOLACvtfcHk0li010ZTG8iF1g"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsleks78%253D&md5=e009eba03f45dd122ba9184f4bc8cdef</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DY.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DCho%26aufirst%3DC.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DAdrian%26aufirst%3DF.%2BJ.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBach%26aufirst%3DS.%26aulast%3DMayer%26aufirst%3DT.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DSynthesis%2520and%2520target%2520identification%2520of%2520hymenialdisine%2520analogs%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26issue%3D2%26spage%3D247%26epage%3D259%26doi%3D10.1016%2Fj.chembiol.2004.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Nuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renhowe, P. A.</span><span> </span><span class="NLM_article-title">Advances in solid-supported organic synthesis methods, 1998 to 1999</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">631</span><span class="NLM_x">â</span> <span class="NLM_lpage">650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1999&pages=631-650&issue=6&author=J.+M.+Nussauthor=P.+A.+Renhowe&title=Advances+in+solid-supported+organic+synthesis+methods%2C+1998+to+1999"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DRenhowe%26aufirst%3DP.%2BA.%26atitle%3DAdvances%2520in%2520solid-supported%2520organic%2520synthesis%2520methods%252C%25201998%2520to%25201999%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D1999%26volume%3D2%26issue%3D6%26spage%3D631%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Schultz, P.; Ring, D. B.; Harrison, S. D.; Bray, A. M.</span><span> </span><span class="NLM_article-title">Preparation of Purines as Inhibitors of Glycogen Synthase Kinase 3 (GSK3)</span>. Patent 97-US19472 19971010,<span class="NLM_x"> </span><span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=P.+Schultz&author=D.+B.+Ring&author=S.+D.+Harrison&author=A.+M.+Bray&title=Preparation+of+Purines+as+Inhibitors+of+Glycogen+Synthase+Kinase+3+%28GSK3%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchultz%26aufirst%3DP.%26atitle%3DPreparation%2520of%2520Purines%2520as%2520Inhibitors%2520of%2520Glycogen%2520Synthase%2520Kinase%25203%2520%2528GSK3%2529%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Desai, M. C.; Nuss, J. M.; Spear, K. L.; Singh, R.; Renhowe, P. A.; Brown, E. G.; Richter, L.; Scott, B. O.</span><span> </span><span class="NLM_article-title">Combinatorial Libraries of Substrate-Bound Cyclic Organic Compounds</span>. U.S. Patent 5,958,792,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=M.+C.+Desai&author=J.+M.+Nuss&author=K.+L.+Spear&author=R.+Singh&author=P.+A.+Renhowe&author=E.+G.+Brown&author=L.+Richter&author=B.+O.+Scott&title=Combinatorial+Libraries+of+Substrate-Bound+Cyclic+Organic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DM.%2BC.%26atitle%3DCombinatorial%2520Libraries%2520of%2520Substrate-Bound%2520Cyclic%2520Organic%2520Compounds%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Norman, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">A structure-based library approach to kinase inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x"> (</span><span class="NLM_issue">31</span><span class="NLM_x">) </span> <span class="NLM_fpage">7430</span><span class="NLM_x">â</span> <span class="NLM_lpage">7431</span><span class="refDoi">Â DOI: 10.1021/ja9614934</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9614934" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=7430-7431&issue=31&author=T.+C.+Normanauthor=N.+S.+Grayauthor=J.+T.+Kohauthor=P.+G.+Schultz&title=A+structure-based+library+approach+to+kinase+inhibitors&doi=10.1021%2Fja9614934"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fja9614934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9614934%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DT.%2BC.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKoh%26aufirst%3DJ.%2BT.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DA%2520structure-based%2520library%2520approach%2520to%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26issue%3D31%26spage%3D7430%26epage%3D7431%26doi%3D10.1021%2Fja9614934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group">Nuss, J. M.; Harrison, S. D.; Ring, D. B.; Boyce, R. S.; Brown, S. P.; Goff, D.; Johnson, K.; Pfister, K. B.; Ramurthy, S.; Renhowe, P. A.; Seely, L.; Subramanian, S.; Wagman, A. S.; Zhou, X. A.</span><span> </span><span class="NLM_article-title">Inhibitors of Glycogen Synthase Kinase 3</span>. U.S. Patent 6,489,344 B1,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+M.+Nuss&author=S.+D.+Harrison&author=D.+B.+Ring&author=R.+S.+Boyce&author=S.+P.+Brown&author=D.+Goff&author=K.+Johnson&author=K.+B.+Pfister&author=S.+Ramurthy&author=P.+A.+Renhowe&author=L.+Seely&author=S.+Subramanian&author=A.+S.+Wagman&author=X.+A.+Zhou&title=Inhibitors+of+Glycogen+Synthase+Kinase+3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26atitle%3DInhibitors%2520of%2520Glycogen%2520Synthase%2520Kinase%25203%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovnyak, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreland, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gougoutas, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malley, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, D. M.</span><span> </span><span class="NLM_article-title">Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1510</span><span class="NLM_x">â</span> <span class="NLM_lpage">1515</span><span class="refDoi">Â DOI: 10.1021/jm00167a035</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00167a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=1510-1515&issue=5&author=K.+S.+Atwalauthor=G.+C.+Rovnyakauthor=J.+Schwartzauthor=S.+Morelandauthor=A.+Hedbergauthor=J.+Z.+Gougoutasauthor=M.+F.+Malleyauthor=D.+M.+Floyd&title=Dihydropyrimidine+calcium+channel+blockers%3A+2-heterosubstituted+4-aryl-1%2C4-dihydro-6-methyl-5-pyrimidinecarboxylic+acid+esters+as+potent+mimics+of+dihydropyridines&doi=10.1021%2Fjm00167a035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm00167a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00167a035%26sid%3Dliteratum%253Aachs%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DRovnyak%26aufirst%3DG.%2BC.%26aulast%3DSchwartz%26aufirst%3DJ.%26aulast%3DMoreland%26aufirst%3DS.%26aulast%3DHedberg%26aufirst%3DA.%26aulast%3DGougoutas%26aufirst%3DJ.%2BZ.%26aulast%3DMalley%26aufirst%3DM.%2BF.%26aulast%3DFloyd%26aufirst%3DD.%2BM.%26atitle%3DDihydropyrimidine%2520calcium%2520channel%2520blockers%253A%25202-heterosubstituted%25204-aryl-1%252C4-dihydro-6-methyl-5-pyrimidinecarboxylic%2520acid%2520esters%2520as%2520potent%2520mimics%2520of%2520dihydropyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26issue%3D5%26spage%3D1510%26epage%3D1515%26doi%3D10.1021%2Fjm00167a035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group">Wagman, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuss, J. M.</span><span> </span><span class="NLM_article-title">Simple and efficient synthesis of 3,4-dihydro-2-pyridones via novel solid-supported aza-annulation</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">9103</span><span class="NLM_x">â</span> <span class="NLM_lpage">9113</span><span class="refDoi">Â DOI: 10.1021/jo005609x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo005609x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=9103-9113&issue=26&author=A.+S.+Wagmanauthor=L.+Wangauthor=J.+M.+Nuss&title=Simple+and+efficient+synthesis+of+3%2C4-dihydro-2-pyridones+via+novel+solid-supported+aza-annulation&doi=10.1021%2Fjo005609x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjo005609x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo005609x%26sid%3Dliteratum%253Aachs%26aulast%3DWagman%26aufirst%3DA.%2BS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26atitle%3DSimple%2520and%2520efficient%2520synthesis%2520of%25203%252C4-dihydro-2-pyridones%2520via%2520novel%2520solid-supported%2520aza-annulation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26issue%3D26%26spage%3D9103%26epage%3D9113%26doi%3D10.1021%2Fjo005609x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group">Bedford, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dailey, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolen, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winterle, J. S.</span><span> </span><span class="NLM_article-title">Nonquaternary cholinesterase reactivators. 3. 3(5)-Substituted 1,2,4-oxadiazol-5(3)-aldoximes and 1,2,4-oxadiazole-5(3)-thiocarbohydroximates as reactivators of organophosphonate-inhibited eel and human acetylcholinesterase in vitro</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2174</span><span class="NLM_x">â</span> <span class="NLM_lpage">2183</span><span class="refDoi">Â DOI: 10.1021/jm00161a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00161a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=2174-2183&issue=11&author=C.+D.+Bedfordauthor=R.+A.+Howdauthor=O.+D.+Daileyauthor=A.+Millerauthor=H.+W.+Nolenauthor=R.+A.+Kenleyauthor=J.+R.+Kernauthor=J.+S.+Winterle&title=Nonquaternary+cholinesterase+reactivators.+3.+3%285%29-Substituted+1%2C2%2C4-oxadiazol-5%283%29-aldoximes+and+1%2C2%2C4-oxadiazole-5%283%29-thiocarbohydroximates+as+reactivators+of+organophosphonate-inhibited+eel+and+human+acetylcholinesterase+in+vitro&doi=10.1021%2Fjm00161a008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm00161a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00161a008%26sid%3Dliteratum%253Aachs%26aulast%3DBedford%26aufirst%3DC.%2BD.%26aulast%3DHowd%26aufirst%3DR.%2BA.%26aulast%3DDailey%26aufirst%3DO.%2BD.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DNolen%26aufirst%3DH.%2BW.%26aulast%3DKenley%26aufirst%3DR.%2BA.%26aulast%3DKern%26aufirst%3DJ.%2BR.%26aulast%3DWinterle%26aufirst%3DJ.%2BS.%26atitle%3DNonquaternary%2520cholinesterase%2520reactivators.%25203.%25203%25285%2529-Substituted%25201%252C2%252C4-oxadiazol-5%25283%2529-aldoximes%2520and%25201%252C2%252C4-oxadiazole-5%25283%2529-thiocarbohydroximates%2520as%2520reactivators%2520of%2520organophosphonate-inhibited%2520eel%2520and%2520human%2520acetylcholinesterase%2520in%2520vitro%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26issue%3D11%26spage%3D2174%26epage%3D2183%26doi%3D10.1021%2Fjm00161a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group">Sakurai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, H.</span><span> </span><span class="NLM_article-title">Synthesis of [[(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives containing pyridyl or imidazolyl groups and their thromboxane A2 receptor antagonistic and thromboxane A2 synthase inhibitory activities</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1510</span><span class="NLM_x">â</span> <span class="NLM_lpage">1520</span><span class="refDoi">Â DOI: 10.1248/cpb.44.1510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1248%2Fcpb.44.1510" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1996&pages=1510-1520&issue=8&author=S.+Sakuraiauthor=N.+Ogawaauthor=T.+Suzukiauthor=K.+Katoauthor=T.+Ohashiauthor=S.+Yasudaauthor=H.+Kato&title=Synthesis+of+%5B%5B%28benzenesulfonamido%29alkyl%5Dphenyl%5Dalkanoic+acid+derivatives+containing+pyridyl+or+imidazolyl+groups+and+their+thromboxane+A2+receptor+antagonistic+and+thromboxane+A2+synthase+inhibitory+activities&doi=10.1248%2Fcpb.44.1510"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1248%2Fcpb.44.1510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.44.1510%26sid%3Dliteratum%253Aachs%26aulast%3DSakurai%26aufirst%3DS.%26aulast%3DOgawa%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DOhashi%26aufirst%3DT.%26aulast%3DYasuda%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520%255B%255B%2528benzenesulfonamido%2529alkyl%255Dphenyl%255Dalkanoic%2520acid%2520derivatives%2520containing%2520pyridyl%2520or%2520imidazolyl%2520groups%2520and%2520their%2520thromboxane%2520A2%2520receptor%2520antagonistic%2520and%2520thromboxane%2520A2%2520synthase%2520inhibitory%2520activities%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1996%26volume%3D44%26issue%3D8%26spage%3D1510%26epage%3D1520%26doi%3D10.1248%2Fcpb.44.1510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group">Bastiaansen, L. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godefroi, E. F.</span><span> </span><span class="NLM_article-title">2-(2-Imidazolyl)acetophenones via aroylation of N-substituted 2-methylimidazoles</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="refDoi">Â DOI: 10.1039/c39740000036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1039%2Fc39740000036" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1974&pages=36&author=L.+A.+M.+Bastiaansenauthor=A.+A.+Maccoauthor=E.+F.+Godefroi&title=2-%282-Imidazolyl%29acetophenones+via+aroylation+of+N-substituted+2-methylimidazoles&doi=10.1039%2Fc39740000036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1039%2Fc39740000036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39740000036%26sid%3Dliteratum%253Aachs%26aulast%3DBastiaansen%26aufirst%3DL.%2BA.%2BM.%26aulast%3DMacco%26aufirst%3DA.%2BA.%26aulast%3DGodefroi%26aufirst%3DE.%2BF.%26atitle%3D2-%25282-Imidazolyl%2529acetophenones%2520via%2520aroylation%2520of%2520N-substituted%25202-methylimidazoles%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1974%26spage%3D36%26doi%3D10.1039%2Fc39740000036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group">Macco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godefroi, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drouen, J. J. M.</span><span> </span><span class="NLM_article-title">2-(2-Imidazolyl)acetophenones. Preparation and some reactions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">252</span><span class="NLM_x">â</span> <span class="NLM_lpage">255</span><span class="refDoi">Â DOI: 10.1021/jo00890a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00890a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1975&pages=252-255&issue=2&author=A.+A.+Maccoauthor=E.+F.+Godefroiauthor=J.+J.+M.+Drouen&title=2-%282-Imidazolyl%29acetophenones.+Preparation+and+some+reactions&doi=10.1021%2Fjo00890a024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjo00890a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00890a024%26sid%3Dliteratum%253Aachs%26aulast%3DMacco%26aufirst%3DA.%2BA.%26aulast%3DGodefroi%26aufirst%3DE.%2BF.%26aulast%3DDrouen%26aufirst%3DJ.%2BJ.%2BM.%26atitle%3D2-%25282-Imidazolyl%2529acetophenones.%2520Preparation%2520and%2520some%2520reactions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1975%26volume%3D40%26issue%3D2%26spage%3D252%26epage%3D255%26doi%3D10.1021%2Fjo00890a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group">KnÃ¶lker, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitzemann, R.</span><span> </span><span class="NLM_article-title">Imidazole derivatives. Part II. Synthesis of imidazo[1,2-a]pyridin-5-ones</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1551</span><span class="NLM_x">â</span> <span class="NLM_lpage">1558</span><span class="refDoi">Â DOI: 10.3987/COM-89-5003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.3987%2FCOM-89-5003" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1989&pages=1551-1558&issue=8&author=H.-J.+Kn%C3%B6lkerauthor=R.+Boeseauthor=R.+Hitzemann&title=Imidazole+derivatives.+Part+II.+Synthesis+of+imidazo%5B1%2C2-a%5Dpyridin-5-ones&doi=10.3987%2FCOM-89-5003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3987%2FCOM-89-5003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-89-5003%26sid%3Dliteratum%253Aachs%26aulast%3DKn%25C3%25B6lker%26aufirst%3DH.-J.%26aulast%3DBoese%26aufirst%3DR.%26aulast%3DHitzemann%26aufirst%3DR.%26atitle%3DImidazole%2520derivatives.%2520Part%2520II.%2520Synthesis%2520of%2520imidazo%255B1%252C2-a%255Dpyridin-5-ones%26jtitle%3DHeterocycles%26date%3D1989%26volume%3D29%26issue%3D8%26spage%3D1551%26epage%3D1558%26doi%3D10.3987%2FCOM-89-5003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group">Lipshutz, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morey, M. C.</span><span> </span><span class="NLM_article-title">An approach to the cyclopeptide alkaloids (phencyclopeptines) via heterocyclic diamide/dipeptide equivalents. Preparation and N-alkylation studies of 2,4(5)-disubstituted imidazoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">3745</span><span class="NLM_x">â</span> <span class="NLM_lpage">3750</span><span class="refDoi">Â DOI: 10.1021/jo00169a027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00169a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1983&pages=3745-3750&issue=21&author=B.+H.+Lipshutzauthor=M.+C.+Morey&title=An+approach+to+the+cyclopeptide+alkaloids+%28phencyclopeptines%29+via+heterocyclic+diamide%2Fdipeptide+equivalents.+Preparation+and+N-alkylation+studies+of+2%2C4%285%29-disubstituted+imidazoles&doi=10.1021%2Fjo00169a027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjo00169a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00169a027%26sid%3Dliteratum%253Aachs%26aulast%3DLipshutz%26aufirst%3DB.%2BH.%26aulast%3DMorey%26aufirst%3DM.%2BC.%26atitle%3DAn%2520approach%2520to%2520the%2520cyclopeptide%2520alkaloids%2520%2528phencyclopeptines%2529%2520via%2520heterocyclic%2520diamide%252Fdipeptide%2520equivalents.%2520Preparation%2520and%2520N-alkylation%2520studies%2520of%25202%252C4%25285%2529-disubstituted%2520imidazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1983%26volume%3D48%26issue%3D21%26spage%3D3745%26epage%3D3750%26doi%3D10.1021%2Fjo00169a027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group">Groarke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKervey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieuwenhuyzen, M.</span><span> </span><span class="NLM_article-title">Synthesis of amino acid-derived imidazoles from enantiopure N-protected a-amino glyoxals</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1275</span><span class="NLM_x">â</span> <span class="NLM_lpage">1278</span><span class="refDoi">Â DOI: 10.1016/S0040-4039(99)02267-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FS0040-4039%2899%2902267-4" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=1275-1278&author=M.+Groarkeauthor=M.+A.+McKerveyauthor=M.+Nieuwenhuyzen&title=Synthesis+of+amino+acid-derived+imidazoles+from+enantiopure+N-protected+a-amino+glyoxals&doi=10.1016%2FS0040-4039%2899%2902267-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2899%2902267-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252899%252902267-4%26sid%3Dliteratum%253Aachs%26aulast%3DGroarke%26aufirst%3DM.%26aulast%3DMcKervey%26aufirst%3DM.%2BA.%26aulast%3DNieuwenhuyzen%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520amino%2520acid-derived%2520imidazoles%2520from%2520enantiopure%2520N-protected%2520a-amino%2520glyoxals%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D1275%26epage%3D1278%26doi%3D10.1016%2FS0040-4039%2899%2902267-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group">Palucki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed alpha-arylation of ketones</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x"> (</span><span class="NLM_issue">45</span><span class="NLM_x">) </span> <span class="NLM_fpage">11108</span><span class="NLM_x">â</span> <span class="NLM_lpage">11109</span><span class="refDoi">Â DOI: 10.1021/ja972593s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja972593s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=11108-11109&issue=45&author=M.+Paluckiauthor=S.+L.+Buchwald&title=Palladium-catalyzed+alpha-arylation+of+ketones&doi=10.1021%2Fja972593s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fja972593s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja972593s%26sid%3Dliteratum%253Aachs%26aulast%3DPalucki%26aufirst%3DM.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPalladium-catalyzed%2520alpha-arylation%2520of%2520ketones%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26issue%3D45%26spage%3D11108%26epage%3D11109%26doi%3D10.1021%2Fja972593s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group">Galante, R. J.</span><span> </span><span class="NLM_article-title">Method of synthesizing sterically hindered 5-substituted-1<i>H</i>-tetrazoles from nitriles using a Lewis acid and an azide</span>. U.S. Patent 5,502,191,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=R.+J.+Galante&title=Method+of+synthesizing+sterically+hindered+5-substituted-1H-tetrazoles+from+nitriles+using+a+Lewis+acid+and+an+azide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGalante%26aufirst%3DR.%2BJ.%26atitle%3DMethod%2520of%2520synthesizing%2520sterically%2520hindered%25205-substituted-1H-tetrazoles%2520from%2520nitriles%2520using%2520a%2520Lewis%2520acid%2520and%2520an%2520azide%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group">Stiefl, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buenemann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polyakov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tommasi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Drie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehead, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totrov, M.</span><span> </span><span class="NLM_article-title">FOCUS-Development of a global communication and modeling platform for applied and computational medicinal chemists</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">896</span><span class="NLM_x">â</span> <span class="NLM_lpage">908</span><span class="refDoi">Â DOI: 10.1021/ci500598e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVShtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=896-908&issue=4&author=N.+Stieflauthor=P.+Gedeckauthor=D.+Chinauthor=P.+Huntauthor=M.+Lindvallauthor=K.+Spiegelauthor=C.+Springerauthor=S.+Billerauthor=C.+Buenemannauthor=T.+Kanazawaauthor=M.+Katoauthor=R.+Lewisauthor=E.+Martinauthor=V.+Polyakovauthor=R.+Tommasiauthor=J.+van+Drieauthor=B.+Vashauthor=L.+Whiteheadauthor=Y.+Xuauthor=R.+Abagyanauthor=E.+Raushauthor=M.+Totrov&title=FOCUS-Development+of+a+global+communication+and+modeling+platform+for+applied+and+computational+medicinal+chemists&doi=10.1021%2Fci500598e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">FOCUS - Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal Chemists</span></div><div class="casAuthors">Stiefl, Nikolaus; Gedeck, Peter; Chin, Donovan; Hunt, Peter; Lindvall, Mika; Spiegel, Katrin; Springer, Clayton; Biller, Scott; Buenemann, Christoph; Kanazawa, Takanori; Kato, Mitsunori; Lewis, Richard; Martin, Eric; Polyakov, Valery; Tommasi, Ruben; van Drie, John; Vash, Brian; Whitehead, Lewis; Xu, Yongjin; Abagyan, Ruben; Raush, Eugene; Totrov, Max</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">896-908</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Communication of data and ideas within a medicinal chem. project on a global as well as local level is a crucial aspect in the drug design cycle.  Over a time frame of eight years, we built and optimized FOCUS, a platform to produce, visualize, and share information on various aspects of a drug discovery project such as cheminformatics, data anal., structural information, and design.  FOCUS is tightly integrated with internal services that involve-among others-data retrieval systems and in-silico models and provides easy access to automated modeling procedures such as pharmacophore searches, R-group anal., and similarity searches.  In addn., an interactive 3D editor was developed to assist users in the generation and docking of close analogs of a known lead.  In this paper, we will specifically conc. on issues we faced during development, deployment, and maintenance of the software and how we continually adapted the software in order to improve usability.  We will provide usage examples to highlight the functionality as well as limitations of FOCUS at the various stages of the development process.  We aim to make the discussion as independent of the software platform as possible, so that our experiences can be of more general value to the drug discovery community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozGiXPjxVBHrVg90H21EOLACvtfcHk0lhG_y00u-1Ftw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVShtr8%253D&md5=00541e43a6212701678a400e36996caf</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fci500598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500598e%26sid%3Dliteratum%253Aachs%26aulast%3DStiefl%26aufirst%3DN.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DChin%26aufirst%3DD.%26aulast%3DHunt%26aufirst%3DP.%26aulast%3DLindvall%26aufirst%3DM.%26aulast%3DSpiegel%26aufirst%3DK.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DBiller%26aufirst%3DS.%26aulast%3DBuenemann%26aufirst%3DC.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DPolyakov%26aufirst%3DV.%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3Dvan%2BDrie%26aufirst%3DJ.%26aulast%3DVash%26aufirst%3DB.%26aulast%3DWhitehead%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DRaush%26aufirst%3DE.%26aulast%3DTotrov%26aufirst%3DM.%26atitle%3DFOCUS-Development%2520of%2520a%2520global%2520communication%2520and%2520modeling%2520platform%2520for%2520applied%2520and%2520computational%2520medicinal%2520chemists%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26issue%3D4%26spage%3D896%26epage%3D908%26doi%3D10.1021%2Fci500598e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group">Gedeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dollinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berellini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span> </span><span class="NLM_article-title">Benefit of retraining p<i>K</i><sub>a</sub> models studied using internally measured data</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1449</span><span class="NLM_x">â</span> <span class="NLM_lpage">1459</span><span class="refDoi">Â DOI: 10.1021/acs.jcim.5b00172</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.5b00172" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVShtrvJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=1449-1459&issue=7&author=P.+Gedeckauthor=Y.+Luauthor=S.+Skolnikauthor=S.+Roddeauthor=G.+Dollingerauthor=W.+Jiaauthor=G.+Berelliniauthor=R.+Vianelloauthor=B.+Fallerauthor=F.+Lombardo&title=Benefit+of+retraining+pKa+models+studied+using+internally+measured+data&doi=10.1021%2Facs.jcim.5b00172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Benefit of Retraining pKa Models Studied Using Internally Measured Data</span></div><div class="casAuthors">Gedeck, Peter; Lu, Yipin; Skolnik, Suzanne; Rodde, Stephane; Dollinger, Gavin; Jia, Weiping; Berellini, Giuliano; Vianello, Riccardo; Faller, Bernard; Lombardo, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1449-1459</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ionization state of drugs influences many pharmaceutical properties such as their soly., permeability, and biol. activity.  It is therefore important to understand the structure property relation for the acid-base dissocn. const. pKa during the lead optimization process to make better-informed design decisions.  Computational approaches, such as implemented in MoKa, can help with this; however, they often predict with too large error esp. for proprietary compds.  In this contribution, the authors look at how retraining helps to greatly improve prediction error.  Using a longitudinal study with data measured over 15 years in a drug discovery environment, the authors assess the impact of model training on prediction accuracy and look at model degrdn. over time.  Using the MoKa software, regular retraining is required to address changes in chem. space leading to model degrdn. over six to nine months.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNCUz-ylPu6bVg90H21EOLACvtfcHk0lhG_y00u-1Ftw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVShtrvJ&md5=6a178b50d5ac0a597391cc2b19af8e32</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.5b00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.5b00172%26sid%3Dliteratum%253Aachs%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DRodde%26aufirst%3DS.%26aulast%3DDollinger%26aufirst%3DG.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DBerellini%26aufirst%3DG.%26aulast%3DVianello%26aufirst%3DR.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DLombardo%26aufirst%3DF.%26atitle%3DBenefit%2520of%2520retraining%2520pKa%2520models%2520studied%2520using%2520internally%2520measured%2520data%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26issue%3D7%26spage%3D1449%26epage%3D1459%26doi%3D10.1021%2Facs.jcim.5b00172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group">Aoki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okumura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzaki, T.</span><span> </span><span class="NLM_article-title">Structural insight into nucleotide recognition in tau-protein kinase I/glycogen synthase kinase 3 beta</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">439</span><span class="NLM_x">â</span> <span class="NLM_lpage">446</span><span class="refDoi">Â DOI: 10.1107/S090744490302938X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1107%2FS090744490302938X" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=439-446&issue=3&author=M.+Aokiauthor=T.+Yokotaauthor=I.+Sugiuraauthor=C.+Sasakiauthor=T.+Hasegawaauthor=C.+Okumuraauthor=K.+Ishiguroauthor=T.+Kohnoauthor=S.+Sugioauthor=T.+Matsuzaki&title=Structural+insight+into+nucleotide+recognition+in+tau-protein+kinase+I%2Fglycogen+synthase+kinase+3+beta&doi=10.1107%2FS090744490302938X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS090744490302938X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090744490302938X%26sid%3Dliteratum%253Aachs%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DYokota%26aufirst%3DT.%26aulast%3DSugiura%26aufirst%3DI.%26aulast%3DSasaki%26aufirst%3DC.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DOkumura%26aufirst%3DC.%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DKohno%26aufirst%3DT.%26aulast%3DSugio%26aufirst%3DS.%26aulast%3DMatsuzaki%26aufirst%3DT.%26atitle%3DStructural%2520insight%2520into%2520nucleotide%2520recognition%2520in%2520tau-protein%2520kinase%2520I%252Fglycogen%2520synthase%2520kinase%25203%2520beta%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26issue%3D3%26spage%3D439%26epage%3D446%26doi%3D10.1107%2FS090744490302938X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarakeshwar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. Y.</span><span> </span><span class="NLM_article-title">Molecular clusters of Ï-systems: Theoretical studies of structures, spectra, and origin of interaction energies</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">4145</span><span class="NLM_x">â</span> <span class="NLM_lpage">4186</span><span class="refDoi">Â DOI: 10.1021/cr990051i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr990051i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslGjtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=4145-4186&issue=11&author=K.+S.+Kimauthor=P.+Tarakeshwarauthor=J.+Y.+Lee&title=Molecular+clusters+of+%CF%80-systems%3A+Theoretical+studies+of+structures%2C+spectra%2C+and+origin+of+interaction+energies&doi=10.1021%2Fcr990051i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Clusters of Ï-Systems: Theoretical Studies of Structures, Spectra, and Origin of Interaction Energies</span></div><div class="casAuthors">Kim, Kwang S.; Tarakeshwar, P.; Lee, Jin Yong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4145-4185</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 522 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAKpuRX5mQ57Vg90H21EOLACvtfcHk0ljvxmW4fyG7EQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslGjtbw%253D&md5=e7ec9c0f0a7f004761b8a76efa8db502</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fcr990051i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr990051i%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DTarakeshwar%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26atitle%3DMolecular%2520clusters%2520of%2520%25CF%2580-systems%253A%2520Theoretical%2520studies%2520of%2520structures%252C%2520spectra%252C%2520and%2520origin%2520of%2520interaction%2520energies%26jtitle%3DChem.%2520Rev.%26date%3D2000%26volume%3D100%26issue%3D11%26spage%3D4145%26epage%3D4186%26doi%3D10.1021%2Fcr990051i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GagnÃ©, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">RappÃ©, A. K.</span><span> </span><span class="NLM_article-title">pi-Stacking interactions. Alive and well in proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">15458</span><span class="NLM_x">â</span> <span class="NLM_lpage">15463</span><span class="refDoi">Â DOI: 10.1074/jbc.273.25.15458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1074%2Fjbc.273.25.15458" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=15458-15463&issue=25&author=G.+B.+McGaugheyauthor=M.+Gagn%C3%A9author=A.+K.+Rapp%C3%A9&title=pi-Stacking+interactions.+Alive+and+well+in+proteins&doi=10.1074%2Fjbc.273.25.15458"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.25.15458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.25.15458%26sid%3Dliteratum%253Aachs%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DGagn%25C3%25A9%26aufirst%3DM.%26aulast%3DRapp%25C3%25A9%26aufirst%3DA.%2BK.%26atitle%3Dpi-Stacking%2520interactions.%2520Alive%2520and%2520well%2520in%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26issue%3D25%26spage%3D15458%26epage%3D15463%26doi%3D10.1074%2Fjbc.273.25.15458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group">Sinnokrot, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrill, C. D.</span><span> </span><span class="NLM_article-title">Substituent effects in ÏâÏ Interactions: Sandwich and T-shaped configurations</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">7690</span><span class="NLM_x">â</span> <span class="NLM_lpage">7697</span><span class="refDoi">Â DOI: 10.1021/ja049434a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja049434a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVejur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=7690-7697&issue=24&author=M.+O.+Sinnokrotauthor=C.+D.+Sherrill&title=Substituent+effects+in+%CF%80%E2%80%93%CF%80+Interactions%3A+Sandwich+and+T-shaped+configurations&doi=10.1021%2Fja049434a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Substituent Effects in Ï-Ï Interactions: Sandwich and T-Shaped Configurations</span></div><div class="casAuthors">Sinnokrot, Mutasem Omar; Sherrill, C. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7690-7697</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sandwich and T-shaped configurations of benzene dimer, benzene-phenol, benzene-toluene, benzene-fluorobenzene, and benzene-benzonitrile are studied by coupled-cluster theory to elucidate how substituents tune Ï-Ï interactions.  All substituted sandwich dimers bind more strongly than benzene dimer, whereas the T-shaped configurations bind more or less favorably depending on the substituent.  Symmetry-adapted perturbation theory (SAPT) indicates that electrostatic, dispersion, induction, and exchange-repulsion contributions are all significant to the overall binding energies, and all but induction are important in detg. relative energies.  Models of Ï-Ï interactions based solely on electrostatics, such as the Hunter-Sanders rules, do not seem capable of explaining the energetic ordering of the dimers considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFBZHgFWNA5rVg90H21EOLACvtfcHk0ljvxmW4fyG7EQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVejur4%253D&md5=f9c4afdd96f98ecc1d46f93a0ce0f17a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fja049434a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja049434a%26sid%3Dliteratum%253Aachs%26aulast%3DSinnokrot%26aufirst%3DM.%2BO.%26aulast%3DSherrill%26aufirst%3DC.%2BD.%26atitle%3DSubstituent%2520effects%2520in%2520%25CF%2580%25E2%2580%2593%25CF%2580%2520Interactions%253A%2520Sandwich%2520and%2520T-shaped%2520configurations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26issue%3D24%26spage%3D7690%26epage%3D7697%26doi%3D10.1021%2Fja049434a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bregman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debreczeni, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Delft, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">e7112</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0007112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1371%2Fjournal.pone.0007112" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7112&issue=10&author=A.+N.+Bullockauthor=S.+Russoauthor=A.+Amosauthor=N.+Paganoauthor=H.+Bregmanauthor=J.+E.+Debreczeniauthor=W.+H.+Leeauthor=F.+von+Delftauthor=E.+Meggersauthor=S.+Knapp&title=Crystal+structure+of+the+PIM2+kinase+in+complex+with+an+organoruthenium+inhibitor&doi=10.1371%2Fjournal.pone.0007112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007112%26sid%3Dliteratum%253Aachs%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DRusso%26aufirst%3DS.%26aulast%3DAmos%26aufirst%3DA.%26aulast%3DPagano%26aufirst%3DN.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DDebreczeni%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DW.%2BH.%26aulast%3Dvon%2BDelft%26aufirst%3DF.%26aulast%3DMeggers%26aufirst%3DE.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520the%2520PIM2%2520kinase%2520in%2520complex%2520with%2520an%2520organoruthenium%2520inhibitor%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26issue%3D10%26spage%3De7112%26doi%3D10.1371%2Fjournal.pone.0007112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group">GuimarÃ£es, C. R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckbinder, L.</span><span> </span><span class="NLM_article-title">Understanding the impact of the P-loop conformation on kinase selectivity</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1199</span><span class="NLM_x">â</span> <span class="NLM_lpage">1204</span><span class="refDoi">Â DOI: 10.1021/ci200153c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200153c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVWls78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=1199-1204&issue=6&author=C.+R.+W.+Guimar%C3%A3esauthor=B.+K.+Raiauthor=M.+J.+Munchhofauthor=S.+Liuauthor=J.+Wangauthor=S.+K.+Bhattacharyaauthor=L.+Buckbinder&title=Understanding+the+impact+of+the+P-loop+conformation+on+kinase+selectivity&doi=10.1021%2Fci200153c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the impact of the P-loop conformation on kinase selectivity</span></div><div class="casAuthors">Guimaraes, Cristiano R. W.; Rai, Brajesh K.; Munchhof, Michael J.; Liu, Shenping; Wang, Jian; Bhattacharya, Samit K.; Buckbinder, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1199-1204</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work addresses the link between selectivity and an unusual, folded conformation for the P-loop obsd. initially for MAP4K4 kinase and subsequently for other kinases.  Statistical and computational analyses of the authors' crystal structure database demonstrated that inhibitors that induced the P-loop folded conformation tended to be more selective, esp. if they took advantage of this specific conformation by interacting more favorably with a conserved Tyr or Phe residue from the P-loop.  The role of the P-loop in the crystal structures of MAP4K4 kinase and 2 selective inhibitors was discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofyL-cXXqwPLVg90H21EOLACvtfcHk0ljvxmW4fyG7EQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVWls78%253D&md5=3179e5f43bf2534badc595dced50d8c4</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fci200153c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200153c%26sid%3Dliteratum%253Aachs%26aulast%3DGuimar%25C3%25A3es%26aufirst%3DC.%2BR.%2BW.%26aulast%3DRai%26aufirst%3DB.%2BK.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBuckbinder%26aufirst%3DL.%26atitle%3DUnderstanding%2520the%2520impact%2520of%2520the%2520P-loop%2520conformation%2520on%2520kinase%2520selectivity%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26issue%3D6%26spage%3D1199%26epage%3D1204%26doi%3D10.1021%2Fci200153c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group">MÃ¼ller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikuad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">The ins and outs of selective kinase inhibitor development</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">818</span><span class="NLM_x">â</span> <span class="NLM_lpage">821</span><span class="refDoi">Â DOI: 10.1038/nchembio.1938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1038%2Fnchembio.1938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=26485069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ykt7fF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=818-821&issue=11&author=S.+M%C3%BCllerauthor=A.+Chaikuadauthor=N.+S.+Grayauthor=S.+Knapp&title=The+ins+and+outs+of+selective+kinase+inhibitor+development&doi=10.1038%2Fnchembio.1938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The ins and outs of selective kinase inhibitor development</span></div><div class="casAuthors">Muller, Susanne; Chaikuad, Apirat; Gray, Nathanael S.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">818-821</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases have emerged as one of the most successful families of drug targets.  To date, most selective kinase inhibitors have been discovered serendipitously either through broad selectivity screening or through the discovery of unique binding modes.  Here the authors discuss design strategies that could lead to a broader coverage of the kinome with selective inhibitors and to a more rational approach for developing them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQzaMrxSYx_rVg90H21EOLACvtfcHk0ljoxeqBG05Ucw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ykt7fF&md5=f5adf0bbaa388c87b26bae23cfad0bae</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1938%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DThe%2520ins%2520and%2520outs%2520of%2520selective%2520kinase%2520inhibitor%2520development%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26issue%3D11%26spage%3D818%26epage%3D821%26doi%3D10.1038%2Fnchembio.1938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group">Pettersen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couch, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrin, T. E.</span><span> </span><span class="NLM_article-title">UCSF Chimera-A visualization system for exploratory research and analysis</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">1605</span><span class="NLM_x">â</span> <span class="NLM_lpage">1612</span><span class="refDoi">Â DOI: 10.1002/jcc.20084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1002%2Fjcc.20084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=15264254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&issue=13&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+Chimera-A+visualization+system+for+exploratory+research+and+analysis&doi=10.1002%2Fjcc.20084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">UCSF Chimera-A visualization system for exploratory research and analysis</span></div><div class="casAuthors">Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.; Couch, Gregory S.; Greenblatt, Daniel M.; Meng, Elaine C.; Ferrin, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed.  Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality.  This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features.  Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale mol. assemblies such as viral coats, and Collab., which allows researchers to share a Chimera session interactively despite being at sep. locales.  Other extensions include Multalign Viewer, for showing multiple sequence alignments and assocd. structures; ViewDock, for screening docked ligand orientations; Movie, for replaying mol. dynamics trajectories; and Vol. Viewer, for display and anal. of volumetric data.  A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions.  Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmD4M5S0cPbVg90H21EOLACvtfcHk0ljoxeqBG05Ucw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D&md5=944b175f440c1ff323705987cf937ee7</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20084%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520Chimera-A%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26issue%3D13%26spage%3D1605%26epage%3D1612%26doi%3D10.1002%2Fjcc.20084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group">Ring, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriksen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goff, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnick, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeder, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slabiak, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagman, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, M.-E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. D.</span><span> </span><span class="NLM_article-title">Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">588</span><span class="NLM_x">â</span> <span class="NLM_lpage">595</span><span class="refDoi">Â DOI: 10.2337/diabetes.52.3.588</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdiabetes.52.3.588" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=588-595&issue=3&author=D.+B.+Ringauthor=K.+W.+Johnsonauthor=E.+J.+Henriksenauthor=J.+M.+Nussauthor=D.+Goffauthor=T.+R.+Kinnickauthor=S.+T.+Maauthor=J.+W.+Reederauthor=I.+Samuelsauthor=T.+Slabiakauthor=A.+S.+Wagmanauthor=M.-E.+W.+Hammondauthor=S.+D.+Harrison&title=Selective+glycogen+synthase+kinase+3+inhibitors+potentiate+insulin+activation+of+glucose+transport+and+utilization+in+vitro+and+in+vivo&doi=10.2337%2Fdiabetes.52.3.588"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.52.3.588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.52.3.588%26sid%3Dliteratum%253Aachs%26aulast%3DRing%26aufirst%3DD.%2BB.%26aulast%3DJohnson%26aufirst%3DK.%2BW.%26aulast%3DHenriksen%26aufirst%3DE.%2BJ.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DGoff%26aufirst%3DD.%26aulast%3DKinnick%26aufirst%3DT.%2BR.%26aulast%3DMa%26aufirst%3DS.%2BT.%26aulast%3DReeder%26aufirst%3DJ.%2BW.%26aulast%3DSamuels%26aufirst%3DI.%26aulast%3DSlabiak%26aufirst%3DT.%26aulast%3DWagman%26aufirst%3DA.%2BS.%26aulast%3DHammond%26aufirst%3DM.-E.%2BW.%26aulast%3DHarrison%26aufirst%3DS.%2BD.%26atitle%3DSelective%2520glycogen%2520synthase%2520kinase%25203%2520inhibitors%2520potentiate%2520insulin%2520activation%2520of%2520glucose%2520transport%2520and%2520utilization%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DDiabetes%26date%3D2003%26volume%3D52%26issue%3D3%26spage%3D588%26epage%3D595%26doi%3D10.2337%2Fdiabetes.52.3.588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span> </span><span class="NLM_article-title">GSK3 inhibitors: development and therapeutic potential</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">479</span><span class="NLM_x">â</span> <span class="NLM_lpage">487</span><span class="refDoi">Â DOI: 10.1038/nrd1415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1038%2Fnrd1415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=15173837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVaqsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=479-487&issue=6&author=P.+Cohenauthor=M.+Goedert&title=GSK3+inhibitors%3A+development+and+therapeutic+potential&doi=10.1038%2Fnrd1415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">GSK3 inhibitors: development and therapeutic potential</span></div><div class="casAuthors">Cohen, Philip; Goedert, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">479-487</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  Glycogen synthase kinase-3 (GSK3) was initially identified more than two decades ago as an enzyme involved in the control of glycogen metab.  In recent years it has been shown to have key roles in regulating a diverse range of cellular functions, which have prompted efforts to develop GSK3 inhibitors as therapeutics.  Here, we describe the biol. of GSK3 relevant to its potential as a target for diabetes and neurodegenerative diseases, and discuss progress in the development of GSK3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL3ua5xi0_qrVg90H21EOLACvtfcHk0ljoxeqBG05Ucw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVaqsrs%253D&md5=165d1354bf11faa6021ac4dba797fda2</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnrd1415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1415%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DGoedert%26aufirst%3DM.%26atitle%3DGSK3%2520inhibitors%253A%2520development%2520and%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26issue%3D6%26spage%3D479%26epage%3D487%26doi%3D10.1038%2Fnrd1415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group">Henriksen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnick, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teachey, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâKeefe, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. D.</span><span> </span><span class="NLM_article-title">Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats</span> <span class="citation_source-journal">Am. J. Physiol. - Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">E892</span><span class="NLM_x">â</span> <span class="NLM_lpage">E900</span><span class="refDoi">Â DOI: 10.1152/ajpendo.00346.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1152%2Fajpendo.00346.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=12517738" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2003&pages=E892-E900&issue=5&author=E.+J.+Henriksenauthor=T.+R.+Kinnickauthor=M.+K.+Teacheyauthor=M.+P.+O%E2%80%99Keefeauthor=D.+Ringauthor=K.+W.+Johnsonauthor=S.+D.+Harrison&title=Modulation+of+muscle+insulin+resistance+by+selective+inhibition+of+GSK-3+in+Zucker+diabetic+fatty+rats&doi=10.1152%2Fajpendo.00346.2002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.00346.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.00346.2002%26sid%3Dliteratum%253Aachs%26aulast%3DHenriksen%26aufirst%3DE.%2BJ.%26aulast%3DKinnick%26aufirst%3DT.%2BR.%26aulast%3DTeachey%26aufirst%3DM.%2BK.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DM.%2BP.%26aulast%3DRing%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DK.%2BW.%26aulast%3DHarrison%26aufirst%3DS.%2BD.%26atitle%3DModulation%2520of%2520muscle%2520insulin%2520resistance%2520by%2520selective%2520inhibition%2520of%2520GSK-3%2520in%2520Zucker%2520diabetic%2520fatty%2520rats%26jtitle%3DAm.%2520J.%2520Physiol.%2520-%2520Endocrinol.%2520Metab.%26date%3D2003%26volume%3D284%26issue%3D5%26spage%3DE892%26epage%3DE900%26doi%3D10.1152%2Fajpendo.00346.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group">Eldar-Finkelman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krebs, E. G.</span><span> </span><span class="NLM_article-title">Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">9660</span><span class="NLM_x">â</span> <span class="NLM_lpage">9664</span><span class="refDoi">Â DOI: 10.1073/pnas.94.18.9660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1073%2Fpnas.94.18.9660" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=9660-9664&issue=18&author=H.+Eldar-Finkelmanauthor=E.+G.+Krebs&title=Phosphorylation+of+insulin+receptor+substrate+1+by+glycogen+synthase+kinase+3+impairs+insulin+action&doi=10.1073%2Fpnas.94.18.9660"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.18.9660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.18.9660%26sid%3Dliteratum%253Aachs%26aulast%3DEldar-Finkelman%26aufirst%3DH.%26aulast%3DKrebs%26aufirst%3DE.%2BG.%26atitle%3DPhosphorylation%2520of%2520insulin%2520receptor%2520substrate%25201%2520by%2520glycogen%2520synthase%2520kinase%25203%2520impairs%2520insulin%2520action%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26issue%3D18%26spage%3D9660%26epage%3D9664%26doi%3D10.1073%2Fpnas.94.18.9660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group">Smith, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, C. W.</span><span> </span><span class="NLM_article-title">The insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">81</span><span class="NLM_x">â</span> <span class="NLM_lpage">92</span><span class="refDoi">Â DOI: 10.1016/0303-7207(96)03875-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2F0303-7207%2896%2903875-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=8898350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADyaK28Xls1KltL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1996&pages=81-92&issue=1&author=L.+K.+Smithauthor=K.+M.+Riceauthor=C.+W.+Garner&title=The+insulin-induced+down-regulation+of+IRS-1+in+3T3-L1+adipocytes+is+mediated+by+a+calcium-dependent+thiol+protease&doi=10.1016%2F0303-7207%2896%2903875-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease</span></div><div class="casAuthors">Smith, L. Keith; Rice, K. Michael; Garner, Charles W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-92</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Insulin receptor substrate-1 (IRS-1) is a protein expressed in 3T3-L1 adipocytes that is involved in most, if not all of the biol. responses to insulin.  Chronic exposure of these cells to insulin down-regulates IRS-1 by stimulating its degrdn. (K.M. Rice, et al., 1993).  This insulin-induced down-regulation of IRS-1 was totally abolished by BAPTA-AM (cell-permeable calcium chelator), E-64d (cell-permeable thiol protease inhibitor), Cbz-Leu-Nleu-H and Cbz-Leu-Leu-Tyr-CHN2 (selective cell-permeable calpain inhibitor peptides).  Calpastatin (specific calpain inhibitor protein) also inhibited the insulin-induced down-regulation of IRS-1 in transiently permeabilized cells.  In addn., 3T3-L1 adipocytes express endogenous calpain which can degrade IRS-1 in cell-free exts.  These results suggest that the insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease which is sensitive to inhibition by calpain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcVtkHodvnXrVg90H21EOLACvtfcHk0lg7WFp7i0snaA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xls1KltL0%253D&md5=4051c35fa9dd724838a04e67f60eb296</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2F0303-7207%2896%2903875-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0303-7207%252896%252903875-0%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DL.%2BK.%26aulast%3DRice%26aufirst%3DK.%2BM.%26aulast%3DGarner%26aufirst%3DC.%2BW.%26atitle%3DThe%2520insulin-induced%2520down-regulation%2520of%2520IRS-1%2520in%25203T3-L1%2520adipocytes%2520is%2520mediated%2520by%2520a%2520calcium-dependent%2520thiol%2520protease%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D1996%26volume%3D122%26issue%3D1%26spage%3D81%26epage%3D92%26doi%3D10.1016%2F0303-7207%2896%2903875-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group">Welsh, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proud, C. G.</span><span> </span><span class="NLM_article-title">GSK3: a SHAGGY frog story</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">274</span><span class="NLM_x">â</span> <span class="NLM_lpage">279</span><span class="refDoi">Â DOI: 10.1016/0962-8924(96)10023-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2F0962-8924%2896%2910023-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=15157454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADyaK28XkslGktbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=274-279&issue=7&author=G.+I.+Welshauthor=C.+Wilsonauthor=C.+G.+Proud&title=GSK3%3A+a+SHAGGY+frog+story&doi=10.1016%2F0962-8924%2896%2910023-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">GSK3: a SHAGGY frog story</span></div><div class="casAuthors">Welsh, Gavin I.; Wilson, Clive; Proud, Christopher G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">274-279</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Trends Journals</span>)
        </div><div class="casAbstract">A review with 45 refs.  Glycogen synthase kinase 3 (GSK3) was discovered in mammals several years ago but only recently has it become clear that this enzyme is acutely regulated by hormones such as insulin and by growth factors.  In mammals, it appears to be controlled by a signaling pathway linked to phosphoinositide 3-kinase and may regulate a range of biosynthetic processes.  Evidence is now accumulating that GSK3 plays a key role in the regulation of cell fate and differentiation in many eukaryotic species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpquMXmFeajCLVg90H21EOLACvtfcHk0lg7WFp7i0snaA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkslGktbw%253D&md5=acf3abccadbdabd39a1bef73d49f646d</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0962-8924%2896%2910023-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0962-8924%252896%252910023-4%26sid%3Dliteratum%253Aachs%26aulast%3DWelsh%26aufirst%3DG.%2BI.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DProud%26aufirst%3DC.%2BG.%26atitle%3DGSK3%253A%2520a%2520SHAGGY%2520frog%2520story%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D1996%26volume%3D6%26issue%3D7%26spage%3D274%26epage%3D279%26doi%3D10.1016%2F0962-8924%2896%2910023-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group">Kolterman, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saekow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olefsky, J. M.</span><span> </span><span class="NLM_article-title">Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1272</span><span class="NLM_x">â</span> <span class="NLM_lpage">1284</span><span class="refDoi">Â DOI: 10.1172/JCI109790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1172%2FJCI109790" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1980&pages=1272-1284&issue=6&author=O.+G.+Koltermanauthor=J.+Inselauthor=M.+Saekowauthor=J.+M.+Olefsky&title=Mechanisms+of+insulin+resistance+in+human+obesity%3A+evidence+for+receptor+and+postreceptor+defects&doi=10.1172%2FJCI109790"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1172%2FJCI109790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI109790%26sid%3Dliteratum%253Aachs%26aulast%3DKolterman%26aufirst%3DO.%2BG.%26aulast%3DInsel%26aufirst%3DJ.%26aulast%3DSaekow%26aufirst%3DM.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26atitle%3DMechanisms%2520of%2520insulin%2520resistance%2520in%2520human%2520obesity%253A%2520evidence%2520for%2520receptor%2520and%2520postreceptor%2520defects%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1980%26volume%3D65%26issue%3D6%26spage%3D1272%26epage%3D1284%26doi%3D10.1172%2FJCI109790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group">Reaven, G. M.</span><span> </span><span class="NLM_article-title">Role of insulin resistance in human disease (syndrome X): an expanded definition</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">121</span><span class="NLM_x">â</span> <span class="NLM_lpage">131</span><span class="refDoi">Â DOI: 10.1146/annurev.me.44.020193.001005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1146%2Fannurev.me.44.020193.001005" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=121-131&issue=1&author=G.+M.+Reaven&title=Role+of+insulin+resistance+in+human+disease+%28syndrome+X%29%3A+an+expanded+definition&doi=10.1146%2Fannurev.me.44.020193.001005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1146%2Fannurev.me.44.020193.001005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.me.44.020193.001005%26sid%3Dliteratum%253Aachs%26aulast%3DReaven%26aufirst%3DG.%2BM.%26atitle%3DRole%2520of%2520insulin%2520resistance%2520in%2520human%2520disease%2520%2528syndrome%2520X%2529%253A%2520an%2520expanded%2520definition%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D1993%26volume%3D44%26issue%3D1%26spage%3D121%26epage%3D131%26doi%3D10.1146%2Fannurev.me.44.020193.001005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group">Shulman, G. I.</span><span> </span><span class="NLM_article-title">Cellular mechanisms of insulin resistance</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">171</span><span class="NLM_x">â</span> <span class="NLM_lpage">176</span><span class="refDoi">Â DOI: 10.1172/JCI10583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1172%2FJCI10583" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2000&pages=171-176&issue=2&author=G.+I.+Shulman&title=Cellular+mechanisms+of+insulin+resistance&doi=10.1172%2FJCI10583"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1172%2FJCI10583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI10583%26sid%3Dliteratum%253Aachs%26aulast%3DShulman%26aufirst%3DG.%2BI.%26atitle%3DCellular%2520mechanisms%2520of%2520insulin%2520resistance%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D106%26issue%3D2%26spage%3D171%26epage%3D176%26doi%3D10.1172%2FJCI10583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group">Embi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rylatt, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">519</span><span class="NLM_x">â</span> <span class="NLM_lpage">527</span><span class="refDoi">Â DOI: 10.1111/j.1432-1033.1980.tb06059.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1111%2Fj.1432-1033.1980.tb06059.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=6249596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADyaL3cXkvFSrt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1980&pages=519-527&issue=2&author=N.+Embiauthor=D.+B.+Rylattauthor=P.+Cohen&title=Glycogen+synthase+kinase-3+from+rabbit+skeletal+muscle.+Separation+from+cyclic-AMP-dependent+protein+kinase+and+phosphorylase+kinase&doi=10.1111%2Fj.1432-1033.1980.tb06059.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase-3 from rabbit skeletal muscle.  Separation from cyclic AMP-dependent protein kinase and phosphorylase kinase</span></div><div class="casAuthors">Embi, Noor; Rylatt, Dennis B.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">519-27</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">A glycogen synthase kinase (I) was partially purified from rabbit skeletal muscle.  I was highly specific for glycogen synthase (II) and was sepd. from virtually all phosvitin kinase and casein kinase activity.  The Km values for ATP and GTP were 0.02 mM and 0.5 mM, resp., and a similar Vmax was obtained with each nucleoside triphosphate.  I was unaffected by cAMP, cGMP, Ca2+, Ca2+ plus calmodulin, and the specific protein inhibitor of cAMP-dependent protein kinase.  I was distinct from both cAMP-dependent protein kinase and phosphorylase kinase, the 2 well characterized I activities in skeletal muscle.  This enzyme was therefore termed I-3.  The phosphorylation of II by I-3 reached a plateau near 1.5 mols. phosphate incorporated/subunit under optimal conditions.  The activity of II measured in the absence of glucose 6-phosphate was decreased 5-fold and the apparent Ka for glucose 6-phosphate was increased 15-fold, when 1.2 mols. phosphate/subunit had been introduced into the enzyme.  Phosphorylation to a similar ext. with either cAMP-dependent protein kinase or phosphorylase kinase produced smaller changes in activity.  II was phosphorylated by cAMP-dependent protein kinase, phosphorylase kinase, and I-3, using conditions where the phosphorylation by any one protein kinase reached a plateau near 1 mol. phosphate incorporated/subunit.  The different protein kinases were used sep. and in combination to generate 7 different phosphorylated species of II.  The phosphorylation of II approached 2 mols./subunit when any 2 protein kinases were combined, and 3 mols./subunit when all 3 protein kinases were combined, and the inactivation produced by the different protein kinases was essentially additive.  The results imply that each protein kinase preferentially phosphorylates a different site(s) on II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUA4fJprDxL7Vg90H21EOLACvtfcHk0lg7WFp7i0snaA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXkvFSrt7Y%253D&md5=c7bcf25feb6257362c577bb5cff4a7f1</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1980.tb06059.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1980.tb06059.x%26sid%3Dliteratum%253Aachs%26aulast%3DEmbi%26aufirst%3DN.%26aulast%3DRylatt%26aufirst%3DD.%2BB.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520from%2520rabbit%2520skeletal%2520muscle.%2520Separation%2520from%2520cyclic-AMP-dependent%2520protein%2520kinase%2520and%2520phosphorylase%2520kinase%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1980%26volume%3D107%26issue%3D2%26spage%3D519%26epage%3D527%26doi%3D10.1111%2Fj.1432-1033.1980.tb06059.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group">Fisher, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolte, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, D.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloszy, J. O.</span><span> </span><span class="NLM_article-title">Glucose transport rate and glycogen synthase activity both limit skeletal muscle glycogen accumulation</span> <span class="citation_source-journal">Am. J. Physiol. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">E1214</span><span class="NLM_x">â</span> <span class="NLM_lpage">E1221</span><span class="refDoi">Â DOI: 10.1152/ajpendo.00254.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1152%2Fajpendo.00254.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=12006350" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2002&pages=E1214-E1221&issue=6&author=J.+S.+Fisherauthor=L.+A.+Nolteauthor=K.+Kawanakaauthor=D.-H.+Hanauthor=T.+E.+Jonesauthor=J.+O.+Holloszy&title=Glucose+transport+rate+and+glycogen+synthase+activity+both+limit+skeletal+muscle+glycogen+accumulation&doi=10.1152%2Fajpendo.00254.2001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.00254.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.00254.2001%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DJ.%2BS.%26aulast%3DNolte%26aufirst%3DL.%2BA.%26aulast%3DKawanaka%26aufirst%3DK.%26aulast%3DHan%26aufirst%3DD.-H.%26aulast%3DJones%26aufirst%3DT.%2BE.%26aulast%3DHolloszy%26aufirst%3DJ.%2BO.%26atitle%3DGlucose%2520transport%2520rate%2520and%2520glycogen%2520synthase%2520activity%2520both%2520limit%2520skeletal%2520muscle%2520glycogen%2520accumulation%26jtitle%3DAm.%2520J.%2520Physiol.%2520Endocrinol.%2520Metab.%26date%3D2002%26volume%3D282%26issue%3D6%26spage%3DE1214%26epage%3DE1221%26doi%3D10.1152%2Fajpendo.00254.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group">Fioderek, F. T.</span><span> </span><span class="NLM_article-title">Rodent genetic models for obesity and non-insulin-dependent diabetes mellitus</span> <span class="citation_source-journal">Diabetes Mellit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_fpage">604</span><span class="NLM_x">â</span> <span class="NLM_lpage">618</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=604-618&author=F.+T.+Fioderek&title=Rodent+genetic+models+for+obesity+and+non-insulin-dependent+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFioderek%26aufirst%3DF.%2BT.%26atitle%3DRodent%2520genetic%2520models%2520for%2520obesity%2520and%2520non-insulin-dependent%2520diabetes%2520mellitus%26jtitle%3DDiabetes%2520Mellit.%26date%3D1996%26spage%3D604%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group">Ionescu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauter, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanrenaud, B.</span><span> </span><span class="NLM_article-title">Abnormal oral glucose tolerance in genetically obese (<i>fa</i>/<i>fa</i>) rats</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x"> (</span><span class="NLM_issue">5 Pt 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">E500</span><span class="NLM_x">â</span> <span class="NLM_lpage">E506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=1985&pages=E500-E506&issue=5+Pt+1&author=E.+Ionescuauthor=J.+F.+Sauterauthor=B.+Jeanrenaud&title=Abnormal+oral+glucose+tolerance+in+genetically+obese+%28fa%2Ffa%29+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIonescu%26aufirst%3DE.%26aulast%3DSauter%26aufirst%3DJ.%2BF.%26aulast%3DJeanrenaud%26aufirst%3DB.%26atitle%3DAbnormal%2520oral%2520glucose%2520tolerance%2520in%2520genetically%2520obese%2520%2528fa%252Ffa%2529%2520rats%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1985%26volume%3D248%26issue%3D5%2520Pt%25201%26spage%3DE500%26epage%3DE506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group">Terrettaz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assimacopoulos-Jeannet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanrenaud, B.</span><span> </span><span class="NLM_article-title">Severe hepatic and peripheral insulin resistance as evidenced by euglycemic clamps in genetically obese <i>fa</i>/<i>fa</i> rats</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">674</span><span class="NLM_x">â</span> <span class="NLM_lpage">678</span><span class="refDoi">Â DOI: 10.1210/endo-118-2-674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1210%2Fendo-118-2-674" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1986&pages=674-678&issue=2&author=J.+Terrettazauthor=F.+Assimacopoulos-Jeannetauthor=B.+Jeanrenaud&title=Severe+hepatic+and+peripheral+insulin+resistance+as+evidenced+by+euglycemic+clamps+in+genetically+obese+fa%2Ffa+rats&doi=10.1210%2Fendo-118-2-674"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1210%2Fendo-118-2-674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fendo-118-2-674%26sid%3Dliteratum%253Aachs%26aulast%3DTerrettaz%26aufirst%3DJ.%26aulast%3DAssimacopoulos-Jeannet%26aufirst%3DF.%26aulast%3DJeanrenaud%26aufirst%3DB.%26atitle%3DSevere%2520hepatic%2520and%2520peripheral%2520insulin%2520resistance%2520as%2520evidenced%2520by%2520euglycemic%2520clamps%2520in%2520genetically%2520obese%2520fa%252Ffa%2520rats%26jtitle%3DEndocrinology%26date%3D1986%26volume%3D118%26issue%3D2%26spage%3D674%26epage%3D678%26doi%3D10.1210%2Fendo-118-2-674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group">MuÃ±oz, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BarberÃ , A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DomÃ­nguez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FernÃ ndez-Alvarez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guinovart, J. J.</span><span> </span><span class="NLM_article-title">Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">131</span><span class="NLM_x">â</span> <span class="NLM_lpage">138</span><span class="refDoi">Â DOI: 10.2337/diabetes.50.1.131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdiabetes.50.1.131" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=131-138&issue=1&author=M.+C.+Mu%C3%B1ozauthor=A.+Barber%C3%A0author=J.+Dom%C3%ADnguezauthor=J.+Fern%C3%A0ndez-Alvarezauthor=R.+Gomisauthor=J.+J.+Guinovart&title=Effects+of+tungstate%2C+a+new+potential+oral+antidiabetic+agent%2C+in+Zucker+diabetic+fatty+rats&doi=10.2337%2Fdiabetes.50.1.131"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.50.1.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.50.1.131%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz%26aufirst%3DM.%2BC.%26aulast%3DBarber%25C3%25A0%26aufirst%3DA.%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DJ.%26aulast%3DFern%25C3%25A0ndez-Alvarez%26aufirst%3DJ.%26aulast%3DGomis%26aufirst%3DR.%26aulast%3DGuinovart%26aufirst%3DJ.%2BJ.%26atitle%3DEffects%2520of%2520tungstate%252C%2520a%2520new%2520potential%2520oral%2520antidiabetic%2520agent%252C%2520in%2520Zucker%2520diabetic%2520fatty%2520rats%26jtitle%3DDiabetes%26date%3D2001%26volume%3D50%26issue%3D1%26spage%3D131%26epage%3D138%26doi%3D10.2337%2Fdiabetes.50.1.131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group">Sparks, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phung, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianci, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khurana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowden, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsetti, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparks, C. E.</span><span> </span><span class="NLM_article-title">Lipoprotein alterations in 10- and 20-week-old Zucker diabetic fatty rats: hyperinsulinemic versus insulinopenic hyperglycemia</span> <span class="citation_source-journal">Metab., Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1315</span><span class="NLM_x">â</span> <span class="NLM_lpage">1324</span><span class="refDoi">Â DOI: 10.1016/S0026-0495(98)90298-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FS0026-0495%2898%2990298-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=9826206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADyaK1cXnsFSmuro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1998&pages=1315-1324&issue=11&author=J.+D.+Sparksauthor=T.+L.+Phungauthor=M.+Bologninoauthor=J.+Cianciauthor=R.+Khuranaauthor=R.+G.+Petersonauthor=M.+P.+Sowdenauthor=J.+P.+Corsettiauthor=C.+E.+Sparks&title=Lipoprotein+alterations+in+10-+and+20-week-old+Zucker+diabetic+fatty+rats%3A+hyperinsulinemic+versus+insulinopenic+hyperglycemia&doi=10.1016%2FS0026-0495%2898%2990298-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Lipoprotein alterations in 10- and 20-week-old Zucker diabetic fatty rats: hyperinsulinemic versus insulinopenic hyperglycemia</span></div><div class="casAuthors">Sparks, Janet D.; Phung, Thuy L.; Bolognino, Mary; Cianci, Joanne; Khurana, Rohit; Peterson, Richard G.; Sowden, Mark P.; Corsetti, James P.; Sparks, Charles E.</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1315-1324</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">Lipoprotein and apolipoprotein parameters were studied in the male Zucker diabetic fatty (ZDF) rat at 10 and 20 wk of age, corresponding to hyperinsulinemic and insulinopenic type 2 diabetes mellitus, resp.  At both ages, ZDF rats had elevated serum triglycerides, free fatty acids, and corticosterone, whereas 20-wk ZDF rats had reduced thyroid hormones.  At 10 wk, the hyperlipidemia was confined to elevations in pre-Î² triglyceride-rich (d < 1.006 g/mL) lipoproteins.  By 20 wk, all lipoprotein d. fractions were increased compared with lean rats, with substantial increases in both low-d. lipoprotein (LDL) and high-d. lipoprotein (HDL) cholesterol.  In ZDF rats, there was a progressive increase in apolipoprotein B (apo B) from 1.9 times control at 10 wk to three times control at 20 wk.  The increase in apo B was accompanied by a shift of apo B, particularly B100, from very-low-d. lipoprotein (VLDL) into denser lipoproteins corresponding to intermediate-d. lipoproteins plus LDLs (1.006 < d < 1.063 g/mL).  In Zucker and 10-wk ZDF rats, in the presence of hyperinsulinemia, the increase in serum apo B was predominantly apo B48 present in VLDL.  By 20 wk, when ZDF rats are insulinopenic, the mass ratio of B48:B 100 shifted from 2.7 to 0.7.  The shift was assocd. with a decrease in hepatic-edited apo B mRNA.  Apo E increased in lean rats between 10 and 20 wk of age.  Although apo E also increased in ZDF rats, the increase by 20 wk was less than that of lean rats.  The molar ratio of apo E to B in VLDL was decreased in ZDF rats.  In lean rats, greater than 50% of apo E was present in HDL, in contrast to ZDF rats, where less than 20% of apo E was present in HDL.  VLDL apo E shifted to denser fractions by 20 wk of age, similar to apo B.  The apo C level was more than double compared with the level in lean rats and was redistributed from the HDL fraction to lipoprotein fractions contg. apo B.  Both apo A-I and apo A-IV levels more than doubled between 10 and 20 wk in ZDF rats.  The ZDF rat model may be useful in comparative studies of lipoproteins during diabetic progression from hyperinsulinemia to insulinopenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkekuFJNEGybVg90H21EOLACvtfcHk0ljDfLeN2vgbcg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsFSmuro%253D&md5=229ad7207172990365a75bfe1420ed77</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2FS0026-0495%2898%2990298-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0026-0495%252898%252990298-0%26sid%3Dliteratum%253Aachs%26aulast%3DSparks%26aufirst%3DJ.%2BD.%26aulast%3DPhung%26aufirst%3DT.%2BL.%26aulast%3DBolognino%26aufirst%3DM.%26aulast%3DCianci%26aufirst%3DJ.%26aulast%3DKhurana%26aufirst%3DR.%26aulast%3DPeterson%26aufirst%3DR.%2BG.%26aulast%3DSowden%26aufirst%3DM.%2BP.%26aulast%3DCorsetti%26aufirst%3DJ.%2BP.%26aulast%3DSparks%26aufirst%3DC.%2BE.%26atitle%3DLipoprotein%2520alterations%2520in%252010-%2520and%252020-week-old%2520Zucker%2520diabetic%2520fatty%2520rats%253A%2520hyperinsulinemic%2520versus%2520insulinopenic%2520hyperglycemia%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D1998%26volume%3D47%26issue%3D11%26spage%3D1315%26epage%3D1324%26doi%3D10.1016%2FS0026-0495%2898%2990298-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group">Anai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inukai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katagiri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, T.</span><span> </span><span class="NLM_article-title">Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">13</span><span class="NLM_x">â</span> <span class="NLM_lpage">23</span><span class="refDoi">Â DOI: 10.2337/diab.47.1.13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdiab.47.1.13" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1998&pages=13-23&issue=1&author=M.+Anaiauthor=M.+Funakiauthor=T.+Ogiharaauthor=J.+Terasakiauthor=K.+Inukaiauthor=H.+Katagiriauthor=Y.+Fukushimaauthor=Y.+Yazakiauthor=M.+Kikuchiauthor=Y.+Okaauthor=T.+Asano&title=Altered+expression+levels+and+impaired+steps+in+the+pathway+to+phosphatidylinositol+3-kinase+activation+via+insulin+receptor+substrates+1+and+2+in+Zucker+fatty+rats&doi=10.2337%2Fdiab.47.1.13"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.2337%2Fdiab.47.1.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiab.47.1.13%26sid%3Dliteratum%253Aachs%26aulast%3DAnai%26aufirst%3DM.%26aulast%3DFunaki%26aufirst%3DM.%26aulast%3DOgihara%26aufirst%3DT.%26aulast%3DTerasaki%26aufirst%3DJ.%26aulast%3DInukai%26aufirst%3DK.%26aulast%3DKatagiri%26aufirst%3DH.%26aulast%3DFukushima%26aufirst%3DY.%26aulast%3DYazaki%26aufirst%3DY.%26aulast%3DKikuchi%26aufirst%3DM.%26aulast%3DOka%26aufirst%3DY.%26aulast%3DAsano%26aufirst%3DT.%26atitle%3DAltered%2520expression%2520levels%2520and%2520impaired%2520steps%2520in%2520the%2520pathway%2520to%2520phosphatidylinositol%25203-kinase%2520activation%2520via%2520insulin%2520receptor%2520substrates%25201%2520and%25202%2520in%2520Zucker%2520fatty%2520rats%26jtitle%3DDiabetes%26date%3D1998%26volume%3D47%26issue%3D1%26spage%3D13%26epage%3D23%26doi%3D10.2337%2Fdiab.47.1.13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group">Brozinick, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misener, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohm, G. L.</span><span> </span><span class="NLM_article-title">Impaired insulin signaling through GSK3 in insulin resistant skeletal muscle</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">A326</span><span class="NLM_x">â</span> <span class="NLM_lpage">A326</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2000&pages=A326-A326&issue=5&author=J.+T.+Brozinickauthor=E.+A.+Misenerauthor=B.+Niauthor=J.+W.+Ryderauthor=G.+L.+Dohm&title=Impaired+insulin+signaling+through+GSK3+in+insulin+resistant+skeletal+muscle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrozinick%26aufirst%3DJ.%2BT.%26aulast%3DMisener%26aufirst%3DE.%2BA.%26aulast%3DNi%26aufirst%3DB.%26aulast%3DRyder%26aufirst%3DJ.%2BW.%26aulast%3DDohm%26aufirst%3DG.%2BL.%26atitle%3DImpaired%2520insulin%2520signaling%2520through%2520GSK3%2520in%2520insulin%2520resistant%2520skeletal%2520muscle%26jtitle%3DDiabetes%26date%3D2000%26volume%3D49%26issue%3D5%26spage%3DA326%26epage%3DA326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobensack, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hector, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaven, G. M.</span><span> </span><span class="NLM_article-title">Nongenetic mouse models of non-insulin-dependent diabetes mellitus</span> <span class="citation_source-journal">Metab., Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">663</span><span class="NLM_x">â</span> <span class="NLM_lpage">668</span><span class="refDoi">Â DOI: 10.1016/S0026-0495(98)90027-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FS0026-0495%2898%2990027-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=9627363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADyaK1cXjslymtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1998&pages=663-668&issue=6&author=J.+Luoauthor=J.+Quanauthor=J.+Tsaiauthor=C.+K.+Hobensackauthor=C.+Sullivanauthor=R.+Hectorauthor=G.+M.+Reaven&title=Nongenetic+mouse+models+of+non-insulin-dependent+diabetes+mellitus&doi=10.1016%2FS0026-0495%2898%2990027-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Nongenetic mouse models of non-insulin-dependent diabetes mellitus</span></div><div class="casAuthors">Luo, Jian; Quan, Josephine; Tsai, Joyce; Hobensack, Christina K.; Sullivan, Cynthia; Hector, Richard; Reaven, Gerald M.</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">663-668</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">The purpose of the study was to develop a mouse model of non-insulin-dependent diabetes mellitus (NIDDM) that closely simulates the metabolic abnormalities of the human disease and is also cost-effective compared with the genetic models currently available.  For this purpose, insulin resistance was induced in male C57BL/6J or Institute of Cancer Research (ICR) mice by feeding diets enriched in either fructose or fat, and hyperglycemia was induced by injecting these mice with a dose of streptozotocin (STZ) that does not cause diabetes in chow-fed mice.  In the case of C57BL/6J mice, insulin levels initially increased in response to the fructose- and fat-enriched diets and then decreased to levels comparable to or still higher than those in chow-fed mice following STZ injection.  Assocd. with the decrease in insulin levels following STZ, fat-fed and fructose-fed C57BL/6J mice became significantly hyperglycemic, reaching values of 388Â±38 and 366Â±58 mg/dL, resp.  In contrast, neither plasma glucose nor insulin concns. changed in chow-fed mice injected with an identical amt. of STZ.  Essentially identical findings were seen before and after STZ injection in fat-fed compared with chow-fed ICR mice.  Although a direct comparison was not made, sensitivity to the diabetogenic effects of STZ appeared to be greater in fat-fed ICR compared with fat-fed C57BL/6J mice.  Finally, plasma glucose decreased when mice with these exptl. models of NIDDM were treated with either metformin or tolbutamide.  Given these results, it seems reasonable to suggest that the combination of dietary-induced insulin resistance and relatively low-dose STZ results in mouse models that should be of use in studying the pathophysiol. of NIDDM or in evaluating therapeutic compds. for the treatment of NIDDM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYE_OOsozDprVg90H21EOLACvtfcHk0lg2PzaKCaVhZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslymtLk%253D&md5=79ac9a5094e2f9dccebce770f0b14332</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2FS0026-0495%2898%2990027-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0026-0495%252898%252990027-0%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DQuan%26aufirst%3DJ.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DHobensack%26aufirst%3DC.%2BK.%26aulast%3DSullivan%26aufirst%3DC.%26aulast%3DHector%26aufirst%3DR.%26aulast%3DReaven%26aufirst%3DG.%2BM.%26atitle%3DNongenetic%2520mouse%2520models%2520of%2520non-insulin-dependent%2520diabetes%2520mellitus%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D1998%26volume%3D47%26issue%3D6%26spage%3D663%26epage%3D668%26doi%3D10.1016%2FS0026-0495%2898%2990027-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group">Cline, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regittnig, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perret, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damico, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shulman, G. I.</span><span> </span><span class="NLM_article-title">Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2903</span><span class="NLM_x">â</span> <span class="NLM_lpage">2910</span><span class="refDoi">Â DOI: 10.2337/diabetes.51.10.2903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdiabetes.51.10.2903" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=2903-2910&issue=10&author=G.+W.+Clineauthor=K.+Johnsonauthor=W.+Regittnigauthor=P.+Perretauthor=E.+Tozzoauthor=L.+Xiaoauthor=C.+Damicoauthor=G.+I.+Shulman&title=Effects+of+a+novel+glycogen+synthase+kinase-3+inhibitor+on+insulin-stimulated+glucose+metabolism+in+Zucker+diabetic+fatty+%28fa%2Ffa%29+rats&doi=10.2337%2Fdiabetes.51.10.2903"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.51.10.2903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.51.10.2903%26sid%3Dliteratum%253Aachs%26aulast%3DCline%26aufirst%3DG.%2BW.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DRegittnig%26aufirst%3DW.%26aulast%3DPerret%26aufirst%3DP.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DDamico%26aufirst%3DC.%26aulast%3DShulman%26aufirst%3DG.%2BI.%26atitle%3DEffects%2520of%2520a%2520novel%2520glycogen%2520synthase%2520kinase-3%2520inhibitor%2520on%2520insulin-stimulated%2520glucose%2520metabolism%2520in%2520Zucker%2520diabetic%2520fatty%2520%2528fa%252Ffa%2529%2520rats%26jtitle%3DDiabetes%26date%3D2002%26volume%3D51%26issue%3D10%26spage%3D2903%26epage%3D2910%26doi%3D10.2337%2Fdiabetes.51.10.2903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group">Ali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeflich, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3: Properties, functions, and regulation</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2527</span><span class="NLM_x">â</span> <span class="NLM_lpage">2540</span><span class="refDoi">Â DOI: 10.1021/cr000110o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr000110o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvVWnt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=2527-2540&issue=8&author=A.+Aliauthor=K.+P.+Hoeflichauthor=J.+R.+Woodgett&title=Glycogen+synthase+kinase-3%3A+Properties%2C+functions%2C+and+regulation&doi=10.1021%2Fcr000110o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen Synthase Kinase-3: Properties, Functions, and Regulation</span></div><div class="casAuthors">Ali, Adnan; Hoeflich, Klaus P.; Woodgett, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2527-2540</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with 174 refs., on the isolation, characterization, regulation, and homologs of glycogen synthase kinase-3 and its function in signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7lmtr41nE-7Vg90H21EOLACvtfcHk0lg2PzaKCaVhZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvVWnt7s%253D&md5=9372d1f49c2e978ce5cb5b10e025809a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fcr000110o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr000110o%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DA.%26aulast%3DHoeflich%26aufirst%3DK.%2BP.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DGlycogen%2520synthase%2520kinase-3%253A%2520Properties%252C%2520functions%252C%2520and%2520regulation%26jtitle%3DChem.%2520Rev.%26date%3D2001%26volume%3D101%26issue%3D8%26spage%3D2527%26epage%3D2540%26doi%3D10.1021%2Fcr000110o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group">Polakis, P.</span><span> </span><span class="NLM_article-title">Wnt signaling in cancer</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">a008052</span><span class="NLM_x">â</span> <span class="NLM_lpage">a008052</span><span class="refDoi">Â DOI: 10.1101/cshperspect.a008052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1101%2Fcshperspect.a008052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFyrs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=a008052-a008052&issue=5&author=P.+Polakis&title=Wnt+signaling+in+cancer&doi=10.1101%2Fcshperspect.a008052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signaling in cancer</span></div><div class="casAuthors">Polakis, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">a008052, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">CSHPEU</span>;
        ISSN:<span class="NLM_cas:issn">1943-0264</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Aberrant regulation of the Wnt signaling pathway is a prevalent theme in cancer biol.  From the earliest observation that Wnt overexpression could lead to malignant transformation of mouse mammary tissue to the most recent genetic discoveries gleaned from tumor genome sequencing, the Wnt pathway continues to evolve as a central mechanism in cancer biol.  This article summarizes the evidence supporting a role for Wnt signaling in human cancer.  This includes a review of the genetic mutations affecting Wnt pathway components, as well as some of epigenetic mechanisms that alter expression of genes relevant to Wnt.  I also highlight some research on the cooperativity of Wnt with other signaling pathways in cancer.  Finally, some emphasis is placed on lab. research that provides a proof of concept for the therapeutic inhibition of Wnt signaling in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEgUax4MaMv7Vg90H21EOLACvtfcHk0lg2PzaKCaVhZQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFyrs7Y%253D&md5=5a1360a833fa6f284c26c77786758ce8</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a008052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a008052%26sid%3Dliteratum%253Aachs%26aulast%3DPolakis%26aufirst%3DP.%26atitle%3DWnt%2520signaling%2520in%2520cancer%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2012%26volume%3D4%26issue%3D5%26spage%3Da008052%26epage%3Da008052%26doi%3D10.1101%2Fcshperspect.a008052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group">Polakis, P.</span><span> </span><span class="NLM_article-title">The many ways of Wnt in cancer</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">45</span><span class="NLM_x">â</span> <span class="NLM_lpage">51</span><span class="refDoi">Â DOI: 10.1016/j.gde.2006.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.gde.2006.12.007" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=45-51&issue=1&author=P.+Polakis&title=The+many+ways+of+Wnt+in+cancer&doi=10.1016%2Fj.gde.2006.12.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2006.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2006.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DPolakis%26aufirst%3DP.%26atitle%3DThe%2520many%2520ways%2520of%2520Wnt%2520in%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2007%26volume%3D17%26issue%3D1%26spage%3D45%26epage%3D51%26doi%3D10.1016%2Fj.gde.2006.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group">Polakis, P.</span><span> </span><span class="NLM_article-title">Wnt signaling and cancer</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">1837</span><span class="NLM_x">â</span> <span class="NLM_lpage">1851</span><span class="refDoi">Â DOI: 10.1101/gad.14.15.1837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1101%2Fgad.14.15.1837" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=1837-1851&issue=15&author=P.+Polakis&title=Wnt+signaling+and+cancer&doi=10.1101%2Fgad.14.15.1837"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1101%2Fgad.14.15.1837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.14.15.1837%26sid%3Dliteratum%253Aachs%26aulast%3DPolakis%26aufirst%3DP.%26atitle%3DWnt%2520signaling%2520and%2520cancer%26jtitle%3DGenes%2520Dev.%26date%3D2000%26volume%3D14%26issue%3D15%26spage%3D1837%26epage%3D1851%26doi%3D10.1101%2Fgad.14.15.1837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group">Harada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaku, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taketo, M. M.</span><span> </span><span class="NLM_article-title">Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">5931</span><span class="NLM_x">â</span> <span class="NLM_lpage">5942</span><span class="refDoi">Â DOI: 10.1093/emboj/18.21.5931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1093%2Femboj%2F18.21.5931" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=5931-5942&issue=21&author=N.+Haradaauthor=Y.+Tamaiauthor=T.+Ishikawaauthor=B.+Sauerauthor=K.+Takakuauthor=M.+Oshimaauthor=M.+M.+Taketo&title=Intestinal+polyposis+in+mice+with+a+dominant+stable+mutation+of+the+beta-catenin+gene&doi=10.1093%2Femboj%2F18.21.5931"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F18.21.5931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F18.21.5931%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DN.%26aulast%3DTamai%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DSauer%26aufirst%3DB.%26aulast%3DTakaku%26aufirst%3DK.%26aulast%3DOshima%26aufirst%3DM.%26aulast%3DTaketo%26aufirst%3DM.%2BM.%26atitle%3DIntestinal%2520polyposis%2520in%2520mice%2520with%2520a%2520dominant%2520stable%2520mutation%2520of%2520the%2520beta-catenin%2520gene%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26issue%3D21%26spage%3D5931%26epage%3D5942%26doi%3D10.1093%2Femboj%2F18.21.5931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group">Coghlan, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culbert, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corcoran, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rausch, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roxbee Cox, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holder, J. C.</span><span> </span><span class="NLM_article-title">Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">793</span><span class="NLM_x">â</span> <span class="NLM_lpage">803</span><span class="refDoi">Â DOI: 10.1016/S1074-5521(00)00025-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FS1074-5521%2800%2900025-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=11033082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVWitrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=793-803&issue=10&author=M.+P.+Coghlanauthor=A.+A.+Culbertauthor=D.+A.+Crossauthor=S.+L.+Corcoranauthor=J.+W.+Yatesauthor=N.+J.+Pearceauthor=O.+L.+Rauschauthor=G.+J.+Murphyauthor=P.+S.+Carterauthor=L.+Roxbee+Coxauthor=D.+Millsauthor=M.+J.+Brownauthor=D.+Haighauthor=R.+W.+Wardauthor=D.+G.+Smithauthor=K.+J.+Murrayauthor=A.+D.+Reithauthor=J.+C.+Holder&title=Selective+small+molecule+inhibitors+of+glycogen+synthase+kinase-3+modulate+glycogen+metabolism+and+gene+transcription&doi=10.1016%2FS1074-5521%2800%2900025-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription</span></div><div class="casAuthors">Coghlan, Matthew P.; Culbert, Ainsley A.; Cross, Darren A. E.; Corcoran, Stacey L.; Yates, John W.; Pearce, Nigel J.; Rausch, Oliver L.; Murphy, Gregory J.; Carter, Paul S.; Cox, Lynne Roxbee; Mills, David; Brown, Murray J.; Haigh, David; Ward, Robert W.; Smith, David G.; Murray, Kenneth J.; Reith, Alastair D.; Holder, Julie C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">793-803</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: Glycogen synthase kinase-3 (GSK-3) is a serine/threonine protein kinase, the activity of which is inhibited by a variety of extracellular stimuli including insulin, growth factors, cell specification factors and cell adhesion.  Consequently, inhibition of GSK-3 activity has been proposed to play a role in the regulation of numerous signaling pathways that elicit pleiotropic cellular responses.  This report describes the identification and characterization of potent and selective small mol. inhibitors of GSK-3.  Results: SB-216763 and SB-415286 are structurally distinct maleimides that inhibit GSK-3Î± in vitro, with Kis of 9 nM and 31 nM resp., in an ATP competitive manner.  These compds. inhibited GSK-3Î² with similar potency.  However, neither compd. significantly inhibited any member of a panel of 24 other protein kinases.  Furthermore, treatment of cells with either compd. stimulated responses characteristic of extracellular stimuli that are known to inhibit GSK-3 activity.  Thus, SB-216763 and SB-415286 stimulated glycogen synthesis in human liver cells and induced expression of a Î²-catenin-LEF/TCF regulated reporter gene in HEK293 cells.  In both cases, compd. treatment was demonstrated to inhibit cellular GSK-3 activity as assessed by activation of glycogen synthase, which is a direct target of this kinase.  Conclusions: SB-216763 and SB-415286 are novel, potent and selective cell permeable inhibitors of GSK-3.  Therefore, these compds. represent valuable pharmacol. tools with which the role of GSK-3 in cellular signaling can be further elucidated.  Furthermore, development of similar compds. may be of use therapeutically in disease states assocd. with elevated GSK-3 activity such as non-insulin dependent diabetes mellitus and neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFzezTCpDxdLVg90H21EOLACvtfcHk0ljjT74xQS-bpw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVWitrs%253D&md5=86fd3630ddf003af035dd42a20e1a52e</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2800%2900025-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252800%252900025-9%26sid%3Dliteratum%253Aachs%26aulast%3DCoghlan%26aufirst%3DM.%2BP.%26aulast%3DCulbert%26aufirst%3DA.%2BA.%26aulast%3DCross%26aufirst%3DD.%2BA.%26aulast%3DCorcoran%26aufirst%3DS.%2BL.%26aulast%3DYates%26aufirst%3DJ.%2BW.%26aulast%3DPearce%26aufirst%3DN.%2BJ.%26aulast%3DRausch%26aufirst%3DO.%2BL.%26aulast%3DMurphy%26aufirst%3DG.%2BJ.%26aulast%3DCarter%26aufirst%3DP.%2BS.%26aulast%3DRoxbee%2BCox%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DM.%2BJ.%26aulast%3DHaigh%26aufirst%3DD.%26aulast%3DWard%26aufirst%3DR.%2BW.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DMurray%26aufirst%3DK.%2BJ.%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DHolder%26aufirst%3DJ.%2BC.%26atitle%3DSelective%2520small%2520molecule%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%2520modulate%2520glycogen%2520metabolism%2520and%2520gene%2520transcription%26jtitle%3DChem.%2520Biol.%26date%3D2000%26volume%3D7%26issue%3D10%26spage%3D793%26epage%3D803%26doi%3D10.1016%2FS1074-5521%2800%2900025-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group">Cohen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chetrit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirota, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modan, B.</span><span> </span><span class="NLM_article-title">Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment</span> <span class="citation_source-journal">Med. Oncol. Tumor Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">32</span><span class="NLM_x">â</span> <span class="NLM_lpage">36</span><span class="refDoi">Â DOI: 10.1007/BF02787342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1007%2FBF02787342" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=32-36&issue=1&author=Y.+Cohenauthor=A.+Chetritauthor=Y.+Cohenauthor=P.+Sirotaauthor=B.+Modan&title=Cancer+morbidity+in+psychiatric+patients%3A+influence+of+lithium+carbonate+treatment&doi=10.1007%2FBF02787342"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1007%2FBF02787342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02787342%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DY.%26aulast%3DChetrit%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DY.%26aulast%3DSirota%26aufirst%3DP.%26aulast%3DModan%26aufirst%3DB.%26atitle%3DCancer%2520morbidity%2520in%2520psychiatric%2520patients%253A%2520influence%2520of%2520lithium%2520carbonate%2520treatment%26jtitle%3DMed.%2520Oncol.%2520Tumor%2520Pharmacother.%26date%3D1998%26volume%3D15%26issue%3D1%26spage%3D32%26epage%3D36%26doi%3D10.1007%2FBF02787342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group">Kratz, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huso, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slunt, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borchelt, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberhart, C. G.</span><span> </span><span class="NLM_article-title">Expression of stabilized Î²-catenin in differentiated neurons of transgenic mice does not result in tumor formation</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">33</span><span class="refDoi">Â DOI: 10.1186/1471-2407-2-33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1186%2F1471-2407-2-33" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=33&issue=1&author=J.+E.+Kratzauthor=D.+Stearnsauthor=D.+L.+Husoauthor=H.+H.+Sluntauthor=D.+L.+Priceauthor=D.+R.+Borcheltauthor=C.+G.+Eberhart&title=Expression+of+stabilized+%CE%B2-catenin+in+differentiated+neurons+of+transgenic+mice+does+not+result+in+tumor+formation&doi=10.1186%2F1471-2407-2-33"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-2-33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-2-33%26sid%3Dliteratum%253Aachs%26aulast%3DKratz%26aufirst%3DJ.%2BE.%26aulast%3DStearns%26aufirst%3DD.%26aulast%3DHuso%26aufirst%3DD.%2BL.%26aulast%3DSlunt%26aufirst%3DH.%2BH.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DBorchelt%26aufirst%3DD.%2BR.%26aulast%3DEberhart%26aufirst%3DC.%2BG.%26atitle%3DExpression%2520of%2520stabilized%2520%25CE%25B2-catenin%2520in%2520differentiated%2520neurons%2520of%2520transgenic%2520mice%2520does%2520not%2520result%2520in%2520tumor%2520formation%26jtitle%3DBMC%2520Cancer%26date%3D2002%26volume%3D2%26issue%3D1%26spage%3D33%26doi%3D10.1186%2F1471-2407-2-33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group">Johnson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puntis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, R.</span><span> </span><span class="NLM_article-title">Randomized, dose-finding phase III study of lithium gamolenate in patients with advanced pancreatic adenocarcinoma</span> <span class="citation_source-journal">Br. J. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">662</span><span class="NLM_x">â</span> <span class="NLM_lpage">668</span><span class="refDoi">Â DOI: 10.1046/j.0007-1323.2001.01770.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1046%2Fj.0007-1323.2001.01770.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=11350436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A280%3ADC%252BD3M3mslentg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2001&pages=662-668&issue=5&author=C.+D.+Johnsonauthor=M.+Puntisauthor=N.+Davidsonauthor=S.+Toddauthor=R.+Bryce&title=Randomized%2C+dose-finding+phase+III+study+of+lithium+gamolenate+in+patients+with+advanced+pancreatic+adenocarcinoma&doi=10.1046%2Fj.0007-1323.2001.01770.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized, dose-finding phase III study of lithium gamolenate in patients with advanced pancreatic adenocarcinoma</span></div><div class="casAuthors">Johnson C D; Puntis M; Davidson N; Todd S; Bryce R</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of surgery</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">662-8</span>
        ISSN:<span class="NLM_cas:issn">0007-1323</span>.
    </div><div class="casAbstract">BACKGROUND:  Chemotherapy for pancreatic cancer offers small survival benefits and considerable side-effects.  Unsaturated fatty acids have an antitumour effect in experimental studies; in phase II studies few side-effects were seen.  METHODS:  In this group-sequential, open-label, randomized study, 278 patients with a diagnosis of inoperable pancreatic cancer were treated with either oral (700 mg daily for 15 days), low-dose (0.28 g/kg) or high-dose (0.84 g/kg) intravenous lithium gamolenate (LiGLA).  The primary endpoint was survival time from randomization using Kaplan-Meier estimates.  RESULTS:  Median survival after oral and low-dose intravenous treatment was 129 and 121 days respectively.  Median survival after high-dose intravenous treatment was 94 days.  A good Karnofsky score and the absence of metastases were associated with increased survival.  Haemolysis, a marker of rapid infusion, was associated with a median survival time of 249 days in the low-dose intravenous group.  CONCLUSION:  Oral or low-dose intravenous LiGLA led to survival times similar to those of other treatments for pancreatic cancer although one subgroup (low-dose intravenous LiGLA with haemolysis) had longer survival.  High-dose intravenous treatment appeared to have an adverse effect.  Systemic treatment with LiGLA cannot be recommended for the treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuN9MrH1V98S6Ufuk_1xoTfW6udTcc2eYKxowq9vOjbbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3mslentg%253D%253D&md5=62b2e7065dadbf9c971f9b3deebe3885</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1046%2Fj.0007-1323.2001.01770.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0007-1323.2001.01770.x%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BD.%26aulast%3DPuntis%26aufirst%3DM.%26aulast%3DDavidson%26aufirst%3DN.%26aulast%3DTodd%26aufirst%3DS.%26aulast%3DBryce%26aufirst%3DR.%26atitle%3DRandomized%252C%2520dose-finding%2520phase%2520III%2520study%2520of%2520lithium%2520gamolenate%2520in%2520patients%2520with%2520advanced%2520pancreatic%2520adenocarcinoma%26jtitle%3DBr.%2520J.%2520Surg.%26date%3D2001%26volume%3D88%26issue%3D5%26spage%3D662%26epage%3D668%26doi%3D10.1046%2Fj.0007-1323.2001.01770.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group">Gould, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manji, H. K.</span><span> </span><span class="NLM_article-title">Effects of a glycogen synthase kinase-3 inhibitor, lithium, in adenomatous polyposis coli mutant mice</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">53</span><span class="refDoi">Â DOI: 10.1016/S1043-6618(03)00096-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FS1043-6618%2803%2900096-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=12770514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktVOgtrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2003&pages=49-53&issue=1&author=T.+D.+Gouldauthor=N.+A.+Grayauthor=H.+K.+Manji&title=Effects+of+a+glycogen+synthase+kinase-3+inhibitor%2C+lithium%2C+in+adenomatous+polyposis+coli+mutant+mice&doi=10.1016%2FS1043-6618%2803%2900096-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a glycogen synthase kinase-3 inhibitor, lithium, in adenomatous polyposis coli mutant mice</span></div><div class="casAuthors">Gould, Todd D.; Gray, Neil A.; Manji, Husseini K.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-53</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3 (GSK-3) is an intermediary enzyme in various cellular pathways, and has been implicated in the pathophysiol. and treatment of numerous diseases, including Alzheimer's disease, diabetes, and bipolar disorder.  There is therefore interest in developing potent, selective GSK-3 inhibitors for the treatment of these devastating illnesses.  A concern, however, is that the Wnt-signaling pathway, of which GSK-3 is an important intermediary mol., has been implicated in many human cancers.  It is thus of considerable importance to det. if GSK-3 inhibitors have tumorigenic potential in systems predisposed to developing tumors by virtue of mutations of the Wnt-signaling pathway.  We therefore investigated the effects of a GSK-3 inhibitor, lithium, in a murine model predisposed to the formation of tumors due to activation of the Wnt pathway, the adenomatous polyposis coli (APC) multiple intestinal neoplasia (min) mouse.  We found that 60 days of lithium treatment did not produce a significant increase in the no. of tumors in these genetically predisposed mice.  Lithium treatment resulted in a modest overall increase in the tumor size.  The APC (min) mouse has previously been shown to be a robust indicator of tumorigenesis, with large increases in tumor no. obsd. in response to a variety of agents; thus, our results suggest that lithium, and perhaps other inhibitors of GSK-3, pose a low risk for the development of cancers of the Wnt pathway.  These results are consistent with the available epidemiol. evidence that long-term lithium therapy does not increase cancer morbidity or mortality, but rather is assocd. with reduced overall mortality in bipolar disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_aSY15kuwOLVg90H21EOLACvtfcHk0lj2b-d-_T8toA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktVOgtrg%253D&md5=16fcfc1a37a087443a259749b1571413</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2FS1043-6618%2803%2900096-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-6618%252803%252900096-3%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DT.%2BD.%26aulast%3DGray%26aufirst%3DN.%2BA.%26aulast%3DManji%26aufirst%3DH.%2BK.%26atitle%3DEffects%2520of%2520a%2520glycogen%2520synthase%2520kinase-3%2520inhibitor%252C%2520lithium%252C%2520in%2520adenomatous%2520polyposis%2520coli%2520mutant%2520mice%26jtitle%3DPharmacol.%2520Res.%26date%3D2003%26volume%3D48%26issue%3D1%26spage%3D49%26epage%3D53%26doi%3D10.1016%2FS1043-6618%2803%2900096-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group">Cross, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culbert, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalmers, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaper, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span> </span><span class="NLM_article-title">Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">94</span><span class="NLM_x">â</span> <span class="NLM_lpage">102</span><span class="refDoi">Â DOI: 10.1046/j.1471-4159.2001.00251.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1046%2Fj.1471-4159.2001.00251.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=11279265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3MXis1Klt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2001&pages=94-102&issue=1&author=D.+A.+Crossauthor=A.+A.+Culbertauthor=K.+A.+Chalmersauthor=L.+Facciauthor=S.+D.+Skaperauthor=A.+D.+Reith&title=Selective+small-molecule+inhibitors+of+glycogen+synthase+kinase-3+activity+protect+primary+neurones+from+death&doi=10.1046%2Fj.1471-4159.2001.00251.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurons from death</span></div><div class="casAuthors">Cross, Darren A. E.; Culbert, Ainsley A.; Chalmers, Katy A.; Facci, Laura; Skaper, Stephen D.; Reith, Alastair D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-102</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI 3-kinase)/protein kinase B (PKB; also known as Akt) signaling pathway is recognized as playing a central role in the survival of diverse cell types.  Glycogen synthase kinase-3 (GSK-3) is a ubiquitously expressed serine/threonine protein kinase that is one of several known substrates of PKB.  PKB phosphorylates GSK-3 in response to insulin and growth factors, which inhibits GSK-3 activity and leads to the modulation of multiple GSK-3 regulated cellular processes.  We show that the novel potent and selective small-mol. inhibitors of GSK-3; SB-415286 and SB-216763, protect both central and peripheral nervous system neurons in culture from death induced by reduced PI 3-kinase pathway activity.  The inhibition of neuronal death mediated by these compds. correlated with inhibition of GSK-3 activity and modulation of GSK-3 substrates tau and Î²-catenin.  Thus, in addn. to the previously assigned roles of GSK-3, our data provide clear pharmacol. and biochem. evidence that selective inhibition of the endogenous pool of GSK-3 activity in primary neurons is sufficient to prevent death, implicating GSK-3 as a physiol. relevant principal regulatory target of the PI 3-kinase/PKB neuronal survival pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE0yo5rwTmELVg90H21EOLACvtfcHk0lj2b-d-_T8toA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXis1Klt7s%253D&md5=991edcb9e3ed5d6164374b89eb746c00</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2001.00251.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2001.00251.x%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DD.%2BA.%26aulast%3DCulbert%26aufirst%3DA.%2BA.%26aulast%3DChalmers%26aufirst%3DK.%2BA.%26aulast%3DFacci%26aufirst%3DL.%26aulast%3DSkaper%26aufirst%3DS.%2BD.%26aulast%3DReith%26aufirst%3DA.%2BD.%26atitle%3DSelective%2520small-molecule%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%2520activity%2520protect%2520primary%2520neurones%2520from%2520death%26jtitle%3DJ.%2520Neurochem.%26date%3D2001%26volume%3D77%26issue%3D1%26spage%3D94%26epage%3D102%26doi%3D10.1046%2Fj.1471-4159.2001.00251.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group">Harada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyoshi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taketo, M. M.</span><span> </span><span class="NLM_article-title">Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1971</span><span class="NLM_x">â</span> <span class="NLM_lpage">1977</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=1971-1977&issue=7&author=N.+Haradaauthor=H.+Miyoshiauthor=N.+Muraiauthor=H.+Oshimaauthor=Y.+Tamaiauthor=M.+Oshimaauthor=M.+M.+Taketo&title=Lack+of+tumorigenesis+in+the+mouse+liver+after+adenovirus-mediated+expression+of+a+dominant+stable+mutant+of+beta-catenin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DN.%26aulast%3DMiyoshi%26aufirst%3DH.%26aulast%3DMurai%26aufirst%3DN.%26aulast%3DOshima%26aufirst%3DH.%26aulast%3DTamai%26aufirst%3DY.%26aulast%3DOshima%26aufirst%3DM.%26aulast%3DTaketo%26aufirst%3DM.%2BM.%26atitle%3DLack%2520of%2520tumorigenesis%2520in%2520the%2520mouse%2520liver%2520after%2520adenovirus-mediated%2520expression%2520of%2520a%2520dominant%2520stable%2520mutant%2520of%2520beta-catenin%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26issue%3D7%26spage%3D1971%26epage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzig, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picard, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyriakis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aronovitz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claycomb, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanton, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galper, J. B.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 inhibition ameliorates cardiac parasympathetic dysfunction in type 1 diabetic Akita mice</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2097</span><span class="NLM_x">â</span> <span class="NLM_lpage">2113</span><span class="refDoi">Â DOI: 10.2337/db12-1459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdb12-1459" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=2097-2113&issue=6&author=Y.+Zhangauthor=C.+M.+Welzigauthor=K.+L.+Picardauthor=C.+Duauthor=B.+Wangauthor=J.+Q.+Panauthor=J.+M.+Kyriakisauthor=M.+J.+Aronovitzauthor=W.+C.+Claycombauthor=R.+M.+Blantonauthor=H.-J.+Parkauthor=J.+B.+Galper&title=Glycogen+synthase+kinase-3+inhibition+ameliorates+cardiac+parasympathetic+dysfunction+in+type+1+diabetic+Akita+mice&doi=10.2337%2Fdb12-1459"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.2337%2Fdb12-1459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb12-1459%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWelzig%26aufirst%3DC.%2BM.%26aulast%3DPicard%26aufirst%3DK.%2BL.%26aulast%3DDu%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DPan%26aufirst%3DJ.%2BQ.%26aulast%3DKyriakis%26aufirst%3DJ.%2BM.%26aulast%3DAronovitz%26aufirst%3DM.%2BJ.%26aulast%3DClaycomb%26aufirst%3DW.%2BC.%26aulast%3DBlanton%26aufirst%3DR.%2BM.%26aulast%3DPark%26aufirst%3DH.-J.%26aulast%3DGalper%26aufirst%3DJ.%2BB.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520inhibition%2520ameliorates%2520cardiac%2520parasympathetic%2520dysfunction%2520in%2520type%25201%2520diabetic%2520Akita%2520mice%26jtitle%3DDiabetes%26date%3D2014%26volume%3D63%26issue%3D6%26spage%3D2097%26epage%3D2113%26doi%3D10.2337%2Fdb12-1459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group">Weikel, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacicedo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruderman, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ido, Y.</span><span> </span><span class="NLM_article-title">Knockdown of GSK3 increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cells</span> <span class="citation_source-journal">Biosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">e00382</span><span class="NLM_x">â</span> <span class="NLM_lpage">e00382</span><span class="refDoi">Â DOI: 10.1042/BSR20160174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1042%2FBSR20160174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=27534430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Ont7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=e00382-e00382&issue=5&author=K.+A.+Weikelauthor=J.+M.+Cacicedoauthor=N.+B.+Rudermanauthor=Y.+Ido&title=Knockdown+of+GSK3+increases+basal+autophagy+and+AMPK+signalling+in+nutrient-laden+human+aortic+endothelial+cells&doi=10.1042%2FBSR20160174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Knockdown of GSK3Î² increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cells</span></div><div class="casAuthors">Weikel, Karen A.; Cacicedo, Jose M.; Ruderman, Neil B.; Ido, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Bioscience Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e00382/1-e00382/16</span>CODEN:
                <span class="NLM_cas:coden">BRPTDT</span>;
        ISSN:<span class="NLM_cas:issn">0144-8463</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">High concns. of glucose and palmitate increase endothelial cell inflammation and apoptosis, events that often precede atherogenesis.  They may do so by decreasing basal autophagy and AMP-activated protein kinase (AMPK) activity, although the mechanisms by which this occurs are not clear.  Decreased function of the lysosome, an organelle required for autophagy and AMPK, have been assocd. with hyperactivity of glycogen synthase kinase 3Î² (GSK3Î²).  To det. whether GSK3Î² affects nutrient-induced changes in autophagy and AMPK activity, we used a primary human aortic endothelial cell (HAEC) model of type 2 diabetes that we had previously characterized with impaired AMPK activity and autophagy.  Presently, we found that incubation of HAECs with excess nutrients (25 mM glucose and 0.4 mM palmitate) increased GSK3Î² activity and impaired lysosome acidification.  Suppression of GSK3Î² in these cells by treatment with a chem. inhibitor or overexpression of kinase-dead GSK3Î² attenuated these lysosomal changes.  Under control and excess nutrient conditions, knockdown of GSK3Î² increased autophagosome formation, forkhead box protein O1 (FOXO1) activity and AMPK signalling and decreased Akt signalling.  Similar changes in autophagy, AMPK and Akt signalling were obsd. in aortas from mice treated with the GSK3Î² inhibitor CHIR 99021.  Thus, increasing basal autophagy and AMPK activity by inhibiting GSK3Î² may be an effective strategy in the setting of hyperglycemia and dyslipidemia for restoring endothelial cell health and reducing atherogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUk-NlyPIEaLVg90H21EOLACvtfcHk0lgaN6NjOHSfhA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Ont7g%253D&md5=59a6cca974121cd52eab168554b3c488</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1042%2FBSR20160174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBSR20160174%26sid%3Dliteratum%253Aachs%26aulast%3DWeikel%26aufirst%3DK.%2BA.%26aulast%3DCacicedo%26aufirst%3DJ.%2BM.%26aulast%3DRuderman%26aufirst%3DN.%2BB.%26aulast%3DIdo%26aufirst%3DY.%26atitle%3DKnockdown%2520of%2520GSK3%2520increases%2520basal%2520autophagy%2520and%2520AMPK%2520signalling%2520in%2520nutrient-laden%2520human%2520aortic%2520endothelial%2520cells%26jtitle%3DBiosci.%2520Rep.%26date%3D2016%26volume%3D36%26issue%3D5%26spage%3De00382%26epage%3De00382%26doi%3D10.1042%2FBSR20160174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group">Marchand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, M.-J.</span><span> </span><span class="NLM_article-title">Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">529</span><span class="NLM_x">â</span> <span class="NLM_lpage">537</span><span class="refDoi">Â DOI: 10.1093/carcin/bgr309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1093%2Fcarcin%2Fbgr309" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=529-537&issue=3&author=B.+Marchandauthor=I.+Tremblayauthor=S.+Cagnolauthor=M.-J.+Boucher&title=Inhibition+of+glycogen+synthase+kinase-3+activity+triggers+an+apoptotic+response+in+pancreatic+cancer+cells+through+JNK-dependent+mechanisms&doi=10.1093%2Fcarcin%2Fbgr309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgr309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgr309%26sid%3Dliteratum%253Aachs%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DTremblay%26aufirst%3DI.%26aulast%3DCagnol%26aufirst%3DS.%26aulast%3DBoucher%26aufirst%3DM.-J.%26atitle%3DInhibition%2520of%2520glycogen%2520synthase%2520kinase-3%2520activity%2520triggers%2520an%2520apoptotic%2520response%2520in%2520pancreatic%2520cancer%2520cells%2520through%2520JNK-dependent%2520mechanisms%26jtitle%3DCarcinogenesis%26date%3D2012%26volume%3D33%26issue%3D3%26spage%3D529%26epage%3D537%26doi%3D10.1093%2Fcarcin%2Fbgr309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group">Bock, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leigh, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryda, E. C.</span><span> </span><span class="NLM_article-title">Effect of Gsk3 inhibitor CHIR99021 on aneuploidy levels in rat embryonic stem cells</span> <span class="citation_source-journal">In Vitro Cell. Dev. Biol.: Anim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">572</span><span class="NLM_x">â</span> <span class="NLM_lpage">579</span><span class="refDoi">Â DOI: 10.1007/s11626-014-9734-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1007%2Fs11626-014-9734-5" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=572-579&issue=6&author=A.+S.+Bockauthor=N.+D.+Leighauthor=E.+C.+Bryda&title=Effect+of+Gsk3+inhibitor+CHIR99021+on+aneuploidy+levels+in+rat+embryonic+stem+cells&doi=10.1007%2Fs11626-014-9734-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1007%2Fs11626-014-9734-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11626-014-9734-5%26sid%3Dliteratum%253Aachs%26aulast%3DBock%26aufirst%3DA.%2BS.%26aulast%3DLeigh%26aufirst%3DN.%2BD.%26aulast%3DBryda%26aufirst%3DE.%2BC.%26atitle%3DEffect%2520of%2520Gsk3%2520inhibitor%2520CHIR99021%2520on%2520aneuploidy%2520levels%2520in%2520rat%2520embryonic%2520stem%2520cells%26jtitle%3DIn%2520Vitro%2520Cell.%2520Dev.%2520Biol.%253A%2520Anim.%26date%3D2014%26volume%3D50%26issue%3D6%26spage%3D572%26epage%3D579%26doi%3D10.1007%2Fs11626-014-9734-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group">Buikema, J. W.; Zwetsloot, P.-P. M.; Doevendans, P. A.; Sluijter, J. P. G.; Domian, I. J.</span><span> </span><span class="NLM_article-title">Expanding Mouse Ventricular Cardiomyocytes Through GSK-3 Inhibition</span>. In  <span class="citation_source-book">Current Protocols in Cell Biology</span>; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">61</span>, pp  <span class="NLM_fpage">23.9.1</span><span class="NLM_x">â</span> <span class="NLM_lpage">23.9.10</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1002%2F0471143030.cb2309s61" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=23.9.1-23.9.10&author=J.+W.+Buikema&author=P.-P.+M.+Zwetsloot&author=P.+A.+Doevendans&author=J.+P.+G.+Sluijter&author=I.+J.+Domian&title=Current+Protocols+in+Cell+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1002%2F0471143030.cb2309s61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471143030.cb2309s61%26sid%3Dliteratum%253Aachs%26aulast%3DBuikema%26aufirst%3DJ.%2BW.%26atitle%3DExpanding%2520Mouse%2520Ventricular%2520Cardiomyocytes%2520Through%2520GSK-3%2520Inhibition%26btitle%3DCurrent%2520Protocols%2520in%2520Cell%2520Biology%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2013%26volume%3D61%26spage%3D23.9.1%26epage%3D23.9.10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group">Carter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VancurovÃ¡, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLeon, S.</span><span> </span><span class="NLM_article-title">A DNA-Activated Protein Kinase from HeLa Cell Nuclei</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">6460</span><span class="NLM_x">â</span> <span class="NLM_lpage">6471</span><span class="refDoi">Â DOI: 10.1128/MCB.10.12.6460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1128%2FMCB.10.12.6460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=2247066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADyaK3MXlsl2itg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1990&pages=6460-6471&issue=12&author=T.+Carterauthor=I.+Vancurov%C3%A1author=I.+Sunauthor=W.+Louauthor=S.+DeLeon&title=A+DNA-Activated+Protein+Kinase+from+HeLa+Cell+Nuclei&doi=10.1128%2FMCB.10.12.6460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">A DNA-activated protein kinase from HeLa cell nuclei</span></div><div class="casAuthors">Carter, Timothy; Vancurova, Ivana; Sun, Ivon; Lou, Willard; DeLeon, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6460-71</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">A DNA-activated protein kinase (DNA-PK) was purified from nuclei of HeLa cells.  The activity was assocd. with a single high-mol.-wt. (â¼300,000) polypeptide when analyzed by gel filtration, denaturing PAGE, and Western immunoblotting using a monoclonal antibody that also inhibited enzyme activity.  Nuclear localization was indicated by subcellular fractionation and confirmed by immunofluorescence on whole cells.  Double-stranded DNA stimulated phosphorylation of the 300-kDa polypeptide in purified prepns. as well as phosphorylation of the exogenous substrates, Î±-casein, simian virus 40 large T antigen, and human heat-shock protein hsp90.  Autophosphorylation led to inactivation of the enzyme.  The phosphorylation of casein was stimulated >30-fold by DNA and was specific for serine and threonine residues.  Bovine serum albumin and histone H1 were poor substrates for DNA-PK, and no phosphorylation of IgG or histones other than H1 was obsd.  Supercoiled or heat-denatured DNA and synthetic double-stranded RNA or RNA-DNA copolymers did not stimulate casein phosphorylation by DNA-PK.  The interaction of the enzyme with DNA in the absence of exogenous substrates was demonstrated by thermal inactivation and gel mobility shifts.  These characteristics identified DNA-PK as distinct from other protein kinases described in the literature and suggested that activation by DNA is an important feature of the enzyme's in vivo function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMF7b5JvuxXrVg90H21EOLACvtfcHk0ljTsVbgiBVDNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsl2itg%253D%253D&md5=7c4ff2dabb9b0545bae4c97e7b466b5f</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1128%2FMCB.10.12.6460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.10.12.6460%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DT.%26aulast%3DVancurov%25C3%25A1%26aufirst%3DI.%26aulast%3DSun%26aufirst%3DI.%26aulast%3DLou%26aufirst%3DW.%26aulast%3DDeLeon%26aufirst%3DS.%26atitle%3DA%2520DNA-Activated%2520Protein%2520Kinase%2520from%2520HeLa%2520Cell%2520Nuclei%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1990%26volume%3D10%26issue%3D12%26spage%3D6460%26epage%3D6471%26doi%3D10.1128%2FMCB.10.12.6460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group">Rubinfeld, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munemitsu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conroy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosier, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polakis, P.</span><span> </span><span class="NLM_article-title">Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1033</span><span class="NLM_x">â</span> <span class="NLM_lpage">1042</span><span class="refDoi">Â DOI: 10.1016/0092-8674(91)90555-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2F0092-8674%2891%2990555-D" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1991&pages=1033-1042&issue=6&author=B.+Rubinfeldauthor=S.+Munemitsuauthor=R.+Clarkauthor=L.+Conroyauthor=K.+Wattauthor=W.+J.+Crosierauthor=F.+McCormickauthor=P.+Polakis&title=Molecular+cloning+of+a+GTPase+activating+protein+specific+for+the+Krev-1+protein+p21rap1&doi=10.1016%2F0092-8674%2891%2990555-D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2891%2990555-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252891%252990555-D%26sid%3Dliteratum%253Aachs%26aulast%3DRubinfeld%26aufirst%3DB.%26aulast%3DMunemitsu%26aufirst%3DS.%26aulast%3DClark%26aufirst%3DR.%26aulast%3DConroy%26aufirst%3DL.%26aulast%3DWatt%26aufirst%3DK.%26aulast%3DCrosier%26aufirst%3DW.%2BJ.%26aulast%3DMcCormick%26aufirst%3DF.%26aulast%3DPolakis%26aufirst%3DP.%26atitle%3DMolecular%2520cloning%2520of%2520a%2520GTPase%2520activating%2520protein%2520specific%2520for%2520the%2520Krev-1%2520protein%2520p21rap1%26jtitle%3DCell%26date%3D1991%26volume%3D65%26issue%3D6%26spage%3D1033%26epage%3D1042%26doi%3D10.1016%2F0092-8674%2891%2990555-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group">Klein, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalewski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drenckhan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neugebauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthaei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotzke, G.</span><span> </span><span class="NLM_article-title">A Microtiter well assay system to measure insulin activation of insulin receptor kinase in intact human mononuclear cells. Decreased insulin effect in cells from patients with NIDDM</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">883</span><span class="NLM_x">â</span> <span class="NLM_lpage">890</span><span class="refDoi">Â DOI: 10.2337/diab.42.6.883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdiab.42.6.883" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1993&pages=883-890&issue=6&author=H.+H.+Kleinauthor=B.+Kowalewskiauthor=M.+Drenckhanauthor=S.+Neugebauerauthor=S.+Matthaeiauthor=G.+Kotzke&title=A+Microtiter+well+assay+system+to+measure+insulin+activation+of+insulin+receptor+kinase+in+intact+human+mononuclear+cells.+Decreased+insulin+effect+in+cells+from+patients+with+NIDDM&doi=10.2337%2Fdiab.42.6.883"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.2337%2Fdiab.42.6.883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiab.42.6.883%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DH.%2BH.%26aulast%3DKowalewski%26aufirst%3DB.%26aulast%3DDrenckhan%26aufirst%3DM.%26aulast%3DNeugebauer%26aufirst%3DS.%26aulast%3DMatthaei%26aufirst%3DS.%26aulast%3DKotzke%26aufirst%3DG.%26atitle%3DA%2520Microtiter%2520well%2520assay%2520system%2520to%2520measure%2520insulin%2520activation%2520of%2520insulin%2520receptor%2520kinase%2520in%2520intact%2520human%2520mononuclear%2520cells.%2520Decreased%2520insulin%2520effect%2520in%2520cells%2520from%2520patients%2520with%2520NIDDM%26jtitle%3DDiabetes%26date%3D1993%26volume%3D42%26issue%3D6%26spage%3D883%26epage%3D890%26doi%3D10.2337%2Fdiab.42.6.883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group">Osterop, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medema, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">vd Zon, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ¼ller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flier, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ¶ller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maassen, J. A.</span><span> </span><span class="NLM_article-title">Relation between the insulin receptor number in cells, autophosphorylation and insulin-stimulated Ras.GTP formation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">14647</span><span class="NLM_x">â</span> <span class="NLM_lpage">14653</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=14647-14653&issue=21&author=A.+P.+Osteropauthor=R.+H.+Medemaauthor=J.+L.+Bosauthor=G.+C.+vd+Zonauthor=D.+E.+M%C3%BCllerauthor=J.+S.+Flierauthor=W.+M%C3%B6llerauthor=J.+A.+Maassen&title=Relation+between+the+insulin+receptor+number+in+cells%2C+autophosphorylation+and+insulin-stimulated+Ras.GTP+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOsterop%26aufirst%3DA.%2BP.%26aulast%3DMedema%26aufirst%3DR.%2BH.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26aulast%3Dvd%2BZon%26aufirst%3DG.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BE.%26aulast%3DFlier%26aufirst%3DJ.%2BS.%26aulast%3DM%25C3%25B6ller%26aufirst%3DW.%26aulast%3DMaassen%26aufirst%3DJ.%2BA.%26atitle%3DRelation%2520between%2520the%2520insulin%2520receptor%2520number%2520in%2520cells%252C%2520autophosphorylation%2520and%2520insulin-stimulated%2520Ras.GTP%2520formation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26issue%3D21%26spage%3D14647%26epage%3D14653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group">Thomas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlender, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larner, J.</span><span> </span><span class="NLM_article-title">A Rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">486</span><span class="NLM_x">â</span> <span class="NLM_lpage">499</span><span class="refDoi">Â DOI: 10.1016/0003-2697(68)90127-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2F0003-2697%2868%2990127-9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1968&pages=486-499&issue=1&author=J.+A.+Thomasauthor=K.+K.+Schlenderauthor=J.+Larner&title=A+Rapid+filter+paper+assay+for+UDPglucose-glycogen+glucosyltransferase%2C+including+an+improved+biosynthesis+of+UDP-14C-glucose&doi=10.1016%2F0003-2697%2868%2990127-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2868%2990127-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252868%252990127-9%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DJ.%2BA.%26aulast%3DSchlender%26aufirst%3DK.%2BK.%26aulast%3DLarner%26aufirst%3DJ.%26atitle%3DA%2520Rapid%2520filter%2520paper%2520assay%2520for%2520UDPglucose-glycogen%2520glucosyltransferase%252C%2520including%2520an%2520improved%2520biosynthesis%2520of%2520UDP-14C-glucose%26jtitle%3DAnal.%2520Biochem.%26date%3D1968%26volume%3D25%26issue%3D1%26spage%3D486%26epage%3D499%26doi%3D10.1016%2F0003-2697%2868%2990127-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group">Henriksen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halseth, A. E.</span><span> </span><span class="NLM_article-title">Early alterations in soleus GLUT-4, glucose transport, and glycogen in voluntary running rats</span> <span class="citation_source-journal">J. Appl. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1862</span><span class="NLM_x">â</span> <span class="NLM_lpage">1867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1994&pages=1862-1867&issue=5&author=E.+J.+Henriksenauthor=A.+E.+Halseth&title=Early+alterations+in+soleus+GLUT-4%2C+glucose+transport%2C+and+glycogen+in+voluntary+running+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHenriksen%26aufirst%3DE.%2BJ.%26aulast%3DHalseth%26aufirst%3DA.%2BE.%26atitle%3DEarly%2520alterations%2520in%2520soleus%2520GLUT-4%252C%2520glucose%2520transport%252C%2520and%2520glycogen%2520in%2520voluntary%2520running%2520rats%26jtitle%3DJ.%2520Appl.%2520Physiol.%26date%3D1994%26volume%3D76%26issue%3D5%26spage%3D1862%26epage%3D1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">486</span><span class="NLM_x">â</span> <span class="NLM_lpage">501</span><span class="refDoi">Â DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&issue=4&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0ljTsVbgiBVDNA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D4%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span> <span class="citation_source-book">BUSTER</span>; <span class="NLM_publisher-name">Global Phasing Ltd</span>: <span class="NLM_publisher-loc">Cambridge, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26btitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BunkÃ³czi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: A comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">213</span><span class="NLM_x">â</span> <span class="NLM_lpage">221</span><span class="refDoi">Â DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&issue=2&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+A+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lhkzeWvXcCW5Q"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520A%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D2%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 16 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keshab M.  Bairagi</span>, <span class="hlFld-ContribAuthor ">Nancy Safwat  Younis</span>, <span class="hlFld-ContribAuthor ">Promise Madu  Emeka</span>, <span class="hlFld-ContribAuthor ">Katharigatta N.  Venugopala</span>, <span class="hlFld-ContribAuthor ">Osama I.  Alwassil</span>, <span class="hlFld-ContribAuthor ">Hany Ezzat  Khalil</span>, <span class="hlFld-ContribAuthor ">Ekta  Sangtani</span>, <span class="hlFld-ContribAuthor ">Rajesh G.  Gonnade</span>, <span class="hlFld-ContribAuthor ">Viresh  Mohanlall</span>, <span class="hlFld-ContribAuthor ">Susanta K.  Nayak</span>. </span><span class="cited-content_cbyCitation_article-title">Chemistry, anti-diabetic activity and structural analysis of substituted dihydropyrimidine analogues. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1227 </em>, 129412. <a href="https://doi.org/10.1016/j.molstruc.2020.129412" title="DOI URL">https://doi.org/10.1016/j.molstruc.2020.129412</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2020.129412&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2020.129412%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DChemistry%25252C%252Banti-diabetic%252Bactivity%252Band%252Bstructural%252Banalysis%252Bof%252Bsubstituted%252Bdihydropyrimidine%252Banalogues%26aulast%3DBairagi%26aufirst%3DKeshab%2BM.%26date%3D2021%26volume%3D1227%26spage%3D129412" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shuwen  Han</span>, <span class="hlFld-ContribAuthor ">Chunlin  Zhuang</span>, <span class="hlFld-ContribAuthor ">Wei  Zhou</span>, <span class="hlFld-ContribAuthor ">Fener  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Structural-Based Optimizations of the Marine-Originated Meridianin C as Glucose Uptake Agents by Inhibiting GSK-3Î². </span><span class="cited-content_cbyCitation_journal-name">Marine Drugs</span><span> <strong>2021,</strong> <em>19 </em>
                                    (3)
                                     , 149. <a href="https://doi.org/10.3390/md19030149" title="DOI URL">https://doi.org/10.3390/md19030149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/md19030149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmd19030149%26sid%3Dliteratum%253Aachs%26jtitle%3DMarine%2520Drugs%26atitle%3DStructural-Based%252BOptimizations%252Bof%252Bthe%252BMarine-Originated%252BMeridianin%252BC%252Bas%252BGlucose%252BUptake%252BAgents%252Bby%252BInhibiting%252BGSK-3%2525CE%2525B2%26aulast%3DHan%26aufirst%3DShuwen%26date%3D2021%26date%3D2021%26volume%3D19%26issue%3D3%26spage%3D149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Min  Wang</span>, <span class="hlFld-ContribAuthor ">Tongtong  Liu</span>, <span class="hlFld-ContribAuthor ">Shiming  Chen</span>, <span class="hlFld-ContribAuthor ">Mingfei  Wu</span>, <span class="hlFld-ContribAuthor ">Jianfei  Han</span>, <span class="hlFld-ContribAuthor ">Zeng  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3Î² inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>209 </em>, 112874. <a href="https://doi.org/10.1016/j.ejmech.2020.112874" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112874</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112874&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112874%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252Bsynthesis%252Bof%252B3-%2525284-pyridyl%252529-5-%2525284-sulfamido-phenyl%252529-1%25252C2%25252C4-oxadiazole%252Bderivatives%252Bas%252Bnovel%252BGSK-3%2525CE%2525B2%252Binhibitors%252Band%252Bevaluation%252Bof%252Btheir%252Bpotential%252Bas%252Bmultifunctional%252Banti-Alzheimer%252Bagents%26aulast%3DWang%26aufirst%3DMin%26date%3D2021%26volume%3D209%26spage%3D112874" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qingxiu  He</span>, <span class="hlFld-ContribAuthor ">Chu  Han</span>, <span class="hlFld-ContribAuthor ">Guangping  Li</span>, <span class="hlFld-ContribAuthor ">Haiqiong  Guo</span>, <span class="hlFld-ContribAuthor ">Yuxuan  Wang</span>, <span class="hlFld-ContribAuthor ">Yong  Hu</span>, <span class="hlFld-ContribAuthor ">Zhihua  Lin</span>, <span class="hlFld-ContribAuthor ">Yuanqiang  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">In silico design novel (5-imidazol-2-yl-4-phenylpyrimidin-2-yl)[2-(2-pyridylamino)ethyl]amine derivatives as inhibitors for glycogen synthase kinase 3 based on 3D-QSAR, molecular docking and molecular dynamics simulation. </span><span class="cited-content_cbyCitation_journal-name">Computational Biology and Chemistry</span><span> <strong>2020,</strong> <em>88 </em>, 107328. <a href="https://doi.org/10.1016/j.compbiolchem.2020.107328" title="DOI URL">https://doi.org/10.1016/j.compbiolchem.2020.107328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.compbiolchem.2020.107328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.compbiolchem.2020.107328%26sid%3Dliteratum%253Aachs%26jtitle%3DComputational%2520Biology%2520and%2520Chemistry%26atitle%3DIn%252Bsilico%252Bdesign%252Bnovel%252B%2525285-imidazol-2-yl-4-phenylpyrimidin-2-yl%252529%25255B2-%2525282-pyridylamino%252529ethyl%25255Damine%252Bderivatives%252Bas%252Binhibitors%252Bfor%252Bglycogen%252Bsynthase%252Bkinase%252B3%252Bbased%252Bon%252B3D-QSAR%25252C%252Bmolecular%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulation%26aulast%3DHe%26aufirst%3DQingxiu%26date%3D2020%26volume%3D88%26spage%3D107328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yahui  Ding</span>, <span class="hlFld-ContribAuthor ">Shan  Gao</span>, <span class="hlFld-ContribAuthor ">Jian  Shen</span>, <span class="hlFld-ContribAuthor ">Tairan  Bai</span>, <span class="hlFld-ContribAuthor ">Ming  Yang</span>, <span class="hlFld-ContribAuthor ">Shiqi  Xu</span>, <span class="hlFld-ContribAuthor ">Yingdai  Gao</span>, <span class="hlFld-ContribAuthor ">Zhisong  Zhang</span>, <span class="hlFld-ContribAuthor ">Luyuan  Li</span>. </span><span class="cited-content_cbyCitation_article-title">TNFSF15 facilitates human umbilical cord blood haematopoietic stem cell expansion by activating Notch signal pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Cellular and Molecular Medicine</span><span> <strong>2020,</strong> <em>24 </em>
                                    (19)
                                     , 11146-11157. <a href="https://doi.org/10.1111/jcmm.15626" title="DOI URL">https://doi.org/10.1111/jcmm.15626</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jcmm.15626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjcmm.15626%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Cellular%2520and%2520Molecular%2520Medicine%26atitle%3DTNFSF15%252Bfacilitates%252Bhuman%252Bumbilical%252Bcord%252Bblood%252Bhaematopoietic%252Bstem%252Bcell%252Bexpansion%252Bby%252Bactivating%252BNotch%252Bsignal%252Bpathway%26aulast%3DDing%26aufirst%3DYahui%26date%3D2020%26date%3D2020%26volume%3D24%26issue%3D19%26spage%3D11146%26epage%3D11157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Simon  Miller</span>, <span class="hlFld-ContribAuthor ">Tsuyoshi  Hirota</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacological Interventions to Circadian Clocks and Their Molecular Bases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Biology</span><span> <strong>2020,</strong> <em>432 </em>
                                    (12)
                                     , 3498-3514. <a href="https://doi.org/10.1016/j.jmb.2020.01.003" title="DOI URL">https://doi.org/10.1016/j.jmb.2020.01.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmb.2020.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmb.2020.01.003%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Biology%26atitle%3DPharmacological%252BInterventions%252Bto%252BCircadian%252BClocks%252Band%252BTheir%252BMolecular%252BBases%26aulast%3DMiller%26aufirst%3DSimon%26date%3D2020%26volume%3D432%26issue%3D12%26spage%3D3498%26epage%3D3514" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Laura  Llorach-Pares</span>, <span class="hlFld-ContribAuthor ">Ened  Rodriguez-Urgelles</span>, <span class="hlFld-ContribAuthor ">Alfons  Nonell-Canals</span>, <span class="hlFld-ContribAuthor ">Jordi  Alberch</span>, <span class="hlFld-ContribAuthor ">Conxita  Avila</span>, <span class="hlFld-ContribAuthor ">Melchor  Sanchez-Martinez</span>, <span class="hlFld-ContribAuthor ">Albert  Giralt</span>. </span><span class="cited-content_cbyCitation_article-title">Meridianins and Lignarenone B as Potential GSK3Î² Inhibitors and Inductors of Structural Neuronal Plasticity. </span><span class="cited-content_cbyCitation_journal-name">Biomolecules</span><span> <strong>2020,</strong> <em>10 </em>
                                    (4)
                                     , 639. <a href="https://doi.org/10.3390/biom10040639" title="DOI URL">https://doi.org/10.3390/biom10040639</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/biom10040639&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fbiom10040639%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomolecules%26atitle%3DMeridianins%252Band%252BLignarenone%252BB%252Bas%252BPotential%252BGSK3%2525CE%2525B2%252BInhibitors%252Band%252BInductors%252Bof%252BStructural%252BNeuronal%252BPlasticity%26aulast%3DLlorach-Pares%26aufirst%3DLaura%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D4%26spage%3D639" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Savithri  Ramurthy</span>, <span class="hlFld-ContribAuthor ">Keith B.  Pfister</span>, <span class="hlFld-ContribAuthor ">Rustum S.  Boyce</span>, <span class="hlFld-ContribAuthor ">Sean P.  Brown</span>, <span class="hlFld-ContribAuthor ">Abran Q.  Costales</span>, <span class="hlFld-ContribAuthor ">Manoj C.  Desai</span>, <span class="hlFld-ContribAuthor ">Eric  Fang</span>, <span class="hlFld-ContribAuthor ">Barry H.  Levine</span>, <span class="hlFld-ContribAuthor ">Simon C.  Ng</span>, <span class="hlFld-ContribAuthor ">John M.  Nuss</span>, <span class="hlFld-ContribAuthor ">David B.  Ring</span>, <span class="hlFld-ContribAuthor ">Cynthia M.  Shafer</span>, <span class="hlFld-ContribAuthor ">Wei  Shu</span>, <span class="hlFld-ContribAuthor ">Sharadha  Subramanian</span>, <span class="hlFld-ContribAuthor ">Allan S.  Wagman</span>, <span class="hlFld-ContribAuthor ">Haixia  Wang</span>, <span class="hlFld-ContribAuthor ">Dirksen E.  Bussiere</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and optimization of novel pyridines as highly potent and selective glycogen synthase kinase 3 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (4)
                                     , 126930. <a href="https://doi.org/10.1016/j.bmcl.2019.126930" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126930</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126930%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Band%252Boptimization%252Bof%252Bnovel%252Bpyridines%252Bas%252Bhighly%252Bpotent%252Band%252Bselective%252Bglycogen%252Bsynthase%252Bkinase%252B3%252Binhibitors%26aulast%3DRamurthy%26aufirst%3DSavithri%26date%3D2020%26volume%3D30%26issue%3D4%26spage%3D126930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satbir  Mor</span>, <span class="hlFld-ContribAuthor ">Suchita  Sindhu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis, Type II diabetes inhibitory activity, antimicrobial evaluation and docking studies of indeno[1,2-c]pyrazol-4(1H)-ones. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2020,</strong> <em>29 </em>
                                    (1)
                                     , 46-62. <a href="https://doi.org/10.1007/s00044-019-02457-8" title="DOI URL">https://doi.org/10.1007/s00044-019-02457-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-019-02457-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-019-02457-8%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DSynthesis%25252C%252BType%252BII%252Bdiabetes%252Binhibitory%252Bactivity%25252C%252Bantimicrobial%252Bevaluation%252Band%252Bdocking%252Bstudies%252Bof%252Bindeno%25255B1%25252C2-c%25255Dpyrazol-4%2525281H%252529-ones%26aulast%3DMor%26aufirst%3DSatbir%26date%3D2020%26date%3D2019%26volume%3D29%26issue%3D1%26spage%3D46%26epage%3D62" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">FrÃ©dÃ©ric  Lassagne</span>, <span class="hlFld-ContribAuthor ">Camille  DuguÃ©pÃ©roux</span>, <span class="hlFld-ContribAuthor ">Carlos  Roca</span>, <span class="hlFld-ContribAuthor ">Concepcion  Perez</span>, <span class="hlFld-ContribAuthor ">Ana  Martinez</span>, <span class="hlFld-ContribAuthor ">Blandine  Baratte</span>, <span class="hlFld-ContribAuthor ">Thomas  Robert</span>, <span class="hlFld-ContribAuthor ">Sandrine  Ruchaud</span>, <span class="hlFld-ContribAuthor ">StÃ©phane  Bach</span>, <span class="hlFld-ContribAuthor ">William  Erb</span>, <span class="hlFld-ContribAuthor ">Thierry  Roisnel</span>, <span class="hlFld-ContribAuthor ">Florence  Mongin</span>. </span><span class="cited-content_cbyCitation_article-title">From simple quinoxalines to potent oxazolo[5,4-
              f
              ]quinoxaline inhibitors of glycogen-synthase kinase 3 (GSK3). </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2020,</strong> <em>18 </em>
                                    (1)
                                     , 154-162. <a href="https://doi.org/10.1039/C9OB02002K" title="DOI URL">https://doi.org/10.1039/C9OB02002K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9OB02002K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9OB02002K%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DFrom%252Bsimple%252Bquinoxalines%252Bto%252Bpotent%252Boxazolo%25255B5%25252C4-%252Bf%252B%25255Dquinoxaline%252Binhibitors%252Bof%252Bglycogen-synthase%252Bkinase%252B3%252B%252528GSK3%252529%26aulast%3DLassagne%26aufirst%3DFr%25C3%25A9d%25C3%25A9ric%26date%3D2020%26date%3D2020%26volume%3D18%26issue%3D1%26spage%3D154%26epage%3D162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanping  Zhou</span>, <span class="hlFld-ContribAuthor ">Lijuan  Zhang</span>, <span class="hlFld-ContribAuthor ">Xiujuan  Fu</span>, <span class="hlFld-ContribAuthor ">Zhongliang  Jiang</span>, <span class="hlFld-ContribAuthor ">Rongsheng  Tong</span>, <span class="hlFld-ContribAuthor ">Jianyou  Shi</span>, <span class="hlFld-ContribAuthor ">Jian  Li</span>, <span class="hlFld-ContribAuthor ">Lei  Zhong</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis and
              in Vitro
              Tumor Cytotoxicity Evaluation of 3,5âDiaminoâNâsubstituted Benzamide Derivatives as Novel GSKâ3
              Î²
              Small Molecule Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2019,</strong> <em>16 </em>
                                    (9)
                                     <a href="https://doi.org/10.1002/cbdv.201900304" title="DOI URL">https://doi.org/10.1002/cbdv.201900304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201900304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201900304%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DDesign%25252C%252BSynthesis%252Band%252Bin%252BVitro%252BTumor%252BCytotoxicity%252BEvaluation%252Bof%252B3%25252C5%2525E2%252580%252590Diamino%2525E2%252580%252590N%2525E2%252580%252590substituted%252BBenzamide%252BDerivatives%252Bas%252BNovel%252BGSK%2525E2%252580%2525903%252B%2525CE%2525B2%252BSmall%252BMolecule%252BInhibitors%26aulast%3DZhou%26aufirst%3DYanping%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Taner  ERDOÄAN</span>, <span class="hlFld-ContribAuthor ">Fatma  OÄuz ErdoÄan</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleophilic Substitution Reaction of Imidazole with Various 2-Bromo-1-arylethanone Derivatives: A Computational Study. </span><span class="cited-content_cbyCitation_journal-name">Sakarya University Journal of Science</span><span> <strong>2019,</strong> <em> </em>, 1-1. <a href="https://doi.org/10.16984/saufenbilder.418343" title="DOI URL">https://doi.org/10.16984/saufenbilder.418343</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.16984/saufenbilder.418343&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.16984%2Fsaufenbilder.418343%26sid%3Dliteratum%253Aachs%26jtitle%3DSakarya%2520University%2520Journal%2520of%2520Science%26atitle%3DNucleophilic%252BSubstitution%252BReaction%252Bof%252BImidazole%252Bwith%252BVarious%252B2-Bromo-1-arylethanone%252BDerivatives%25253A%252BA%252BComputational%252BStudy%26aulast%3DERDO%25C4%259EAN%26aufirst%3DTaner%26date%3D2019%26date%3D2019%26spage%3D1%26epage%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">A. K.  Shiryaev</span>, <span class="hlFld-ContribAuthor ">E. A.  Lashmanova</span>, <span class="hlFld-ContribAuthor ">A. V.  Trofimova</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of a 2-Hydrazinyl-1,6-dihydropyrimidine Derivative. </span><span class="cited-content_cbyCitation_journal-name">Russian Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>55 </em>
                                    (3)
                                     , 335-338. <a href="https://doi.org/10.1134/S1070428019030102" title="DOI URL">https://doi.org/10.1134/S1070428019030102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1134/S1070428019030102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1134%2FS1070428019030102%26sid%3Dliteratum%253Aachs%26jtitle%3DRussian%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Ba%252B2-Hydrazinyl-1%25252C6-dihydropyrimidine%252BDerivative%26aulast%3DShiryaev%26aufirst%3DA.%2BK.%26date%3D2019%26date%3D2019%26volume%3D55%26issue%3D3%26spage%3D335%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Gui-Mei  Tang</span>, <span class="hlFld-ContribAuthor ">Yong-Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Seik Weng  Ng</span>. </span><span class="cited-content_cbyCitation_article-title">Mediated luminescent properties of salts with 4-((1H-imidazol-1-yl)methyl)benzonitrile: Syntheses, crystal structures and properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Luminescence</span><span> <strong>2018,</strong> <em>203 </em>, 629-638. <a href="https://doi.org/10.1016/j.jlumin.2018.07.013" title="DOI URL">https://doi.org/10.1016/j.jlumin.2018.07.013</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jlumin.2018.07.013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jlumin.2018.07.013%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Luminescence%26atitle%3DMediated%252Bluminescent%252Bproperties%252Bof%252Bsalts%252Bwith%252B4-%252528%2525281H-imidazol-1-yl%252529methyl%252529benzonitrile%25253A%252BSyntheses%25252C%252Bcrystal%252Bstructures%252Band%252Bproperties%26aulast%3DTang%26aufirst%3DGui-Mei%26date%3D2018%26volume%3D203%26spage%3D629%26epage%3D638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ming  Guo</span>, <span class="hlFld-ContribAuthor ">Daiying  Zuo</span>, <span class="hlFld-ContribAuthor ">Junlong  Zhang</span>, <span class="hlFld-ContribAuthor ">Lingyun  Xing</span>, <span class="hlFld-ContribAuthor ">Wenfeng  Gou</span>, <span class="hlFld-ContribAuthor ">Feng  Jiang</span>, <span class="hlFld-ContribAuthor ">Nan  Jiang</span>, <span class="hlFld-ContribAuthor ">Dajun  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhai</span>. </span><span class="cited-content_cbyCitation_article-title">Dual potent ALK and ROS1 inhibitors combating drug-resistant mutants: Synthesis and biological evaluation of aminopyridine-containing diarylaminopyrimidine derivatives. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>158 </em>, 322-333. <a href="https://doi.org/10.1016/j.ejmech.2018.09.012" title="DOI URL">https://doi.org/10.1016/j.ejmech.2018.09.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2018.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2018.09.012%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDual%252Bpotent%252BALK%252Band%252BROS1%252Binhibitors%252Bcombating%252Bdrug-resistant%252Bmutants%25253A%252BSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Baminopyridine-containing%252Bdiarylaminopyrimidine%252Bderivatives%26aulast%3DGuo%26aufirst%3DMing%26date%3D2018%26volume%3D158%26spage%3D322%26epage%3D333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0028.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0001.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Potent and selective GSK3 inhibitors with oral antihyperglycemic efficacy.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of <b>9a</b>â<b>c</b> and <b>11a</b>â<b>d</b> (See Also <a class="ref internalNav" href="#tbl1" aria-label="Table 1">Table 1</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) piperidine, EtOH, dioxane, 25 Â°C, 20 h; (b) NaHCO<sub>3</sub>, NMP, 70 Â°C, 24 h; (c) (i) AcOH, NMP, 80 Â°C, (ii) TFA, CH<sub>2</sub>Cl<sub>2</sub>; (d) DDQ, THF, 25 Â°C, 30 min.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of <b>16</b>, <b>17</b>, <b>18a</b>â<b>d</b>, <b>19a</b>â<b>l</b>, and <b>20</b> (See Also <a class="ref internalNav" href="#tbl2" aria-label="Table 2">Table 2</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) DIEA, ACN, 25 Â°C, 12 h; (b) DMFDMA, THF, AcOH, 80 Â°C, 3 h; (c) EtOH (dry), NaOEt, 80 Â°C, 12 h; (d) MeOH/H<sub>2</sub>O (1:1), NaOH, 65 Â°C, 45 min; (e) HBTU, various alcohols (ROH), DIEA, DMA, 25 Â°C; (f) HBTU, various amines (R<sub>2</sub>NH), DMA, 25 Â°C; (g) (i) isobutyl chloroformate, TEA, THF, 25 Â°C, 12 h, (ii) MeC(NOH)NH<sub>2</sub>, 70 Â°C, 6 h.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of <b>25a</b>â<b>w</b>, <b>26</b> (See Also <a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a> and <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) toluene 75 Â°C 2.5 h; (b) DMFDMA, reflux, 12 h; (c) Cs<sub>2</sub>CO<sub>3</sub>, THF or DMF, 80 Â°C, 8 h.</p></p></figure><figure data-id="sch4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthesis of <b>1</b>, <b>35a</b>,<b>b</b>, <b>36a</b>â<b>d</b>, and <b>37a</b>â<b>c</b> (See Also <a class="ref internalNav" href="#tbl2" aria-label="Tables 2">Tables 2</a>,<a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) HÃ¼nigâs base, CH<sub>2</sub>Cl<sub>2</sub>, rt to reflux, 3.5 h, (ii) HCl/AcOH; (b) DMFDMA, reflux, 12 h; (c) NaOEt, EtOH, 80 Â°C, 2.5 h.</p></p></figure><figure data-id="sch5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0012.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. Synthesis of <b>46a</b>â<b>h</b> (<a class="ref internalNav" href="#tbl4" aria-label="Table 4">Table 4</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) (i) 2-chloro-5-nitropyridine, DIEA, NMP, 120 Â°C, 12 h, (ii) TMSOTf, 2,6-lutidine, CH<sub>2</sub>Cl<sub>2</sub>, 23 Â°C, 3 h; (b) 2-nitrobenzenesulfonyl chloride, DIEA, CH<sub>2</sub>Cl<sub>2</sub>, 23 Â°C, 6 h; (c) RCH<sub>2</sub>OH, Ph<sub>3</sub>P, DIAD, CH<sub>2</sub>Cl<sub>2</sub>, 23 Â°C, 12 h; (d) PhSH, K<sub>2</sub>CO<sub>3</sub> (powder), water, DMF, 23 Â°C, 12 h; (e) 1<i>H</i>-pyrazole-1-carboxamidine hydrochloride, DIEA, NMP, 90 Â°C, 18 h; (f) (i) 1-(2,4-dichlorophenyl)-3-(dimethylamino)-2-imidazolylprop-2-en-1-one (<b>24</b>), MTBD, NMP, 120 Â°C, 20 h, (ii) 80% TFA/CH<sub>2</sub>Cl<sub>2</sub>, 23 Â°C, 1.5 h.</p></p></figure><figure data-id="sch6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0013.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthesis of <b>51a</b>â<b>s</b> (<a class="ref internalNav" href="#tbl5" aria-label="Table 5">Table 5</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) 1<i>H</i>-pyrazole-1-carboxamidine hydrochloride, CH<sub>3</sub>CN, 80 Â°C, 24 h; (b) 1-(2,4-dichlorophenyl)-3-(dimethylamino)-2-imidazolylprop-2-en-1-one (<b>24</b>), Cs<sub>2</sub>CO<sub>3</sub>, NMP, 100 Â°C, 48 h; (c) aq HCl (3 M), CH<sub>3</sub>CN, 25 Â°C, 16 h; (d) chloro-arene, HÃ¼nigâs base, DMF, 80 Â°C, 12 h.</p></p></figure><figure data-id="sch7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0014.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. Synthesis of <b>60a</b>â<b>t</b> (<a class="ref internalNav" href="#tbl6" aria-label="Table 6">Table 6</a>)<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) Cs<sub>2</sub>CO<sub>3</sub>, DMF, 25 Â°C, 14 h; (b) DMFDMA, 80 Â°C, 6 h; (c) (i) guanidine <b>32</b>, Cs<sub>2</sub>CO<sub>3</sub>, DMF, 90 Â°C, 14 h, (ii) gal AcOH, 120 Â°C, 4 h; (d) hydrazine, ethanol, 75 Â°C, 2 h; (e) Ms<sub>2</sub>O (for <b>60b</b>) or Ac<sub>2</sub>O (for <b>60c</b>), THF, 25 Â°C, 4 h.</p></p></figure><figure data-id="fig2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0002.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Co-crystal structure of compound <b>1</b> in the ATP-binding site of human GSK3-Î². The electrostatic potential is superimposed on the solvent-accessible surface of human GSK3-Î². The calculations and visualizations were performed using the CHIMERA program.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> The ranges of red (negative) and blue (positive) represent electrostatic potentials of < â7 to > +7 <i>k</i><sub>b</sub><i>T</i>, where <i>k</i><sub>b</sub> is the Boltzmann constant and <i>T</i> is temperature. White surface represents nonpolar amino acid residues. In the figures, the N-terminal and C-terminal domains of the kinase are positioned as indicated. (a) Overall view into the ATP-binding pocket with the compound bound; key hydrogen bonds are shown as dashed lines and key residues are labeled; key waters are shown as red spheres. Note the position of Phe167, which forms the edge of the binding pocket. (b) Orthogonal view of the pocket at a 90Â° rotation to view (a). The co-crystal structure was refined against diffraction data collected to 2.6 Ã.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0003.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) Activation of GS in isolated rat soleus muscle with insulin or compound <b>2</b>. Isolated rat soleus muscle was incubated with vehicle as a control (Con), compound <b>2</b>, insulin (Ins), or both <b>2</b> and insulin (<b>2</b> + Ins) for 15 min. The effects of GSK3 inhibitor and insulin were tested in muscle from lean normal rats (left) or muscle from diabetic ZDF rats (right). Inhibitor was used at 0.5 Î¼M and insulin at 2 mU/mL. Data represent means Â± SE for five muscles per group. *<i>P</i> < 0.05 vs vehicle; **<i>P</i> < 0.05 vs all other groups. (b) Effect of compound <b>2</b> on insulin stimulated glucose transport in isolated soleus muscle from diabetic ZDF rats. Muscles were incubated with increasing concentrations of insulin and intracellular 2-deoxyglucose accumulation was measured. The EC<sub>50</sub> values for insulin stimulated glucose transport were 115 nM for insulin alone bottom line (â ) and 66 nM for insulin plus 0.5 Î¼M compound <b>2</b> top line (â). Values are means Â± SE for five muscles per group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0004.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Oral exposure and efficacy of compound <b>1</b> administered to diabetic <i>db</i>/<i>db</i> mice. (a) Improved glucose tolerance with insulin conservation. Treatment with vehicle control (10% captisol) or indicated doses of compound <b>1</b> at â4.5 and â0.5 h relative to <i>t</i> = 0 oral glucose. Groups of 6â8 mice per treatment fasted for â¼6 h prior to a oGTT, SEM â¤ 15%. (b) Plasma concentration vs time profile: 50 mg/kg compound <b>1</b> formulated in 15% captisol administered once orally to 8â9 week old female <i>db</i>/<i>db</i> mice. Quantitation by LC/MS/MS. Results are mean Â± SE< from six animals.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0005.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Improved glucose tolerance with insulin sparing in diabetic <i>ob</i>/<i>ob</i> mice treated orally with compound <b>1</b>. (a) Improved glucose tolerance. oGTT as described in <a class="ref internalNav" href="#fig4" aria-label="Figure 4">Figure 4</a> with 9â10 week old <i>ob</i>/<i>ob</i> mice. <i>n</i> = 6â8 animals/group, mean Â± SEM. (b) Insulin conservation. Plasma insulin levels (<i>n</i> = 6â8 animals/group, mean Â± SEM).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0006.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Differential responsiveness of obese vs lean ZDF rats to oral treatment with compound <b>1</b>. (a) Obese ZDF rats. Ten-week-old ZDF (<i>fa</i>/<i>fa</i>) rats fasted overnight and treated with vehicle control (captisol solution) or 30 mg/kg compound <b>1</b> 4.5 and 0.5 h prior to oGTT. Methods as described above, <i>n</i> = 8/group, results are mean Â± SEM. (b) Lean littermates. Same as in (a) except age-matched lean littermates.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/medium/jm-2017-00922z_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0007.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Given orally, compound <b>1</b> reduces hyperglycemia with insulin conservation in ZDF (<i>fa</i>/<i>fa</i>) rats. (a) Reduced hyperglycemia. Twelve week old male ZDF (<i>fa</i>/<i>fa</i>) rats with food removal 3â4 h prior to single oral administration of vehicle control (15% captisol) or indicated doses of compound <b>1</b>. Serial tail-snip bleeds from <i>n</i> = 8/group. (b) Insulin conservation. Plasma insulin levels in same animals. Results are mean Â± SEM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2017/jmcmar.2017.60.issue-20/acs.jmedchem.7b00922/20171020/images/large/jm-2017-00922z_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.7b00922&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i139">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34328" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34328" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 104 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span> <span class="citation_source-book">IDF Diabetes Atlas</span>, <span class="NLM_edition">7th</span> ed.; <span class="NLM_publisher-name">International Diabetes Foundation</span>: <span class="NLM_publisher-loc">Brussels</span>,<span class="NLM_x"> </span><span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=IDF+Diabetes+Atlas%2C+7th+ed.%3B+International+Diabetes+Foundation%3A+Brussels%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26btitle%3DIDF%2520Diabetes%2520Atlas%26pub%3DInternational%2520Diabetes%2520Foundation%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Turner, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cull, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Frighi, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holman, R. R.</span><span> </span><span class="NLM_article-title">Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)</span> <span class="citation_source-journal">JAMA</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">281</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">2005</span><span class="NLM_x">â</span> <span class="NLM_lpage">2012</span><span class="refDoi">Â DOI: 10.1001/jama.281.21.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1001%2Fjama.281.21.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10359389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADyaK1MXjvFOls7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=1999&pages=2005-2012&issue=21&author=R.+C.+Turnerauthor=C.+A.+Cullauthor=V.+Frighiauthor=R.+R.+Holman&title=Glycemic+control+with+diet%2C+sulfonylurea%2C+metformin%2C+or+insulin+in+patients+with+type+2+diabetes+mellitus%3A+progressive+requirement+for+multiple+therapies+%28UKPDS+49%29&doi=10.1001%2Fjama.281.21.2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)</span></div><div class="casAuthors">Turner, Robert C.; Cull, Carole A.; Frighi, Valeria; Holman, Rury R.</div><div class="citationInfo"><span class="NLM_cas:title">JAMA, the Journal of the American Medical Association</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">281</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2005-2012</span>CODEN:
                <span class="NLM_cas:coden">JAMAAP</span>;
        ISSN:<span class="NLM_cas:issn">0098-7484</span>.
    
            (<span class="NLM_cas:orgname">American Medical Association</span>)
        </div><div class="casAbstract">Treatment with diet alone, insulin, sulfonylurea, or metformin is known to improve glycemia in patients with type 2 diabetes mellitus, but which treatment most frequently attains target fasting plasma glucose (FPG) concn. of less than 7.8 mmol/L (140 mg/dL) or glycosylated Hb A1c (HbA1c) below 7% is unknown.  To assess how often each therapy can achieve the glycemic control target levels set by the American Diabetes Assocn, a randomized controlled trial was conducted between 1977 and 1997.  Patients were recruited between 1977 and 1991 and were followed up every 3 mo for 3, 6, and 9 yr after enrollment.  A total of 4075 patients newly diagnosed as having type 2 diabetes ranged in age between 25 and 65 yr and had a median (interquartile range) FPG concn. of 11.5(9.0-14.4) mmol/L [207 (162-259) mg/dL], HbA1c levels of 9.1% (7.5%-10.7%), and a mean (SD) body mass index of 29 (6) kg/m2.  After 3 mo on a low-fat, high-carbohydrate, high-fiber diet, patients were randomized to therapy with diet alone, insulin, sulfonylurea, or metformin.  Fasting plasma glucose and HbA1c levels, and the proportion of patients who achieved target levels below 7% HbA1c or less than 7.8 mmol/L (140 mg/dL) FPG at 3, 6, or 9 yr following diagnosis were measured.  The proportion of patients who maintained target glycemic levels declined markedly over 9 yr of follow-up.  After 9 yr of monotherapy with diet, insulin, or sulfonylurea, 8%, 42%, and 24%, resp., achieved FPG levels of less than 7.8 mmol/L (140 mg/dL) and 9%, 28%, and 24% achieved HbA1c levels below 7%.  In obese patients randomized to metformin, 18% attained FPG levels of less than 7.8 mmol/L (140 mg/dL) and 13% attained HbA1c levels below 7%.  Patients less likely to achieve target levels were younger, more obese, or more hyperglycemic than other patients.  Each therapeutic agent, as monotherapy, increased 2- to 3-fold the proportion of patients who attained HbA1c below 7% compared with diet alone.  However, the progressive deterioration of diabetes control was such that after 3 yr approx. 50% of patients could attain this goal with monotherapy, and by 9 yr this declined to approx. 25%.  The majority of patients need multiple therapies to attain these glycemic target levels in the longer term.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp0Zh8zDye3SrVg90H21EOLACvtfcHk0ljsH-RgvD3JSg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvFOls7g%253D&md5=a95773f6579a175ce288930779f0434e</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1001%2Fjama.281.21.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjama.281.21.2005%26sid%3Dliteratum%253Aachs%26aulast%3DTurner%26aufirst%3DR.%2BC.%26aulast%3DCull%26aufirst%3DC.%2BA.%26aulast%3DFrighi%26aufirst%3DV.%26aulast%3DHolman%26aufirst%3DR.%2BR.%26atitle%3DGlycemic%2520control%2520with%2520diet%252C%2520sulfonylurea%252C%2520metformin%252C%2520or%2520insulin%2520in%2520patients%2520with%2520type%25202%2520diabetes%2520mellitus%253A%2520progressive%2520requirement%2520for%2520multiple%2520therapies%2520%2528UKPDS%252049%2529%26jtitle%3DJAMA%26date%3D1999%26volume%3D281%26issue%3D21%26spage%3D2005%26epage%3D2012%26doi%3D10.1001%2Fjama.281.21.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">UK Prospective Diabetes Study (UKPDS) Group</span><span> </span><span class="NLM_article-title">Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">352</span><span class="NLM_x"> (</span><span class="NLM_issue">9131</span><span class="NLM_x">) </span> <span class="NLM_fpage">837</span><span class="NLM_x">â</span> <span class="NLM_lpage">853</span><span class="refDoi">Â DOI: 10.1016/S0140-6736(98)07019-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FS0140-6736%2898%2907019-6" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=1998&pages=837-853&issue=9131&author=UK+Prospective+Diabetes+Study+%28UKPDS%29+Group&title=Intensive+blood-glucose+control+with+sulphonylureas+or+insulin+compared+with+conventional+treatment+and+risk+of+complications+in+patients+with+type+2+diabetes+%28UKPDS+33%29&doi=10.1016%2FS0140-6736%2898%2907019-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2898%2907019-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252898%252907019-6%26sid%3Dliteratum%253Aachs%26aulast%3D%26atitle%3DIntensive%2520blood-glucose%2520control%2520with%2520sulphonylureas%2520or%2520insulin%2520compared%2520with%2520conventional%2520treatment%2520and%2520risk%2520of%2520complications%2520in%2520patients%2520with%2520type%25202%2520diabetes%2520%2528UKPDS%252033%2529%26jtitle%3DLancet%26date%3D1998%26volume%3D352%26issue%3D9131%26spage%3D837%26epage%3D853%26doi%3D10.1016%2FS0140-6736%2898%2907019-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Hauner, H.</span><span> </span><span class="NLM_article-title">Managing type 2 diabetes mellitus in patients with obesity</span> <span class="citation_source-journal">Treat. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">223</span><span class="NLM_x">â</span> <span class="NLM_lpage">232</span><span class="refDoi">Â DOI: 10.2165/00024677-200403040-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2165%2F00024677-200403040-00004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=16026105" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2cXms1Wqu70%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=223-232&issue=4&author=H.+Hauner&title=Managing+type+2+diabetes+mellitus+in+patients+with+obesity&doi=10.2165%2F00024677-200403040-00004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Managing type 2 diabetes mellitus in patients with obesity</span></div><div class="casAuthors">Hauner, Hans</div><div class="citationInfo"><span class="NLM_cas:title">Treatments in Endocrinology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">223-232</span>CODEN:
                <span class="NLM_cas:coden">TERNAN</span>;
        ISSN:<span class="NLM_cas:issn">1175-6349</span>.
    
            (<span class="NLM_cas:orgname">Adis International Ltd.</span>)
        </div><div class="casAbstract">A review.  Obesity is the most important modifiable risk factor for type 2 diabetes mellitus and most patients with diabetes are overweight or obese.  It is well known that excess bodyweight induces or aggravates insulin resistance, which is a characteristic feature of type 2 diabetes.  Thus, bodyweight plays a central role in the prevention and treatment of diabetes.  Recent data suggest that lifestyle intervention in patients with impaired glucose tolerance results in an impressive redn. in the conversion to overt diabetes, which is greater than the effect of early intervention with drugs such as metformin or acarbose.  The prevention of diabetes has been shown to be assocd. with the extent of wt. loss.  In patients with type 2 diabetes, wt. loss by any means is followed by an improvement of metabolic control and assocd. risk factors.  The most appropriate recommendation for obese patients with type 2 diabetes is a nutritionally balanced, moderately hypocaloric diet with a reduced intake of satd. fat and an increase in phys. activity.  If this std. approach is only partly successful or not at all, addnl. strategies such as wt.-lowering drugs, very low-calorie diets for limited periods of up to 12 wk, and, for severely obese patients, bariatric surgery should be carefully considered.  A large body of data suggests that such measures can be very effective in this patient group by improving metabolic disturbances and blood pressure.  However, it is extremely important for the long-term outcome that the treatment is tailored to the needs and wishes of the individual patient.  There is growing agreement that due to the low success rate of conventional therapies and the overwhelming benefit from wt. loss, more detd. and aggressive strategies may be appropriate to achieve the central goal of wt. redn. in obese patients with type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFlS595fjBYbVg90H21EOLACvtfcHk0ljkp8OV1CV9bw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXms1Wqu70%253D&md5=ffc56378538e6a7080e294320c86c172</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.2165%2F00024677-200403040-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00024677-200403040-00004%26sid%3Dliteratum%253Aachs%26aulast%3DHauner%26aufirst%3DH.%26atitle%3DManaging%2520type%25202%2520diabetes%2520mellitus%2520in%2520patients%2520with%2520obesity%26jtitle%3DTreat.%2520Endocrinol.%26date%3D2004%26volume%3D3%26issue%3D4%26spage%3D223%26epage%3D232%26doi%3D10.2165%2F00024677-200403040-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Davidson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holland, W. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roth, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCorkle, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scherer, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unger, R. H.</span><span> </span><span class="NLM_article-title">Glucagon therapeutics: Dawn of a new era for diabetes care</span> <span class="citation_source-journal">Diabetes/Metab. Res. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">660</span><span class="NLM_x">â</span> <span class="NLM_lpage">665</span><span class="refDoi">Â DOI: 10.1002/dmrr.2773</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1002%2Fdmrr.2773" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=26729301" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A280%3ADC%252BC28rmvFOhsQ%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2016&pages=660-665&issue=7&author=J.+A.+Davidsonauthor=W.+L.+Hollandauthor=M.+G.+Rothauthor=M.+Wangauthor=Y.+Leeauthor=X.+Yuauthor=S.+K.+McCorkleauthor=P.+E.+Schererauthor=R.+H.+Unger&title=Glucagon+therapeutics%3A+Dawn+of+a+new+era+for+diabetes+care&doi=10.1002%2Fdmrr.2773"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Glucagon therapeutics: Dawn of a new era for diabetes care</span></div><div class="casAuthors">Davidson Jaime A; Holland William L; Wang May-Yun; Lee Young; Yu Xinxin; Scherer Philipp E; Unger Roger H; Roth Michael G; McCorkle Sara K; Unger Roger H</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes/metabolism research and reviews</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">660-665</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Although insulin monotherapy prevents death from ketoacidosis, it does not prevent either the hyperglycemic surges or the hypoglycemic plunges of glucose levels that plague the majority of patients with type 1 diabetes.  However, significant improvements have occurred with the combination of continuous insulin delivery matched by continuous glucose monitoring, but the technology is not available for all patients, requires extensive education, is expensive and moreover, while much better than standard care, it almost never reduces haemoglobin A1c (HbA1c ) to below 6%.  This may indicate that an improved diabetes therapy involving antagonism of glucagon action will for the first time control glucose levels to normal and eradicate the long-term complications of diabetes.  Although one can never predict that results in animals will be reproduced in humans, the available evidence suggests that patients with type 1 and type 2 diabetes may expect far superior control of the metabolic abnormalities without the need for significant monitoring of glucose, a very important but expensive part of any insulin regimen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR_4D_xHoAY3nO4gDb7JggCfW6udTcc2ea0f2a9_kvAqbntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28rmvFOhsQ%253D%253D&md5=23d9961e0610ac9d2f4cc068b57631dc</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1002%2Fdmrr.2773&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fdmrr.2773%26sid%3Dliteratum%253Aachs%26aulast%3DDavidson%26aufirst%3DJ.%2BA.%26aulast%3DHolland%26aufirst%3DW.%2BL.%26aulast%3DRoth%26aufirst%3DM.%2BG.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DLee%26aufirst%3DY.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DMcCorkle%26aufirst%3DS.%2BK.%26aulast%3DScherer%26aufirst%3DP.%2BE.%26aulast%3DUnger%26aufirst%3DR.%2BH.%26atitle%3DGlucagon%2520therapeutics%253A%2520Dawn%2520of%2520a%2520new%2520era%2520for%2520diabetes%2520care%26jtitle%3DDiabetes%252FMetab.%2520Res.%2520Rev.%26date%3D2016%26volume%3D32%26issue%3D7%26spage%3D660%26epage%3D665%26doi%3D10.1002%2Fdmrr.2773" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Rotella, D. P.</span><span> </span><span class="NLM_article-title">Novel âsecond-generationâ approaches for the control of type 2 diabetes</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">17</span><span class="NLM_x">) </span> <span class="NLM_fpage">4111</span><span class="NLM_x">â</span> <span class="NLM_lpage">4112</span><span class="refDoi">Â DOI: 10.1021/jm030626a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030626a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4111-4112&issue=17&author=D.+P.+Rotella&title=Novel+%E2%80%9Csecond-generation%E2%80%9D+approaches+for+the+control+of+type+2+diabetes&doi=10.1021%2Fjm030626a"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Fjm030626a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030626a%26sid%3Dliteratum%253Aachs%26aulast%3DRotella%26aufirst%3DD.%2BP.%26atitle%3DNovel%2520%25E2%2580%259Csecond-generation%25E2%2580%259D%2520approaches%2520for%2520the%2520control%2520of%2520type%25202%2520diabetes%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D17%26spage%3D4111%26epage%3D4112%26doi%3D10.1021%2Fjm030626a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Physiological roles of glycogen synthase kinase-3: potential as a therapeutic target for diabetes and other disorders</span> <span class="citation_source-journal">Curr. Drug Targets: Immune, Endocr. Metab. Disord.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">281</span><span class="NLM_x">â</span> <span class="NLM_lpage">290</span><span class="refDoi">Â DOI: 10.2174/1568008033340153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2174%2F1568008033340153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=14683459" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpvVaktLY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2003&pages=281-290&issue=4&author=J.+R.+Woodgett&title=Physiological+roles+of+glycogen+synthase+kinase-3%3A+potential+as+a+therapeutic+target+for+diabetes+and+other+disorders&doi=10.2174%2F1568008033340153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Physiological roles of glycogen synthase kinase-3: Potential as a therapeutic target for diabetes and other disorders</span></div><div class="casAuthors">Woodgett, J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Current Drug Targets: Immune, Endocrine and Metabolic Disorders</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">281-290</span>CODEN:
                <span class="NLM_cas:coden">CDTIBT</span>;
        ISSN:<span class="NLM_cas:issn">1568-0088</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3 (GSK-3) has perplexed signal transduction researchers since its detection in skeletal muscle 25 yr ago.  The enzyme confounds most of the rules normally assocd. with protein kinases in that it exhibits significant activity, even in resting, unstimulated cells.  However, the protein is highly regulated and potently inactivated in response to signals such as insulin and polypeptide growth factors.  The enzyme also displays a distinct and unusual preference for substrates that have been previously phosphorylated by other protein kinases which provides obvious opportunities for cross-talk.  Its substrates are diverse and are predominantly regulatory mols.  The mol. cloning of the kinase revealed it to be encoded by two related but distinct genes.  Moreover, the mammalian proteins showed remarkable similarity to a fruitfly protein isolated on the basis of its role in cell fate detn.  From these humble beginnings, study of the enzyme has accrued further surprises such as its inhibition by lithium, its regulation by serine and tyrosine phosphorylation and its implication in several human disorders including Alzheimer's disease, bipolar disorder, cancer and diabetes.  Most recently, small mol. inhibitors of GSK-3 have been developed and assessed for therapeutic potential in several of models of pathophysiol.  The question is whether modulation of such an "involved" enzyme could lead to selective restoration of defects without multiple unwanted side effects.  This review summarizes current knowledge of GSK-3 with respect to its known functions, together with an assessment of its real-life potential as a drug target for chronic conditions such as type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ji6S5PgFELVg90H21EOLACvtfcHk0ljzXTjCNJfXIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpvVaktLY%253D&md5=ff6419934a458e33e7a63ff0b0323a12</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.2174%2F1568008033340153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568008033340153%26sid%3Dliteratum%253Aachs%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DPhysiological%2520roles%2520of%2520glycogen%2520synthase%2520kinase-3%253A%2520potential%2520as%2520a%2520therapeutic%2520target%2520for%2520diabetes%2520and%2520other%2520disorders%26jtitle%3DCurr.%2520Drug%2520Targets%253A%2520Immune%252C%2520Endocr.%2520Metab.%2520Disord.%26date%3D2003%26volume%3D3%26issue%3D4%26spage%3D281%26epage%3D290%26doi%3D10.2174%2F1568008033340153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Jope, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, G. V. W.</span><span> </span><span class="NLM_article-title">The glamour and gloom of glycogen synthase kinase-3</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">95</span><span class="NLM_x">â</span> <span class="NLM_lpage">102</span><span class="refDoi">Â DOI: 10.1016/j.tibs.2003.12.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.tibs.2003.12.004" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=95-102&issue=2&author=R.+S.+Jopeauthor=G.+V.+W.+Johnson&title=The+glamour+and+gloom+of+glycogen+synthase+kinase-3&doi=10.1016%2Fj.tibs.2003.12.004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2003.12.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2003.12.004%26sid%3Dliteratum%253Aachs%26aulast%3DJope%26aufirst%3DR.%2BS.%26aulast%3DJohnson%26aufirst%3DG.%2BV.%2BW.%26atitle%3DThe%2520glamour%2520and%2520gloom%2520of%2520glycogen%2520synthase%2520kinase-3%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2004%26volume%3D29%26issue%3D2%26spage%3D95%26epage%3D102%26doi%3D10.1016%2Fj.tibs.2003.12.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Nikoulina, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaraldi, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudaliar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohideen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. R.</span><span> </span><span class="NLM_article-title">Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">263</span><span class="NLM_x">â</span> <span class="NLM_lpage">271</span><span class="refDoi">Â DOI: 10.2337/diabetes.49.2.263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdiabetes.49.2.263" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2000&pages=263-271&issue=2&author=S.+E.+Nikoulinaauthor=T.+P.+Ciaraldiauthor=S.+Mudaliarauthor=P.+Mohideenauthor=L.+Carterauthor=R.+R.+Henry&title=Potential+role+of+glycogen+synthase+kinase-3+in+skeletal+muscle+insulin+resistance+of+type+2+diabetes&doi=10.2337%2Fdiabetes.49.2.263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.49.2.263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.49.2.263%26sid%3Dliteratum%253Aachs%26aulast%3DNikoulina%26aufirst%3DS.%2BE.%26aulast%3DCiaraldi%26aufirst%3DT.%2BP.%26aulast%3DMudaliar%26aufirst%3DS.%26aulast%3DMohideen%26aufirst%3DP.%26aulast%3DCarter%26aufirst%3DL.%26aulast%3DHenry%26aufirst%3DR.%2BR.%26atitle%3DPotential%2520role%2520of%2520glycogen%2520synthase%2520kinase-3%2520in%2520skeletal%2520muscle%2520insulin%2520resistance%2520of%2520type%25202%2520diabetes%26jtitle%3DDiabetes%26date%3D2000%26volume%3D49%26issue%3D2%26spage%3D263%26epage%3D271%26doi%3D10.2337%2Fdiabetes.49.2.263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Nikoulina, S. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ciaraldi, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudaliar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. R.</span><span> </span><span class="NLM_article-title">Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">2190</span><span class="NLM_x">â</span> <span class="NLM_lpage">2198</span><span class="refDoi">Â DOI: 10.2337/diabetes.51.7.2190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdiabetes.51.7.2190" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=2190-2198&issue=7&author=S.+E.+Nikoulinaauthor=T.+P.+Ciaraldiauthor=S.+Mudaliarauthor=L.+Carterauthor=K.+Johnsonauthor=R.+R.+Henry&title=Inhibition+of+glycogen+synthase+kinase+3+improves+insulin+action+and+glucose+metabolism+in+human+skeletal+muscle&doi=10.2337%2Fdiabetes.51.7.2190"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.51.7.2190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.51.7.2190%26sid%3Dliteratum%253Aachs%26aulast%3DNikoulina%26aufirst%3DS.%2BE.%26aulast%3DCiaraldi%26aufirst%3DT.%2BP.%26aulast%3DMudaliar%26aufirst%3DS.%26aulast%3DCarter%26aufirst%3DL.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DHenry%26aufirst%3DR.%2BR.%26atitle%3DInhibition%2520of%2520glycogen%2520synthase%2520kinase%25203%2520improves%2520insulin%2520action%2520and%2520glucose%2520metabolism%2520in%2520human%2520skeletal%2520muscle%26jtitle%3DDiabetes%26date%3D2002%26volume%3D51%26issue%3D7%26spage%3D2190%26epage%3D2198%26doi%3D10.2337%2Fdiabetes.51.7.2190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Ciaraldi, T. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mudaliar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, R. R.</span><span> </span><span class="NLM_article-title">GSK-3Î² and control of glucose metabolism and insulin action in human skeletal muscle</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">315</span><span class="NLM_x"> (</span><span class="NLM_issue">1â2</span><span class="NLM_x">) </span> <span class="NLM_fpage">153</span><span class="NLM_x">â</span> <span class="NLM_lpage">158</span><span class="refDoi">Â DOI: 10.1016/j.mce.2009.05.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.mce.2009.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=19505532" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFyms7bE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=315&publication_year=2010&pages=153-158&issue=1%E2%80%932&author=T.+P.+Ciaraldiauthor=L.+Carterauthor=S.+Mudaliarauthor=R.+R.+Henry&title=GSK-3%CE%B2+and+control+of+glucose+metabolism+and+insulin+action+in+human+skeletal+muscle&doi=10.1016%2Fj.mce.2009.05.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">GSK-3Î² and control of glucose metabolism and insulin action in human skeletal muscle</span></div><div class="casAuthors">Ciaraldi, T. P.; Carter, L.; Mudaliar, S.; Henry, R. R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">315</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">153-158</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The involvement of the Î²-isoform of glycogen synthase kinase (GSK-3) in glucose metab. and insulin action was investigated in cultured human skeletal muscle cells.  A 60% redn. in GSK-3Î² protein expression was attained by treatment with siRNA; GSK-3Î± expression was unaltered.  GSK-3Î² knockdown did not influence total glycogen synthase (GS) activity, but increased the phosphorylation-dependent activity (fractional velocity-FV) in the basal state.  Insulin responsiveness of GSFV was doubled by GSK-3Î² knockdown (p < 0.05).  Basal rates of glucose uptake (GU) were not significantly influenced by GSK-3Î² knockdown, while insulin stimulation of GU was increased.  Improvements in insulin action on GS and GU did not involve changes in protein expression of either IRS-1 or Akt 1/2.  Maximal insulin stimulation of phosphorylation of Akt was unaltered by GSK-3Î² knockdown.  Unlike GSK-3Î±, GSK-3Î² directly regulates both GS activity in the absence of added insulin and through control of insulin action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvKhT1c5rYWLVg90H21EOLACvtfcHk0ljzXTjCNJfXIQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFyms7bE&md5=0ad04a4bf0e209dd2dde51c441bfe3ab</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.mce.2009.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mce.2009.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DCiaraldi%26aufirst%3DT.%2BP.%26aulast%3DCarter%26aufirst%3DL.%26aulast%3DMudaliar%26aufirst%3DS.%26aulast%3DHenry%26aufirst%3DR.%2BR.%26atitle%3DGSK-3%25CE%25B2%2520and%2520control%2520of%2520glucose%2520metabolism%2520and%2520insulin%2520action%2520in%2520human%2520skeletal%2520muscle%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D2010%26volume%3D315%26issue%3D1%25E2%2580%25932%26spage%3D153%26epage%3D158%26doi%3D10.1016%2Fj.mce.2009.05.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Tanti, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gual, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GrÃ©meaux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gonzalez, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BarrÃ¨s, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Marchand-Brustel, Y.</span><span> </span><span class="NLM_article-title">Alteration in insulin action: role of IRS-1 serine phosphorylation in the retroregulation of insulin signalling</span> <span class="citation_source-journal">Ann. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">43</span><span class="NLM_x">â</span> <span class="NLM_lpage">48</span><span class="refDoi">Â DOI: 10.1016/S0003-4266(04)95629-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FS0003-4266%2804%2995629-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkslymtLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2004&pages=43-48&issue=1&author=J.+F.+Tantiauthor=P.+Gualauthor=T.+Gr%C3%A9meauxauthor=T.+Gonzalezauthor=R.+Barr%C3%A8sauthor=Y.+Le+Marchand-Brustel&title=Alteration+in+insulin+action%3A+role+of+IRS-1+serine+phosphorylation+in+the+retroregulation+of+insulin+signalling&doi=10.1016%2FS0003-4266%2804%2995629-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Alteration in insulin action: Role of IRS-1 serine phosphorylation in the retroregulation of insulin signalling</span></div><div class="casAuthors">Tanti, J. F.; Gual, P.; Gremeaux, T.; Gonzalez, T.; Barres, R.; Le Marchand-Brustel, Y.</div><div class="citationInfo"><span class="NLM_cas:title">Annales d'Endocrinologie</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">ANENAG</span>;
        ISSN:<span class="NLM_cas:issn">0003-4266</span>.
    
            (<span class="NLM_cas:orgname">Masson Editeur</span>)
        </div><div class="casAbstract">A review.  Insulin resistance, when combined with impaired insulin secretion, contributes to the development of type 2 diabetes.  Insulin resistance is characterized by a decrease in insulin effect on glucose transport in muscle and adipose tissue.  Tyrosine phosphorylation of insulin receptor substrate 1 (IRS-1) and its binding to phosphatidylinositol 3-kinase (PI 3-kinase) are crit. events in the insulin signaling cascade leading to insulin-stimulated glucose transport.  Modification of IRS-1 by serine phosphorylation could be one of the mechanisms leading to a decrease in IRS-1 tyrosine phosphorylation, PI 3-kinase activity and glucose transport.  Recent findings demonstrate that "diabetogenic" factors such as free fatty acids (FFA), TNFÎ±, hyperinsulinemia and cellular stress, increase the serine phosphorylation of IRS-1 and identified Ser307/612/632 as phosphorylated sites.  Moreover, several kinases able to phosphorylate these serine residues have been identified.  These exciting results suggest that serine phosphorylation of IRS-1 is a possible hallmark of insulin resistance in biol. insulin responsive cells or tissues.  Identifying the pathways by which "diabetogenic" factors activate IRS-1 kinases and defining the precise role of serine phosphorylation events in IRS-1 regulation represent important goals.  Such studies may enable rational drug design to selectively inhibit the activity of the relevant enzymes and generate a novel class of therapeutic agents for type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOowz0kZ8hJbVg90H21EOLACvtfcHk0lhUHZYNNe6H0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkslymtLs%253D&md5=8f55af63948905c6b6bff0e0a99a6fb5</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1016%2FS0003-4266%2804%2995629-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0003-4266%252804%252995629-6%26sid%3Dliteratum%253Aachs%26aulast%3DTanti%26aufirst%3DJ.%2BF.%26aulast%3DGual%26aufirst%3DP.%26aulast%3DGr%25C3%25A9meaux%26aufirst%3DT.%26aulast%3DGonzalez%26aufirst%3DT.%26aulast%3DBarr%25C3%25A8s%26aufirst%3DR.%26aulast%3DLe%2BMarchand-Brustel%26aufirst%3DY.%26atitle%3DAlteration%2520in%2520insulin%2520action%253A%2520role%2520of%2520IRS-1%2520serine%2520phosphorylation%2520in%2520the%2520retroregulation%2520of%2520insulin%2520signalling%26jtitle%3DAnn.%2520Endocrinol.%26date%3D2004%26volume%3D65%26issue%3D1%26spage%3D43%26epage%3D48%26doi%3D10.1016%2FS0003-4266%2804%2995629-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Kirwan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">del Aguila, L. F.</span><span> </span><span class="NLM_article-title">Insulin signalling, exercise and cellular integrity</span> <span class="citation_source-journal">Biochem. Soc. Trans.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">31</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1281</span><span class="NLM_x">â</span> <span class="NLM_lpage">1285</span><span class="refDoi">Â DOI: 10.1042/bst0311281</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1042%2Fbst0311281" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=14641043" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3sXps12jsLs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2003&pages=1281-1285&issue=6&author=J.+P.+Kirwanauthor=L.+F.+del+Aguila&title=Insulin+signalling%2C+exercise+and+cellular+integrity&doi=10.1042%2Fbst0311281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Insulin signalling, exercise and cellular integrity</span></div><div class="casAuthors">Kirwan, J. P.; del aguila, L. F.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1281-1285</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">A review.  Although the effects of exercise on insulin sensitivity are generally pos., eccentric exercise presents a paradox because it induces a transient state of insulin resistance that persists for up to 48 h after the exercise bout.  Excessive eccentric contractions, such as prolonged downhill running, or marathon running, causes muscle damage and disruption of the integrity of the cell.  Down-regulation of insulin receptor tyrosine phosphorylation and subsequent steps in the insulin signaling pathway, including insulin receptor substrate-1 (IRS-1)-assocd. phosphoinositide 3-kinase (PI3K), Akt kinase serine phosphorylation and activity and glucose transporter (GLUT-4) protein content, are evident in skeletal muscle after eccentric exercise.  Furthermore, increased tumor necrosis factor Î± (TNF-Î±) secretion from monocytes is assocd. with the decrease in PI3K activity after this type of exercise.  Recent studies have shown that TNF-Î± can increase IRS-1 serine/threonine phosphorylation, which impairs IRS-1 docking to the insulin receptor, and this inhibits insulin signaling.  Thus a unifying hypothesis to explain insulin resistance after eccentric exercise may include inflammation arising from the disruption of muscle-cell integrity, leading to an acute-phase response that includes TNF-Î±, with the latter inhibiting insulin signaling and subsequent metabolic events.  In contrast, exercise training increases insulin signaling and GLUT-4 expression, decreases TNF-Î± expression in skeletal muscle, and is assocd. with enhanced insulin sensitivity.  These observations highlight the complexity of the cellular and mol. adaptations to exercise.  Understanding these adaptations is essential to establish a sound theor. basis for recommending exercise as a therapeutic intervention for insulin resistance and type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkqiluKHSk27Vg90H21EOLACvtfcHk0lhUHZYNNe6H0w"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXps12jsLs%253D&md5=e73833668083cc0f0ae3a2a104e5862b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1042%2Fbst0311281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbst0311281%26sid%3Dliteratum%253Aachs%26aulast%3DKirwan%26aufirst%3DJ.%2BP.%26aulast%3Ddel%2BAguila%26aufirst%3DL.%2BF.%26atitle%3DInsulin%2520signalling%252C%2520exercise%2520and%2520cellular%2520integrity%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2003%26volume%3D31%26issue%3D6%26spage%3D1281%26epage%3D1285%26doi%3D10.1042%2Fbst0311281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Qiao, L. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goldberg, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russell, J. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, X. J.</span><span> </span><span class="NLM_article-title">Identification of enhanced serine kinase activity in insulin resistance</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">274</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">10625</span><span class="NLM_x">â</span> <span class="NLM_lpage">10632</span><span class="refDoi">Â DOI: 10.1074/jbc.274.15.10625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1074%2Fjbc.274.15.10625" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=274&publication_year=1999&pages=10625-10632&issue=15&author=L.+Y.+Qiaoauthor=J.+L.+Goldbergauthor=J.+C.+Russellauthor=X.+J.+Sun&title=Identification+of+enhanced+serine+kinase+activity+in+insulin+resistance&doi=10.1074%2Fjbc.274.15.10625"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1074%2Fjbc.274.15.10625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.274.15.10625%26sid%3Dliteratum%253Aachs%26aulast%3DQiao%26aufirst%3DL.%2BY.%26aulast%3DGoldberg%26aufirst%3DJ.%2BL.%26aulast%3DRussell%26aufirst%3DJ.%2BC.%26aulast%3DSun%26aufirst%3DX.%2BJ.%26atitle%3DIdentification%2520of%2520enhanced%2520serine%2520kinase%2520activity%2520in%2520insulin%2520resistance%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1999%26volume%3D274%26issue%3D15%26spage%3D10625%26epage%3D10632%26doi%3D10.1074%2Fjbc.274.15.10625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Tanti, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GrÃ©meaux, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Obberghen, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le Marchand-Brustel, Y.</span><span> </span><span class="NLM_article-title">Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">269</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">6051</span><span class="NLM_x">â</span> <span class="NLM_lpage">6057</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=269&publication_year=1994&pages=6051-6057&issue=8&author=J.+F.+Tantiauthor=T.+Gr%C3%A9meauxauthor=E.+van+Obberghenauthor=Y.+Le+Marchand-Brustel&title=Serine%2Fthreonine+phosphorylation+of+insulin+receptor+substrate+1+modulates+insulin+receptor+signaling"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DTanti%26aufirst%3DJ.%2BF.%26aulast%3DGr%25C3%25A9meaux%26aufirst%3DT.%26aulast%3Dvan%2BObberghen%26aufirst%3DE.%26aulast%3DLe%2BMarchand-Brustel%26aufirst%3DY.%26atitle%3DSerine%252Fthreonine%2520phosphorylation%2520of%2520insulin%2520receptor%2520substrate%25201%2520modulates%2520insulin%2520receptor%2520signaling%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1994%26volume%3D269%26issue%3D8%26spage%3D6051%26epage%3D6057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Wagman, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bussiere, D. E.</span><span> </span><span class="NLM_article-title">Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">1105</span><span class="NLM_x">â</span> <span class="NLM_lpage">1137</span><span class="refDoi">Â DOI: 10.2174/1381612043452668</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2174%2F1381612043452668" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=1105-1137&issue=10&author=A.+S.+Wagmanauthor=K.+W.+Johnsonauthor=D.+E.+Bussiere&title=Discovery+and+development+of+GSK3+inhibitors+for+the+treatment+of+type+2+diabetes&doi=10.2174%2F1381612043452668"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F1381612043452668&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612043452668%26sid%3Dliteratum%253Aachs%26aulast%3DWagman%26aufirst%3DA.%2BS.%26aulast%3DJohnson%26aufirst%3DK.%2BW.%26aulast%3DBussiere%26aufirst%3DD.%2BE.%26atitle%3DDiscovery%2520and%2520development%2520of%2520GSK3%2520inhibitors%2520for%2520the%2520treatment%2520of%2520type%25202%2520diabetes%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2004%26volume%3D10%26issue%3D10%26spage%3D1105%26epage%3D1137%26doi%3D10.2174%2F1381612043452668" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Jope, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lowell, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Worthen, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sitbon, Y. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beurel, E.</span><span> </span><span class="NLM_article-title">Stressed and inflamed, can GSK3 be blamed?</span> <span class="citation_source-journal">Trends Biochem. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">180</span><span class="NLM_x">â</span> <span class="NLM_lpage">192</span><span class="refDoi">Â DOI: 10.1016/j.tibs.2016.10.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.tibs.2016.10.009" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2017&pages=180-192&issue=3&author=R.+S.+Jopeauthor=Y.+Chengauthor=J.+A.+Lowellauthor=R.+J.+Worthenauthor=Y.+H.+Sitbonauthor=E.+Beurel&title=Stressed+and+inflamed%2C+can+GSK3+be+blamed%3F&doi=10.1016%2Fj.tibs.2016.10.009"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.tibs.2016.10.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tibs.2016.10.009%26sid%3Dliteratum%253Aachs%26aulast%3DJope%26aufirst%3DR.%2BS.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DLowell%26aufirst%3DJ.%2BA.%26aulast%3DWorthen%26aufirst%3DR.%2BJ.%26aulast%3DSitbon%26aufirst%3DY.%2BH.%26aulast%3DBeurel%26aufirst%3DE.%26atitle%3DStressed%2520and%2520inflamed%252C%2520can%2520GSK3%2520be%2520blamed%253F%26jtitle%3DTrends%2520Biochem.%2520Sci.%26date%3D2017%26volume%3D42%26issue%3D3%26spage%3D180%26epage%3D192%26doi%3D10.1016%2Fj.tibs.2016.10.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">McCubrey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rakus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gizak, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steelman, L. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abrams, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lertpiriyapong, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fitzgerald, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, L. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Montalto, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cervello, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Libra, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nicoletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scalisi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Torino, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fenga, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neri, L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marmiroli, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cocco, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martelli, A. M.</span><span> </span><span class="NLM_article-title">Effects of mutations in Wnt/Î²-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activityâDiverse effects on cell growth, metabolism and cancer</span> <span class="citation_source-journal">Biochim. Biophys. Acta, Mol. Cell Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">1863</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">2942</span><span class="NLM_x">â</span> <span class="NLM_lpage">2976</span><span class="refDoi">Â DOI: 10.1016/j.bbamcr.2016.09.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.bbamcr.2016.09.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=27612668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVyjsL%252FE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1863&publication_year=2016&pages=2942-2976&issue=12&author=J.+A.+McCubreyauthor=D.+Rakusauthor=A.+Gizakauthor=L.+S.+Steelmanauthor=S.+L.+Abramsauthor=K.+Lertpiriyapongauthor=T.+L.+Fitzgeraldauthor=L.+V.+Yangauthor=G.+Montaltoauthor=M.+Cervelloauthor=M.+Libraauthor=F.+Nicolettiauthor=A.+Scalisiauthor=F.+Torinoauthor=C.+Fengaauthor=L.+M.+Neriauthor=S.+Marmiroliauthor=L.+Coccoauthor=A.+M.+Martelli&title=Effects+of+mutations+in+Wnt%2F%CE%B2-catenin%2C+hedgehog%2C+Notch+and+PI3K+pathways+on+GSK-3+activity%E2%80%94Diverse+effects+on+cell+growth%2C+metabolism+and+cancer&doi=10.1016%2Fj.bbamcr.2016.09.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of mutations in Wnt/Î²-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity-Diverse effects on cell growth, metabolism and cancer</span></div><div class="casAuthors">McCubrey, James A.; Rakus, Dariusz; Gizak, Agnieszka; Steelman, Linda S.; Abrams, Steve L.; Lertpiriyapong, Kvin; Fitzgerald, Timothy L.; Yang, Li V.; Montalto, Giuseppe; Cervello, Melchiorre; Libra, Massimo; Nicoletti, Ferdinando; Scalisi, Aurora; Torino, Francesco; Fenga, Concettina; Neri, Luca M.; Marmiroli, Sandra; Cocco, Lucio; Martelli, Alberto M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Molecular Cell Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">1863</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2942-2976</span>CODEN:
                <span class="NLM_cas:coden">BBAMCO</span>;
        ISSN:<span class="NLM_cas:issn">0167-4889</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase that participates in an array of crit. cellular processes.  GSK-3 was first characterized as an enzyme that phosphorylated and inactivated glycogen synthase.  However, subsequent studies have revealed that this moon-lighting protein is involved in numerous signaling pathways that regulate not only metab. but also have roles in: apoptosis, cell cycle progression, cell renewal, differentiation, embryogenesis, migration, regulation of gene transcription, stem cell biol. and survival.  In this review, we will discuss the roles that GSK-3 plays in various diseases as well as how this pivotal kinase interacts with multiple signaling pathways such as: PI3K/PTEN/Akt/mTOR, Ras/Raf/MEK/ERK, Wnt/beta-catenin, hedgehog, Notch and TP53.  Mutations that occur in these and other pathways can alter the effects that natural GSK-3 activity has on regulating these signaling circuits that can lead to cancer as well as other diseases.  The novel roles that microRNAs play in regulation of the effects of GSK-3 will also be evaluated.  Targeting GSK-3 and these other pathways may improve therapy and overcome therapeutic resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOccRRGe88_7Vg90H21EOLACvtfcHk0ljyrAq654p3kg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVyjsL%252FE&md5=528be1c3c5faac0bb11b501a5fc65af3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.bbamcr.2016.09.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbamcr.2016.09.004%26sid%3Dliteratum%253Aachs%26aulast%3DMcCubrey%26aufirst%3DJ.%2BA.%26aulast%3DRakus%26aufirst%3DD.%26aulast%3DGizak%26aufirst%3DA.%26aulast%3DSteelman%26aufirst%3DL.%2BS.%26aulast%3DAbrams%26aufirst%3DS.%2BL.%26aulast%3DLertpiriyapong%26aufirst%3DK.%26aulast%3DFitzgerald%26aufirst%3DT.%2BL.%26aulast%3DYang%26aufirst%3DL.%2BV.%26aulast%3DMontalto%26aufirst%3DG.%26aulast%3DCervello%26aufirst%3DM.%26aulast%3DLibra%26aufirst%3DM.%26aulast%3DNicoletti%26aufirst%3DF.%26aulast%3DScalisi%26aufirst%3DA.%26aulast%3DTorino%26aufirst%3DF.%26aulast%3DFenga%26aufirst%3DC.%26aulast%3DNeri%26aufirst%3DL.%2BM.%26aulast%3DMarmiroli%26aufirst%3DS.%26aulast%3DCocco%26aufirst%3DL.%26aulast%3DMartelli%26aufirst%3DA.%2BM.%26atitle%3DEffects%2520of%2520mutations%2520in%2520Wnt%252F%25CE%25B2-catenin%252C%2520hedgehog%252C%2520Notch%2520and%2520PI3K%2520pathways%2520on%2520GSK-3%2520activity%25E2%2580%2594Diverse%2520effects%2520on%2520cell%2520growth%252C%2520metabolism%2520and%2520cancer%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Mol.%2520Cell%2520Res.%26date%3D2016%26volume%3D1863%26issue%3D12%26spage%3D2942%26epage%3D2976%26doi%3D10.1016%2Fj.bbamcr.2016.09.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Zeidan-Chulia, F.; Moreira, J. C. F.</span><span> </span><span class="NLM_article-title">Targeting the GSK3Î²/Î²-catenin signaling to treat Alzheimerâs disease: Plausible or utopic?</span> In  <span class="citation_source-book">Drug Design and Discovery in Alzheimerâs Disease</span>; <span class="NLM_publisher-name">Bentham Science</span>: <span class="NLM_publisher-loc">Sharjah</span>,<span class="NLM_x"> </span><span class="NLM_year">2014</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">6</span>, pp  <span class="NLM_fpage">623</span><span class="NLM_x">â</span> <span class="NLM_lpage">642</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FB978-0-12-803959-5.50014-3" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=623-642&author=F.+Zeidan-Chulia&author=J.+C.+F.+Moreira&title=Drug+Design+and+Discovery+in+Alzheimer%E2%80%99s+Disease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-803959-5.50014-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1016%252FB978-0-12-803959-5.50014-3%26sid%3Dliteratum%253Aachs%26aulast%3DZeidan-Chulia%26aufirst%3DF.%26atitle%3DTargeting%2520the%2520GSK3%25CE%25B2%252F%25CE%25B2-catenin%2520signaling%2520to%2520treat%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520Plausible%2520or%2520utopic%253F%26btitle%3DDrug%2520Design%2520and%2520Discovery%2520in%2520Alzheimer%25E2%2580%2599s%2520Disease%26pub%3DBentham%2520Science%26date%3D2014%26volume%3D6%26spage%3D623%26epage%3D642" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Golpich, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hemmati, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ibrahim, N. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahmani, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohamed, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raymond, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dargahi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghasemi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmadiani, A.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 beta (GSK-3Î²) signaling: Implications for Parkinsonâs disease</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">97</span><span class="NLM_x">, </span> <span class="NLM_fpage">16</span><span class="NLM_x">â</span> <span class="NLM_lpage">26</span><span class="refDoi">Â DOI: 10.1016/j.phrs.2015.03.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.phrs.2015.03.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=25829335" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlslCktrc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2015&pages=16-26&author=M.+Golpichauthor=E.+Aminiauthor=F.+Hemmatiauthor=N.+M.+Ibrahimauthor=B.+Rahmaniauthor=Z.+Mohamedauthor=A.+A.+Raymondauthor=L.+Dargahiauthor=R.+Ghasemiauthor=A.+Ahmadiani&title=Glycogen+synthase+kinase-3+beta+%28GSK-3%CE%B2%29+signaling%3A+Implications+for+Parkinson%E2%80%99s+disease&doi=10.1016%2Fj.phrs.2015.03.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase-3 beta (GSK-3Î²) signaling: Implications for Parkinson's disease</span></div><div class="casAuthors">Golpich, Mojtaba; Amini, Elham; Hemmati, Fatemeh; Ibrahim, Norlinah Mohamed; Rahmani, Behrouz; Mohamed, Zahurin; Raymond, Azman Ali; Dargahi, Leila; Ghasemi, Rasoul; Ahmadiani, Abolhassan</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">16-26</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Glycogen synthase kinase 3 (GSK-3) dysregulation plays an important role in the pathogenesis of numerous disorders, affecting the central nervous system (CNS) encompassing both neuroinflammation and neurodegenerative diseases.  Several lines of evidence have illustrated a key role of the GSK-3 and its cellular and mol. signaling cascades in the control of neuroinflammation.  Glycogen synthase kinase 3 beta (GSK-3Î²), one of the GSK-3 isomers, plays a major role in neuronal apoptosis and its inhibition decreases expression of alpha-Synuclein (Î±-Synuclein), which make this kinase an attractive therapeutic target for neurodegenerative disorders.  Parkinson's disease (PD) is a chronic neurodegenerative movement disorder characterized by the progressive and massive loss of dopaminergic neurons by neuronal apoptosis in the substantia nigra pars compacta and depletion of dopamine in the striatum, which lead to pathol. and clin. abnormalities.  Thus, understanding the role of GSK-3Î² in PD will enhance our knowledge of the basic mechanisms underlying the pathogenesis of this disorder and facilitate the identification of new therapeutic avenues.  In recent years, GSK-3Î² has been shown to play essential roles in modulating a variety of cellular functions, which have prompted efforts to develop GSK-3Î² inhibitors as therapeutics.  In this review, we summarize GSK-3 signaling pathways and its assocn. with neuroinflammation.  Moreover, we highlight the interaction between GSK-3Î² and several cellular processes involved in the pathogenesis of PD, including the accumulation of Î±-Synuclein aggregates, oxidative stress and mitochondrial dysfunction.  Finally, we discuss about GSK-3Î² inhibitors as a potential therapeutic strategy in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwfZuHcsXpsrVg90H21EOLACvtfcHk0ljyrAq654p3kg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlslCktrc%253D&md5=72fe420eb5fa1f8135fcb7a862becfb6</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.phrs.2015.03.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phrs.2015.03.010%26sid%3Dliteratum%253Aachs%26aulast%3DGolpich%26aufirst%3DM.%26aulast%3DAmini%26aufirst%3DE.%26aulast%3DHemmati%26aufirst%3DF.%26aulast%3DIbrahim%26aufirst%3DN.%2BM.%26aulast%3DRahmani%26aufirst%3DB.%26aulast%3DMohamed%26aufirst%3DZ.%26aulast%3DRaymond%26aufirst%3DA.%2BA.%26aulast%3DDargahi%26aufirst%3DL.%26aulast%3DGhasemi%26aufirst%3DR.%26aulast%3DAhmadiani%26aufirst%3DA.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520beta%2520%2528GSK-3%25CE%25B2%2529%2520signaling%253A%2520Implications%2520for%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DPharmacol.%2520Res.%26date%3D2015%26volume%3D97%26spage%3D16%26epage%3D26%26doi%3D10.1016%2Fj.phrs.2015.03.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Beurel, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grieco, S. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jope, R. S.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases</span> <span class="citation_source-journal">Pharmacol. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">148</span><span class="NLM_x">, </span> <span class="NLM_fpage">114</span><span class="NLM_x">â</span> <span class="NLM_lpage">131</span><span class="refDoi">Â DOI: 10.1016/j.pharmthera.2014.11.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.pharmthera.2014.11.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=25435019" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVeisr7J" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2015&pages=114-131&author=E.+Beurelauthor=S.+F.+Griecoauthor=R.+S.+Jope&title=Glycogen+synthase+kinase-3+%28GSK3%29%3A+Regulation%2C+actions%2C+and+diseases&doi=10.1016%2Fj.pharmthera.2014.11.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases</span></div><div class="casAuthors">Beurel, Eleonore; Grieco, Steven F.; Jope, Richard S.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114-131</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Glycogen synthase kinase-3 (GSK3) may be the busiest kinase in most cells, with over 100 known substrates to deal with.  How does GSK3 maintain control to selectively phosphorylate each substrate, and why was it evolutionarily favorable for GSK3 to assume such a large responsibility.  GSK3 must be particularly adaptable for incorporating new substrates into its repertoire, and we discuss the distinct properties of GSK3 that may contribute to its capacity to fulfill its roles in multiple signaling pathways.  The mechanisms regulating GSK3 (predominantly post-translational modifications, substrate priming, cellular trafficking, protein complexes) have been reviewed previously, so here we focus on newly identified complexities in these mechanisms, how each of these regulatory mechanism contributes to the ability of GSK3 to select which substrates to phosphorylate, and how these mechanisms may have contributed to its adaptability as new substrates evolved.  The current understanding of the mechanisms regulating GSK3 is reviewed, as are emerging topics in the actions of GSK3, particularly its interactions with receptors and receptor-coupled signal transduction events, and differential actions and regulation of the two GSK3 isoforms, GSK3Î± and GSK3Î².  Another remarkable characteristic of GSK3 is its involvement in many prevalent disorders, including psychiatric and neurol. diseases, inflammatory diseases, cancer, and others.  We address the feasibility of targeting GSK3 therapeutically, and provide an update of its involvement in the etiol. and treatment of several disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonota4sOu8PbVg90H21EOLACvtfcHk0lg-hTUrp52VaQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVeisr7J&md5=a6c54e0331492b0b61a9d67b1f07575d</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2014.11.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2014.11.016%26sid%3Dliteratum%253Aachs%26aulast%3DBeurel%26aufirst%3DE.%26aulast%3DGrieco%26aufirst%3DS.%2BF.%26aulast%3DJope%26aufirst%3DR.%2BS.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520%2528GSK3%2529%253A%2520Regulation%252C%2520actions%252C%2520and%2520diseases%26jtitle%3DPharmacol.%2520Ther.%26date%3D2015%26volume%3D148%26spage%3D114%26epage%3D131%26doi%3D10.1016%2Fj.pharmthera.2014.11.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Seira, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Del RÃ­o, J. A.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase 3 beta (GSK3Î²) at the tip of neuronal development and regeneration</span> <span class="citation_source-journal">Mol. Neurobiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">931</span><span class="NLM_x">â</span> <span class="NLM_lpage">944</span><span class="refDoi">Â DOI: 10.1007/s12035-013-8571-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1007%2Fs12035-013-8571-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=24158777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs1OqsLrM" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2014&pages=931-944&issue=2&author=O.+Seiraauthor=J.+A.+Del+R%C3%ADo&title=Glycogen+synthase+kinase+3+beta+%28GSK3%CE%B2%29+at+the+tip+of+neuronal+development+and+regeneration&doi=10.1007%2Fs12035-013-8571-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen Synthase Kinase 3 Beta (GSK3Î²) at the Tip of Neuronal Development and Regeneration</span></div><div class="casAuthors">Seira, Oscar; del Rio, Jose Antonio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">931-944</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  Gaining a basic understanding of the inhibitory mols. and the intracellular signaling involved in axon development and repulsion after neural lesions is of clear biomedical interest.  In recent years, numerous studies have described new mols. and intracellular mechanisms that impair axonal outgrowth after injury.  In this scenario, the role of glycogen synthase kinase 3 beta (GSK3Î²) in the axonal responses that occur after central nervous system (CNS) lesions began to be elucidated.  GSK3Î² function in the nervous tissue is assocd. with neural development, neuron polarization, and, more recently, neurodegeneration.  In fact, GSK3Î² has been considered as a putative therapeutic target for promoting functional recovery in injured or degenerative CNS.  In this review, we summarize current understanding of the role of GSK3Î² during neuronal development and regeneration.  In particular, we discuss GSK3Î² activity levels and their possible impact on cytoskeleton dynamics during both processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnxrCXn4rKvLVg90H21EOLACvtfcHk0lg-hTUrp52VaQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs1OqsLrM&md5=933d4a54fce55644e5b7d43767268ae3</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs12035-013-8571-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-013-8571-y%26sid%3Dliteratum%253Aachs%26aulast%3DSeira%26aufirst%3DO.%26aulast%3DDel%2BR%25C3%25ADo%26aufirst%3DJ.%2BA.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%2520beta%2520%2528GSK3%25CE%25B2%2529%2520at%2520the%2520tip%2520of%2520neuronal%2520development%2520and%2520regeneration%26jtitle%3DMol.%2520Neurobiol.%26date%3D2014%26volume%3D49%26issue%3D2%26spage%3D931%26epage%3D944%26doi%3D10.1007%2Fs12035-013-8571-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Takahashi-Yanaga, F.</span><span> </span><span class="NLM_article-title">Activator or inhibitor? GSK-3 as a new drug target</span> <span class="citation_source-journal">Biochem. Pharmacol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">86</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">191</span><span class="NLM_x">â</span> <span class="NLM_lpage">199</span><span class="refDoi">Â DOI: 10.1016/j.bcp.2013.04.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.bcp.2013.04.022" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2013&pages=191-199&issue=2&author=F.+Takahashi-Yanaga&title=Activator+or+inhibitor%3F+GSK-3+as+a+new+drug+target&doi=10.1016%2Fj.bcp.2013.04.022"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2013.04.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2013.04.022%26sid%3Dliteratum%253Aachs%26aulast%3DTakahashi-Yanaga%26aufirst%3DF.%26atitle%3DActivator%2520or%2520inhibitor%253F%2520GSK-3%2520as%2520a%2520new%2520drug%2520target%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2013%26volume%3D86%26issue%3D2%26spage%3D191%26epage%3D199%26doi%3D10.1016%2Fj.bcp.2013.04.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Osolodkin, D. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palyulin, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zefirov, N. S.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase 3 as an anticancer drug target: novel experimental findings and trends in the design of inhibitors</span> <span class="citation_source-journal">Curr. Pharm. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">665</span><span class="NLM_x">â</span> <span class="NLM_lpage">679</span><span class="refDoi">Â DOI: 10.2174/13816128130407</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2174%2F13816128130407" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2013&pages=665-679&issue=4&author=D.+I.+Osolodkinauthor=V.+A.+Palyulinauthor=N.+S.+Zefirov&title=Glycogen+synthase+kinase+3+as+an+anticancer+drug+target%3A+novel+experimental+findings+and+trends+in+the+design+of+inhibitors&doi=10.2174%2F13816128130407"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.2174%2F13816128130407&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F13816128130407%26sid%3Dliteratum%253Aachs%26aulast%3DOsolodkin%26aufirst%3DD.%2BI.%26aulast%3DPalyulin%26aufirst%3DV.%2BA.%26aulast%3DZefirov%26aufirst%3DN.%2BS.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%2520as%2520an%2520anticancer%2520drug%2520target%253A%2520novel%2520experimental%2520findings%2520and%2520trends%2520in%2520the%2520design%2520of%2520inhibitors%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2013%26volume%3D19%26issue%3D4%26spage%3D665%26epage%3D679%26doi%3D10.2174%2F13816128130407" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Ghaderi, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alidadiani, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dilaver, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heidari, H. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parvizi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rahbarghazi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soleimani-Rad, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baradaran, B.</span><span> </span><span class="NLM_article-title">Role of glycogen synthase kinase following myocardial infarction and ischemiaâreperfusion</span> <span class="citation_source-journal">Apoptosis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2017</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">887</span><span class="NLM_x">â</span> <span class="NLM_lpage">897</span><span class="refDoi">Â DOI: 10.1007/s10495-017-1376-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1007%2Fs10495-017-1376-0" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=887-897&issue=7&author=S.+Ghaderiauthor=N.+Alidadianiauthor=N.+Dilaverauthor=H.+R.+Heidariauthor=R.+Parviziauthor=R.+Rahbarghaziauthor=J.+Soleimani-Radauthor=B.+Baradaran&title=Role+of+glycogen+synthase+kinase+following+myocardial+infarction+and+ischemia%E2%80%93reperfusion&doi=10.1007%2Fs10495-017-1376-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs10495-017-1376-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10495-017-1376-0%26sid%3Dliteratum%253Aachs%26aulast%3DGhaderi%26aufirst%3DS.%26aulast%3DAlidadiani%26aufirst%3DN.%26aulast%3DDilaver%26aufirst%3DN.%26aulast%3DHeidari%26aufirst%3DH.%2BR.%26aulast%3DParvizi%26aufirst%3DR.%26aulast%3DRahbarghazi%26aufirst%3DR.%26aulast%3DSoleimani-Rad%26aufirst%3DJ.%26aulast%3DBaradaran%26aufirst%3DB.%26atitle%3DRole%2520of%2520glycogen%2520synthase%2520kinase%2520following%2520myocardial%2520infarction%2520and%2520ischemia%25E2%2580%2593reperfusion%26jtitle%3DApoptosis%26date%3D2017%26volume%3D22%26issue%3D7%26spage%3D887%26epage%3D897%26doi%3D10.1007%2Fs10495-017-1376-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Ko, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, S. Y.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase 3Î² in Toll-like receptor signaling</span> <span class="citation_source-journal">BMB Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">305</span><span class="NLM_x">â</span> <span class="NLM_lpage">310</span><span class="refDoi">Â DOI: 10.5483/BMBRep.2016.49.6.059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.5483%2FBMBRep.2016.49.6.059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=26996345" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFyqtrzL" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2016&pages=305-310&issue=6&author=R.+Koauthor=S.+Y.+Lee&title=Glycogen+synthase+kinase+3%CE%B2+in+Toll-like+receptor+signaling&doi=10.5483%2FBMBRep.2016.49.6.059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase 3Î² in Toll-like receptor signaling</span></div><div class="casAuthors">Ko, Ryeojin; Lee, Soo Young</div><div class="citationInfo"><span class="NLM_cas:title">BMB Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">49</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">305-310</span>CODEN:
                <span class="NLM_cas:coden">BRMEC2</span>;
        ISSN:<span class="NLM_cas:issn">1976-670X</span>.
    
            (<span class="NLM_cas:orgname">Korean Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">A review.  Toll-like receptors (TLRs) play a crit. role in the innate immune response against pathogens.  Each TLR recognizes specific pathogen-assocd. mol. patterns, after which they activate the adaptor protein MyD88 or TRIF-assembled signaling complex to produce immune mediators, including inflammatory cytokines and type I IFNs.  Although the activation of TLR is important for host defense, its uncontrolled activation can damage the host.  During the past decade, numerous studies have demonstrated that GSK3Î² is a key regulator of inflammatory cytokine prodn. in MyD88-mediated TLR signaling via TLR2 and TLR4.  Recently, GSK3Î² has also been implicated in the TRIF-dependent signaling pathway via TLR3.  In this review, we describe current advances on the regulatory role of GSK3Î² in immune responses assocd. with various TLRs.  A better understanding of the role of GSK3Î² in TLR signaling might lead to more effective anti-inflammatory interventions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUI8aIdn8TkbVg90H21EOLACvtfcHk0lg-hTUrp52VaQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFyqtrzL&md5=722b56ff02fdf7d30b8a321d7250c517</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.5483%2FBMBRep.2016.49.6.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.5483%252FBMBRep.2016.49.6.059%26sid%3Dliteratum%253Aachs%26aulast%3DKo%26aufirst%3DR.%26aulast%3DLee%26aufirst%3DS.%2BY.%26atitle%3DGlycogen%2520synthase%2520kinase%25203%25CE%25B2%2520in%2520Toll-like%2520receptor%2520signaling%26jtitle%3DBMB%2520Rep.%26date%3D2016%26volume%3D49%26issue%3D6%26spage%3D305%26epage%3D310%26doi%3D10.5483%2FBMBRep.2016.49.6.059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">McLauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The specificities of protein kinase inhibitors: an update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">371</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">199</span><span class="NLM_x">â</span> <span class="NLM_lpage">204</span><span class="refDoi">Â DOI: 10.1042/bj20021535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1042%2Fbj20021535" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2003&pages=199-204&issue=1&author=H.+McLauchlanauthor=M.+Elliottauthor=P.+Cohen&title=The+specificities+of+protein+kinase+inhibitors%3A+an+update&doi=10.1042%2Fbj20021535"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1042%2Fbj20021535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj20021535%26sid%3Dliteratum%253Aachs%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520specificities%2520of%2520protein%2520kinase%2520inhibitors%253A%2520an%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2003%26volume%3D371%26issue%3D1%26spage%3D199%26epage%3D204%26doi%3D10.1042%2Fbj20021535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Bain, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Plater, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shpiro, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hastie, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mclauchlan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klevernic, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arthur, J. S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alessi, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">408</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">297</span><span class="NLM_x">â</span> <span class="NLM_lpage">315</span><span class="refDoi">Â DOI: 10.1042/BJ20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&issue=3&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+Mclauchlanauthor=I.+Klevernicauthor=J.+S.+C.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update&doi=10.1042%2FBJ20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0lh_Rz1dYqHROw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMclauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26issue%3D3%26spage%3D297%26epage%3D315%26doi%3D10.1042%2FBJ20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Davies, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reddy, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Caivano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Specificity and mechanism of action of some commonly used protein kinase inhibitors</span> <span class="citation_source-journal">Biochem. J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">351</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">95</span><span class="NLM_x">â</span> <span class="NLM_lpage">105</span><span class="refDoi">Â DOI: 10.1042/bj3510095</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1042%2Fbj3510095" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10998351" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnslWltrY%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=351&publication_year=2000&pages=95-105&issue=1&author=S.+P.+Daviesauthor=H.+Reddyauthor=M.+Caivanoauthor=P.+Cohen&title=Specificity+and+mechanism+of+action+of+some+commonly+used+protein+kinase+inhibitors&doi=10.1042%2Fbj3510095"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Specificity and mechanism of action of some commonly used protein kinase inhibitors</span></div><div class="casAuthors">Davies, Stephen P.; Reddy, Helen; Caivano, Matilde; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">351</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 28 com. available compds. reported to be relatively selective inhibitors of particular serine/threonine-specific protein kinases have been examd. against a large panel of protein kinases.  The compds. KT 5720, Rottlerin and quercetin were found to inhibit many protein kinases, sometimes much more potently than their presumed targets, and conclusions drawn from their use in cell-based expts. are likely to be erroneous.  Ro 318220 and related bisindoylmaleimides, as well as H89, HA1077 and Y 27632, were more selective inhibitors, but still inhibited two or more protein kinases with similar potency.  LY 294002 was found to inhibit casein kinase-2 with similar potency to phosphoinositide (phosphatidylinositol) 3-kinase.  The compds. with the most impressive selectivity profiles were KN62, PD 98059, U0126, PD 184352, rapamycin, wortmannin, SB 203580 and SB 202190.  U0126 and PD 184352, like PD 98059, were found to block the mitogen-activated protein kinase (MAPK) cascade in cell-based assays by preventing the activation of MAPK kinase (MKK1), and not by inhibiting MKK1 activity directly.  Apart from rapamycin and PD 184352, even the most selective inhibitors affected at least one addnl. protein kinase.  Our results demonstrate that the specificities of protein kinase inhibitors cannot be assessed simply by studying their effect on kinases that are closely related in primary structure.  The authors propose guidelines for the use of protein kinase inhibitors in cell-based assays.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqCs5LPDkzaGrVg90H21EOLACvtfcHk0lh_Rz1dYqHROw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnslWltrY%253D&md5=e14eb47a52dc43afca7373c276b2d147</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1042%2Fbj3510095&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252Fbj3510095%26sid%3Dliteratum%253Aachs%26aulast%3DDavies%26aufirst%3DS.%2BP.%26aulast%3DReddy%26aufirst%3DH.%26aulast%3DCaivano%26aufirst%3DM.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DSpecificity%2520and%2520mechanism%2520of%2520action%2520of%2520some%2520commonly%2520used%2520protein%2520kinase%2520inhibitors%26jtitle%3DBiochem.%2520J.%26date%3D2000%26volume%3D351%26issue%3D1%26spage%3D95%26epage%3D105%26doi%3D10.1042%2Fbj3510095" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Maeda, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nakano, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sato, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyazaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schweiker, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Truesdale, A. T.</span><span> </span><span class="NLM_article-title">4-Acylamino-6-arylfuro[2,3-d]pyrimidines: potent and selective glycogen synthase kinase-3 inhibitors</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">3907</span><span class="NLM_x">â</span> <span class="NLM_lpage">3911</span><span class="refDoi">Â DOI: 10.1016/j.bmcl.2004.05.064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.bmcl.2004.05.064" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=3907-3911&issue=15&author=Y.+Maedaauthor=M.+Nakanoauthor=H.+Satoauthor=Y.+Miyazakiauthor=S.+L.+Schweikerauthor=J.+L.+Smithauthor=A.+T.+Truesdale&title=4-Acylamino-6-arylfuro%5B2%2C3-d%5Dpyrimidines%3A+potent+and+selective+glycogen+synthase+kinase-3+inhibitors&doi=10.1016%2Fj.bmcl.2004.05.064"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.05.064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.05.064%26sid%3Dliteratum%253Aachs%26aulast%3DMaeda%26aufirst%3DY.%26aulast%3DNakano%26aufirst%3DM.%26aulast%3DSato%26aufirst%3DH.%26aulast%3DMiyazaki%26aufirst%3DY.%26aulast%3DSchweiker%26aufirst%3DS.%2BL.%26aulast%3DSmith%26aufirst%3DJ.%2BL.%26aulast%3DTruesdale%26aufirst%3DA.%2BT.%26atitle%3D4-Acylamino-6-arylfuro%255B2%252C3-d%255Dpyrimidines%253A%2520potent%2520and%2520selective%2520glycogen%2520synthase%2520kinase-3%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26issue%3D15%26spage%3D3907%26epage%3D3911%26doi%3D10.1016%2Fj.bmcl.2004.05.064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Tavares, F. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucheron, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dickerson, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Griffin, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Preugschat, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, H.-Q.</span><span> </span><span class="NLM_article-title">N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">19</span><span class="NLM_x">) </span> <span class="NLM_fpage">4716</span><span class="NLM_x">â</span> <span class="NLM_lpage">4730</span><span class="refDoi">Â DOI: 10.1021/jm040063i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm040063i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmsFSgtL4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=4716-4730&issue=19&author=F.+X.+Tavaresauthor=J.+A.+Boucheronauthor=S.+H.+Dickersonauthor=R.+J.+Griffinauthor=F.+Preugschatauthor=S.+A.+Thomsonauthor=T.+Y.+Wangauthor=H.-Q.+Zhou&title=N-Phenyl-4-pyrazolo%5B1%2C5-b%5Dpyridazin-3-ylpyrimidin-2-amines+as+potent+and+selective+inhibitors+of+glycogen+synthase+kinase+3+with+good+cellular+efficacy&doi=10.1021%2Fjm040063i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as Potent and Selective Inhibitors of Glycogen Synthase Kinase 3 with Good Cellular Efficacy</span></div><div class="casAuthors">Tavares, Francis X.; Boucheron, Joyce A.; Dickerson, Scott H.; Griffin, Robert J.; Preugschat, Frank; Thomson, Stephen A.; Wang, Tony Y.; Zhou, Hui-Qiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">4716-4730</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Glycogen synthase kinase 3 regulates glycogen synthase, the rate-detg. enzyme for glycogen synthesis.  Liver and muscle glycogen synthesis is defective in type 2 diabetics, resulting in elevated plasma glucose levels.  Inhibition of GSK-3 could potentially be an effective method to control plasma glucose levels in type 2 diabetics.  Structure-activity studies on a N-phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine series have led to the identification of potent and selective compds. with good cellular efficacy.  Mol. modeling studies have given insights into the mode of binding of these inhibitors.  Since the initial leads were also potent inhibitors of CDK-2/CDK-4, an extensive SAR was performed at various positions of the pyrazolo[1,5-b]pyridazin core to afford potent GSK-3 inhibitors that were highly selective over CDK-2.  In addn., these inhibitors also exhibited very good cell efficacy and functional response.  A representative example was shown to have good oral exposure levels, extending their utility in an in vivo setting.  These inhibitors provide a viable lead series in the discovery of new therapies for the treatment of type 2 diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqY8mmZ2qIdFLVg90H21EOLACvtfcHk0lhpYFWx1QK_bA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmsFSgtL4%253D&md5=934bcecaed8f087510bfc8fb41e2e7a5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Fjm040063i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm040063i%26sid%3Dliteratum%253Aachs%26aulast%3DTavares%26aufirst%3DF.%2BX.%26aulast%3DBoucheron%26aufirst%3DJ.%2BA.%26aulast%3DDickerson%26aufirst%3DS.%2BH.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DPreugschat%26aufirst%3DF.%26aulast%3DThomson%26aufirst%3DS.%2BA.%26aulast%3DWang%26aufirst%3DT.%2BY.%26aulast%3DZhou%26aufirst%3DH.-Q.%26atitle%3DN-Phenyl-4-pyrazolo%255B1%252C5-b%255Dpyridazin-3-ylpyrimidin-2-amines%2520as%2520potent%2520and%2520selective%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase%25203%2520with%2520good%2520cellular%2520efficacy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26issue%3D19%26spage%3D4716%26epage%3D4730%26doi%3D10.1021%2Fjm040063i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Wan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hur, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cho, C. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lozach, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bach, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mayer, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fabbro, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meijer, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span> </span><span class="NLM_article-title">Synthesis and target identification of hymenialdisine analogs</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">247</span><span class="NLM_x">â</span> <span class="NLM_lpage">259</span><span class="refDoi">Â DOI: 10.1016/j.chembiol.2004.01.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.chembiol.2004.01.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=15123286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhsleks78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2004&pages=247-259&issue=2&author=Y.+Wanauthor=W.+Hurauthor=C.+Y.+Choauthor=Y.+Liuauthor=F.+J.+Adrianauthor=O.+Lozachauthor=S.+Bachauthor=T.+Mayerauthor=D.+Fabbroauthor=L.+Meijerauthor=N.+S.+Gray&title=Synthesis+and+target+identification+of+hymenialdisine+analogs&doi=10.1016%2Fj.chembiol.2004.01.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Target Identification of Hymenialdisine Analogs</span></div><div class="casAuthors">Wan, Yongqin; Hur, Wooyoung; Cho, Charles Y.; Liu, Yi; Adrian, Francisco J.; Lozach, Olivier; Bach, Stephane; Mayer, Thomas; Fabbro, Doriano; Meijer, Laurent; Gray, Nathanael S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">247-259</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Hymenialdisine (HMD) is a sponge-derived natural product kinase inhibitor with nanomolar activity against CDKs, Mek1, GSK3Î², and CK1 and micromolar activity against Chk1.  To explore the broader application of the pyrrolo[2,3-c]azepine skeleton of HMD as a general kinase inhibitory scaffold, we searched for addnl. protein targets using affinity chromatog. in conjunction with the synthesis of diverse HMD analogs and profiled HMD against a panel of 60 recombinant enzymes.  This effort has led to nanomolar to micromolar inhibitors of 11 new targets including p90RSK, KDR, c-Kit, Fes, MAPK1, PAK2, PDK1, PKCÎ¸, PKD2, Rsk1, and SGK.  The synthesis of HMD analogs has resulted in the identification of compds. with enhanced and/or dramatically altered selectivities relative to HMD and in mols. with antiproliferative activities 30-fold higher than HMD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoulWkl47lr-bVg90H21EOLACvtfcHk0lhpYFWx1QK_bA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhsleks78%253D&md5=e009eba03f45dd122ba9184f4bc8cdef</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2004.01.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2004.01.015%26sid%3Dliteratum%253Aachs%26aulast%3DWan%26aufirst%3DY.%26aulast%3DHur%26aufirst%3DW.%26aulast%3DCho%26aufirst%3DC.%2BY.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DAdrian%26aufirst%3DF.%2BJ.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DBach%26aufirst%3DS.%26aulast%3DMayer%26aufirst%3DT.%26aulast%3DFabbro%26aufirst%3DD.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DGray%26aufirst%3DN.%2BS.%26atitle%3DSynthesis%2520and%2520target%2520identification%2520of%2520hymenialdisine%2520analogs%26jtitle%3DChem.%2520Biol.%26date%3D2004%26volume%3D11%26issue%3D2%26spage%3D247%26epage%3D259%26doi%3D10.1016%2Fj.chembiol.2004.01.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Nuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Renhowe, P. A.</span><span> </span><span class="NLM_article-title">Advances in solid-supported organic synthesis methods, 1998 to 1999</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">631</span><span class="NLM_x">â</span> <span class="NLM_lpage">650</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1999&pages=631-650&issue=6&author=J.+M.+Nussauthor=P.+A.+Renhowe&title=Advances+in+solid-supported+organic+synthesis+methods%2C+1998+to+1999"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DRenhowe%26aufirst%3DP.%2BA.%26atitle%3DAdvances%2520in%2520solid-supported%2520organic%2520synthesis%2520methods%252C%25201998%2520to%25201999%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D1999%26volume%3D2%26issue%3D6%26spage%3D631%26epage%3D650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Schultz, P.; Ring, D. B.; Harrison, S. D.; Bray, A. M.</span><span> </span><span class="NLM_article-title">Preparation of Purines as Inhibitors of Glycogen Synthase Kinase 3 (GSK3)</span>. Patent 97-US19472 19971010,<span class="NLM_x"> </span><span class="NLM_year">1998</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1998&author=P.+Schultz&author=D.+B.+Ring&author=S.+D.+Harrison&author=A.+M.+Bray&title=Preparation+of+Purines+as+Inhibitors+of+Glycogen+Synthase+Kinase+3+%28GSK3%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchultz%26aufirst%3DP.%26atitle%3DPreparation%2520of%2520Purines%2520as%2520Inhibitors%2520of%2520Glycogen%2520Synthase%2520Kinase%25203%2520%2528GSK3%2529%26date%3D1998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Desai, M. C.; Nuss, J. M.; Spear, K. L.; Singh, R.; Renhowe, P. A.; Brown, E. G.; Richter, L.; Scott, B. O.</span><span> </span><span class="NLM_article-title">Combinatorial Libraries of Substrate-Bound Cyclic Organic Compounds</span>. U.S. Patent 5,958,792,<span class="NLM_x"> </span><span class="NLM_year">1999</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1999&author=M.+C.+Desai&author=J.+M.+Nuss&author=K.+L.+Spear&author=R.+Singh&author=P.+A.+Renhowe&author=E.+G.+Brown&author=L.+Richter&author=B.+O.+Scott&title=Combinatorial+Libraries+of+Substrate-Bound+Cyclic+Organic+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DDesai%26aufirst%3DM.%2BC.%26atitle%3DCombinatorial%2520Libraries%2520of%2520Substrate-Bound%2520Cyclic%2520Organic%2520Compounds%26date%3D1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Norman, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koh, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schultz, P. G.</span><span> </span><span class="NLM_article-title">A structure-based library approach to kinase inhibitors</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x"> (</span><span class="NLM_issue">31</span><span class="NLM_x">) </span> <span class="NLM_fpage">7430</span><span class="NLM_x">â</span> <span class="NLM_lpage">7431</span><span class="refDoi">Â DOI: 10.1021/ja9614934</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja9614934" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1996&pages=7430-7431&issue=31&author=T.+C.+Normanauthor=N.+S.+Grayauthor=J.+T.+Kohauthor=P.+G.+Schultz&title=A+structure-based+library+approach+to+kinase+inhibitors&doi=10.1021%2Fja9614934"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fja9614934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9614934%26sid%3Dliteratum%253Aachs%26aulast%3DNorman%26aufirst%3DT.%2BC.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKoh%26aufirst%3DJ.%2BT.%26aulast%3DSchultz%26aufirst%3DP.%2BG.%26atitle%3DA%2520structure-based%2520library%2520approach%2520to%2520kinase%2520inhibitors%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1996%26volume%3D118%26issue%3D31%26spage%3D7430%26epage%3D7431%26doi%3D10.1021%2Fja9614934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group">Nuss, J. M.; Harrison, S. D.; Ring, D. B.; Boyce, R. S.; Brown, S. P.; Goff, D.; Johnson, K.; Pfister, K. B.; Ramurthy, S.; Renhowe, P. A.; Seely, L.; Subramanian, S.; Wagman, A. S.; Zhou, X. A.</span><span> </span><span class="NLM_article-title">Inhibitors of Glycogen Synthase Kinase 3</span>. U.S. Patent 6,489,344 B1,<span class="NLM_x"> </span><span class="NLM_year">2002</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2002&author=J.+M.+Nuss&author=S.+D.+Harrison&author=D.+B.+Ring&author=R.+S.+Boyce&author=S.+P.+Brown&author=D.+Goff&author=K.+Johnson&author=K.+B.+Pfister&author=S.+Ramurthy&author=P.+A.+Renhowe&author=L.+Seely&author=S.+Subramanian&author=A.+S.+Wagman&author=X.+A.+Zhou&title=Inhibitors+of+Glycogen+Synthase+Kinase+3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26atitle%3DInhibitors%2520of%2520Glycogen%2520Synthase%2520Kinase%25203%26date%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group">Atwal, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rovnyak, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schwartz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moreland, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hedberg, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gougoutas, J. Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malley, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Floyd, D. M.</span><span> </span><span class="NLM_article-title">Dihydropyrimidine calcium channel blockers: 2-heterosubstituted 4-aryl-1,4-dihydro-6-methyl-5-pyrimidinecarboxylic acid esters as potent mimics of dihydropyridines</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1510</span><span class="NLM_x">â</span> <span class="NLM_lpage">1515</span><span class="refDoi">Â DOI: 10.1021/jm00167a035</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00167a035" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=1510-1515&issue=5&author=K.+S.+Atwalauthor=G.+C.+Rovnyakauthor=J.+Schwartzauthor=S.+Morelandauthor=A.+Hedbergauthor=J.+Z.+Gougoutasauthor=M.+F.+Malleyauthor=D.+M.+Floyd&title=Dihydropyrimidine+calcium+channel+blockers%3A+2-heterosubstituted+4-aryl-1%2C4-dihydro-6-methyl-5-pyrimidinecarboxylic+acid+esters+as+potent+mimics+of+dihydropyridines&doi=10.1021%2Fjm00167a035"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fjm00167a035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00167a035%26sid%3Dliteratum%253Aachs%26aulast%3DAtwal%26aufirst%3DK.%2BS.%26aulast%3DRovnyak%26aufirst%3DG.%2BC.%26aulast%3DSchwartz%26aufirst%3DJ.%26aulast%3DMoreland%26aufirst%3DS.%26aulast%3DHedberg%26aufirst%3DA.%26aulast%3DGougoutas%26aufirst%3DJ.%2BZ.%26aulast%3DMalley%26aufirst%3DM.%2BF.%26aulast%3DFloyd%26aufirst%3DD.%2BM.%26atitle%3DDihydropyrimidine%2520calcium%2520channel%2520blockers%253A%25202-heterosubstituted%25204-aryl-1%252C4-dihydro-6-methyl-5-pyrimidinecarboxylic%2520acid%2520esters%2520as%2520potent%2520mimics%2520of%2520dihydropyridines%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26issue%3D5%26spage%3D1510%26epage%3D1515%26doi%3D10.1021%2Fjm00167a035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group">Wagman, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuss, J. M.</span><span> </span><span class="NLM_article-title">Simple and efficient synthesis of 3,4-dihydro-2-pyridones via novel solid-supported aza-annulation</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">26</span><span class="NLM_x">) </span> <span class="NLM_fpage">9103</span><span class="NLM_x">â</span> <span class="NLM_lpage">9113</span><span class="refDoi">Â DOI: 10.1021/jo005609x</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo005609x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2000&pages=9103-9113&issue=26&author=A.+S.+Wagmanauthor=L.+Wangauthor=J.+M.+Nuss&title=Simple+and+efficient+synthesis+of+3%2C4-dihydro-2-pyridones+via+novel+solid-supported+aza-annulation&doi=10.1021%2Fjo005609x"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Fjo005609x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo005609x%26sid%3Dliteratum%253Aachs%26aulast%3DWagman%26aufirst%3DA.%2BS.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26atitle%3DSimple%2520and%2520efficient%2520synthesis%2520of%25203%252C4-dihydro-2-pyridones%2520via%2520novel%2520solid-supported%2520aza-annulation%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2000%26volume%3D65%26issue%3D26%26spage%3D9103%26epage%3D9113%26doi%3D10.1021%2Fjo005609x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group">Bedford, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howd, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dailey, O. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolen, H. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenley, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kern, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winterle, J. S.</span><span> </span><span class="NLM_article-title">Nonquaternary cholinesterase reactivators. 3. 3(5)-Substituted 1,2,4-oxadiazol-5(3)-aldoximes and 1,2,4-oxadiazole-5(3)-thiocarbohydroximates as reactivators of organophosphonate-inhibited eel and human acetylcholinesterase in vitro</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">2174</span><span class="NLM_x">â</span> <span class="NLM_lpage">2183</span><span class="refDoi">Â DOI: 10.1021/jm00161a008</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00161a008" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1986&pages=2174-2183&issue=11&author=C.+D.+Bedfordauthor=R.+A.+Howdauthor=O.+D.+Daileyauthor=A.+Millerauthor=H.+W.+Nolenauthor=R.+A.+Kenleyauthor=J.+R.+Kernauthor=J.+S.+Winterle&title=Nonquaternary+cholinesterase+reactivators.+3.+3%285%29-Substituted+1%2C2%2C4-oxadiazol-5%283%29-aldoximes+and+1%2C2%2C4-oxadiazole-5%283%29-thiocarbohydroximates+as+reactivators+of+organophosphonate-inhibited+eel+and+human+acetylcholinesterase+in+vitro&doi=10.1021%2Fjm00161a008"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1021%2Fjm00161a008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00161a008%26sid%3Dliteratum%253Aachs%26aulast%3DBedford%26aufirst%3DC.%2BD.%26aulast%3DHowd%26aufirst%3DR.%2BA.%26aulast%3DDailey%26aufirst%3DO.%2BD.%26aulast%3DMiller%26aufirst%3DA.%26aulast%3DNolen%26aufirst%3DH.%2BW.%26aulast%3DKenley%26aufirst%3DR.%2BA.%26aulast%3DKern%26aufirst%3DJ.%2BR.%26aulast%3DWinterle%26aufirst%3DJ.%2BS.%26atitle%3DNonquaternary%2520cholinesterase%2520reactivators.%25203.%25203%25285%2529-Substituted%25201%252C2%252C4-oxadiazol-5%25283%2529-aldoximes%2520and%25201%252C2%252C4-oxadiazole-5%25283%2529-thiocarbohydroximates%2520as%2520reactivators%2520of%2520organophosphonate-inhibited%2520eel%2520and%2520human%2520acetylcholinesterase%2520in%2520vitro%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1986%26volume%3D29%26issue%3D11%26spage%3D2174%26epage%3D2183%26doi%3D10.1021%2Fjm00161a008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group">Sakurai, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogawa, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ohashi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yasuda, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, H.</span><span> </span><span class="NLM_article-title">Synthesis of [[(benzenesulfonamido)alkyl]phenyl]alkanoic acid derivatives containing pyridyl or imidazolyl groups and their thromboxane A2 receptor antagonistic and thromboxane A2 synthase inhibitory activities</span> <span class="citation_source-journal">Chem. Pharm. Bull.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1510</span><span class="NLM_x">â</span> <span class="NLM_lpage">1520</span><span class="refDoi">Â DOI: 10.1248/cpb.44.1510</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1248%2Fcpb.44.1510" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1996&pages=1510-1520&issue=8&author=S.+Sakuraiauthor=N.+Ogawaauthor=T.+Suzukiauthor=K.+Katoauthor=T.+Ohashiauthor=S.+Yasudaauthor=H.+Kato&title=Synthesis+of+%5B%5B%28benzenesulfonamido%29alkyl%5Dphenyl%5Dalkanoic+acid+derivatives+containing+pyridyl+or+imidazolyl+groups+and+their+thromboxane+A2+receptor+antagonistic+and+thromboxane+A2+synthase+inhibitory+activities&doi=10.1248%2Fcpb.44.1510"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1248%2Fcpb.44.1510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fcpb.44.1510%26sid%3Dliteratum%253Aachs%26aulast%3DSakurai%26aufirst%3DS.%26aulast%3DOgawa%26aufirst%3DN.%26aulast%3DSuzuki%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DK.%26aulast%3DOhashi%26aufirst%3DT.%26aulast%3DYasuda%26aufirst%3DS.%26aulast%3DKato%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520%255B%255B%2528benzenesulfonamido%2529alkyl%255Dphenyl%255Dalkanoic%2520acid%2520derivatives%2520containing%2520pyridyl%2520or%2520imidazolyl%2520groups%2520and%2520their%2520thromboxane%2520A2%2520receptor%2520antagonistic%2520and%2520thromboxane%2520A2%2520synthase%2520inhibitory%2520activities%26jtitle%3DChem.%2520Pharm.%2520Bull.%26date%3D1996%26volume%3D44%26issue%3D8%26spage%3D1510%26epage%3D1520%26doi%3D10.1248%2Fcpb.44.1510" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group">Bastiaansen, L. A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Macco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godefroi, E. F.</span><span> </span><span class="NLM_article-title">2-(2-Imidazolyl)acetophenones via aroylation of N-substituted 2-methylimidazoles</span> <span class="citation_source-journal">J. Chem. Soc., Chem. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1974</span><span class="NLM_x">, </span> <span class="NLM_fpage">36</span><span class="refDoi">Â DOI: 10.1039/c39740000036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1039%2Fc39740000036" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1974&pages=36&author=L.+A.+M.+Bastiaansenauthor=A.+A.+Maccoauthor=E.+F.+Godefroi&title=2-%282-Imidazolyl%29acetophenones+via+aroylation+of+N-substituted+2-methylimidazoles&doi=10.1039%2Fc39740000036"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1039%2Fc39740000036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc39740000036%26sid%3Dliteratum%253Aachs%26aulast%3DBastiaansen%26aufirst%3DL.%2BA.%2BM.%26aulast%3DMacco%26aufirst%3DA.%2BA.%26aulast%3DGodefroi%26aufirst%3DE.%2BF.%26atitle%3D2-%25282-Imidazolyl%2529acetophenones%2520via%2520aroylation%2520of%2520N-substituted%25202-methylimidazoles%26jtitle%3DJ.%2520Chem.%2520Soc.%252C%2520Chem.%2520Commun.%26date%3D1974%26spage%3D36%26doi%3D10.1039%2Fc39740000036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group">Macco, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Godefroi, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drouen, J. J. M.</span><span> </span><span class="NLM_article-title">2-(2-Imidazolyl)acetophenones. Preparation and some reactions</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1975</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">252</span><span class="NLM_x">â</span> <span class="NLM_lpage">255</span><span class="refDoi">Â DOI: 10.1021/jo00890a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00890a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1975&pages=252-255&issue=2&author=A.+A.+Maccoauthor=E.+F.+Godefroiauthor=J.+J.+M.+Drouen&title=2-%282-Imidazolyl%29acetophenones.+Preparation+and+some+reactions&doi=10.1021%2Fjo00890a024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fjo00890a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00890a024%26sid%3Dliteratum%253Aachs%26aulast%3DMacco%26aufirst%3DA.%2BA.%26aulast%3DGodefroi%26aufirst%3DE.%2BF.%26aulast%3DDrouen%26aufirst%3DJ.%2BJ.%2BM.%26atitle%3D2-%25282-Imidazolyl%2529acetophenones.%2520Preparation%2520and%2520some%2520reactions%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1975%26volume%3D40%26issue%3D2%26spage%3D252%26epage%3D255%26doi%3D10.1021%2Fjo00890a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group">KnÃ¶lker, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hitzemann, R.</span><span> </span><span class="NLM_article-title">Imidazole derivatives. Part II. Synthesis of imidazo[1,2-a]pyridin-5-ones</span> <span class="citation_source-journal">Heterocycles</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">29</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">1551</span><span class="NLM_x">â</span> <span class="NLM_lpage">1558</span><span class="refDoi">Â DOI: 10.3987/COM-89-5003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.3987%2FCOM-89-5003" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1989&pages=1551-1558&issue=8&author=H.-J.+Kn%C3%B6lkerauthor=R.+Boeseauthor=R.+Hitzemann&title=Imidazole+derivatives.+Part+II.+Synthesis+of+imidazo%5B1%2C2-a%5Dpyridin-5-ones&doi=10.3987%2FCOM-89-5003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.3987%2FCOM-89-5003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-89-5003%26sid%3Dliteratum%253Aachs%26aulast%3DKn%25C3%25B6lker%26aufirst%3DH.-J.%26aulast%3DBoese%26aufirst%3DR.%26aulast%3DHitzemann%26aufirst%3DR.%26atitle%3DImidazole%2520derivatives.%2520Part%2520II.%2520Synthesis%2520of%2520imidazo%255B1%252C2-a%255Dpyridin-5-ones%26jtitle%3DHeterocycles%26date%3D1989%26volume%3D29%26issue%3D8%26spage%3D1551%26epage%3D1558%26doi%3D10.3987%2FCOM-89-5003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group">Lipshutz, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morey, M. C.</span><span> </span><span class="NLM_article-title">An approach to the cyclopeptide alkaloids (phencyclopeptines) via heterocyclic diamide/dipeptide equivalents. Preparation and N-alkylation studies of 2,4(5)-disubstituted imidazoles</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1983</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">3745</span><span class="NLM_x">â</span> <span class="NLM_lpage">3750</span><span class="refDoi">Â DOI: 10.1021/jo00169a027</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00169a027" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1983&pages=3745-3750&issue=21&author=B.+H.+Lipshutzauthor=M.+C.+Morey&title=An+approach+to+the+cyclopeptide+alkaloids+%28phencyclopeptines%29+via+heterocyclic+diamide%2Fdipeptide+equivalents.+Preparation+and+N-alkylation+studies+of+2%2C4%285%29-disubstituted+imidazoles&doi=10.1021%2Fjo00169a027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjo00169a027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00169a027%26sid%3Dliteratum%253Aachs%26aulast%3DLipshutz%26aufirst%3DB.%2BH.%26aulast%3DMorey%26aufirst%3DM.%2BC.%26atitle%3DAn%2520approach%2520to%2520the%2520cyclopeptide%2520alkaloids%2520%2528phencyclopeptines%2529%2520via%2520heterocyclic%2520diamide%252Fdipeptide%2520equivalents.%2520Preparation%2520and%2520N-alkylation%2520studies%2520of%25202%252C4%25285%2529-disubstituted%2520imidazoles%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1983%26volume%3D48%26issue%3D21%26spage%3D3745%26epage%3D3750%26doi%3D10.1021%2Fjo00169a027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group">Groarke, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McKervey, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nieuwenhuyzen, M.</span><span> </span><span class="NLM_article-title">Synthesis of amino acid-derived imidazoles from enantiopure N-protected a-amino glyoxals</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">41</span><span class="NLM_x">, </span> <span class="NLM_fpage">1275</span><span class="NLM_x">â</span> <span class="NLM_lpage">1278</span><span class="refDoi">Â DOI: 10.1016/S0040-4039(99)02267-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FS0040-4039%2899%2902267-4" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2000&pages=1275-1278&author=M.+Groarkeauthor=M.+A.+McKerveyauthor=M.+Nieuwenhuyzen&title=Synthesis+of+amino+acid-derived+imidazoles+from+enantiopure+N-protected+a-amino+glyoxals&doi=10.1016%2FS0040-4039%2899%2902267-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2899%2902267-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252899%252902267-4%26sid%3Dliteratum%253Aachs%26aulast%3DGroarke%26aufirst%3DM.%26aulast%3DMcKervey%26aufirst%3DM.%2BA.%26aulast%3DNieuwenhuyzen%26aufirst%3DM.%26atitle%3DSynthesis%2520of%2520amino%2520acid-derived%2520imidazoles%2520from%2520enantiopure%2520N-protected%2520a-amino%2520glyoxals%26jtitle%3DTetrahedron%2520Lett.%26date%3D2000%26volume%3D41%26spage%3D1275%26epage%3D1278%26doi%3D10.1016%2FS0040-4039%2899%2902267-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group">Palucki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buchwald, S. L.</span><span> </span><span class="NLM_article-title">Palladium-catalyzed alpha-arylation of ketones</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">119</span><span class="NLM_x"> (</span><span class="NLM_issue">45</span><span class="NLM_x">) </span> <span class="NLM_fpage">11108</span><span class="NLM_x">â</span> <span class="NLM_lpage">11109</span><span class="refDoi">Â DOI: 10.1021/ja972593s</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja972593s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=119&publication_year=1997&pages=11108-11109&issue=45&author=M.+Paluckiauthor=S.+L.+Buchwald&title=Palladium-catalyzed+alpha-arylation+of+ketones&doi=10.1021%2Fja972593s"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fja972593s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja972593s%26sid%3Dliteratum%253Aachs%26aulast%3DPalucki%26aufirst%3DM.%26aulast%3DBuchwald%26aufirst%3DS.%2BL.%26atitle%3DPalladium-catalyzed%2520alpha-arylation%2520of%2520ketones%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1997%26volume%3D119%26issue%3D45%26spage%3D11108%26epage%3D11109%26doi%3D10.1021%2Fja972593s" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group">Galante, R. J.</span><span> </span><span class="NLM_article-title">Method of synthesizing sterically hindered 5-substituted-1<i>H</i>-tetrazoles from nitriles using a Lewis acid and an azide</span>. U.S. Patent 5,502,191,<span class="NLM_x"> </span><span class="NLM_year">1996</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&author=R.+J.+Galante&title=Method+of+synthesizing+sterically+hindered+5-substituted-1H-tetrazoles+from+nitriles+using+a+Lewis+acid+and+an+azide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGalante%26aufirst%3DR.%2BJ.%26atitle%3DMethod%2520of%2520synthesizing%2520sterically%2520hindered%25205-substituted-1H-tetrazoles%2520from%2520nitriles%2520using%2520a%2520Lewis%2520acid%2520and%2520an%2520azide%26date%3D1996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group">Stiefl, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gedeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chin, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunt, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindvall, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegel, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springer, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Biller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buenemann, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kanazawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kato, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polyakov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tommasi, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Drie, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vash, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whitehead, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Abagyan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raush, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Totrov, M.</span><span> </span><span class="NLM_article-title">FOCUS-Development of a global communication and modeling platform for applied and computational medicinal chemists</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">896</span><span class="NLM_x">â</span> <span class="NLM_lpage">908</span><span class="refDoi">Â DOI: 10.1021/ci500598e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci500598e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVShtr8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=896-908&issue=4&author=N.+Stieflauthor=P.+Gedeckauthor=D.+Chinauthor=P.+Huntauthor=M.+Lindvallauthor=K.+Spiegelauthor=C.+Springerauthor=S.+Billerauthor=C.+Buenemannauthor=T.+Kanazawaauthor=M.+Katoauthor=R.+Lewisauthor=E.+Martinauthor=V.+Polyakovauthor=R.+Tommasiauthor=J.+van+Drieauthor=B.+Vashauthor=L.+Whiteheadauthor=Y.+Xuauthor=R.+Abagyanauthor=E.+Raushauthor=M.+Totrov&title=FOCUS-Development+of+a+global+communication+and+modeling+platform+for+applied+and+computational+medicinal+chemists&doi=10.1021%2Fci500598e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">FOCUS - Development of a Global Communication and Modeling Platform for Applied and Computational Medicinal Chemists</span></div><div class="casAuthors">Stiefl, Nikolaus; Gedeck, Peter; Chin, Donovan; Hunt, Peter; Lindvall, Mika; Spiegel, Katrin; Springer, Clayton; Biller, Scott; Buenemann, Christoph; Kanazawa, Takanori; Kato, Mitsunori; Lewis, Richard; Martin, Eric; Polyakov, Valery; Tommasi, Ruben; van Drie, John; Vash, Brian; Whitehead, Lewis; Xu, Yongjin; Abagyan, Ruben; Raush, Eugene; Totrov, Max</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">896-908</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Communication of data and ideas within a medicinal chem. project on a global as well as local level is a crucial aspect in the drug design cycle.  Over a time frame of eight years, we built and optimized FOCUS, a platform to produce, visualize, and share information on various aspects of a drug discovery project such as cheminformatics, data anal., structural information, and design.  FOCUS is tightly integrated with internal services that involve-among others-data retrieval systems and in-silico models and provides easy access to automated modeling procedures such as pharmacophore searches, R-group anal., and similarity searches.  In addn., an interactive 3D editor was developed to assist users in the generation and docking of close analogs of a known lead.  In this paper, we will specifically conc. on issues we faced during development, deployment, and maintenance of the software and how we continually adapted the software in order to improve usability.  We will provide usage examples to highlight the functionality as well as limitations of FOCUS at the various stages of the development process.  We aim to make the discussion as independent of the software platform as possible, so that our experiences can be of more general value to the drug discovery community.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozGiXPjxVBHrVg90H21EOLACvtfcHk0liINK8J9INwaA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVShtr8%253D&md5=00541e43a6212701678a400e36996caf</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Fci500598e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci500598e%26sid%3Dliteratum%253Aachs%26aulast%3DStiefl%26aufirst%3DN.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DChin%26aufirst%3DD.%26aulast%3DHunt%26aufirst%3DP.%26aulast%3DLindvall%26aufirst%3DM.%26aulast%3DSpiegel%26aufirst%3DK.%26aulast%3DSpringer%26aufirst%3DC.%26aulast%3DBiller%26aufirst%3DS.%26aulast%3DBuenemann%26aufirst%3DC.%26aulast%3DKanazawa%26aufirst%3DT.%26aulast%3DKato%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DR.%26aulast%3DMartin%26aufirst%3DE.%26aulast%3DPolyakov%26aufirst%3DV.%26aulast%3DTommasi%26aufirst%3DR.%26aulast%3Dvan%2BDrie%26aufirst%3DJ.%26aulast%3DVash%26aufirst%3DB.%26aulast%3DWhitehead%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DAbagyan%26aufirst%3DR.%26aulast%3DRaush%26aufirst%3DE.%26aulast%3DTotrov%26aufirst%3DM.%26atitle%3DFOCUS-Development%2520of%2520a%2520global%2520communication%2520and%2520modeling%2520platform%2520for%2520applied%2520and%2520computational%2520medicinal%2520chemists%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26issue%3D4%26spage%3D896%26epage%3D908%26doi%3D10.1021%2Fci500598e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group">Gedeck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skolnik, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodde, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dollinger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berellini, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vianello, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faller, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lombardo, F.</span><span> </span><span class="NLM_article-title">Benefit of retraining p<i>K</i><sub>a</sub> models studied using internally measured data</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1449</span><span class="NLM_x">â</span> <span class="NLM_lpage">1459</span><span class="refDoi">Â DOI: 10.1021/acs.jcim.5b00172</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jcim.5b00172" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtVShtrvJ" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2015&pages=1449-1459&issue=7&author=P.+Gedeckauthor=Y.+Luauthor=S.+Skolnikauthor=S.+Roddeauthor=G.+Dollingerauthor=W.+Jiaauthor=G.+Berelliniauthor=R.+Vianelloauthor=B.+Fallerauthor=F.+Lombardo&title=Benefit+of+retraining+pKa+models+studied+using+internally+measured+data&doi=10.1021%2Facs.jcim.5b00172"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Benefit of Retraining pKa Models Studied Using Internally Measured Data</span></div><div class="casAuthors">Gedeck, Peter; Lu, Yipin; Skolnik, Suzanne; Rodde, Stephane; Dollinger, Gavin; Jia, Weiping; Berellini, Giuliano; Vianello, Riccardo; Faller, Bernard; Lombardo, Franco</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1449-1459</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The ionization state of drugs influences many pharmaceutical properties such as their soly., permeability, and biol. activity.  It is therefore important to understand the structure property relation for the acid-base dissocn. const. pKa during the lead optimization process to make better-informed design decisions.  Computational approaches, such as implemented in MoKa, can help with this; however, they often predict with too large error esp. for proprietary compds.  In this contribution, the authors look at how retraining helps to greatly improve prediction error.  Using a longitudinal study with data measured over 15 years in a drug discovery environment, the authors assess the impact of model training on prediction accuracy and look at model degrdn. over time.  Using the MoKa software, regular retraining is required to address changes in chem. space leading to model degrdn. over six to nine months.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNCUz-ylPu6bVg90H21EOLACvtfcHk0liINK8J9INwaA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtVShtrvJ&md5=6a178b50d5ac0a597391cc2b19af8e32</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1021%2Facs.jcim.5b00172&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jcim.5b00172%26sid%3Dliteratum%253Aachs%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DRodde%26aufirst%3DS.%26aulast%3DDollinger%26aufirst%3DG.%26aulast%3DJia%26aufirst%3DW.%26aulast%3DBerellini%26aufirst%3DG.%26aulast%3DVianello%26aufirst%3DR.%26aulast%3DFaller%26aufirst%3DB.%26aulast%3DLombardo%26aufirst%3DF.%26atitle%3DBenefit%2520of%2520retraining%2520pKa%2520models%2520studied%2520using%2520internally%2520measured%2520data%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2015%26volume%3D55%26issue%3D7%26spage%3D1449%26epage%3D1459%26doi%3D10.1021%2Facs.jcim.5b00172" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group">Aoki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yokota, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugiura, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sasaki, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hasegawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okumura, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishiguro, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohno, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sugio, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matsuzaki, T.</span><span> </span><span class="NLM_article-title">Structural insight into nucleotide recognition in tau-protein kinase I/glycogen synthase kinase 3 beta</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">439</span><span class="NLM_x">â</span> <span class="NLM_lpage">446</span><span class="refDoi">Â DOI: 10.1107/S090744490302938X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1107%2FS090744490302938X" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=439-446&issue=3&author=M.+Aokiauthor=T.+Yokotaauthor=I.+Sugiuraauthor=C.+Sasakiauthor=T.+Hasegawaauthor=C.+Okumuraauthor=K.+Ishiguroauthor=T.+Kohnoauthor=S.+Sugioauthor=T.+Matsuzaki&title=Structural+insight+into+nucleotide+recognition+in+tau-protein+kinase+I%2Fglycogen+synthase+kinase+3+beta&doi=10.1107%2FS090744490302938X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS090744490302938X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS090744490302938X%26sid%3Dliteratum%253Aachs%26aulast%3DAoki%26aufirst%3DM.%26aulast%3DYokota%26aufirst%3DT.%26aulast%3DSugiura%26aufirst%3DI.%26aulast%3DSasaki%26aufirst%3DC.%26aulast%3DHasegawa%26aufirst%3DT.%26aulast%3DOkumura%26aufirst%3DC.%26aulast%3DIshiguro%26aufirst%3DK.%26aulast%3DKohno%26aufirst%3DT.%26aulast%3DSugio%26aufirst%3DS.%26aulast%3DMatsuzaki%26aufirst%3DT.%26atitle%3DStructural%2520insight%2520into%2520nucleotide%2520recognition%2520in%2520tau-protein%2520kinase%2520I%252Fglycogen%2520synthase%2520kinase%25203%2520beta%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26issue%3D3%26spage%3D439%26epage%3D446%26doi%3D10.1107%2FS090744490302938X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group">Kim, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tarakeshwar, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. Y.</span><span> </span><span class="NLM_article-title">Molecular clusters of Ï-systems: Theoretical studies of structures, spectra, and origin of interaction energies</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">100</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">4145</span><span class="NLM_x">â</span> <span class="NLM_lpage">4186</span><span class="refDoi">Â DOI: 10.1021/cr990051i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr990051i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmslGjtbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2000&pages=4145-4186&issue=11&author=K.+S.+Kimauthor=P.+Tarakeshwarauthor=J.+Y.+Lee&title=Molecular+clusters+of+%CF%80-systems%3A+Theoretical+studies+of+structures%2C+spectra%2C+and+origin+of+interaction+energies&doi=10.1021%2Fcr990051i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Clusters of Ï-Systems: Theoretical Studies of Structures, Spectra, and Origin of Interaction Energies</span></div><div class="casAuthors">Kim, Kwang S.; Tarakeshwar, P.; Lee, Jin Yong</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4145-4185</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 522 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAKpuRX5mQ57Vg90H21EOLACvtfcHk0ljIAhJ4QABykA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmslGjtbw%253D&md5=e7ec9c0f0a7f004761b8a76efa8db502</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1021%2Fcr990051i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr990051i%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DK.%2BS.%26aulast%3DTarakeshwar%26aufirst%3DP.%26aulast%3DLee%26aufirst%3DJ.%2BY.%26atitle%3DMolecular%2520clusters%2520of%2520%25CF%2580-systems%253A%2520Theoretical%2520studies%2520of%2520structures%252C%2520spectra%252C%2520and%2520origin%2520of%2520interaction%2520energies%26jtitle%3DChem.%2520Rev.%26date%3D2000%26volume%3D100%26issue%3D11%26spage%3D4145%26epage%3D4186%26doi%3D10.1021%2Fcr990051i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group">McGaughey, G. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">GagnÃ©, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">RappÃ©, A. K.</span><span> </span><span class="NLM_article-title">pi-Stacking interactions. Alive and well in proteins</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x"> (</span><span class="NLM_issue">25</span><span class="NLM_x">) </span> <span class="NLM_fpage">15458</span><span class="NLM_x">â</span> <span class="NLM_lpage">15463</span><span class="refDoi">Â DOI: 10.1074/jbc.273.25.15458</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1074%2Fjbc.273.25.15458" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=15458-15463&issue=25&author=G.+B.+McGaugheyauthor=M.+Gagn%C3%A9author=A.+K.+Rapp%C3%A9&title=pi-Stacking+interactions.+Alive+and+well+in+proteins&doi=10.1074%2Fjbc.273.25.15458"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.25.15458&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.25.15458%26sid%3Dliteratum%253Aachs%26aulast%3DMcGaughey%26aufirst%3DG.%2BB.%26aulast%3DGagn%25C3%25A9%26aufirst%3DM.%26aulast%3DRapp%25C3%25A9%26aufirst%3DA.%2BK.%26atitle%3Dpi-Stacking%2520interactions.%2520Alive%2520and%2520well%2520in%2520proteins%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26issue%3D25%26spage%3D15458%26epage%3D15463%26doi%3D10.1074%2Fjbc.273.25.15458" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group">Sinnokrot, M. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherrill, C. D.</span><span> </span><span class="NLM_article-title">Substituent effects in ÏâÏ Interactions: Sandwich and T-shaped configurations</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">126</span><span class="NLM_x"> (</span><span class="NLM_issue">24</span><span class="NLM_x">) </span> <span class="NLM_fpage">7690</span><span class="NLM_x">â</span> <span class="NLM_lpage">7697</span><span class="refDoi">Â DOI: 10.1021/ja049434a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja049434a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVejur4%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=126&publication_year=2004&pages=7690-7697&issue=24&author=M.+O.+Sinnokrotauthor=C.+D.+Sherrill&title=Substituent+effects+in+%CF%80%E2%80%93%CF%80+Interactions%3A+Sandwich+and+T-shaped+configurations&doi=10.1021%2Fja049434a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Substituent Effects in Ï-Ï Interactions: Sandwich and T-Shaped Configurations</span></div><div class="casAuthors">Sinnokrot, Mutasem Omar; Sherrill, C. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">126</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7690-7697</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Sandwich and T-shaped configurations of benzene dimer, benzene-phenol, benzene-toluene, benzene-fluorobenzene, and benzene-benzonitrile are studied by coupled-cluster theory to elucidate how substituents tune Ï-Ï interactions.  All substituted sandwich dimers bind more strongly than benzene dimer, whereas the T-shaped configurations bind more or less favorably depending on the substituent.  Symmetry-adapted perturbation theory (SAPT) indicates that electrostatic, dispersion, induction, and exchange-repulsion contributions are all significant to the overall binding energies, and all but induction are important in detg. relative energies.  Models of Ï-Ï interactions based solely on electrostatics, such as the Hunter-Sanders rules, do not seem capable of explaining the energetic ordering of the dimers considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFBZHgFWNA5rVg90H21EOLACvtfcHk0ljIAhJ4QABykA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVejur4%253D&md5=f9c4afdd96f98ecc1d46f93a0ce0f17a</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fja049434a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja049434a%26sid%3Dliteratum%253Aachs%26aulast%3DSinnokrot%26aufirst%3DM.%2BO.%26aulast%3DSherrill%26aufirst%3DC.%2BD.%26atitle%3DSubstituent%2520effects%2520in%2520%25CF%2580%25E2%2580%2593%25CF%2580%2520Interactions%253A%2520Sandwich%2520and%2520T-shaped%2520configurations%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2004%26volume%3D126%26issue%3D24%26spage%3D7690%26epage%3D7697%26doi%3D10.1021%2Fja049434a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group">Bullock, A. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Russo, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Amos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pagano, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bregman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Debreczeni, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">von Delft, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meggers, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">Crystal structure of the PIM2 kinase in complex with an organoruthenium inhibitor</span> <span class="citation_source-journal">PLoS One</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">e7112</span><span class="refDoi">Â DOI: 10.1371/journal.pone.0007112</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1371%2Fjournal.pone.0007112" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2009&pages=e7112&issue=10&author=A.+N.+Bullockauthor=S.+Russoauthor=A.+Amosauthor=N.+Paganoauthor=H.+Bregmanauthor=J.+E.+Debreczeniauthor=W.+H.+Leeauthor=F.+von+Delftauthor=E.+Meggersauthor=S.+Knapp&title=Crystal+structure+of+the+PIM2+kinase+in+complex+with+an+organoruthenium+inhibitor&doi=10.1371%2Fjournal.pone.0007112"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0007112&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0007112%26sid%3Dliteratum%253Aachs%26aulast%3DBullock%26aufirst%3DA.%2BN.%26aulast%3DRusso%26aufirst%3DS.%26aulast%3DAmos%26aufirst%3DA.%26aulast%3DPagano%26aufirst%3DN.%26aulast%3DBregman%26aufirst%3DH.%26aulast%3DDebreczeni%26aufirst%3DJ.%2BE.%26aulast%3DLee%26aufirst%3DW.%2BH.%26aulast%3Dvon%2BDelft%26aufirst%3DF.%26aulast%3DMeggers%26aufirst%3DE.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DCrystal%2520structure%2520of%2520the%2520PIM2%2520kinase%2520in%2520complex%2520with%2520an%2520organoruthenium%2520inhibitor%26jtitle%3DPLoS%2520One%26date%3D2009%26volume%3D4%26issue%3D10%26spage%3De7112%26doi%3D10.1371%2Fjournal.pone.0007112" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group">GuimarÃ£es, C. R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rai, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhattacharya, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Buckbinder, L.</span><span> </span><span class="NLM_article-title">Understanding the impact of the P-loop conformation on kinase selectivity</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1199</span><span class="NLM_x">â</span> <span class="NLM_lpage">1204</span><span class="refDoi">Â DOI: 10.1021/ci200153c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ci200153c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVWls78%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2011&pages=1199-1204&issue=6&author=C.+R.+W.+Guimar%C3%A3esauthor=B.+K.+Raiauthor=M.+J.+Munchhofauthor=S.+Liuauthor=J.+Wangauthor=S.+K.+Bhattacharyaauthor=L.+Buckbinder&title=Understanding+the+impact+of+the+P-loop+conformation+on+kinase+selectivity&doi=10.1021%2Fci200153c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Understanding the impact of the P-loop conformation on kinase selectivity</span></div><div class="casAuthors">Guimaraes, Cristiano R. W.; Rai, Brajesh K.; Munchhof, Michael J.; Liu, Shenping; Wang, Jian; Bhattacharya, Samit K.; Buckbinder, Leonard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1199-1204</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">This work addresses the link between selectivity and an unusual, folded conformation for the P-loop obsd. initially for MAP4K4 kinase and subsequently for other kinases.  Statistical and computational analyses of the authors' crystal structure database demonstrated that inhibitors that induced the P-loop folded conformation tended to be more selective, esp. if they took advantage of this specific conformation by interacting more favorably with a conserved Tyr or Phe residue from the P-loop.  The role of the P-loop in the crystal structures of MAP4K4 kinase and 2 selective inhibitors was discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofyL-cXXqwPLVg90H21EOLACvtfcHk0lhoYQqz7aMgjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVWls78%253D&md5=3179e5f43bf2534badc595dced50d8c4</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fci200153c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci200153c%26sid%3Dliteratum%253Aachs%26aulast%3DGuimar%25C3%25A3es%26aufirst%3DC.%2BR.%2BW.%26aulast%3DRai%26aufirst%3DB.%2BK.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DBhattacharya%26aufirst%3DS.%2BK.%26aulast%3DBuckbinder%26aufirst%3DL.%26atitle%3DUnderstanding%2520the%2520impact%2520of%2520the%2520P-loop%2520conformation%2520on%2520kinase%2520selectivity%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2011%26volume%3D51%26issue%3D6%26spage%3D1199%26epage%3D1204%26doi%3D10.1021%2Fci200153c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group">MÃ¼ller, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaikuad, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knapp, S.</span><span> </span><span class="NLM_article-title">The ins and outs of selective kinase inhibitor development</span> <span class="citation_source-journal">Nat. Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2015</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">818</span><span class="NLM_x">â</span> <span class="NLM_lpage">821</span><span class="refDoi">Â DOI: 10.1038/nchembio.1938</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1038%2Fnchembio.1938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=26485069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1ykt7fF" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2015&pages=818-821&issue=11&author=S.+M%C3%BCllerauthor=A.+Chaikuadauthor=N.+S.+Grayauthor=S.+Knapp&title=The+ins+and+outs+of+selective+kinase+inhibitor+development&doi=10.1038%2Fnchembio.1938"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">The ins and outs of selective kinase inhibitor development</span></div><div class="casAuthors">Muller, Susanne; Chaikuad, Apirat; Gray, Nathanael S.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">818-821</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Protein kinases have emerged as one of the most successful families of drug targets.  To date, most selective kinase inhibitors have been discovered serendipitously either through broad selectivity screening or through the discovery of unique binding modes.  Here the authors discuss design strategies that could lead to a broader coverage of the kinome with selective inhibitors and to a more rational approach for developing them.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQzaMrxSYx_rVg90H21EOLACvtfcHk0lhoYQqz7aMgjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1ykt7fF&md5=f5adf0bbaa388c87b26bae23cfad0bae</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1938%26sid%3Dliteratum%253Aachs%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DGray%26aufirst%3DN.%2BS.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DThe%2520ins%2520and%2520outs%2520of%2520selective%2520kinase%2520inhibitor%2520development%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2015%26volume%3D11%26issue%3D11%26spage%3D818%26epage%3D821%26doi%3D10.1038%2Fnchembio.1938" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group">Pettersen, E. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goddard, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Couch, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greenblatt, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferrin, T. E.</span><span> </span><span class="NLM_article-title">UCSF Chimera-A visualization system for exploratory research and analysis</span> <span class="citation_source-journal">J. Comput. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">13</span><span class="NLM_x">) </span> <span class="NLM_fpage">1605</span><span class="NLM_x">â</span> <span class="NLM_lpage">1612</span><span class="refDoi">Â DOI: 10.1002/jcc.20084</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1002%2Fjcc.20084" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=15264254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2004&pages=1605-1612&issue=13&author=E.+F.+Pettersenauthor=T.+D.+Goddardauthor=C.+C.+Huangauthor=G.+S.+Couchauthor=D.+M.+Greenblattauthor=E.+C.+Mengauthor=T.+E.+Ferrin&title=UCSF+Chimera-A+visualization+system+for+exploratory+research+and+analysis&doi=10.1002%2Fjcc.20084"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">UCSF Chimera-A visualization system for exploratory research and analysis</span></div><div class="casAuthors">Pettersen, Eric F.; Goddard, Thomas D.; Huang, Conrad C.; Couch, Gregory S.; Greenblatt, Daniel M.; Meng, Elaine C.; Ferrin, Thomas E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computational Chemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1605-1612</span>CODEN:
                <span class="NLM_cas:coden">JCCHDD</span>;
        ISSN:<span class="NLM_cas:issn">0192-8651</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">The design, implementation, and capabilities of an extensible visualization system, UCSF Chimera, are discussed.  Chimera is segmented into a core that provides basic services and visualization, and extensions that provide most higher level functionality.  This architecture ensures that the extension mechanism satisfies the demands of outside developers who wish to incorporate new features.  Two unusual extensions are presented: Multiscale, which adds the ability to visualize large-scale mol. assemblies such as viral coats, and Collab., which allows researchers to share a Chimera session interactively despite being at sep. locales.  Other extensions include Multalign Viewer, for showing multiple sequence alignments and assocd. structures; ViewDock, for screening docked ligand orientations; Movie, for replaying mol. dynamics trajectories; and Vol. Viewer, for display and anal. of volumetric data.  A discussion of the usage of Chimera in real-world situations is given, along with anticipated future directions.  Chimera includes full user documentation, is free to academic and nonprofit users, and is available for Microsoft Windows, Linux, Apple Mac OS X, SGI IRIX, and HP Tru64 Unix from http://www.cgl.ucsf.edu/chimera/.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFmD4M5S0cPbVg90H21EOLACvtfcHk0lhoYQqz7aMgjg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvVOhsbs%253D&md5=944b175f440c1ff323705987cf937ee7</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1002%2Fjcc.20084&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjcc.20084%26sid%3Dliteratum%253Aachs%26aulast%3DPettersen%26aufirst%3DE.%2BF.%26aulast%3DGoddard%26aufirst%3DT.%2BD.%26aulast%3DHuang%26aufirst%3DC.%2BC.%26aulast%3DCouch%26aufirst%3DG.%2BS.%26aulast%3DGreenblatt%26aufirst%3DD.%2BM.%26aulast%3DMeng%26aufirst%3DE.%2BC.%26aulast%3DFerrin%26aufirst%3DT.%2BE.%26atitle%3DUCSF%2520Chimera-A%2520visualization%2520system%2520for%2520exploratory%2520research%2520and%2520analysis%26jtitle%3DJ.%2520Comput.%2520Chem.%26date%3D2004%26volume%3D25%26issue%3D13%26spage%3D1605%26epage%3D1612%26doi%3D10.1002%2Fjcc.20084" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group">Ring, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henriksen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nuss, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goff, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnick, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reeder, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuels, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slabiak, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagman, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hammond, M.-E. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. D.</span><span> </span><span class="NLM_article-title">Selective glycogen synthase kinase 3 inhibitors potentiate insulin activation of glucose transport and utilization in vitro and in vivo</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">588</span><span class="NLM_x">â</span> <span class="NLM_lpage">595</span><span class="refDoi">Â DOI: 10.2337/diabetes.52.3.588</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdiabetes.52.3.588" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2003&pages=588-595&issue=3&author=D.+B.+Ringauthor=K.+W.+Johnsonauthor=E.+J.+Henriksenauthor=J.+M.+Nussauthor=D.+Goffauthor=T.+R.+Kinnickauthor=S.+T.+Maauthor=J.+W.+Reederauthor=I.+Samuelsauthor=T.+Slabiakauthor=A.+S.+Wagmanauthor=M.-E.+W.+Hammondauthor=S.+D.+Harrison&title=Selective+glycogen+synthase+kinase+3+inhibitors+potentiate+insulin+activation+of+glucose+transport+and+utilization+in+vitro+and+in+vivo&doi=10.2337%2Fdiabetes.52.3.588"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.52.3.588&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.52.3.588%26sid%3Dliteratum%253Aachs%26aulast%3DRing%26aufirst%3DD.%2BB.%26aulast%3DJohnson%26aufirst%3DK.%2BW.%26aulast%3DHenriksen%26aufirst%3DE.%2BJ.%26aulast%3DNuss%26aufirst%3DJ.%2BM.%26aulast%3DGoff%26aufirst%3DD.%26aulast%3DKinnick%26aufirst%3DT.%2BR.%26aulast%3DMa%26aufirst%3DS.%2BT.%26aulast%3DReeder%26aufirst%3DJ.%2BW.%26aulast%3DSamuels%26aufirst%3DI.%26aulast%3DSlabiak%26aufirst%3DT.%26aulast%3DWagman%26aufirst%3DA.%2BS.%26aulast%3DHammond%26aufirst%3DM.-E.%2BW.%26aulast%3DHarrison%26aufirst%3DS.%2BD.%26atitle%3DSelective%2520glycogen%2520synthase%2520kinase%25203%2520inhibitors%2520potentiate%2520insulin%2520activation%2520of%2520glucose%2520transport%2520and%2520utilization%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DDiabetes%26date%3D2003%26volume%3D52%26issue%3D3%26spage%3D588%26epage%3D595%26doi%3D10.2337%2Fdiabetes.52.3.588" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group">Cohen, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goedert, M.</span><span> </span><span class="NLM_article-title">GSK3 inhibitors: development and therapeutic potential</span> <span class="citation_source-journal">Nat. Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">479</span><span class="NLM_x">â</span> <span class="NLM_lpage">487</span><span class="refDoi">Â DOI: 10.1038/nrd1415</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1038%2Fnrd1415" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=15173837" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD2cXksVaqsrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=479-487&issue=6&author=P.+Cohenauthor=M.+Goedert&title=GSK3+inhibitors%3A+development+and+therapeutic+potential&doi=10.1038%2Fnrd1415"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">GSK3 inhibitors: development and therapeutic potential</span></div><div class="casAuthors">Cohen, Philip; Goedert, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">479-487</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review with refs.  Glycogen synthase kinase-3 (GSK3) was initially identified more than two decades ago as an enzyme involved in the control of glycogen metab.  In recent years it has been shown to have key roles in regulating a diverse range of cellular functions, which have prompted efforts to develop GSK3 inhibitors as therapeutics.  Here, we describe the biol. of GSK3 relevant to its potential as a target for diabetes and neurodegenerative diseases, and discuss progress in the development of GSK3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrL3ua5xi0_qrVg90H21EOLACvtfcHk0lhuRmQJRkabuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXksVaqsrs%253D&md5=165d1354bf11faa6021ac4dba797fda2</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fnrd1415&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd1415%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DGoedert%26aufirst%3DM.%26atitle%3DGSK3%2520inhibitors%253A%2520development%2520and%2520therapeutic%2520potential%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2004%26volume%3D3%26issue%3D6%26spage%3D479%26epage%3D487%26doi%3D10.1038%2Fnrd1415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group">Henriksen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kinnick, T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teachey, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">OâKeefe, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ring, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, S. D.</span><span> </span><span class="NLM_article-title">Modulation of muscle insulin resistance by selective inhibition of GSK-3 in Zucker diabetic fatty rats</span> <span class="citation_source-journal">Am. J. Physiol. - Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">284</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">E892</span><span class="NLM_x">â</span> <span class="NLM_lpage">E900</span><span class="refDoi">Â DOI: 10.1152/ajpendo.00346.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1152%2Fajpendo.00346.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=12517738" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2003&pages=E892-E900&issue=5&author=E.+J.+Henriksenauthor=T.+R.+Kinnickauthor=M.+K.+Teacheyauthor=M.+P.+O%E2%80%99Keefeauthor=D.+Ringauthor=K.+W.+Johnsonauthor=S.+D.+Harrison&title=Modulation+of+muscle+insulin+resistance+by+selective+inhibition+of+GSK-3+in+Zucker+diabetic+fatty+rats&doi=10.1152%2Fajpendo.00346.2002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.00346.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.00346.2002%26sid%3Dliteratum%253Aachs%26aulast%3DHenriksen%26aufirst%3DE.%2BJ.%26aulast%3DKinnick%26aufirst%3DT.%2BR.%26aulast%3DTeachey%26aufirst%3DM.%2BK.%26aulast%3DO%25E2%2580%2599Keefe%26aufirst%3DM.%2BP.%26aulast%3DRing%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DK.%2BW.%26aulast%3DHarrison%26aufirst%3DS.%2BD.%26atitle%3DModulation%2520of%2520muscle%2520insulin%2520resistance%2520by%2520selective%2520inhibition%2520of%2520GSK-3%2520in%2520Zucker%2520diabetic%2520fatty%2520rats%26jtitle%3DAm.%2520J.%2520Physiol.%2520-%2520Endocrinol.%2520Metab.%26date%3D2003%26volume%3D284%26issue%3D5%26spage%3DE892%26epage%3DE900%26doi%3D10.1152%2Fajpendo.00346.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group">Eldar-Finkelman, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krebs, E. G.</span><span> </span><span class="NLM_article-title">Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">94</span><span class="NLM_x"> (</span><span class="NLM_issue">18</span><span class="NLM_x">) </span> <span class="NLM_fpage">9660</span><span class="NLM_x">â</span> <span class="NLM_lpage">9664</span><span class="refDoi">Â DOI: 10.1073/pnas.94.18.9660</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1073%2Fpnas.94.18.9660" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=1997&pages=9660-9664&issue=18&author=H.+Eldar-Finkelmanauthor=E.+G.+Krebs&title=Phosphorylation+of+insulin+receptor+substrate+1+by+glycogen+synthase+kinase+3+impairs+insulin+action&doi=10.1073%2Fpnas.94.18.9660"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1073%2Fpnas.94.18.9660&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.94.18.9660%26sid%3Dliteratum%253Aachs%26aulast%3DEldar-Finkelman%26aufirst%3DH.%26aulast%3DKrebs%26aufirst%3DE.%2BG.%26atitle%3DPhosphorylation%2520of%2520insulin%2520receptor%2520substrate%25201%2520by%2520glycogen%2520synthase%2520kinase%25203%2520impairs%2520insulin%2520action%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1997%26volume%3D94%26issue%3D18%26spage%3D9660%26epage%3D9664%26doi%3D10.1073%2Fpnas.94.18.9660" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group">Smith, L. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rice, K. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garner, C. W.</span><span> </span><span class="NLM_article-title">The insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease</span> <span class="citation_source-journal">Mol. Cell. Endocrinol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">81</span><span class="NLM_x">â</span> <span class="NLM_lpage">92</span><span class="refDoi">Â DOI: 10.1016/0303-7207(96)03875-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2F0303-7207%2896%2903875-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=8898350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADyaK28Xls1KltL0%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=1996&pages=81-92&issue=1&author=L.+K.+Smithauthor=K.+M.+Riceauthor=C.+W.+Garner&title=The+insulin-induced+down-regulation+of+IRS-1+in+3T3-L1+adipocytes+is+mediated+by+a+calcium-dependent+thiol+protease&doi=10.1016%2F0303-7207%2896%2903875-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">The insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease</span></div><div class="casAuthors">Smith, L. Keith; Rice, K. Michael; Garner, Charles W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Endocrinology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">81-92</span>CODEN:
                <span class="NLM_cas:coden">MCEND6</span>;
        ISSN:<span class="NLM_cas:issn">0303-7207</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Insulin receptor substrate-1 (IRS-1) is a protein expressed in 3T3-L1 adipocytes that is involved in most, if not all of the biol. responses to insulin.  Chronic exposure of these cells to insulin down-regulates IRS-1 by stimulating its degrdn. (K.M. Rice, et al., 1993).  This insulin-induced down-regulation of IRS-1 was totally abolished by BAPTA-AM (cell-permeable calcium chelator), E-64d (cell-permeable thiol protease inhibitor), Cbz-Leu-Nleu-H and Cbz-Leu-Leu-Tyr-CHN2 (selective cell-permeable calpain inhibitor peptides).  Calpastatin (specific calpain inhibitor protein) also inhibited the insulin-induced down-regulation of IRS-1 in transiently permeabilized cells.  In addn., 3T3-L1 adipocytes express endogenous calpain which can degrade IRS-1 in cell-free exts.  These results suggest that the insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes is mediated by a calcium-dependent thiol protease which is sensitive to inhibition by calpain inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcVtkHodvnXrVg90H21EOLACvtfcHk0lhuRmQJRkabuA"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28Xls1KltL0%253D&md5=4051c35fa9dd724838a04e67f60eb296</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1016%2F0303-7207%2896%2903875-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0303-7207%252896%252903875-0%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DL.%2BK.%26aulast%3DRice%26aufirst%3DK.%2BM.%26aulast%3DGarner%26aufirst%3DC.%2BW.%26atitle%3DThe%2520insulin-induced%2520down-regulation%2520of%2520IRS-1%2520in%25203T3-L1%2520adipocytes%2520is%2520mediated%2520by%2520a%2520calcium-dependent%2520thiol%2520protease%26jtitle%3DMol.%2520Cell.%2520Endocrinol.%26date%3D1996%26volume%3D122%26issue%3D1%26spage%3D81%26epage%3D92%26doi%3D10.1016%2F0303-7207%2896%2903875-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group">Welsh, G. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proud, C. G.</span><span> </span><span class="NLM_article-title">GSK3: a SHAGGY frog story</span> <span class="citation_source-journal">Trends Cell Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">274</span><span class="NLM_x">â</span> <span class="NLM_lpage">279</span><span class="refDoi">Â DOI: 10.1016/0962-8924(96)10023-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2F0962-8924%2896%2910023-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=15157454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADyaK28XkslGktbw%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=1996&pages=274-279&issue=7&author=G.+I.+Welshauthor=C.+Wilsonauthor=C.+G.+Proud&title=GSK3%3A+a+SHAGGY+frog+story&doi=10.1016%2F0962-8924%2896%2910023-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">GSK3: a SHAGGY frog story</span></div><div class="casAuthors">Welsh, Gavin I.; Wilson, Clive; Proud, Christopher G.</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Cell Biology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">274-279</span>CODEN:
                <span class="NLM_cas:coden">TCBIEK</span>;
        ISSN:<span class="NLM_cas:issn">0962-8924</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Trends Journals</span>)
        </div><div class="casAbstract">A review with 45 refs.  Glycogen synthase kinase 3 (GSK3) was discovered in mammals several years ago but only recently has it become clear that this enzyme is acutely regulated by hormones such as insulin and by growth factors.  In mammals, it appears to be controlled by a signaling pathway linked to phosphoinositide 3-kinase and may regulate a range of biosynthetic processes.  Evidence is now accumulating that GSK3 plays a key role in the regulation of cell fate and differentiation in many eukaryotic species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpquMXmFeajCLVg90H21EOLACvtfcHk0lgdwCRpYQHxtw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XkslGktbw%253D&md5=acf3abccadbdabd39a1bef73d49f646d</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2F0962-8924%2896%2910023-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0962-8924%252896%252910023-4%26sid%3Dliteratum%253Aachs%26aulast%3DWelsh%26aufirst%3DG.%2BI.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DProud%26aufirst%3DC.%2BG.%26atitle%3DGSK3%253A%2520a%2520SHAGGY%2520frog%2520story%26jtitle%3DTrends%2520Cell%2520Biol.%26date%3D1996%26volume%3D6%26issue%3D7%26spage%3D274%26epage%3D279%26doi%3D10.1016%2F0962-8924%2896%2910023-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group">Kolterman, O. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Insel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saekow, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olefsky, J. M.</span><span> </span><span class="NLM_article-title">Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1272</span><span class="NLM_x">â</span> <span class="NLM_lpage">1284</span><span class="refDoi">Â DOI: 10.1172/JCI109790</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1172%2FJCI109790" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1980&pages=1272-1284&issue=6&author=O.+G.+Koltermanauthor=J.+Inselauthor=M.+Saekowauthor=J.+M.+Olefsky&title=Mechanisms+of+insulin+resistance+in+human+obesity%3A+evidence+for+receptor+and+postreceptor+defects&doi=10.1172%2FJCI109790"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1172%2FJCI109790&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI109790%26sid%3Dliteratum%253Aachs%26aulast%3DKolterman%26aufirst%3DO.%2BG.%26aulast%3DInsel%26aufirst%3DJ.%26aulast%3DSaekow%26aufirst%3DM.%26aulast%3DOlefsky%26aufirst%3DJ.%2BM.%26atitle%3DMechanisms%2520of%2520insulin%2520resistance%2520in%2520human%2520obesity%253A%2520evidence%2520for%2520receptor%2520and%2520postreceptor%2520defects%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1980%26volume%3D65%26issue%3D6%26spage%3D1272%26epage%3D1284%26doi%3D10.1172%2FJCI109790" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group">Reaven, G. M.</span><span> </span><span class="NLM_article-title">Role of insulin resistance in human disease (syndrome X): an expanded definition</span> <span class="citation_source-journal">Annu. Rev. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">44</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">121</span><span class="NLM_x">â</span> <span class="NLM_lpage">131</span><span class="refDoi">Â DOI: 10.1146/annurev.me.44.020193.001005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1146%2Fannurev.me.44.020193.001005" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=121-131&issue=1&author=G.+M.+Reaven&title=Role+of+insulin+resistance+in+human+disease+%28syndrome+X%29%3A+an+expanded+definition&doi=10.1146%2Fannurev.me.44.020193.001005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1146%2Fannurev.me.44.020193.001005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1146%252Fannurev.me.44.020193.001005%26sid%3Dliteratum%253Aachs%26aulast%3DReaven%26aufirst%3DG.%2BM.%26atitle%3DRole%2520of%2520insulin%2520resistance%2520in%2520human%2520disease%2520%2528syndrome%2520X%2529%253A%2520an%2520expanded%2520definition%26jtitle%3DAnnu.%2520Rev.%2520Med.%26date%3D1993%26volume%3D44%26issue%3D1%26spage%3D121%26epage%3D131%26doi%3D10.1146%2Fannurev.me.44.020193.001005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group">Shulman, G. I.</span><span> </span><span class="NLM_article-title">Cellular mechanisms of insulin resistance</span> <span class="citation_source-journal">J. Clin. Invest.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">106</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">171</span><span class="NLM_x">â</span> <span class="NLM_lpage">176</span><span class="refDoi">Â DOI: 10.1172/JCI10583</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1172%2FJCI10583" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=106&publication_year=2000&pages=171-176&issue=2&author=G.+I.+Shulman&title=Cellular+mechanisms+of+insulin+resistance&doi=10.1172%2FJCI10583"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1172%2FJCI10583&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI10583%26sid%3Dliteratum%253Aachs%26aulast%3DShulman%26aufirst%3DG.%2BI.%26atitle%3DCellular%2520mechanisms%2520of%2520insulin%2520resistance%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2000%26volume%3D106%26issue%3D2%26spage%3D171%26epage%3D176%26doi%3D10.1172%2FJCI10583" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group">Embi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rylatt, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, P.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase</span> <span class="citation_source-journal">Eur. J. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1980</span><span class="NLM_x">, </span> <span class="NLM_volume">107</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">519</span><span class="NLM_x">â</span> <span class="NLM_lpage">527</span><span class="refDoi">Â DOI: 10.1111/j.1432-1033.1980.tb06059.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1111%2Fj.1432-1033.1980.tb06059.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=6249596" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADyaL3cXkvFSrt7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=1980&pages=519-527&issue=2&author=N.+Embiauthor=D.+B.+Rylattauthor=P.+Cohen&title=Glycogen+synthase+kinase-3+from+rabbit+skeletal+muscle.+Separation+from+cyclic-AMP-dependent+protein+kinase+and+phosphorylase+kinase&doi=10.1111%2Fj.1432-1033.1980.tb06059.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen synthase kinase-3 from rabbit skeletal muscle.  Separation from cyclic AMP-dependent protein kinase and phosphorylase kinase</span></div><div class="casAuthors">Embi, Noor; Rylatt, Dennis B.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Biochemistry</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">519-27</span>CODEN:
                <span class="NLM_cas:coden">EJBCAI</span>;
        ISSN:<span class="NLM_cas:issn">0014-2956</span>.
    </div><div class="casAbstract">A glycogen synthase kinase (I) was partially purified from rabbit skeletal muscle.  I was highly specific for glycogen synthase (II) and was sepd. from virtually all phosvitin kinase and casein kinase activity.  The Km values for ATP and GTP were 0.02 mM and 0.5 mM, resp., and a similar Vmax was obtained with each nucleoside triphosphate.  I was unaffected by cAMP, cGMP, Ca2+, Ca2+ plus calmodulin, and the specific protein inhibitor of cAMP-dependent protein kinase.  I was distinct from both cAMP-dependent protein kinase and phosphorylase kinase, the 2 well characterized I activities in skeletal muscle.  This enzyme was therefore termed I-3.  The phosphorylation of II by I-3 reached a plateau near 1.5 mols. phosphate incorporated/subunit under optimal conditions.  The activity of II measured in the absence of glucose 6-phosphate was decreased 5-fold and the apparent Ka for glucose 6-phosphate was increased 15-fold, when 1.2 mols. phosphate/subunit had been introduced into the enzyme.  Phosphorylation to a similar ext. with either cAMP-dependent protein kinase or phosphorylase kinase produced smaller changes in activity.  II was phosphorylated by cAMP-dependent protein kinase, phosphorylase kinase, and I-3, using conditions where the phosphorylation by any one protein kinase reached a plateau near 1 mol. phosphate incorporated/subunit.  The different protein kinases were used sep. and in combination to generate 7 different phosphorylated species of II.  The phosphorylation of II approached 2 mols./subunit when any 2 protein kinases were combined, and 3 mols./subunit when all 3 protein kinases were combined, and the inactivation produced by the different protein kinases was essentially additive.  The results imply that each protein kinase preferentially phosphorylates a different site(s) on II.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUA4fJprDxL7Vg90H21EOLACvtfcHk0lgdwCRpYQHxtw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXkvFSrt7Y%253D&md5=c7bcf25feb6257362c577bb5cff4a7f1</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1111%2Fj.1432-1033.1980.tb06059.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1432-1033.1980.tb06059.x%26sid%3Dliteratum%253Aachs%26aulast%3DEmbi%26aufirst%3DN.%26aulast%3DRylatt%26aufirst%3DD.%2BB.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520from%2520rabbit%2520skeletal%2520muscle.%2520Separation%2520from%2520cyclic-AMP-dependent%2520protein%2520kinase%2520and%2520phosphorylase%2520kinase%26jtitle%3DEur.%2520J.%2520Biochem.%26date%3D1980%26volume%3D107%26issue%3D2%26spage%3D519%26epage%3D527%26doi%3D10.1111%2Fj.1432-1033.1980.tb06059.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group">Fisher, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolte, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawanaka, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, D.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jones, T. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloszy, J. O.</span><span> </span><span class="NLM_article-title">Glucose transport rate and glycogen synthase activity both limit skeletal muscle glycogen accumulation</span> <span class="citation_source-journal">Am. J. Physiol. Endocrinol. Metab.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">282</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">E1214</span><span class="NLM_x">â</span> <span class="NLM_lpage">E1221</span><span class="refDoi">Â DOI: 10.1152/ajpendo.00254.2001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1152%2Fajpendo.00254.2001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=12006350" title="">PubMed</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=282&publication_year=2002&pages=E1214-E1221&issue=6&author=J.+S.+Fisherauthor=L.+A.+Nolteauthor=K.+Kawanakaauthor=D.-H.+Hanauthor=T.+E.+Jonesauthor=J.+O.+Holloszy&title=Glucose+transport+rate+and+glycogen+synthase+activity+both+limit+skeletal+muscle+glycogen+accumulation&doi=10.1152%2Fajpendo.00254.2001"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1152%2Fajpendo.00254.2001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpendo.00254.2001%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DJ.%2BS.%26aulast%3DNolte%26aufirst%3DL.%2BA.%26aulast%3DKawanaka%26aufirst%3DK.%26aulast%3DHan%26aufirst%3DD.-H.%26aulast%3DJones%26aufirst%3DT.%2BE.%26aulast%3DHolloszy%26aufirst%3DJ.%2BO.%26atitle%3DGlucose%2520transport%2520rate%2520and%2520glycogen%2520synthase%2520activity%2520both%2520limit%2520skeletal%2520muscle%2520glycogen%2520accumulation%26jtitle%3DAm.%2520J.%2520Physiol.%2520Endocrinol.%2520Metab.%26date%3D2002%26volume%3D282%26issue%3D6%26spage%3DE1214%26epage%3DE1221%26doi%3D10.1152%2Fajpendo.00254.2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group">Fioderek, F. T.</span><span> </span><span class="NLM_article-title">Rodent genetic models for obesity and non-insulin-dependent diabetes mellitus</span> <span class="citation_source-journal">Diabetes Mellit.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1996</span><span class="NLM_x">, </span> <span class="NLM_fpage">604</span><span class="NLM_x">â</span> <span class="NLM_lpage">618</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1996&pages=604-618&author=F.+T.+Fioderek&title=Rodent+genetic+models+for+obesity+and+non-insulin-dependent+diabetes+mellitus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFioderek%26aufirst%3DF.%2BT.%26atitle%3DRodent%2520genetic%2520models%2520for%2520obesity%2520and%2520non-insulin-dependent%2520diabetes%2520mellitus%26jtitle%3DDiabetes%2520Mellit.%26date%3D1996%26spage%3D604%26epage%3D618" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group">Ionescu, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauter, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanrenaud, B.</span><span> </span><span class="NLM_article-title">Abnormal oral glucose tolerance in genetically obese (<i>fa</i>/<i>fa</i>) rats</span> <span class="citation_source-journal">Am. J. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1985</span><span class="NLM_x">, </span> <span class="NLM_volume">248</span><span class="NLM_x"> (</span><span class="NLM_issue">5 Pt 1</span><span class="NLM_x">) </span> <span class="NLM_fpage">E500</span><span class="NLM_x">â</span> <span class="NLM_lpage">E506</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=248&publication_year=1985&pages=E500-E506&issue=5+Pt+1&author=E.+Ionescuauthor=J.+F.+Sauterauthor=B.+Jeanrenaud&title=Abnormal+oral+glucose+tolerance+in+genetically+obese+%28fa%2Ffa%29+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DIonescu%26aufirst%3DE.%26aulast%3DSauter%26aufirst%3DJ.%2BF.%26aulast%3DJeanrenaud%26aufirst%3DB.%26atitle%3DAbnormal%2520oral%2520glucose%2520tolerance%2520in%2520genetically%2520obese%2520%2528fa%252Ffa%2529%2520rats%26jtitle%3DAm.%2520J.%2520Physiol.%26date%3D1985%26volume%3D248%26issue%3D5%2520Pt%25201%26spage%3DE500%26epage%3DE506" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group">Terrettaz, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Assimacopoulos-Jeannet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jeanrenaud, B.</span><span> </span><span class="NLM_article-title">Severe hepatic and peripheral insulin resistance as evidenced by euglycemic clamps in genetically obese <i>fa</i>/<i>fa</i> rats</span> <span class="citation_source-journal">Endocrinology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1986</span><span class="NLM_x">, </span> <span class="NLM_volume">118</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">674</span><span class="NLM_x">â</span> <span class="NLM_lpage">678</span><span class="refDoi">Â DOI: 10.1210/endo-118-2-674</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1210%2Fendo-118-2-674" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=118&publication_year=1986&pages=674-678&issue=2&author=J.+Terrettazauthor=F.+Assimacopoulos-Jeannetauthor=B.+Jeanrenaud&title=Severe+hepatic+and+peripheral+insulin+resistance+as+evidenced+by+euglycemic+clamps+in+genetically+obese+fa%2Ffa+rats&doi=10.1210%2Fendo-118-2-674"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1210%2Fendo-118-2-674&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1210%252Fendo-118-2-674%26sid%3Dliteratum%253Aachs%26aulast%3DTerrettaz%26aufirst%3DJ.%26aulast%3DAssimacopoulos-Jeannet%26aufirst%3DF.%26aulast%3DJeanrenaud%26aufirst%3DB.%26atitle%3DSevere%2520hepatic%2520and%2520peripheral%2520insulin%2520resistance%2520as%2520evidenced%2520by%2520euglycemic%2520clamps%2520in%2520genetically%2520obese%2520fa%252Ffa%2520rats%26jtitle%3DEndocrinology%26date%3D1986%26volume%3D118%26issue%3D2%26spage%3D674%26epage%3D678%26doi%3D10.1210%2Fendo-118-2-674" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group">MuÃ±oz, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BarberÃ , A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DomÃ­nguez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">FernÃ ndez-Alvarez, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gomis, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guinovart, J. J.</span><span> </span><span class="NLM_article-title">Effects of tungstate, a new potential oral antidiabetic agent, in Zucker diabetic fatty rats</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">131</span><span class="NLM_x">â</span> <span class="NLM_lpage">138</span><span class="refDoi">Â DOI: 10.2337/diabetes.50.1.131</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdiabetes.50.1.131" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2001&pages=131-138&issue=1&author=M.+C.+Mu%C3%B1ozauthor=A.+Barber%C3%A0author=J.+Dom%C3%ADnguezauthor=J.+Fern%C3%A0ndez-Alvarezauthor=R.+Gomisauthor=J.+J.+Guinovart&title=Effects+of+tungstate%2C+a+new+potential+oral+antidiabetic+agent%2C+in+Zucker+diabetic+fatty+rats&doi=10.2337%2Fdiabetes.50.1.131"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.50.1.131&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.50.1.131%26sid%3Dliteratum%253Aachs%26aulast%3DMu%25C3%25B1oz%26aufirst%3DM.%2BC.%26aulast%3DBarber%25C3%25A0%26aufirst%3DA.%26aulast%3DDom%25C3%25ADnguez%26aufirst%3DJ.%26aulast%3DFern%25C3%25A0ndez-Alvarez%26aufirst%3DJ.%26aulast%3DGomis%26aufirst%3DR.%26aulast%3DGuinovart%26aufirst%3DJ.%2BJ.%26atitle%3DEffects%2520of%2520tungstate%252C%2520a%2520new%2520potential%2520oral%2520antidiabetic%2520agent%252C%2520in%2520Zucker%2520diabetic%2520fatty%2520rats%26jtitle%3DDiabetes%26date%3D2001%26volume%3D50%26issue%3D1%26spage%3D131%26epage%3D138%26doi%3D10.2337%2Fdiabetes.50.1.131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group">Sparks, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phung, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolognino, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cianci, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khurana, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peterson, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sowden, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corsetti, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sparks, C. E.</span><span> </span><span class="NLM_article-title">Lipoprotein alterations in 10- and 20-week-old Zucker diabetic fatty rats: hyperinsulinemic versus insulinopenic hyperglycemia</span> <span class="citation_source-journal">Metab., Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">11</span><span class="NLM_x">) </span> <span class="NLM_fpage">1315</span><span class="NLM_x">â</span> <span class="NLM_lpage">1324</span><span class="refDoi">Â DOI: 10.1016/S0026-0495(98)90298-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FS0026-0495%2898%2990298-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=9826206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADyaK1cXnsFSmuro%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1998&pages=1315-1324&issue=11&author=J.+D.+Sparksauthor=T.+L.+Phungauthor=M.+Bologninoauthor=J.+Cianciauthor=R.+Khuranaauthor=R.+G.+Petersonauthor=M.+P.+Sowdenauthor=J.+P.+Corsettiauthor=C.+E.+Sparks&title=Lipoprotein+alterations+in+10-+and+20-week-old+Zucker+diabetic+fatty+rats%3A+hyperinsulinemic+versus+insulinopenic+hyperglycemia&doi=10.1016%2FS0026-0495%2898%2990298-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Lipoprotein alterations in 10- and 20-week-old Zucker diabetic fatty rats: hyperinsulinemic versus insulinopenic hyperglycemia</span></div><div class="casAuthors">Sparks, Janet D.; Phung, Thuy L.; Bolognino, Mary; Cianci, Joanne; Khurana, Rohit; Peterson, Richard G.; Sowden, Mark P.; Corsetti, James P.; Sparks, Charles E.</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1315-1324</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">Lipoprotein and apolipoprotein parameters were studied in the male Zucker diabetic fatty (ZDF) rat at 10 and 20 wk of age, corresponding to hyperinsulinemic and insulinopenic type 2 diabetes mellitus, resp.  At both ages, ZDF rats had elevated serum triglycerides, free fatty acids, and corticosterone, whereas 20-wk ZDF rats had reduced thyroid hormones.  At 10 wk, the hyperlipidemia was confined to elevations in pre-Î² triglyceride-rich (d < 1.006 g/mL) lipoproteins.  By 20 wk, all lipoprotein d. fractions were increased compared with lean rats, with substantial increases in both low-d. lipoprotein (LDL) and high-d. lipoprotein (HDL) cholesterol.  In ZDF rats, there was a progressive increase in apolipoprotein B (apo B) from 1.9 times control at 10 wk to three times control at 20 wk.  The increase in apo B was accompanied by a shift of apo B, particularly B100, from very-low-d. lipoprotein (VLDL) into denser lipoproteins corresponding to intermediate-d. lipoproteins plus LDLs (1.006 < d < 1.063 g/mL).  In Zucker and 10-wk ZDF rats, in the presence of hyperinsulinemia, the increase in serum apo B was predominantly apo B48 present in VLDL.  By 20 wk, when ZDF rats are insulinopenic, the mass ratio of B48:B 100 shifted from 2.7 to 0.7.  The shift was assocd. with a decrease in hepatic-edited apo B mRNA.  Apo E increased in lean rats between 10 and 20 wk of age.  Although apo E also increased in ZDF rats, the increase by 20 wk was less than that of lean rats.  The molar ratio of apo E to B in VLDL was decreased in ZDF rats.  In lean rats, greater than 50% of apo E was present in HDL, in contrast to ZDF rats, where less than 20% of apo E was present in HDL.  VLDL apo E shifted to denser fractions by 20 wk of age, similar to apo B.  The apo C level was more than double compared with the level in lean rats and was redistributed from the HDL fraction to lipoprotein fractions contg. apo B.  Both apo A-I and apo A-IV levels more than doubled between 10 and 20 wk in ZDF rats.  The ZDF rat model may be useful in comparative studies of lipoproteins during diabetic progression from hyperinsulinemia to insulinopenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkekuFJNEGybVg90H21EOLACvtfcHk0lj6tYTwmL7k1A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnsFSmuro%253D&md5=229ad7207172990365a75bfe1420ed77</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2FS0026-0495%2898%2990298-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0026-0495%252898%252990298-0%26sid%3Dliteratum%253Aachs%26aulast%3DSparks%26aufirst%3DJ.%2BD.%26aulast%3DPhung%26aufirst%3DT.%2BL.%26aulast%3DBolognino%26aufirst%3DM.%26aulast%3DCianci%26aufirst%3DJ.%26aulast%3DKhurana%26aufirst%3DR.%26aulast%3DPeterson%26aufirst%3DR.%2BG.%26aulast%3DSowden%26aufirst%3DM.%2BP.%26aulast%3DCorsetti%26aufirst%3DJ.%2BP.%26aulast%3DSparks%26aufirst%3DC.%2BE.%26atitle%3DLipoprotein%2520alterations%2520in%252010-%2520and%252020-week-old%2520Zucker%2520diabetic%2520fatty%2520rats%253A%2520hyperinsulinemic%2520versus%2520insulinopenic%2520hyperglycemia%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D1998%26volume%3D47%26issue%3D11%26spage%3D1315%26epage%3D1324%26doi%3D10.1016%2FS0026-0495%2898%2990298-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group">Anai, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Funaki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ogihara, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terasaki, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Inukai, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Katagiri, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fukushima, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yazaki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kikuchi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oka, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Asano, T.</span><span> </span><span class="NLM_article-title">Altered expression levels and impaired steps in the pathway to phosphatidylinositol 3-kinase activation via insulin receptor substrates 1 and 2 in Zucker fatty rats</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">13</span><span class="NLM_x">â</span> <span class="NLM_lpage">23</span><span class="refDoi">Â DOI: 10.2337/diab.47.1.13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdiab.47.1.13" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1998&pages=13-23&issue=1&author=M.+Anaiauthor=M.+Funakiauthor=T.+Ogiharaauthor=J.+Terasakiauthor=K.+Inukaiauthor=H.+Katagiriauthor=Y.+Fukushimaauthor=Y.+Yazakiauthor=M.+Kikuchiauthor=Y.+Okaauthor=T.+Asano&title=Altered+expression+levels+and+impaired+steps+in+the+pathway+to+phosphatidylinositol+3-kinase+activation+via+insulin+receptor+substrates+1+and+2+in+Zucker+fatty+rats&doi=10.2337%2Fdiab.47.1.13"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.2337%2Fdiab.47.1.13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiab.47.1.13%26sid%3Dliteratum%253Aachs%26aulast%3DAnai%26aufirst%3DM.%26aulast%3DFunaki%26aufirst%3DM.%26aulast%3DOgihara%26aufirst%3DT.%26aulast%3DTerasaki%26aufirst%3DJ.%26aulast%3DInukai%26aufirst%3DK.%26aulast%3DKatagiri%26aufirst%3DH.%26aulast%3DFukushima%26aufirst%3DY.%26aulast%3DYazaki%26aufirst%3DY.%26aulast%3DKikuchi%26aufirst%3DM.%26aulast%3DOka%26aufirst%3DY.%26aulast%3DAsano%26aufirst%3DT.%26atitle%3DAltered%2520expression%2520levels%2520and%2520impaired%2520steps%2520in%2520the%2520pathway%2520to%2520phosphatidylinositol%25203-kinase%2520activation%2520via%2520insulin%2520receptor%2520substrates%25201%2520and%25202%2520in%2520Zucker%2520fatty%2520rats%26jtitle%3DDiabetes%26date%3D1998%26volume%3D47%26issue%3D1%26spage%3D13%26epage%3D23%26doi%3D10.2337%2Fdiab.47.1.13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group">Brozinick, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misener, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ni, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ryder, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dohm, G. L.</span><span> </span><span class="NLM_article-title">Impaired insulin signaling through GSK3 in insulin resistant skeletal muscle</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">A326</span><span class="NLM_x">â</span> <span class="NLM_lpage">A326</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2000&pages=A326-A326&issue=5&author=J.+T.+Brozinickauthor=E.+A.+Misenerauthor=B.+Niauthor=J.+W.+Ryderauthor=G.+L.+Dohm&title=Impaired+insulin+signaling+through+GSK3+in+insulin+resistant+skeletal+muscle"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrozinick%26aufirst%3DJ.%2BT.%26aulast%3DMisener%26aufirst%3DE.%2BA.%26aulast%3DNi%26aufirst%3DB.%26aulast%3DRyder%26aufirst%3DJ.%2BW.%26aulast%3DDohm%26aufirst%3DG.%2BL.%26atitle%3DImpaired%2520insulin%2520signaling%2520through%2520GSK3%2520in%2520insulin%2520resistant%2520skeletal%2520muscle%26jtitle%3DDiabetes%26date%3D2000%26volume%3D49%26issue%3D5%26spage%3DA326%26epage%3DA326" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group">Luo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hobensack, C. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sullivan, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hector, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reaven, G. M.</span><span> </span><span class="NLM_article-title">Nongenetic mouse models of non-insulin-dependent diabetes mellitus</span> <span class="citation_source-journal">Metab., Clin. Exp.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">663</span><span class="NLM_x">â</span> <span class="NLM_lpage">668</span><span class="refDoi">Â DOI: 10.1016/S0026-0495(98)90027-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FS0026-0495%2898%2990027-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=9627363" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADyaK1cXjslymtLk%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=1998&pages=663-668&issue=6&author=J.+Luoauthor=J.+Quanauthor=J.+Tsaiauthor=C.+K.+Hobensackauthor=C.+Sullivanauthor=R.+Hectorauthor=G.+M.+Reaven&title=Nongenetic+mouse+models+of+non-insulin-dependent+diabetes+mellitus&doi=10.1016%2FS0026-0495%2898%2990027-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Nongenetic mouse models of non-insulin-dependent diabetes mellitus</span></div><div class="casAuthors">Luo, Jian; Quan, Josephine; Tsai, Joyce; Hobensack, Christina K.; Sullivan, Cynthia; Hector, Richard; Reaven, Gerald M.</div><div class="citationInfo"><span class="NLM_cas:title">Metabolism, Clinical and Experimental</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">663-668</span>CODEN:
                <span class="NLM_cas:coden">METAAJ</span>;
        ISSN:<span class="NLM_cas:issn">0026-0495</span>.
    
            (<span class="NLM_cas:orgname">W. B. Saunders Co.</span>)
        </div><div class="casAbstract">The purpose of the study was to develop a mouse model of non-insulin-dependent diabetes mellitus (NIDDM) that closely simulates the metabolic abnormalities of the human disease and is also cost-effective compared with the genetic models currently available.  For this purpose, insulin resistance was induced in male C57BL/6J or Institute of Cancer Research (ICR) mice by feeding diets enriched in either fructose or fat, and hyperglycemia was induced by injecting these mice with a dose of streptozotocin (STZ) that does not cause diabetes in chow-fed mice.  In the case of C57BL/6J mice, insulin levels initially increased in response to the fructose- and fat-enriched diets and then decreased to levels comparable to or still higher than those in chow-fed mice following STZ injection.  Assocd. with the decrease in insulin levels following STZ, fat-fed and fructose-fed C57BL/6J mice became significantly hyperglycemic, reaching values of 388Â±38 and 366Â±58 mg/dL, resp.  In contrast, neither plasma glucose nor insulin concns. changed in chow-fed mice injected with an identical amt. of STZ.  Essentially identical findings were seen before and after STZ injection in fat-fed compared with chow-fed ICR mice.  Although a direct comparison was not made, sensitivity to the diabetogenic effects of STZ appeared to be greater in fat-fed ICR compared with fat-fed C57BL/6J mice.  Finally, plasma glucose decreased when mice with these exptl. models of NIDDM were treated with either metformin or tolbutamide.  Given these results, it seems reasonable to suggest that the combination of dietary-induced insulin resistance and relatively low-dose STZ results in mouse models that should be of use in studying the pathophysiol. of NIDDM or in evaluating therapeutic compds. for the treatment of NIDDM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYE_OOsozDprVg90H21EOLACvtfcHk0lhcNmL7HM7zKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjslymtLk%253D&md5=79ac9a5094e2f9dccebce770f0b14332</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1016%2FS0026-0495%2898%2990027-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0026-0495%252898%252990027-0%26sid%3Dliteratum%253Aachs%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DQuan%26aufirst%3DJ.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DHobensack%26aufirst%3DC.%2BK.%26aulast%3DSullivan%26aufirst%3DC.%26aulast%3DHector%26aufirst%3DR.%26aulast%3DReaven%26aufirst%3DG.%2BM.%26atitle%3DNongenetic%2520mouse%2520models%2520of%2520non-insulin-dependent%2520diabetes%2520mellitus%26jtitle%3DMetab.%252C%2520Clin.%2520Exp.%26date%3D1998%26volume%3D47%26issue%3D6%26spage%3D663%26epage%3D668%26doi%3D10.1016%2FS0026-0495%2898%2990027-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group">Cline, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regittnig, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perret, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tozzo, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Damico, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shulman, G. I.</span><span> </span><span class="NLM_article-title">Effects of a novel glycogen synthase kinase-3 inhibitor on insulin-stimulated glucose metabolism in Zucker diabetic fatty (fa/fa) rats</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">2903</span><span class="NLM_x">â</span> <span class="NLM_lpage">2910</span><span class="refDoi">Â DOI: 10.2337/diabetes.51.10.2903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdiabetes.51.10.2903" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2002&pages=2903-2910&issue=10&author=G.+W.+Clineauthor=K.+Johnsonauthor=W.+Regittnigauthor=P.+Perretauthor=E.+Tozzoauthor=L.+Xiaoauthor=C.+Damicoauthor=G.+I.+Shulman&title=Effects+of+a+novel+glycogen+synthase+kinase-3+inhibitor+on+insulin-stimulated+glucose+metabolism+in+Zucker+diabetic+fatty+%28fa%2Ffa%29+rats&doi=10.2337%2Fdiabetes.51.10.2903"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.2337%2Fdiabetes.51.10.2903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiabetes.51.10.2903%26sid%3Dliteratum%253Aachs%26aulast%3DCline%26aufirst%3DG.%2BW.%26aulast%3DJohnson%26aufirst%3DK.%26aulast%3DRegittnig%26aufirst%3DW.%26aulast%3DPerret%26aufirst%3DP.%26aulast%3DTozzo%26aufirst%3DE.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DDamico%26aufirst%3DC.%26aulast%3DShulman%26aufirst%3DG.%2BI.%26atitle%3DEffects%2520of%2520a%2520novel%2520glycogen%2520synthase%2520kinase-3%2520inhibitor%2520on%2520insulin-stimulated%2520glucose%2520metabolism%2520in%2520Zucker%2520diabetic%2520fatty%2520%2528fa%252Ffa%2529%2520rats%26jtitle%3DDiabetes%26date%3D2002%26volume%3D51%26issue%3D10%26spage%3D2903%26epage%3D2910%26doi%3D10.2337%2Fdiabetes.51.10.2903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group">Ali, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoeflich, K. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Woodgett, J. R.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3: Properties, functions, and regulation</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">101</span><span class="NLM_x"> (</span><span class="NLM_issue">8</span><span class="NLM_x">) </span> <span class="NLM_fpage">2527</span><span class="NLM_x">â</span> <span class="NLM_lpage">2540</span><span class="refDoi">Â DOI: 10.1021/cr000110o</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cr000110o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3MXkvVWnt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2001&pages=2527-2540&issue=8&author=A.+Aliauthor=K.+P.+Hoeflichauthor=J.+R.+Woodgett&title=Glycogen+synthase+kinase-3%3A+Properties%2C+functions%2C+and+regulation&doi=10.1021%2Fcr000110o"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen Synthase Kinase-3: Properties, Functions, and Regulation</span></div><div class="casAuthors">Ali, Adnan; Hoeflich, Klaus P.; Woodgett, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Reviews (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2527-2540</span>CODEN:
                <span class="NLM_cas:coden">CHREAY</span>;
        ISSN:<span class="NLM_cas:issn">0009-2665</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review, with 174 refs., on the isolation, characterization, regulation, and homologs of glycogen synthase kinase-3 and its function in signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7lmtr41nE-7Vg90H21EOLACvtfcHk0lhcNmL7HM7zKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXkvVWnt7s%253D&md5=9372d1f49c2e978ce5cb5b10e025809a</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1021%2Fcr000110o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr000110o%26sid%3Dliteratum%253Aachs%26aulast%3DAli%26aufirst%3DA.%26aulast%3DHoeflich%26aufirst%3DK.%2BP.%26aulast%3DWoodgett%26aufirst%3DJ.%2BR.%26atitle%3DGlycogen%2520synthase%2520kinase-3%253A%2520Properties%252C%2520functions%252C%2520and%2520regulation%26jtitle%3DChem.%2520Rev.%26date%3D2001%26volume%3D101%26issue%3D8%26spage%3D2527%26epage%3D2540%26doi%3D10.1021%2Fcr000110o" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group">Polakis, P.</span><span> </span><span class="NLM_article-title">Wnt signaling in cancer</span> <span class="citation_source-journal">Cold Spring Harbor Perspect. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">a008052</span><span class="NLM_x">â</span> <span class="NLM_lpage">a008052</span><span class="refDoi">Â DOI: 10.1101/cshperspect.a008052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1101%2Fcshperspect.a008052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC38XpvFyrs7Y%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2012&pages=a008052-a008052&issue=5&author=P.+Polakis&title=Wnt+signaling+in+cancer&doi=10.1101%2Fcshperspect.a008052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Wnt signaling in cancer</span></div><div class="casAuthors">Polakis, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Perspectives in Biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">a008052, 14 pp.</span>CODEN:
                <span class="NLM_cas:coden">CSHPEU</span>;
        ISSN:<span class="NLM_cas:issn">1943-0264</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">A review.  Aberrant regulation of the Wnt signaling pathway is a prevalent theme in cancer biol.  From the earliest observation that Wnt overexpression could lead to malignant transformation of mouse mammary tissue to the most recent genetic discoveries gleaned from tumor genome sequencing, the Wnt pathway continues to evolve as a central mechanism in cancer biol.  This article summarizes the evidence supporting a role for Wnt signaling in human cancer.  This includes a review of the genetic mutations affecting Wnt pathway components, as well as some of epigenetic mechanisms that alter expression of genes relevant to Wnt.  I also highlight some research on the cooperativity of Wnt with other signaling pathways in cancer.  Finally, some emphasis is placed on lab. research that provides a proof of concept for the therapeutic inhibition of Wnt signaling in cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqEgUax4MaMv7Vg90H21EOLACvtfcHk0lhcNmL7HM7zKg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XpvFyrs7Y%253D&md5=5a1360a833fa6f284c26c77786758ce8</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1101%2Fcshperspect.a008052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fcshperspect.a008052%26sid%3Dliteratum%253Aachs%26aulast%3DPolakis%26aufirst%3DP.%26atitle%3DWnt%2520signaling%2520in%2520cancer%26jtitle%3DCold%2520Spring%2520Harbor%2520Perspect.%2520Biol.%26date%3D2012%26volume%3D4%26issue%3D5%26spage%3Da008052%26epage%3Da008052%26doi%3D10.1101%2Fcshperspect.a008052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group">Polakis, P.</span><span> </span><span class="NLM_article-title">The many ways of Wnt in cancer</span> <span class="citation_source-journal">Curr. Opin. Genet. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">45</span><span class="NLM_x">â</span> <span class="NLM_lpage">51</span><span class="refDoi">Â DOI: 10.1016/j.gde.2006.12.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2Fj.gde.2006.12.007" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=45-51&issue=1&author=P.+Polakis&title=The+many+ways+of+Wnt+in+cancer&doi=10.1016%2Fj.gde.2006.12.007"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.gde.2006.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.gde.2006.12.007%26sid%3Dliteratum%253Aachs%26aulast%3DPolakis%26aufirst%3DP.%26atitle%3DThe%2520many%2520ways%2520of%2520Wnt%2520in%2520cancer%26jtitle%3DCurr.%2520Opin.%2520Genet.%2520Dev.%26date%3D2007%26volume%3D17%26issue%3D1%26spage%3D45%26epage%3D51%26doi%3D10.1016%2Fj.gde.2006.12.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group">Polakis, P.</span><span> </span><span class="NLM_article-title">Wnt signaling and cancer</span> <span class="citation_source-journal">Genes Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">14</span><span class="NLM_x"> (</span><span class="NLM_issue">15</span><span class="NLM_x">) </span> <span class="NLM_fpage">1837</span><span class="NLM_x">â</span> <span class="NLM_lpage">1851</span><span class="refDoi">Â DOI: 10.1101/gad.14.15.1837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1101%2Fgad.14.15.1837" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2000&pages=1837-1851&issue=15&author=P.+Polakis&title=Wnt+signaling+and+cancer&doi=10.1101%2Fgad.14.15.1837"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1101%2Fgad.14.15.1837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.14.15.1837%26sid%3Dliteratum%253Aachs%26aulast%3DPolakis%26aufirst%3DP.%26atitle%3DWnt%2520signaling%2520and%2520cancer%26jtitle%3DGenes%2520Dev.%26date%3D2000%26volume%3D14%26issue%3D15%26spage%3D1837%26epage%3D1851%26doi%3D10.1101%2Fgad.14.15.1837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group">Harada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ishikawa, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sauer, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Takaku, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taketo, M. M.</span><span> </span><span class="NLM_article-title">Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene</span> <span class="citation_source-journal">EMBO J.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">5931</span><span class="NLM_x">â</span> <span class="NLM_lpage">5942</span><span class="refDoi">Â DOI: 10.1093/emboj/18.21.5931</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1093%2Femboj%2F18.21.5931" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=1999&pages=5931-5942&issue=21&author=N.+Haradaauthor=Y.+Tamaiauthor=T.+Ishikawaauthor=B.+Sauerauthor=K.+Takakuauthor=M.+Oshimaauthor=M.+M.+Taketo&title=Intestinal+polyposis+in+mice+with+a+dominant+stable+mutation+of+the+beta-catenin+gene&doi=10.1093%2Femboj%2F18.21.5931"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1093%2Femboj%2F18.21.5931&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Femboj%252F18.21.5931%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DN.%26aulast%3DTamai%26aufirst%3DY.%26aulast%3DIshikawa%26aufirst%3DT.%26aulast%3DSauer%26aufirst%3DB.%26aulast%3DTakaku%26aufirst%3DK.%26aulast%3DOshima%26aufirst%3DM.%26aulast%3DTaketo%26aufirst%3DM.%2BM.%26atitle%3DIntestinal%2520polyposis%2520in%2520mice%2520with%2520a%2520dominant%2520stable%2520mutation%2520of%2520the%2520beta-catenin%2520gene%26jtitle%3DEMBO%2520J.%26date%3D1999%26volume%3D18%26issue%3D21%26spage%3D5931%26epage%3D5942%26doi%3D10.1093%2Femboj%2F18.21.5931" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group">Coghlan, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culbert, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cross, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corcoran, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yates, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pearce, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rausch, O. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murphy, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carter, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roxbee Cox, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Haigh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, K. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holder, J. C.</span><span> </span><span class="NLM_article-title">Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x"> (</span><span class="NLM_issue">10</span><span class="NLM_x">) </span> <span class="NLM_fpage">793</span><span class="NLM_x">â</span> <span class="NLM_lpage">803</span><span class="refDoi">Â DOI: 10.1016/S1074-5521(00)00025-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FS1074-5521%2800%2900025-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=11033082" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3cXotVWitrs%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2000&pages=793-803&issue=10&author=M.+P.+Coghlanauthor=A.+A.+Culbertauthor=D.+A.+Crossauthor=S.+L.+Corcoranauthor=J.+W.+Yatesauthor=N.+J.+Pearceauthor=O.+L.+Rauschauthor=G.+J.+Murphyauthor=P.+S.+Carterauthor=L.+Roxbee+Coxauthor=D.+Millsauthor=M.+J.+Brownauthor=D.+Haighauthor=R.+W.+Wardauthor=D.+G.+Smithauthor=K.+J.+Murrayauthor=A.+D.+Reithauthor=J.+C.+Holder&title=Selective+small+molecule+inhibitors+of+glycogen+synthase+kinase-3+modulate+glycogen+metabolism+and+gene+transcription&doi=10.1016%2FS1074-5521%2800%2900025-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription</span></div><div class="casAuthors">Coghlan, Matthew P.; Culbert, Ainsley A.; Cross, Darren A. E.; Corcoran, Stacey L.; Yates, John W.; Pearce, Nigel J.; Rausch, Oliver L.; Murphy, Gregory J.; Carter, Paul S.; Cox, Lynne Roxbee; Mills, David; Brown, Murray J.; Haigh, David; Ward, Robert W.; Smith, David G.; Murray, Kenneth J.; Reith, Alastair D.; Holder, Julie C.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">793-803</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Background: Glycogen synthase kinase-3 (GSK-3) is a serine/threonine protein kinase, the activity of which is inhibited by a variety of extracellular stimuli including insulin, growth factors, cell specification factors and cell adhesion.  Consequently, inhibition of GSK-3 activity has been proposed to play a role in the regulation of numerous signaling pathways that elicit pleiotropic cellular responses.  This report describes the identification and characterization of potent and selective small mol. inhibitors of GSK-3.  Results: SB-216763 and SB-415286 are structurally distinct maleimides that inhibit GSK-3Î± in vitro, with Kis of 9 nM and 31 nM resp., in an ATP competitive manner.  These compds. inhibited GSK-3Î² with similar potency.  However, neither compd. significantly inhibited any member of a panel of 24 other protein kinases.  Furthermore, treatment of cells with either compd. stimulated responses characteristic of extracellular stimuli that are known to inhibit GSK-3 activity.  Thus, SB-216763 and SB-415286 stimulated glycogen synthesis in human liver cells and induced expression of a Î²-catenin-LEF/TCF regulated reporter gene in HEK293 cells.  In both cases, compd. treatment was demonstrated to inhibit cellular GSK-3 activity as assessed by activation of glycogen synthase, which is a direct target of this kinase.  Conclusions: SB-216763 and SB-415286 are novel, potent and selective cell permeable inhibitors of GSK-3.  Therefore, these compds. represent valuable pharmacol. tools with which the role of GSK-3 in cellular signaling can be further elucidated.  Furthermore, development of similar compds. may be of use therapeutically in disease states assocd. with elevated GSK-3 activity such as non-insulin dependent diabetes mellitus and neurodegenerative disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFzezTCpDxdLVg90H21EOLACvtfcHk0lhY3sqgJBqgGQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXotVWitrs%253D&md5=86fd3630ddf003af035dd42a20e1a52e</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2FS1074-5521%2800%2900025-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1074-5521%252800%252900025-9%26sid%3Dliteratum%253Aachs%26aulast%3DCoghlan%26aufirst%3DM.%2BP.%26aulast%3DCulbert%26aufirst%3DA.%2BA.%26aulast%3DCross%26aufirst%3DD.%2BA.%26aulast%3DCorcoran%26aufirst%3DS.%2BL.%26aulast%3DYates%26aufirst%3DJ.%2BW.%26aulast%3DPearce%26aufirst%3DN.%2BJ.%26aulast%3DRausch%26aufirst%3DO.%2BL.%26aulast%3DMurphy%26aufirst%3DG.%2BJ.%26aulast%3DCarter%26aufirst%3DP.%2BS.%26aulast%3DRoxbee%2BCox%26aufirst%3DL.%26aulast%3DMills%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DM.%2BJ.%26aulast%3DHaigh%26aufirst%3DD.%26aulast%3DWard%26aufirst%3DR.%2BW.%26aulast%3DSmith%26aufirst%3DD.%2BG.%26aulast%3DMurray%26aufirst%3DK.%2BJ.%26aulast%3DReith%26aufirst%3DA.%2BD.%26aulast%3DHolder%26aufirst%3DJ.%2BC.%26atitle%3DSelective%2520small%2520molecule%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%2520modulate%2520glycogen%2520metabolism%2520and%2520gene%2520transcription%26jtitle%3DChem.%2520Biol.%26date%3D2000%26volume%3D7%26issue%3D10%26spage%3D793%26epage%3D803%26doi%3D10.1016%2FS1074-5521%2800%2900025-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group">Cohen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chetrit, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cohen, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sirota, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Modan, B.</span><span> </span><span class="NLM_article-title">Cancer morbidity in psychiatric patients: influence of lithium carbonate treatment</span> <span class="citation_source-journal">Med. Oncol. Tumor Pharmacother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">32</span><span class="NLM_x">â</span> <span class="NLM_lpage">36</span><span class="refDoi">Â DOI: 10.1007/BF02787342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1007%2FBF02787342" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=1998&pages=32-36&issue=1&author=Y.+Cohenauthor=A.+Chetritauthor=Y.+Cohenauthor=P.+Sirotaauthor=B.+Modan&title=Cancer+morbidity+in+psychiatric+patients%3A+influence+of+lithium+carbonate+treatment&doi=10.1007%2FBF02787342"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1007%2FBF02787342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF02787342%26sid%3Dliteratum%253Aachs%26aulast%3DCohen%26aufirst%3DY.%26aulast%3DChetrit%26aufirst%3DA.%26aulast%3DCohen%26aufirst%3DY.%26aulast%3DSirota%26aufirst%3DP.%26aulast%3DModan%26aufirst%3DB.%26atitle%3DCancer%2520morbidity%2520in%2520psychiatric%2520patients%253A%2520influence%2520of%2520lithium%2520carbonate%2520treatment%26jtitle%3DMed.%2520Oncol.%2520Tumor%2520Pharmacother.%26date%3D1998%26volume%3D15%26issue%3D1%26spage%3D32%26epage%3D36%26doi%3D10.1007%2FBF02787342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group">Kratz, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stearns, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huso, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Slunt, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borchelt, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eberhart, C. G.</span><span> </span><span class="NLM_article-title">Expression of stabilized Î²-catenin in differentiated neurons of transgenic mice does not result in tumor formation</span> <span class="citation_source-journal">BMC Cancer</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">33</span><span class="refDoi">Â DOI: 10.1186/1471-2407-2-33</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1186%2F1471-2407-2-33" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2002&pages=33&issue=1&author=J.+E.+Kratzauthor=D.+Stearnsauthor=D.+L.+Husoauthor=H.+H.+Sluntauthor=D.+L.+Priceauthor=D.+R.+Borcheltauthor=C.+G.+Eberhart&title=Expression+of+stabilized+%CE%B2-catenin+in+differentiated+neurons+of+transgenic+mice+does+not+result+in+tumor+formation&doi=10.1186%2F1471-2407-2-33"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-2-33&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-2-33%26sid%3Dliteratum%253Aachs%26aulast%3DKratz%26aufirst%3DJ.%2BE.%26aulast%3DStearns%26aufirst%3DD.%26aulast%3DHuso%26aufirst%3DD.%2BL.%26aulast%3DSlunt%26aufirst%3DH.%2BH.%26aulast%3DPrice%26aufirst%3DD.%2BL.%26aulast%3DBorchelt%26aufirst%3DD.%2BR.%26aulast%3DEberhart%26aufirst%3DC.%2BG.%26atitle%3DExpression%2520of%2520stabilized%2520%25CE%25B2-catenin%2520in%2520differentiated%2520neurons%2520of%2520transgenic%2520mice%2520does%2520not%2520result%2520in%2520tumor%2520formation%26jtitle%3DBMC%2520Cancer%26date%3D2002%26volume%3D2%26issue%3D1%26spage%3D33%26doi%3D10.1186%2F1471-2407-2-33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group">Johnson, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Puntis, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Todd, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryce, R.</span><span> </span><span class="NLM_article-title">Randomized, dose-finding phase III study of lithium gamolenate in patients with advanced pancreatic adenocarcinoma</span> <span class="citation_source-journal">Br. J. Surg.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">88</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">662</span><span class="NLM_x">â</span> <span class="NLM_lpage">668</span><span class="refDoi">Â DOI: 10.1046/j.0007-1323.2001.01770.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1046%2Fj.0007-1323.2001.01770.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=11350436" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A280%3ADC%252BD3M3mslentg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=88&publication_year=2001&pages=662-668&issue=5&author=C.+D.+Johnsonauthor=M.+Puntisauthor=N.+Davidsonauthor=S.+Toddauthor=R.+Bryce&title=Randomized%2C+dose-finding+phase+III+study+of+lithium+gamolenate+in+patients+with+advanced+pancreatic+adenocarcinoma&doi=10.1046%2Fj.0007-1323.2001.01770.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Randomized, dose-finding phase III study of lithium gamolenate in patients with advanced pancreatic adenocarcinoma</span></div><div class="casAuthors">Johnson C D; Puntis M; Davidson N; Todd S; Bryce R</div><div class="citationInfo"><span class="NLM_cas:title">The British journal of surgery</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">88</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">662-8</span>
        ISSN:<span class="NLM_cas:issn">0007-1323</span>.
    </div><div class="casAbstract">BACKGROUND:  Chemotherapy for pancreatic cancer offers small survival benefits and considerable side-effects.  Unsaturated fatty acids have an antitumour effect in experimental studies; in phase II studies few side-effects were seen.  METHODS:  In this group-sequential, open-label, randomized study, 278 patients with a diagnosis of inoperable pancreatic cancer were treated with either oral (700 mg daily for 15 days), low-dose (0.28 g/kg) or high-dose (0.84 g/kg) intravenous lithium gamolenate (LiGLA).  The primary endpoint was survival time from randomization using Kaplan-Meier estimates.  RESULTS:  Median survival after oral and low-dose intravenous treatment was 129 and 121 days respectively.  Median survival after high-dose intravenous treatment was 94 days.  A good Karnofsky score and the absence of metastases were associated with increased survival.  Haemolysis, a marker of rapid infusion, was associated with a median survival time of 249 days in the low-dose intravenous group.  CONCLUSION:  Oral or low-dose intravenous LiGLA led to survival times similar to those of other treatments for pancreatic cancer although one subgroup (low-dose intravenous LiGLA with haemolysis) had longer survival.  High-dose intravenous treatment appeared to have an adverse effect.  Systemic treatment with LiGLA cannot be recommended for the treatment of pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQuN9MrH1V98S6Ufuk_1xoTfW6udTcc2ea6TeoBR_5IYrntkvexoksv"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3M3mslentg%253D%253D&md5=62b2e7065dadbf9c971f9b3deebe3885</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1046%2Fj.0007-1323.2001.01770.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.0007-1323.2001.01770.x%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DC.%2BD.%26aulast%3DPuntis%26aufirst%3DM.%26aulast%3DDavidson%26aufirst%3DN.%26aulast%3DTodd%26aufirst%3DS.%26aulast%3DBryce%26aufirst%3DR.%26atitle%3DRandomized%252C%2520dose-finding%2520phase%2520III%2520study%2520of%2520lithium%2520gamolenate%2520in%2520patients%2520with%2520advanced%2520pancreatic%2520adenocarcinoma%26jtitle%3DBr.%2520J.%2520Surg.%26date%3D2001%26volume%3D88%26issue%3D5%26spage%3D662%26epage%3D668%26doi%3D10.1046%2Fj.0007-1323.2001.01770.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group">Gould, T. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, N. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Manji, H. K.</span><span> </span><span class="NLM_article-title">Effects of a glycogen synthase kinase-3 inhibitor, lithium, in adenomatous polyposis coli mutant mice</span> <span class="citation_source-journal">Pharmacol. Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">49</span><span class="NLM_x">â</span> <span class="NLM_lpage">53</span><span class="refDoi">Â DOI: 10.1016/S1043-6618(03)00096-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2FS1043-6618%2803%2900096-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=12770514" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3sXktVOgtrg%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2003&pages=49-53&issue=1&author=T.+D.+Gouldauthor=N.+A.+Grayauthor=H.+K.+Manji&title=Effects+of+a+glycogen+synthase+kinase-3+inhibitor%2C+lithium%2C+in+adenomatous+polyposis+coli+mutant+mice&doi=10.1016%2FS1043-6618%2803%2900096-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of a glycogen synthase kinase-3 inhibitor, lithium, in adenomatous polyposis coli mutant mice</span></div><div class="casAuthors">Gould, Todd D.; Gray, Neil A.; Manji, Husseini K.</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacological Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">49-53</span>CODEN:
                <span class="NLM_cas:coden">PHMREP</span>;
        ISSN:<span class="NLM_cas:issn">1043-6618</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Glycogen synthase kinase-3 (GSK-3) is an intermediary enzyme in various cellular pathways, and has been implicated in the pathophysiol. and treatment of numerous diseases, including Alzheimer's disease, diabetes, and bipolar disorder.  There is therefore interest in developing potent, selective GSK-3 inhibitors for the treatment of these devastating illnesses.  A concern, however, is that the Wnt-signaling pathway, of which GSK-3 is an important intermediary mol., has been implicated in many human cancers.  It is thus of considerable importance to det. if GSK-3 inhibitors have tumorigenic potential in systems predisposed to developing tumors by virtue of mutations of the Wnt-signaling pathway.  We therefore investigated the effects of a GSK-3 inhibitor, lithium, in a murine model predisposed to the formation of tumors due to activation of the Wnt pathway, the adenomatous polyposis coli (APC) multiple intestinal neoplasia (min) mouse.  We found that 60 days of lithium treatment did not produce a significant increase in the no. of tumors in these genetically predisposed mice.  Lithium treatment resulted in a modest overall increase in the tumor size.  The APC (min) mouse has previously been shown to be a robust indicator of tumorigenesis, with large increases in tumor no. obsd. in response to a variety of agents; thus, our results suggest that lithium, and perhaps other inhibitors of GSK-3, pose a low risk for the development of cancers of the Wnt pathway.  These results are consistent with the available epidemiol. evidence that long-term lithium therapy does not increase cancer morbidity or mortality, but rather is assocd. with reduced overall mortality in bipolar disorder.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_aSY15kuwOLVg90H21EOLACvtfcHk0lhfW8wC5qP67A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXktVOgtrg%253D&md5=16fcfc1a37a087443a259749b1571413</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2FS1043-6618%2803%2900096-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1043-6618%252803%252900096-3%26sid%3Dliteratum%253Aachs%26aulast%3DGould%26aufirst%3DT.%2BD.%26aulast%3DGray%26aufirst%3DN.%2BA.%26aulast%3DManji%26aufirst%3DH.%2BK.%26atitle%3DEffects%2520of%2520a%2520glycogen%2520synthase%2520kinase-3%2520inhibitor%252C%2520lithium%252C%2520in%2520adenomatous%2520polyposis%2520coli%2520mutant%2520mice%26jtitle%3DPharmacol.%2520Res.%26date%3D2003%26volume%3D48%26issue%3D1%26spage%3D49%26epage%3D53%26doi%3D10.1016%2FS1043-6618%2803%2900096-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group">Cross, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Culbert, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chalmers, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Facci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skaper, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reith, A. D.</span><span> </span><span class="NLM_article-title">Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death</span> <span class="citation_source-journal">J. Neurochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">77</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">94</span><span class="NLM_x">â</span> <span class="NLM_lpage">102</span><span class="refDoi">Â DOI: 10.1046/j.1471-4159.2001.00251.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1046%2Fj.1471-4159.2001.00251.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=11279265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BD3MXis1Klt7s%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2001&pages=94-102&issue=1&author=D.+A.+Crossauthor=A.+A.+Culbertauthor=K.+A.+Chalmersauthor=L.+Facciauthor=S.+D.+Skaperauthor=A.+D.+Reith&title=Selective+small-molecule+inhibitors+of+glycogen+synthase+kinase-3+activity+protect+primary+neurones+from+death&doi=10.1046%2Fj.1471-4159.2001.00251.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurons from death</span></div><div class="casAuthors">Cross, Darren A. E.; Culbert, Ainsley A.; Chalmers, Katy A.; Facci, Laura; Skaper, Stephen D.; Reith, Alastair D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">94-102</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Science Ltd.</span>)
        </div><div class="casAbstract">The phosphatidylinositol 3-kinase (PI 3-kinase)/protein kinase B (PKB; also known as Akt) signaling pathway is recognized as playing a central role in the survival of diverse cell types.  Glycogen synthase kinase-3 (GSK-3) is a ubiquitously expressed serine/threonine protein kinase that is one of several known substrates of PKB.  PKB phosphorylates GSK-3 in response to insulin and growth factors, which inhibits GSK-3 activity and leads to the modulation of multiple GSK-3 regulated cellular processes.  We show that the novel potent and selective small-mol. inhibitors of GSK-3; SB-415286 and SB-216763, protect both central and peripheral nervous system neurons in culture from death induced by reduced PI 3-kinase pathway activity.  The inhibition of neuronal death mediated by these compds. correlated with inhibition of GSK-3 activity and modulation of GSK-3 substrates tau and Î²-catenin.  Thus, in addn. to the previously assigned roles of GSK-3, our data provide clear pharmacol. and biochem. evidence that selective inhibition of the endogenous pool of GSK-3 activity in primary neurons is sufficient to prevent death, implicating GSK-3 as a physiol. relevant principal regulatory target of the PI 3-kinase/PKB neuronal survival pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoE0yo5rwTmELVg90H21EOLACvtfcHk0lhfW8wC5qP67A"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXis1Klt7s%253D&md5=991edcb9e3ed5d6164374b89eb746c00</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1046%2Fj.1471-4159.2001.00251.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1046%252Fj.1471-4159.2001.00251.x%26sid%3Dliteratum%253Aachs%26aulast%3DCross%26aufirst%3DD.%2BA.%26aulast%3DCulbert%26aufirst%3DA.%2BA.%26aulast%3DChalmers%26aufirst%3DK.%2BA.%26aulast%3DFacci%26aufirst%3DL.%26aulast%3DSkaper%26aufirst%3DS.%2BD.%26aulast%3DReith%26aufirst%3DA.%2BD.%26atitle%3DSelective%2520small-molecule%2520inhibitors%2520of%2520glycogen%2520synthase%2520kinase-3%2520activity%2520protect%2520primary%2520neurones%2520from%2520death%26jtitle%3DJ.%2520Neurochem.%26date%3D2001%26volume%3D77%26issue%3D1%26spage%3D94%26epage%3D102%26doi%3D10.1046%2Fj.1471-4159.2001.00251.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group">Harada, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyoshi, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murai, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tamai, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oshima, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taketo, M. M.</span><span> </span><span class="NLM_article-title">Lack of tumorigenesis in the mouse liver after adenovirus-mediated expression of a dominant stable mutant of beta-catenin</span> <span class="citation_source-journal">Cancer Res.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">62</span><span class="NLM_x"> (</span><span class="NLM_issue">7</span><span class="NLM_x">) </span> <span class="NLM_fpage">1971</span><span class="NLM_x">â</span> <span class="NLM_lpage">1977</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2002&pages=1971-1977&issue=7&author=N.+Haradaauthor=H.+Miyoshiauthor=N.+Muraiauthor=H.+Oshimaauthor=Y.+Tamaiauthor=M.+Oshimaauthor=M.+M.+Taketo&title=Lack+of+tumorigenesis+in+the+mouse+liver+after+adenovirus-mediated+expression+of+a+dominant+stable+mutant+of+beta-catenin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DN.%26aulast%3DMiyoshi%26aufirst%3DH.%26aulast%3DMurai%26aufirst%3DN.%26aulast%3DOshima%26aufirst%3DH.%26aulast%3DTamai%26aufirst%3DY.%26aulast%3DOshima%26aufirst%3DM.%26aulast%3DTaketo%26aufirst%3DM.%2BM.%26atitle%3DLack%2520of%2520tumorigenesis%2520in%2520the%2520mouse%2520liver%2520after%2520adenovirus-mediated%2520expression%2520of%2520a%2520dominant%2520stable%2520mutant%2520of%2520beta-catenin%26jtitle%3DCancer%2520Res.%26date%3D2002%26volume%3D62%26issue%3D7%26spage%3D1971%26epage%3D1977" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group">Zhang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Welzig, C. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Picard, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, J. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kyriakis, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aronovitz, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Claycomb, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanton, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galper, J. B.</span><span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 inhibition ameliorates cardiac parasympathetic dysfunction in type 1 diabetic Akita mice</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">63</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">2097</span><span class="NLM_x">â</span> <span class="NLM_lpage">2113</span><span class="refDoi">Â DOI: 10.2337/db12-1459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdb12-1459" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=2097-2113&issue=6&author=Y.+Zhangauthor=C.+M.+Welzigauthor=K.+L.+Picardauthor=C.+Duauthor=B.+Wangauthor=J.+Q.+Panauthor=J.+M.+Kyriakisauthor=M.+J.+Aronovitzauthor=W.+C.+Claycombauthor=R.+M.+Blantonauthor=H.-J.+Parkauthor=J.+B.+Galper&title=Glycogen+synthase+kinase-3+inhibition+ameliorates+cardiac+parasympathetic+dysfunction+in+type+1+diabetic+Akita+mice&doi=10.2337%2Fdb12-1459"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.2337%2Fdb12-1459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb12-1459%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWelzig%26aufirst%3DC.%2BM.%26aulast%3DPicard%26aufirst%3DK.%2BL.%26aulast%3DDu%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DPan%26aufirst%3DJ.%2BQ.%26aulast%3DKyriakis%26aufirst%3DJ.%2BM.%26aulast%3DAronovitz%26aufirst%3DM.%2BJ.%26aulast%3DClaycomb%26aufirst%3DW.%2BC.%26aulast%3DBlanton%26aufirst%3DR.%2BM.%26aulast%3DPark%26aufirst%3DH.-J.%26aulast%3DGalper%26aufirst%3DJ.%2BB.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520inhibition%2520ameliorates%2520cardiac%2520parasympathetic%2520dysfunction%2520in%2520type%25201%2520diabetic%2520Akita%2520mice%26jtitle%3DDiabetes%26date%3D2014%26volume%3D63%26issue%3D6%26spage%3D2097%26epage%3D2113%26doi%3D10.2337%2Fdb12-1459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group">Weikel, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cacicedo, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruderman, N. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ido, Y.</span><span> </span><span class="NLM_article-title">Knockdown of GSK3 increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cells</span> <span class="citation_source-journal">Biosci. Rep.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2016</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">e00382</span><span class="NLM_x">â</span> <span class="NLM_lpage">e00382</span><span class="refDoi">Â DOI: 10.1042/BSR20160174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1042%2FBSR20160174" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=27534430" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Ont7g%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2016&pages=e00382-e00382&issue=5&author=K.+A.+Weikelauthor=J.+M.+Cacicedoauthor=N.+B.+Rudermanauthor=Y.+Ido&title=Knockdown+of+GSK3+increases+basal+autophagy+and+AMPK+signalling+in+nutrient-laden+human+aortic+endothelial+cells&doi=10.1042%2FBSR20160174"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Knockdown of GSK3Î² increases basal autophagy and AMPK signalling in nutrient-laden human aortic endothelial cells</span></div><div class="casAuthors">Weikel, Karen A.; Cacicedo, Jose M.; Ruderman, Neil B.; Ido, Yasuo</div><div class="citationInfo"><span class="NLM_cas:title">Bioscience Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e00382/1-e00382/16</span>CODEN:
                <span class="NLM_cas:coden">BRPTDT</span>;
        ISSN:<span class="NLM_cas:issn">0144-8463</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">High concns. of glucose and palmitate increase endothelial cell inflammation and apoptosis, events that often precede atherogenesis.  They may do so by decreasing basal autophagy and AMP-activated protein kinase (AMPK) activity, although the mechanisms by which this occurs are not clear.  Decreased function of the lysosome, an organelle required for autophagy and AMPK, have been assocd. with hyperactivity of glycogen synthase kinase 3Î² (GSK3Î²).  To det. whether GSK3Î² affects nutrient-induced changes in autophagy and AMPK activity, we used a primary human aortic endothelial cell (HAEC) model of type 2 diabetes that we had previously characterized with impaired AMPK activity and autophagy.  Presently, we found that incubation of HAECs with excess nutrients (25 mM glucose and 0.4 mM palmitate) increased GSK3Î² activity and impaired lysosome acidification.  Suppression of GSK3Î² in these cells by treatment with a chem. inhibitor or overexpression of kinase-dead GSK3Î² attenuated these lysosomal changes.  Under control and excess nutrient conditions, knockdown of GSK3Î² increased autophagosome formation, forkhead box protein O1 (FOXO1) activity and AMPK signalling and decreased Akt signalling.  Similar changes in autophagy, AMPK and Akt signalling were obsd. in aortas from mice treated with the GSK3Î² inhibitor CHIR 99021.  Thus, increasing basal autophagy and AMPK activity by inhibiting GSK3Î² may be an effective strategy in the setting of hyperglycemia and dyslipidemia for restoring endothelial cell health and reducing atherogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUk-NlyPIEaLVg90H21EOLACvtfcHk0lhRPSz84cEeTQ"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Ont7g%253D&md5=59a6cca974121cd52eab168554b3c488</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1042%2FBSR20160174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBSR20160174%26sid%3Dliteratum%253Aachs%26aulast%3DWeikel%26aufirst%3DK.%2BA.%26aulast%3DCacicedo%26aufirst%3DJ.%2BM.%26aulast%3DRuderman%26aufirst%3DN.%2BB.%26aulast%3DIdo%26aufirst%3DY.%26atitle%3DKnockdown%2520of%2520GSK3%2520increases%2520basal%2520autophagy%2520and%2520AMPK%2520signalling%2520in%2520nutrient-laden%2520human%2520aortic%2520endothelial%2520cells%26jtitle%3DBiosci.%2520Rep.%26date%3D2016%26volume%3D36%26issue%3D5%26spage%3De00382%26epage%3De00382%26doi%3D10.1042%2FBSR20160174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group">Marchand, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tremblay, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cagnol, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boucher, M.-J.</span><span> </span><span class="NLM_article-title">Inhibition of glycogen synthase kinase-3 activity triggers an apoptotic response in pancreatic cancer cells through JNK-dependent mechanisms</span> <span class="citation_source-journal">Carcinogenesis</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">33</span><span class="NLM_x"> (</span><span class="NLM_issue">3</span><span class="NLM_x">) </span> <span class="NLM_fpage">529</span><span class="NLM_x">â</span> <span class="NLM_lpage">537</span><span class="refDoi">Â DOI: 10.1093/carcin/bgr309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1093%2Fcarcin%2Fbgr309" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2012&pages=529-537&issue=3&author=B.+Marchandauthor=I.+Tremblayauthor=S.+Cagnolauthor=M.-J.+Boucher&title=Inhibition+of+glycogen+synthase+kinase-3+activity+triggers+an+apoptotic+response+in+pancreatic+cancer+cells+through+JNK-dependent+mechanisms&doi=10.1093%2Fcarcin%2Fbgr309"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1093%2Fcarcin%2Fbgr309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcarcin%252Fbgr309%26sid%3Dliteratum%253Aachs%26aulast%3DMarchand%26aufirst%3DB.%26aulast%3DTremblay%26aufirst%3DI.%26aulast%3DCagnol%26aufirst%3DS.%26aulast%3DBoucher%26aufirst%3DM.-J.%26atitle%3DInhibition%2520of%2520glycogen%2520synthase%2520kinase-3%2520activity%2520triggers%2520an%2520apoptotic%2520response%2520in%2520pancreatic%2520cancer%2520cells%2520through%2520JNK-dependent%2520mechanisms%26jtitle%3DCarcinogenesis%26date%3D2012%26volume%3D33%26issue%3D3%26spage%3D529%26epage%3D537%26doi%3D10.1093%2Fcarcin%2Fbgr309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group">Bock, A. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leigh, N. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bryda, E. C.</span><span> </span><span class="NLM_article-title">Effect of Gsk3 inhibitor CHIR99021 on aneuploidy levels in rat embryonic stem cells</span> <span class="citation_source-journal">In Vitro Cell. Dev. Biol.: Anim.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">572</span><span class="NLM_x">â</span> <span class="NLM_lpage">579</span><span class="refDoi">Â DOI: 10.1007/s11626-014-9734-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1007%2Fs11626-014-9734-5" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=572-579&issue=6&author=A.+S.+Bockauthor=N.+D.+Leighauthor=E.+C.+Bryda&title=Effect+of+Gsk3+inhibitor+CHIR99021+on+aneuploidy+levels+in+rat+embryonic+stem+cells&doi=10.1007%2Fs11626-014-9734-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1007%2Fs11626-014-9734-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11626-014-9734-5%26sid%3Dliteratum%253Aachs%26aulast%3DBock%26aufirst%3DA.%2BS.%26aulast%3DLeigh%26aufirst%3DN.%2BD.%26aulast%3DBryda%26aufirst%3DE.%2BC.%26atitle%3DEffect%2520of%2520Gsk3%2520inhibitor%2520CHIR99021%2520on%2520aneuploidy%2520levels%2520in%2520rat%2520embryonic%2520stem%2520cells%26jtitle%3DIn%2520Vitro%2520Cell.%2520Dev.%2520Biol.%253A%2520Anim.%26date%3D2014%26volume%3D50%26issue%3D6%26spage%3D572%26epage%3D579%26doi%3D10.1007%2Fs11626-014-9734-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group">Buikema, J. W.; Zwetsloot, P.-P. M.; Doevendans, P. A.; Sluijter, J. P. G.; Domian, I. J.</span><span> </span><span class="NLM_article-title">Expanding Mouse Ventricular Cardiomyocytes Through GSK-3 Inhibition</span>. In  <span class="citation_source-book">Current Protocols in Cell Biology</span>; <span class="NLM_publisher-name">John Wiley & Sons, Inc.</span>: <span class="NLM_publisher-loc">Hoboken, NJ</span>,<span class="NLM_x"> </span><span class="NLM_year">2013</span><span class="NLM_x">; </span>Vol.  <span class="NLM_volume">61</span>, pp  <span class="NLM_fpage">23.9.1</span><span class="NLM_x">â</span> <span class="NLM_lpage">23.9.10</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1002%2F0471143030.cb2309s61" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=23.9.1-23.9.10&author=J.+W.+Buikema&author=P.-P.+M.+Zwetsloot&author=P.+A.+Doevendans&author=J.+P.+G.+Sluijter&author=I.+J.+Domian&title=Current+Protocols+in+Cell+Biology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1002%2F0471143030.cb2309s61&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F0471143030.cb2309s61%26sid%3Dliteratum%253Aachs%26aulast%3DBuikema%26aufirst%3DJ.%2BW.%26atitle%3DExpanding%2520Mouse%2520Ventricular%2520Cardiomyocytes%2520Through%2520GSK-3%2520Inhibition%26btitle%3DCurrent%2520Protocols%2520in%2520Cell%2520Biology%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26date%3D2013%26volume%3D61%26spage%3D23.9.1%26epage%3D23.9.10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group">Carter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">VancurovÃ¡, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lou, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeLeon, S.</span><span> </span><span class="NLM_article-title">A DNA-Activated Protein Kinase from HeLa Cell Nuclei</span> <span class="citation_source-journal">Mol. Cell. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x"> (</span><span class="NLM_issue">12</span><span class="NLM_x">) </span> <span class="NLM_fpage">6460</span><span class="NLM_x">â</span> <span class="NLM_lpage">6471</span><span class="refDoi">Â DOI: 10.1128/MCB.10.12.6460</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1128%2FMCB.10.12.6460" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=2247066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADyaK3MXlsl2itg%253D%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=1990&pages=6460-6471&issue=12&author=T.+Carterauthor=I.+Vancurov%C3%A1author=I.+Sunauthor=W.+Louauthor=S.+DeLeon&title=A+DNA-Activated+Protein+Kinase+from+HeLa+Cell+Nuclei&doi=10.1128%2FMCB.10.12.6460"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">A DNA-activated protein kinase from HeLa cell nuclei</span></div><div class="casAuthors">Carter, Timothy; Vancurova, Ivana; Sun, Ivon; Lou, Willard; DeLeon, Susan</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biology</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6460-71</span>CODEN:
                <span class="NLM_cas:coden">MCEBD4</span>;
        ISSN:<span class="NLM_cas:issn">0270-7306</span>.
    </div><div class="casAbstract">A DNA-activated protein kinase (DNA-PK) was purified from nuclei of HeLa cells.  The activity was assocd. with a single high-mol.-wt. (â¼300,000) polypeptide when analyzed by gel filtration, denaturing PAGE, and Western immunoblotting using a monoclonal antibody that also inhibited enzyme activity.  Nuclear localization was indicated by subcellular fractionation and confirmed by immunofluorescence on whole cells.  Double-stranded DNA stimulated phosphorylation of the 300-kDa polypeptide in purified prepns. as well as phosphorylation of the exogenous substrates, Î±-casein, simian virus 40 large T antigen, and human heat-shock protein hsp90.  Autophosphorylation led to inactivation of the enzyme.  The phosphorylation of casein was stimulated >30-fold by DNA and was specific for serine and threonine residues.  Bovine serum albumin and histone H1 were poor substrates for DNA-PK, and no phosphorylation of IgG or histones other than H1 was obsd.  Supercoiled or heat-denatured DNA and synthetic double-stranded RNA or RNA-DNA copolymers did not stimulate casein phosphorylation by DNA-PK.  The interaction of the enzyme with DNA in the absence of exogenous substrates was demonstrated by thermal inactivation and gel mobility shifts.  These characteristics identified DNA-PK as distinct from other protein kinases described in the literature and suggested that activation by DNA is an important feature of the enzyme's in vivo function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMF7b5JvuxXrVg90H21EOLACvtfcHk0liNgHjKTl8Tqw"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXlsl2itg%253D%253D&md5=7c4ff2dabb9b0545bae4c97e7b466b5f</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1128%2FMCB.10.12.6460&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FMCB.10.12.6460%26sid%3Dliteratum%253Aachs%26aulast%3DCarter%26aufirst%3DT.%26aulast%3DVancurov%25C3%25A1%26aufirst%3DI.%26aulast%3DSun%26aufirst%3DI.%26aulast%3DLou%26aufirst%3DW.%26aulast%3DDeLeon%26aufirst%3DS.%26atitle%3DA%2520DNA-Activated%2520Protein%2520Kinase%2520from%2520HeLa%2520Cell%2520Nuclei%26jtitle%3DMol.%2520Cell.%2520Biol.%26date%3D1990%26volume%3D10%26issue%3D12%26spage%3D6460%26epage%3D6471%26doi%3D10.1128%2FMCB.10.12.6460" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group">Rubinfeld, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munemitsu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clark, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Conroy, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Watt, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crosier, W. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCormick, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Polakis, P.</span><span> </span><span class="NLM_article-title">Molecular cloning of a GTPase activating protein specific for the Krev-1 protein p21rap1</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">65</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">1033</span><span class="NLM_x">â</span> <span class="NLM_lpage">1042</span><span class="refDoi">Â DOI: 10.1016/0092-8674(91)90555-D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2F0092-8674%2891%2990555-D" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=1991&pages=1033-1042&issue=6&author=B.+Rubinfeldauthor=S.+Munemitsuauthor=R.+Clarkauthor=L.+Conroyauthor=K.+Wattauthor=W.+J.+Crosierauthor=F.+McCormickauthor=P.+Polakis&title=Molecular+cloning+of+a+GTPase+activating+protein+specific+for+the+Krev-1+protein+p21rap1&doi=10.1016%2F0092-8674%2891%2990555-D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2F0092-8674%2891%2990555-D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0092-8674%252891%252990555-D%26sid%3Dliteratum%253Aachs%26aulast%3DRubinfeld%26aufirst%3DB.%26aulast%3DMunemitsu%26aufirst%3DS.%26aulast%3DClark%26aufirst%3DR.%26aulast%3DConroy%26aufirst%3DL.%26aulast%3DWatt%26aufirst%3DK.%26aulast%3DCrosier%26aufirst%3DW.%2BJ.%26aulast%3DMcCormick%26aufirst%3DF.%26aulast%3DPolakis%26aufirst%3DP.%26atitle%3DMolecular%2520cloning%2520of%2520a%2520GTPase%2520activating%2520protein%2520specific%2520for%2520the%2520Krev-1%2520protein%2520p21rap1%26jtitle%3DCell%26date%3D1991%26volume%3D65%26issue%3D6%26spage%3D1033%26epage%3D1042%26doi%3D10.1016%2F0092-8674%2891%2990555-D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group">Klein, H. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kowalewski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Drenckhan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Neugebauer, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Matthaei, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kotzke, G.</span><span> </span><span class="NLM_article-title">A Microtiter well assay system to measure insulin activation of insulin receptor kinase in intact human mononuclear cells. Decreased insulin effect in cells from patients with NIDDM</span> <span class="citation_source-journal">Diabetes</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x"> (</span><span class="NLM_issue">6</span><span class="NLM_x">) </span> <span class="NLM_fpage">883</span><span class="NLM_x">â</span> <span class="NLM_lpage">890</span><span class="refDoi">Â DOI: 10.2337/diab.42.6.883</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.2337%2Fdiab.42.6.883" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1993&pages=883-890&issue=6&author=H.+H.+Kleinauthor=B.+Kowalewskiauthor=M.+Drenckhanauthor=S.+Neugebauerauthor=S.+Matthaeiauthor=G.+Kotzke&title=A+Microtiter+well+assay+system+to+measure+insulin+activation+of+insulin+receptor+kinase+in+intact+human+mononuclear+cells.+Decreased+insulin+effect+in+cells+from+patients+with+NIDDM&doi=10.2337%2Fdiab.42.6.883"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.2337%2Fdiab.42.6.883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdiab.42.6.883%26sid%3Dliteratum%253Aachs%26aulast%3DKlein%26aufirst%3DH.%2BH.%26aulast%3DKowalewski%26aufirst%3DB.%26aulast%3DDrenckhan%26aufirst%3DM.%26aulast%3DNeugebauer%26aufirst%3DS.%26aulast%3DMatthaei%26aufirst%3DS.%26aulast%3DKotzke%26aufirst%3DG.%26atitle%3DA%2520Microtiter%2520well%2520assay%2520system%2520to%2520measure%2520insulin%2520activation%2520of%2520insulin%2520receptor%2520kinase%2520in%2520intact%2520human%2520mononuclear%2520cells.%2520Decreased%2520insulin%2520effect%2520in%2520cells%2520from%2520patients%2520with%2520NIDDM%26jtitle%3DDiabetes%26date%3D1993%26volume%3D42%26issue%3D6%26spage%3D883%26epage%3D890%26doi%3D10.2337%2Fdiab.42.6.883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group">Osterop, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Medema, R. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bos, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">vd Zon, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ¼ller, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flier, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MÃ¶ller, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maassen, J. A.</span><span> </span><span class="NLM_article-title">Relation between the insulin receptor number in cells, autophosphorylation and insulin-stimulated Ras.GTP formation</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1992</span><span class="NLM_x">, </span> <span class="NLM_volume">267</span><span class="NLM_x"> (</span><span class="NLM_issue">21</span><span class="NLM_x">) </span> <span class="NLM_fpage">14647</span><span class="NLM_x">â</span> <span class="NLM_lpage">14653</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=1992&pages=14647-14653&issue=21&author=A.+P.+Osteropauthor=R.+H.+Medemaauthor=J.+L.+Bosauthor=G.+C.+vd+Zonauthor=D.+E.+M%C3%BCllerauthor=J.+S.+Flierauthor=W.+M%C3%B6llerauthor=J.+A.+Maassen&title=Relation+between+the+insulin+receptor+number+in+cells%2C+autophosphorylation+and+insulin-stimulated+Ras.GTP+formation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DOsterop%26aufirst%3DA.%2BP.%26aulast%3DMedema%26aufirst%3DR.%2BH.%26aulast%3DBos%26aufirst%3DJ.%2BL.%26aulast%3Dvd%2BZon%26aufirst%3DG.%2BC.%26aulast%3DM%25C3%25BCller%26aufirst%3DD.%2BE.%26aulast%3DFlier%26aufirst%3DJ.%2BS.%26aulast%3DM%25C3%25B6ller%26aufirst%3DW.%26aulast%3DMaassen%26aufirst%3DJ.%2BA.%26atitle%3DRelation%2520between%2520the%2520insulin%2520receptor%2520number%2520in%2520cells%252C%2520autophosphorylation%2520and%2520insulin-stimulated%2520Ras.GTP%2520formation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1992%26volume%3D267%26issue%3D21%26spage%3D14647%26epage%3D14653" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group">Thomas, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schlender, K. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Larner, J.</span><span> </span><span class="NLM_article-title">A Rapid filter paper assay for UDPglucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1968</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x"> (</span><span class="NLM_issue">1</span><span class="NLM_x">) </span> <span class="NLM_fpage">486</span><span class="NLM_x">â</span> <span class="NLM_lpage">499</span><span class="refDoi">Â DOI: 10.1016/0003-2697(68)90127-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1016%2F0003-2697%2868%2990127-9" title="">Crossref</a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1968&pages=486-499&issue=1&author=J.+A.+Thomasauthor=K.+K.+Schlenderauthor=J.+Larner&title=A+Rapid+filter+paper+assay+for+UDPglucose-glycogen+glucosyltransferase%2C+including+an+improved+biosynthesis+of+UDP-14C-glucose&doi=10.1016%2F0003-2697%2868%2990127-9"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2F0003-2697%2868%2990127-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0003-2697%252868%252990127-9%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DJ.%2BA.%26aulast%3DSchlender%26aufirst%3DK.%2BK.%26aulast%3DLarner%26aufirst%3DJ.%26atitle%3DA%2520Rapid%2520filter%2520paper%2520assay%2520for%2520UDPglucose-glycogen%2520glucosyltransferase%252C%2520including%2520an%2520improved%2520biosynthesis%2520of%2520UDP-14C-glucose%26jtitle%3DAnal.%2520Biochem.%26date%3D1968%26volume%3D25%26issue%3D1%26spage%3D486%26epage%3D499%26doi%3D10.1016%2F0003-2697%2868%2990127-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group">Henriksen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halseth, A. E.</span><span> </span><span class="NLM_article-title">Early alterations in soleus GLUT-4, glucose transport, and glycogen in voluntary running rats</span> <span class="citation_source-journal">J. Appl. Physiol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">76</span><span class="NLM_x"> (</span><span class="NLM_issue">5</span><span class="NLM_x">) </span> <span class="NLM_fpage">1862</span><span class="NLM_x">â</span> <span class="NLM_lpage">1867</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1994&pages=1862-1867&issue=5&author=E.+J.+Henriksenauthor=A.+E.+Halseth&title=Early+alterations+in+soleus+GLUT-4%2C+glucose+transport%2C+and+glycogen+in+voluntary+running+rats"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHenriksen%26aufirst%3DE.%2BJ.%26aulast%3DHalseth%26aufirst%3DA.%2BE.%26atitle%3DEarly%2520alterations%2520in%2520soleus%2520GLUT-4%252C%2520glucose%2520transport%252C%2520and%2520glycogen%2520in%2520voluntary%2520running%2520rats%26jtitle%3DJ.%2520Appl.%2520Physiol.%26date%3D1994%26volume%3D76%26issue%3D5%26spage%3D1862%26epage%3D1867" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group">Emsley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lohkamp, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cowtan, K.</span><span> </span><span class="NLM_article-title">Features and development of Coot</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">4</span><span class="NLM_x">) </span> <span class="NLM_fpage">486</span><span class="NLM_x">â</span> <span class="NLM_lpage">501</span><span class="refDoi">Â DOI: 10.1107/S0907444910007493</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1107%2FS0907444910007493" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=20383002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=486-501&issue=4&author=P.+Emsleyauthor=B.+Lohkampauthor=W.+G.+Scottauthor=K.+Cowtan&title=Features+and+development+of+Coot&doi=10.1107%2FS0907444910007493"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Features and development of Coot</span></div><div class="casAuthors">Emsley, P.; Lohkamp, B.; Scott, W. G.; Cowtan, K.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">486-501</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Coot is a mol.-graphics application for model building and validation of biol. macromols.  The program displays electron-d. maps and at. models and allows model manipulations such as idealization, real-space refinement, manual rotation/translation, rigid-body fitting, ligand search, solvation, mutations, rotamers and Ramachandran idealization.  Furthermore, tools are provided for model validation as well as interfaces to external programs for refinement, validation and graphics.  The software is designed to be easy to learn for novice users, which is achieved by ensuring that tools for common tasks are 'discoverable' through familiar user-interface elements (menus and toolbars) or by intuitive behavior (mouse controls).  Recent developments have focused on providing tools for expert users, with customisable key bindings, extensions and an extensive scripting interface.  The software is under rapid development, but has already achieved very widespread use within the crystallog. community.  The current state of the software is presented, with a description of the facilities available and of some of the underlying methods employed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqAKBKszbqb_7Vg90H21EOLACvtfcHk0lj2vI0fk-jHgg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXksFKisb8%253D&md5=67262cbfc60004de5ef962d5c043c910</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1107%2FS0907444910007493&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444910007493%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DLohkamp%26aufirst%3DB.%26aulast%3DScott%26aufirst%3DW.%2BG.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DFeatures%2520and%2520development%2520of%2520Coot%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D4%26spage%3D486%26epage%3D501%26doi%3D10.1107%2FS0907444910007493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group">Bricogne, G.; Blanc, E.; Brandl, M.; Flensburg, C.; Keller, P.; Paciorek, W.; Roversi, P.; Sharff, A.; Smart, O. S.; Vonrhein, C.; Womack, T. O.</span> <span class="citation_source-book">BUSTER</span>; <span class="NLM_publisher-name">Global Phasing Ltd</span>: <span class="NLM_publisher-loc">Cambridge, UK</span>,<span class="NLM_x"> </span><span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=G.+Bricogne&author=E.+Blanc&author=M.+Brandl&author=C.+Flensburg&author=P.+Keller&author=W.+Paciorek&author=P.+Roversi&author=A.+Sharff&author=O.+S.+Smart&author=C.+Vonrhein&author=T.+O.+Womack&title=BUSTER"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DBricogne%26aufirst%3DG.%26btitle%3DBUSTER%26pub%3DGlobal%2520Phasing%2520Ltd%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group">Adams, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Afonine, P. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">BunkÃ³czi, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, V. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, I. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Echols, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Headd, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hung, L.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kapral, G. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grosse-Kunstleve, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCoy, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriarty, N. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oeffner, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Terwilliger, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwart, P. H.</span><span> </span><span class="NLM_article-title">PHENIX: A comprehensive Python-based system for macromolecular structure solution</span> <span class="citation_source-journal">Acta Crystallogr., Sect. D: Biol. Crystallogr.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">66</span><span class="NLM_x"> (</span><span class="NLM_issue">2</span><span class="NLM_x">) </span> <span class="NLM_fpage">213</span><span class="NLM_x">â</span> <span class="NLM_lpage">221</span><span class="refDoi">Â DOI: 10.1107/S0907444909052925</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=10.1107%2FS0907444909052925" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=20124702" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D" title="">CAS</a></a>],Â <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=213-221&issue=2&author=P.+D.+Adamsauthor=P.+V.+Afonineauthor=G.+Bunk%C3%B3cziauthor=V.+B.+Chenauthor=I.+W.+Davisauthor=N.+Echolsauthor=J.+J.+Headdauthor=L.-W.+Hungauthor=G.+J.+Kapralauthor=R.+W.+Grosse-Kunstleveauthor=A.+J.+McCoyauthor=N.+W.+Moriartyauthor=R.+Oeffnerauthor=R.+J.+Readauthor=D.+C.+Richardsonauthor=J.+S.+Richardsonauthor=T.+C.+Terwilligerauthor=P.+H.+Zwart&title=PHENIX%3A+A+comprehensive+Python-based+system+for+macromolecular+structure+solution&doi=10.1107%2FS0907444909052925"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">PHENIX: a comprehensive Python-based system for macromolecular structure solution</span></div><div class="casAuthors">Adams, Paul D.; Afonine, Pavel V.; Bunkoczi, Gabor; Chen, Vincent B.; Davis, Ian W.; Echols, Nathaniel; Headd, Jeffrey J.; Hung, Li Wei; Kapral, Gary J.; Grosse-Kunstleve, Ralf W.; McCoy, Airlie J.; Moriarty, Nigel W.; Oeffner, Robert; Read, Randy J.; Richardson, David C.; Richardson, Jane S.; Terwilliger, Thomas C.; Zwart, Peter H.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">213-221</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">A review.  Macromol. X-ray crystallog. is routinely applied to understand biol. processes at a mol. level.  However, significant time and effort are still required to solve and complete many of these structures because of the need for manual interpretation of complex numerical data using many software packages and the repeated use of interactive three-dimensional graphics.  PHENIX has been developed to provide a comprehensive system for macromol. crystallog. structure soln. with an emphasis on the automation of all procedures.  This has relied on the development of algorithms that minimize or eliminate subjective input, the development of algorithms that automate procedures that are traditionally performed by hand and, finally, the development of a framework that allows a tight integration between the algorithms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm_HgKRpa-ObVg90H21EOLACvtfcHk0lj2vI0fk-jHgg"> >> More from SciFinder <sup>Â®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1Sisbc%253D&md5=67b439ff4bd61c659cae37ca4209b7bc</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1107%2FS0907444909052925&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909052925%26sid%3Dliteratum%253Aachs%26aulast%3DAdams%26aufirst%3DP.%2BD.%26aulast%3DAfonine%26aufirst%3DP.%2BV.%26aulast%3DBunk%25C3%25B3czi%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DV.%2BB.%26aulast%3DDavis%26aufirst%3DI.%2BW.%26aulast%3DEchols%26aufirst%3DN.%26aulast%3DHeadd%26aufirst%3DJ.%2BJ.%26aulast%3DHung%26aufirst%3DL.-W.%26aulast%3DKapral%26aufirst%3DG.%2BJ.%26aulast%3DGrosse-Kunstleve%26aufirst%3DR.%2BW.%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26aulast%3DMoriarty%26aufirst%3DN.%2BW.%26aulast%3DOeffner%26aufirst%3DR.%26aulast%3DRead%26aufirst%3DR.%2BJ.%26aulast%3DRichardson%26aufirst%3DD.%2BC.%26aulast%3DRichardson%26aufirst%3DJ.%2BS.%26aulast%3DTerwilliger%26aufirst%3DT.%2BC.%26aulast%3DZwart%26aufirst%3DP.%2BH.%26atitle%3DPHENIX%253A%2520A%2520comprehensive%2520Python-based%2520system%2520for%2520macromolecular%2520structure%2520solution%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26issue%3D2%26spage%3D213%26epage%3D221%26doi%3D10.1107%2FS0907444909052925" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1B" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1J1B','PDB','1J1B'); return false;">PDB: 1J1B</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B8J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B8J','PDB','6B8J'); return false;">PDB: 6B8J</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i119"><a href="/doi/suppl/10.1021/acs.jmedchem.7b00922">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_71818"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.7b00922">10.1021/acs.jmedchem.7b00922</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Copies of <sup>1</sup>H and <sup>13</sup>C NMR spectra, HPLC and LCMS traces of representative compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00922/suppl_file/jm7b00922_si_002.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.7b00922/suppl_file/jm7b00922_si_001.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00922/suppl_file/jm7b00922_si_001.csv">jm7b00922_si_001.csv (9.12 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.7b00922/suppl_file/jm7b00922_si_002.pdf">jm7b00922_si_002.pdf (2.52 MB)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Coordinates and structure factors for the GSK3:compound <b>1</b> costructure have been deposited in the Protein Data Bank (RCSB) under PDB accession code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6B8J">6B8J</a>. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.7b00922&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2017.60.issue-20%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.7b00922%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.7b00922" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright Â© 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">Youâve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993ab088f0d1d7","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
